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Bradykinin belongs to a group of peptides
which stimulate smooth muscle and have been
given the generic name of plasma kinin; this name
has been adopted by general consent of most
workers in the field (see Lewis, 1958). The formation
of bradykinin from ox-plasma proteins by the
action of trypsin or the venom of the snake,
Bothrops jararaca, was first observed by Rocha e
Silva, Beraldo & Rosenfeld (1949). Blood and
many other tissues are known to contain enzymes
which can be activated under certain conditions
and will then cause liberation of a plasma kinin
from the plasma proteins (Frey, Kraut & Werle,
1950). Bradykinin is pharmacologically indisting¬
uishable from other plasma kinins (Lewis, 1958;
Gaddum & Horton, 1959; Werle, 1953; Holdstock,
Mathias & Schachter, 1957; Mathias & Schachter,
1958; Hilton & Lewis, 1956).
The experiments described in this paper have
led to the isolation of bradykinin, which is the
first member of the plasma-kinin group to be
obtained in the pure state.
EXPERIMENTAL
Materials. (NH4)2S04 was a commercial grade. Am¬
monium acetate was A.R. grade. Ammonium acetate
buffer, pH 5, was prepared from stock solutions of 10 m-
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ammonium acetate and 10M-acetic acid. The solutions
were diluted to the required molarity and then the acetic
acid solution was added to the ammonium acetate solution
until pH 5 was reached (glass electrode). Approximately
160 ml. of acetic acid soln./oOO ml. of ammonium acetate
soln. was required.
Carboxymethyl(CM)-cellulose was prepared from Solka
Floe cellulose powder by a slight modification of the
method of Peterson & Sober (1956). Before its conversion
into the carboxymethyl derivative, fine particles were
removed from the cellulose by sedimentation. The cellulose
powder was stirred with about 6 vol. of water and the
mixture was allowed to settle for several hours. Particles
which had not settled by this time were rejected by de-
cantation. The process was repeated several times. The
sludge was filtered, washed with methanol and dried in air.
After the reaction of 60 g. of cellulose with chloroacetic
acid and addition of 500 ml. of 10 % acetic acid to the
reaction mixture, as described by Peterson & Sober (1956),
a further addition of acetic acid was made, with stirring,
f until a pH of 5-6 was obtained. Fine particles were re¬
moved by sedimentation as before. It was then transferred
f to a glass tube 7 cm. x 50 cm., fitted with a filtration plate
at the bottom and washed with 10% (v/v) acetic acid until
t the flame test in the eluate was negative. It was washed
with 2 1. of water, transferred to a filter funnel, washed with
» ethanol and dried in air. The yield was approx. 20 g.
Except in two-dimensional chromatography butan-l-ol
was redistilled.
Trichloroacetic acid was A.R. grade, redistilled at 65°/
15 mm. Hg.
Ether (d 0-720) was allowed to stand for several days over
NaOH flakes and redistilled.
Phenol-water for chromatography was prepared by
f adding 5 vol. of liquid phenol to 2 vol. of water and dis¬
solving in the mixture 0-0003% of ethylenediaminetetra-
acetic acid (EDTA).
Butanol-acetic acid for chromatography was prepared
by shaking together butan-l-ol, water and acetic acid
(63:27:10, by vol.) and keeping for several days before
using the upper layer.
Bradykinin at P 4 stage and subsequent stages was
handled in glassware which had been treated with a solu¬
tion of dimethyldichlorosilane in carbon tetrachloride and
washed with warm water.
Fractionation of ox blood. Fresh ox blood was collected
at the slaughterhouse and defibrinated immediately. The
red cells were separated by centrifuging in a De Laval
Industrial Separator, type 1229 G, at room temperature with
a gravity disk of 37 mm. internal diam. The rate of feed
was 90 l./hr. and the yield of serum was about 44 1. To this
amount of serum was added, with mechanical stirring,
22 1. of (NH4)2S04 soln. saturated at room temperature.
The ppt. was removed as completely as possible by centri¬
fuging once in a Sharpies no. 5 Centrifuge with a 5 mm.
diam. jet and the supernatant (60 1.) was treated with 13 1.
of saturated (NH4)2S04. Except that a 2 mm. diam. jet
was used, the ppt. was collected by centrifuging as before,
dissolved in 5 1. of water and dialysed in Visking dialysis
tubing against deionized tap water. The latter was pre-
i pared with the aid of a Permutit Portable Deminrolit
Plant MK4. Dialysis was continued until S042~ ion had
been removed. The final volume was 9 1.
Preparation of crude bradykinin. The substrate solution,
prepared as described above, was treated with 90 ml. of
10n-HC1 and then heated at 37° for 30 min. with gentle
stirring (cf. Gaddum & Horton, 1959). The pH of the solu¬
tion was adjusted to 7-5 with 4N-NaOH and incubated for
6 hr. at 37° with crystallized salt-free trypsin (Armour
Pharmaceutical Co. Ltd., Eastbourne). The trypsin was
added in portions of 75, 37-5 and 37-5 mg. respectively at
zero time, 2 hr. and 4 hr. from the commencement of the
incubation. The solution was then poured rapidly into 30 1.
of boiling ethanol and when the mixture had cooled it was
centrifuged and the ppt. was discarded. The supernatant
was evaporated under reduced pressure at a temperature
not exceeding 40° to a volume of approximately 300 ml.
Redistilled butanol was added in small portions to this
solution, with gentle shaking, until no more would dissolve.
Trichloroacetic acid solution (50%, w/v) was then added to
bring the concentration of trichloroacetic acid in the solu¬
tion to 0-3%. The resulting solution formed the first lower
phase of a countercurrent-distribution process carried out
in five bottles. The solvent system was prepared by equili¬
bration of equal volumes of butanol and aqueous 1 % (w/v)
trichloroacetic acid solution. The volumes of upper and
lower phases were equal to each other and to the volume of
the crude bradykinin soln. forming the lower layer in the
first bottle. Emulsions which formed were separated by
centrifuging. The process was continued until all bottles
were filled with both layers, the upper layer forming the
moving phase. The upper phase in the fifth bottle was
removed and equilibrations were continued, with addi¬
tion of a fresh upper phase to the first bottle, until all
bottles were again filled. The lower phases in the first two
bottles were rejected. The upper phase that had been
removed from the fifth bottle was mixed with twice its
volume of peroxide-free ether and equal volumes of water
and the mixture were equilibrated. The resulting upper
layer was rejected and the aqueous phase was combined
with the remaining upper and lower phases. The two-
phase mixture was evaporated under reduced pressure to a
volume of about 200 ml. at a temperature not exceeding
35°. The mixture was fed continuously into a cyclic
evaporator, it being so arranged that the upper (butanol)
layer formed the major portion of the liquid entering the
evaporator until it had all been removed. The aqueous
solution was treated with 3n-HC1 until pH 1 (glass
electrode) was reached and was then extracted nine times
with equal volumes of peroxide-free ether, and the ether
extracts were rejected. After the fifth extraction the pH
of the aqueous layer was readjusted to 1. The aqueous
solution was freed of ether by heating it for about 10 min.
under atmospheric pressure in a steam bath and then
heating it for a few minutes under reduced pressure at
about 35°. It was then freeze-dried, yielding a pale-yellow
powder. The amount obtained varied considerably, but on
average was about 5 g. It was stored in a vacuum desic¬
cator at —2° over NaOH pellets. The crude material (P2)
was stable for long periods under thtse conditions.
Biological assay of bradykinin. The biological activity of
samples was estimated by assay on the isolated guinea-pig
intestine against a standard sample of P 2 which had been
set aside at the beginning of this investigation. Results
were expressed in terms of the weight of P 2 to which the
test sample was equivalent in biological activity. The
terminal portion of the guinea-pig ileum was suspended
in 15 ml. of oxygenated Tyrode solution and maintained
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at 34°. Contractions of the tissue were recorded by
means of a frontal lever writing on a smoked drum of a
kymograph.
Chromatography of bradykinin on carboxymethylcellulose.
Columns were run at 20°; they were packed without
application of external pressure, but during equilibration
the head of liquid used generally caused further settlement.
Buffer solutions were saturated with toluene to inhibit
growth of micro-organisms. Chromatography of P2 was
carried out on 32 g. of CM-cellulose in a column of 3-2cm.
diam. through which 0-01 M-ammonium acetate had been
passed at approx. 50 ml./hr. until the pH values of the
influent and effluent fluids were identical. The pH of the
solution was not accurately controlled and varied with
different batches of the A.R.-grade ammonium acetate
used; it was generally pH 6-4-6-5. A portion (4 g.) of P2
was dissolved in 100 ml. of 0-01 M-ammonium acetate and
allowed to run into the column. The column was then
washed with 0-01 M-ammonium acetate soln. at the rate of
50 ml./hr. until the extinction of the effluent at 280 mp
was less than 0-02. Gradient elution was then commenced
with 0-2 M-ammonium acetate in the reservoir and with a
mixing vessel of 250 ml. capacity. In this and other
gradient experiments the mixing vessel had only two
outlets, one to the column and the other to the reservoir;
it had no outlet to the atmosphere. The upper reservoir
was open to the air. The effluent was collected in fractions
of 30 ml. Fractions containing biological activity were
combined, boiled for 2 min., cooled and evaporated to
dryness under reduced pressure at a temperature of
approx. 35°. The evaporation was completed in a rotary
evaporator and the syrupy residue heated at 50°/0-01 mm.
Hg until ammonium acetate had been removed. This
product was described as P4.
Chromatography of P4 was carried out on 2 g. of CM-
cellulose in a column of 9 mm. diam. which had been
equilibrated with 0-01 M-ammonium acetate buffer, pH 5,
in the manner already described. A portion (50 mg.) of P4
was dissolved in 0-1 ml. of 0-01 M-ammonium acetate buffer
and, after allowing liquid to drain from the top of the
column, the solution was added to the column and allowed
to soak in. Two successive portions of 0-1 ml. of the buffer
were then added in a similar way. The column was then
washed with 0-01 M-ammonium acetate buffer, pH 5,
which was also 1 ma with respect to EDTA. The hydro¬
static head was adjusted to give a flow rate of 5-6 ml./hr
and washing was continued until at least 80 ml. of effluent
had been collected. The washing fluid was then changed to
0-01 M-ammonium acetate, pH 5; 40 ml. of effluent was
collected. Gradient elution was then commenced with a
mixing vessel of 100 ml. capacity and 0-5M-ammonium
acetate in the reservoir. Under these conditions the
gradient was approximately linear. Tubes containing
biologically active material were placed in a vacuum
desiccator over NaOH and H2S04, until a solid residue
remained. They were then placed in a wide glass tube
closed at one end and open at the other and fitted with a
side arm near the open end. The position of the side arm
was above the open ends of the tubes containing the solid.
The tube was stoppered, evacuated to approx. 0-01 mm.
Hg and immersed as far as the side arm in a bath of water
at 50°. Heating under these conditions was continued for
1 hr. The combined solid was described as P5.
Chromatography of P 5 was carried out on 4 g. of CM-
cellulose in a column of 9 mm. diam. It was carried out
exactly as for P4 with a mixing vessel of identical
capacity.
Electrophoresis of P 5. This was carried out on Whatman
no. 1 filter paper which had been washed by descending
solvent flow with 2N-acetic acid for 3 days and then with
water for 1 day. P5 at a concentration of lOpg./pl. was
applied in the form of a band 2-3 mm. wide and 2 cm.
less in length than the total width of the paper. The
loading was generally about lOOpg./cm. of paper width;
occasionally double this amount was applied with success¬
ful results. The buffer used was 2x-acetic acid and the
voltage gradient was 25v/cm. Electrophoresis was con¬
tinued for 1 hr. in an apparatus similar to that of Durrum
(1950). At the conclusion of the experiment the strip was
dried in air at room temperature and a marker strip
0-3 cm. wide was cut lengthwise from the centre of the
paper. It was stained with ninhydrin and with Sakaguchi
reagent. The section of paper containing the bradykinin
was cut out and eluted with water by descending capillary
flow, water being allowed to drip from the bottom end of
the strip. Elution was generally continued for 16 hr. and the
eluate was evaporated to dryness in a vacuum desiccator.
The recovery of biological activity was about 70 % of that
applied to the paper.
Paper chromatography. Two-dimensional chromatograms
were carried out with butanol-acetic acid in the first
dimension and phenol-water-NH3 in the second dimension
on Whatman no. 1 paper. For one-dimensional chromato¬
graphy butanol-acetic acid or pyridine-water (80:20, v/v)
was used. Chromatograms were dried at 40°. Quanti¬
tative ammo acid analysis was carried out by the method of
Mandelstam & Rogers (1959), a slight modification being
made to permit estimation of proline. The chromatogram
was developed in butanol-acetic acid on Whatman no. 3
paper, and, after formation of the spots with ninhydrin, all
those except the yellow spot of proline were cut out. The
remainder of the sheet was moistened by steaming and
heated at 110° for 15 min. The yellow spots due to proline
became purple and were then cut out. Reproducible
results were obtained in the range 0-01-0-1 pM.
Chromatography of dinitrophenyl amino acids (DNP
amino acids) was carried out on Whatman no. 1 paper with
the fert.-pentanol (2-methylbutan-2-ol) system of Black¬
burn & Lowther (1951) and l-5M-phosphate buffer (Levy,
1954), used either singly or for two-dimensional chromato¬
grams. For quantitative work, sections of paper of known
area surrounding the spots were cut out, shredded and
allowed to stand with 4-5 ml. of 1 % NaHC03 soln. at room
temperature for 10 min. Extinction of the extract was
measured at 350 mp, except with DNP-proline, where
measurement was made at 370 mp. Blank estimations
were made on pieces of paper cut from the same sheet.
Use of fi.uoro-2-A-dinitrobenzene for end-group determina¬
tion and dinitrophenylation of amino acid mixtures. To the
peptide or mixture of amino acids (containing between 0-1
and 1 pequiv. of free amino groups), dissolved in a mixture
of 1 ml. of 2% (w/v) NaHC03 and 1 ml. of ethanol, was
added 5 pi. of fluoro-2:4-dinitrobenzene. The mixture was
shaken by hand for a few minutes, when a homogeneous
solution resulted; this was allowed to stand in the dark at
room temperature for 3 hr. The solution was then ex¬
tracted three times with an equal volume of ether. In the
determination of end groups the aqueous layer was made
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acid (pH 1), evaporated to dryness and hydrolysed with
6n-HC1 at 115° for 16 hr. DNP amino acids with the
exception of DNP-arginine were extracted from acid
solution (pH 1 or less) with ether. If much dinitrophenol
was present in the ether extract, this was removed by the
vacuum-sublimation technique of Mills (1952). DNP-







Pig. 1. Results of chromatography of 4 g. of P 2 on 32 g. of
CM-celluIose at pH 6-4. The fraction volume was 30 ml.
The gradient from 0-01 to 0-2n-ammonium acetate was
commenced at tube no. 100. Smooth-muscle-stimulating
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Fig. 2. Results of chromatography of 32 mg. of P4 on 2 g.
of CM-cellulose at pH 5. The fraction volume was 1-4 ml.
After washing with EDTA (see text) the gradient from
0-01 to 0-oM-ammonium acetate was commenced at tube
no. 1. Results are expressed in terms of the wt. of standard
P 2 to which the tube contents were equivalent in biological
activity.
RESULTS
Chromatography of bradykinin on
carboxymethylcellulose
Fig. 1 illustrates the results obtained on chro¬
matography of 4 g. of crude bradykinin (P 2) on
CM-cellulose. It will be seen that a large amount of
inactive peptide that absorbs light at 280 nay
emerges in the first 300 ml. of effluent. Further
washing with O-OlM-ammonium acetate decreased
the extinction of the effluent to about 0-02 at
280 nay and thereafter it remained almost con¬
stant. Tubes nos. 102-125 each contained smooth-
muscle-stimulating activity equivalent to more
than 5 mg. of P 2 and the contents of these were
combined. The yield of P4 obtained in this ex¬
periment and similar ones was 60-70 mg., which
was equivalent in biological activity to 2-4-2-8 g.
of P2. The recovery was therefore 60-70%.
Inferior results were obtained when chromato¬
graphy was carried out at 2°.
In Fig. 2 are shown the results of chromato¬
graphy of P4 on CM-cellulose. The contents of
tubes containing biological activity equivalent to
more than 10 mg. of P2 were combined. The yield
of P5 was 7-8 mg., which was equivalent in
biological activity to 925 mg. of P 2. An amount of
P4 equivalent to 1-4 g. of P2 was used in this
experiment and therefore the recovery was 66%.
The results shown in Fig. 3 were obtained on
chromatography of 15 mg. of P5 on CM-cellulose.
In this experiment there was false indication of
incipient separation into two peaks. The contents
of tubes nos. 105-110 had the properties of pure
bradykinin. The yield was 5-3 mg. It was con¬
cluded that the low yield of biological activity in
tube 108 was due to a defect in the experimental
procedure.
Electrophoresis and paper chromatography of P 5
When P5 was submitted to chromatography on
Whatman no. 1 paper with butanol-acetic acid as
solvent, separation of bradykinin from the in¬
active peptides was achieved after the chromato-
gram had been allowed to develop for several days.
These results were not sufficiently reproducible to
warrant their continued use. At times no senara-
tion was achieved and the bradykinin did not
leave the origin. It was considered possible that
this difficulty was due to contamination with
metal ions. Flame-spectrographic analysis (by
Johnson, Matthey and Co. Ltd., Wembley, Middx.)
revealed that P 5 contained 1 % by wt. of mag¬
nesium. A number of other metallic elements were
present, but these were in much smaller quantities
than magnesium.
In subsequent experiments paper electrophoresis
was used in preference to paper chromatography,
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as it was more easily applicable to preparative
work. In order to achieve the isolation of pure
bradykinin it was necessary to include in the
chromatography of P 5 a stage of washing with
EDTA. Plate 1 shows the results obtained on
electrophoresis of P5 prepared with and without
the aid of EDTA. It would clearly be impossible to
achieve the isolation of pure material from an
electrophoresis experiment such as that illustrated
in strip no. 1. Strips nos. 2 and 3 show that
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Fig. 3. Results of chromatography of 15 mg. of P5 on 4 g.
of CM-cellulose at pH 5. Conditions were identical with
those given in Fig. 2.
Fig. 4. Responses of the guinea-pig ileum suspended in
15 ml. of Tyrode solution to pure bradykinin (P6), 40ping,
and 50 pmg. at (b) and (d) respectively, and to P 2, 22-5 pg.
and 20 fig. at (a) and (c) respectively.
strongly with the Sakaguchi reagent. By the use
of the dipping technique of Jepson & Smith (1953)
it was possible to stain the same strip with both
ninhydrin and Sakaguchi reagents. The substances
stained strongly by ninhydrin on strips nos. 2 and 3
in Plate 1 were biologically inactive.
Properties of pure bradykinin
The substance prepared by electrophoresis of P 5
as shown in Plate 1 or by further CM-cellulose
chromatography of P5 as shown in Fig. 3 was
found to contain a single AT-terminal residue, that
of arginine. Hydrolysis followed by two-dimen¬
sional paper chromatography revealed the presence
of five amino acids, serine, glycine, proline, argi¬
nine and phenylalanine. The molar proportions of
each amino acid, found by quantitative paper
chromatography of the amino acids themselves or of
their DNP derivatives, were serine 1, glycine 1,
proline 2, arginine 2 and phenylalanine 2. [Degra-
dative work recently carried out by the authors
(Elliott, Lewis & Horton, 1960) has revealed that
the result obtained for proline is incorrect. The
molecule of bradykinin contains three residues of
proline.]
Bradykinin was found to possess very high bio¬
logical potency. For example, the threshold dose
for contraction of the isolated guinea-pig ileum
was approx. 1 pmg./ml. Fig. 4 shows the results
obtained when the biological activity of pure
bradykinin (P6) was compared with that of P2.
The slow contraction is a characteristic feature of
the response of guinea-pig ileum to bradykinin.
P 6 at a concentration of 3 pmg./ml. produced a
marked contraction of the tissue. From these
results it was concluded that P 6 was 444 times as
active as P 2. The biological activity of bradykinin
was destroyed by chymotrypsin, but not by
trypsin. Bradykinin resisted attack by OTn-HCI
at 100° for at least 1 hr. and by 0-1 x-XaOH at
room temperature for at least 2 hr.
DISCUSSION
The purification of bradykinin on columns of
IRC-50 resin was described by Andrade & Rocha e
Silva (1956). These authors used phosphate buffers
for elution and were unable to remove inorganic
ions from the eluates. In the present investigation
it was decided that if a volatile buffer could be used
this would be much more convenient than a non¬
volatile buffer. It was decided to explore the
potentialities of CM-cellulose in the chromato¬
graphy of bradykinin. In the course of another
investigation, one of us (E.W. H., unpublished
work) found that urinary kinin, a peptide closely
related to, if not identical with, bradykinin, was
irreversibly adsorbed on to IRC-50 in the presence
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Results of four separate electrophoresis experiments performed under identical conditions (see text).
(I) Electrophoresis of Po which had been prepared on a CM-cellulosc column without E.DTA treatment.
The strip was stained with ninhydrin. (2) The same technique applied to P5 from a CM-cellulose column with
EI )TA treatment. (3) Identical with 2, except that the strip was stained with Sakaguchi reagent after ninhydrin.
The spots marked by a (pencil) line were positive only to ninhydrin. (4) Electrophoresis of pure bradykinin.
The strip was stained with ninhydrin and Sakaguchi reagents.
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of ammonium acetate. Losses of activity occurred,
in all the CM-cellulose columns used and these
could have been due to irreversible adsorption.
It was surprising to find that bradykinin con¬
tained magnesium after passage twice through CM-
cellulose. Accurate data are not available for the
magnesium content of pure bradykinin obtained
from EDTA-treated columns, owing to the rela¬
tively large amount needed for flame-spectro-
graphic analysis. Qualitative results show that it
is still present in the purest material, although in
decreased amount compared with P 5 prepared
without the aid of EDTA.
Recent work has shown (Elliott, Horton &
Lewis, 1960) that bradykinin exerts all the actions
which have been attributed to one or another of
the plasma kinins (smooth-muscle stimulation,
vasodilatation, increased capillary permeability,
pain production), but the question whether or not
the plasma kinins constitute several biologically
active peptides or a single peptide (bradykinin)
must remain open until other plasma kinins have
been isolated and their structures determined.
SUMMARY
1. Bradykinin was formed by trypsin digestion
of the fraction of ox-serum proteins which pre¬
cipitated between 33 and 45 % of saturation with
ammonium sulphate.
2. Bradykinin was isolated in the pure state by
application of the techniques of countercurrent
distribution, chromatography on carboxymethyl-
cellulose and paper electrophoresis.
3. Bradykinin contained the five amino acids
glycine, serine, proline, phenylalanine and arginine
in the molar proportions 1:1:3:2:2 and one of the
arginine residues was N-terminal.
The authors are indebted to Mr A. W. Hemmings, who
devised techniques for the large-scale fractionation of
blood, and to Mr R. Blakemore, Miss M. Kinsella, Mr E.
Stevens and Mr I. Croker for valuable experimental
assistance.
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The Structure of Bradykinin. By D. F. Elliott, G. P. Lewis and E. W. Morton. (National
Institute for Medical Research, Mill Hill, London, N.W. 7)
Bradykinin, isolated from ox blood, was found to
have the amino acid composition Ser(l):Gly(l):Pro-
(2):Phe(2):Arg(2) and a single A?-terrninal residue of
arginine (Elliott, Lewis & Horton, 1960). The
structure has now been elucidated by chemical and
enzymic degradation. Chymotrypsin hydrolysed
two peptide bonds in the molecule, one bond being
more rapidly split than the other. The main hydro¬
lysis products were arginine and a heptapeptide;
the latter was shown to possess a C-terminal
phenylalanine residue by the use of carboxypep-
tidase. At a higher concentration of chymotrypsin,
appreciable hydrolysis of the second phenylalanyl
bond took place yielding, as one of the products, a
pentapeptide containing arginine, proline, glycine
and phenylalanine and as another a peptide
yielding serine and phenylalanine on hydrolysis.
Stepwise degradation of bradykinin by the Edman
method indicated the sequence Arg. Pro. Pro. Gly. -
Phe for the first five residues. Therefore the
structure of bradykinin is Arg. Pro. Pro. Gly. Phe. -
Ser. Phe. Arg.
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THE STRUCTURE OF BRADYKININ - A PLASMA KININ
FROM OX BLOOD
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Mill Hill, London, N.W. 7.
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In a previous communication it was stated that hradykinin
yielded on acid hydrolysis the amino acids serine, glycine,
proline, phenylalanine and arginine in the molar proportions
1:1:2:2:2 and contained a single N - terminal residue of
arginine (Elliott, Lewis and Horton, 1960a). In a later
communication the sequence Arg.Pro.Pro.Gly.Phe.Ser.Phe.Arg.
was proposed for hradykinin (Elliott, Lewis and Horton, 1960h).
In the light of synthetic work carried out by Dr. Boissonnas
and his collaborators (Boissonnas, Guttmann, Jaquenoud, Konzett
and Sturmer, 1960) and communicated to the authors before
publication, the above structure for bradykinin was clearly
incorrect. Discussions between Dr. Boissonnas and ourselves led
to the view that bradykinin contained three residues of proline
and that its structure was Arg.Pro.Pro.Gly.Phe.Ser.Pro.Phe.Arg.
Further degradative work has confirmed that this structure is
the correct one.
Edman degradation of bradykinin.
Bradykinin (0.5 mg.) was degraded by the Edman method using
the technique adopted for hypertensin (Elliott and Peart, 1957)
whereby the phenylthiohydantoins obtained at each stage were
converted into amino acids by reductive hydrolysis with
hydriodic acid. Under these conditions a synthetic sample of
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the PTH-derivative of serine was converted into alanine. The
amino acids were identified by paper chromatography in
pyridine:water (4:1). As expected, the first stage of the
degradation gave no amino acid because arginine gives a
PTH-derivative which cannot be extracted from aqueous solution.
The sequence of the next four amino acids was found to be
Pro.Pro.Gly.Phe., consequently the sequence of the first five
residues of bradykinin was Arg.Pro.Pro.Gly.Phe. It was decided
not to continue beyond this point owing to the accumulation of
artefacts which made chromatographic identification progress¬
ively more difficult.
Action of chymotrypsin on bradykinin.
Bradykinin (0.5 mg.) was dissolved in 2 ml. of 0.05M
ammonium bicarbonate:ammonium acetate buffer, pH 7.5, the
solution was mixed with 0.15 ml. of a solution of chymotrypsin
in the same buffer containing 2 mg. of the enzyme per ml. and
was incubated for 18 hr. at 37° After addition of 0.1 ml.
of glacial acetic acid the solution was evaporated to dryness
in a vacuum desiccator at room temperature. The residue had
no action upon isolated smooth muscle preparations. Electro¬
phoresis, on Whatman No. 1 paper, of a small portion of the
residue in 2M-acetic acid using a voltage gradient of 25V/cm.,
gave the results shown in Fig. 1. Bands 2, 3 and 4, could be
+ 5 cm. IO -
i i —i >.
12 3 4
Fig. 1. Electrophoresis of a chymotryptic digest of
bradykinin.
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revealed by the Sakaguchi reagent (Jepson and Smith, 1953),
or by ninhydrin, whereas band 1 was stained only by ninhydrin.
The enzyme:substrate molar ratio in this experiment was 1:40;
at a ratio of 1:100 bands 2 and 4 formed the main products and
bands 1 and 3 were scarcely visible. This showed that one
bond was hydrolysed more rapidly than the other by the enzyme.
The main bulk of the chymotryptic digest was then submitted
to electrophoresis as before and the products isolated by a
technique previously described (Elliott and Peart, 1957). It
was deduced that band 4 was arginine on the basis of the
chromatographic behaviour of the substance itself and of its
dinitrophenyl derivative; band 2 yielded on hydrolysis all
five amino acids present in bradykinin. These two substances
were clearly the products of fission of the first bond in
bradykinin by chymotrypsin. When band 2 was submitted to the
action of carboxypeptidase at 37° and pH 8 phenylalanine was
liberated, thus showing that the C - terminal sequence of
bradykinin was Phe.Arg. Hydrolysis of band 3 yielded arginine,
proline, glycine and phenylalanine which were estimated as
their dinitrophenyl derivatives by the method of Elliott,
Lewis and Horton (1960b) and found to be in the molar
proportions 1:2:1:1. Band 3 was evidently one of the products
of fission of the second bond in bradykinin by chymotrypsin
and its amino acid composition was consistent with the sequence
Arg.Pro.Pro.Gly.Phe. deduced from the results of the Edman
degradation on bradykinin. The N - terminal residue of band 1
was found to be serine by the fluorodinitrobenzene technique.
Hydrolysis of band 1 and chromatography of the hydrolysate in
butanol/acetic acid revealed the presence of serine,
phenylalanine and a smaller amount of proline, but in view of
the fact that two proline residues had already been placed it
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was assumed that the presence of proline was due to contamin¬
ation of band 1 hy self-digestion products of the enzyme.
Band 1 was therefore assigned the structure Ser.Phe. (Elliott,
Lewis and Horton, 1960b), but as a result of the information
given to us by Dr. Boissonnas it has now been examined more
closely. After separation from a chymotryptic digest of 0.5 mg.
of bradykinin by electrophoresis as already described, band 1
was further purified by chromatography on Whatman No. 1 filter
paper in n-butanol:acetic acid:water (63:27:10).
Two equal portions of the product were hydrolysed with
6N-HC1 for 16 hr. and 48 hr. respectively and the products
subjected to chromatography in butanol/acetic acid. The yields
of the amino acids in the hydrolysates were roughly estimated
by comparison of the size and intensity of the spots with
those of standard amounts of serine, proline and phenylalanine
on the same chromatogram. The yield of proline from-both the
16 hr. and the 48 hr. hydrolysates of band 1 was about 50% of
the theoretical amount. Evidently destruction of proline took
place at some stage before complete hydrolysis, but these
results leave no doubt that band 1 has the structure Ser.Pro.Phe
and not Ser.Phe as originally thought. The presence of proline
in this position is also consistent with the fact that
carboxypeptidase had no further action on the octapeptide
(band 2) or its dinitrophenyl derivative after it had liberated
phenylalanine. This was the case even at an enzyme:substrate
molar ratio of 1:10.
Conclusions
Bradykinin has the structure Arg.Pro.Pro.Gly.Phe.Ser.Pro.Phe.Arg
and not Arg.Pro.Pro.Gly.Phe.Ser.Phe.Arg as originally proposed
(Elliott, Lewis and Horton, 1960b). Destruction during acid
hydrolysis probably accounts for the incorrect result obtained
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for the proline content of bradykinin.
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ACTIONS OF PURE BRADYKININ
BY D. F. ELLIOTT, E. W. HORTON AND G. P. LEWIS
From the National Institute for Medical Research, Mill Hill, London, N. W. 7
(Received 9 May 1960)
Bradykinin, first described by Rocha e Silva, Beraldo & Rosenfeld (1949),
is one of a group of polypeptides called plasma kinins. Plasma kinins are
known to stimulate certain types of smooth muscle, to cause vasodilatation,
to increase capillary permeability and to produce pain when brought into
contact with pain fibres. It has not been clear hitherto whether brady¬
kinin is responsible for all these actions or whether several peptides are
involved, as in all experiments crude extracts have been employed.
However, recently bradykinin has been isolated (Elliott, Lewis & Horton,
1960a) and its structure determined (Elliott, Lewis & Horton, 19606,c).
It is therefore now possible to examine the actions of the pure peptide.
The present investigation was carried out to answer the question, does
the crude preparation of bradykinin contain one peptide having all the
actions reported for the crude mixture, or does it contain a group of related
peptides each of which is responsible for one or more of the biological
actions? The results show that pure bradykinin possesses all the actions
of the crude mixture, that is, smooth-muscle stimulation, vasodilatation,
increased capillary permeability and pain production.
METHODS
Where comparisons have been made on a molar basis the molecular weight of bradykinin
has been taken as 1131, which is the molecular weight of bradykinin dihydrochloride.
Actions on isolated smooth-muscle preparations
Guinea-pig ileum. A 3-4 cm segment of terminal ileum from animals weighing 250-400 g
was suspended in a 15 ml. bath containing oxygenated Tyrode solution at 34° C. Tests were
made every 4 min, and the contact time was 45 sec.
jRat uterus. Virgin rats weighing 120—200 g were injected subcutaneously with stilboestrol
(10/itg/100 g) 16-18 hr before use. A 2 cm segment of uterine horn was suspended in a
10 ml. bath containing de Jalon's uterus solution at 30° C. Tests were made every 4 min
and the time of contact was 45 sec.
Rat duodenum. The proximal 3 cm of duodenum from rats weighing 120-200 g was
suspended in a 10 ml. bath containing de Jalon's solution at 30° C. Tests were made every
3 min, and the contact time was 30 sec.
Rabbit duodenum. The proximal 4—5 cm of duodenum from rabbits was suspended in a
15 ml. bath containing Locke's solution at 37° C. Tests were made every 3 min, and the
contact time was 1 min.
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Blood pressure experiments
Cats were anaesthetized with pentobarbitone sodium 40 mg/kg. The trachea was cannulated
and blood pressure was recorded from the femoral artery. Intravenous injections were made
into a cannula tied into the femoral vein.
Rats (300-400 g) were anaesthetized with urethane 175 mg/100 g, and were prepared by
the method of Crawford & Outschoorn (1951). Blood pressure was recorded from the carotid
artery with a Condon capillary manometer.
Vasodilatation was examined in the skin of the hind limb supplied by the saphenous
artery. Cats were anaesthetized with chloralose 60 mg/kg. The preparation was the same as
that described previously (Lewis, 1958).
Capillary permeability was examined by the method of Miles & Miles (1952). Guinea-pigs
and rabbits were injected intravenously with Pontamine sky blue 60 mg/kg. A few minutes
after injection of the dye pure or crude bradykinin or histamine in 0-1 ml. saline was injected
intradermally into the abdominal skin. One hour later the area of blueing was measured.
Pain production was examined by the method of Armstrong, Dry, Keele & Markham
(1953). Blisters were raised on the flexor surface of the forearms of human subjects by the
application of cantharidin plasters, 2x2 cm. The plasters were applied in the evening before
the experiment and allowed to act for 6 hr. The area was covered with a sterile dressing and
a blister allowed to form during the night. The skin of the blister was cut away and the
blister base was washed with a warm Ringer's solution containing (g/1.) NaCl 9-2, KC1 0-4,
CaCl2 0-24 and NaHC03 0*15. Drugs to be tested were dissolved in physiological saline and
kept at 37° C during the experiment.
The test was carried out as follows. The solution to be tested was applied to the blister
area with a Pasteur pipette until the area was filled. Each dose was allowed to act until
the pain reached a plateau, or began to subside, up to a maximum of 2 min. The area was
then thoroughly washed with the Ringer's solution. Doses were given at intervals of
10 or 20 or 30 min or 1 hr, and before each application the area was washed periodically
with Ringer's solution. The subject was not told the nature of the applied solution; he assessed
the pain intensity of each solution subjectively, grading it from 0 to + + +.
Guinea-pig bronchoconstriction
The method described by Konzett & Rossler (1940) was used. Injections were made
intravenously through a cannula in the superior vena cava.
RESULTS
A comparison was made of the actions of pure bradykinin (P6) and of
the crude mixture (P2) produced at the first stage of purification in the
procedure of Elliott et al. (1960 a). It was found that the increase in activity
from P2 to P6 was of the same order when estimated on various isolated
smooth-muscle preparations as well as when estimated for broncho¬
constriction in guinea-pigs, for vasodilatation on the skin vessels of the '
cat hind limb, for depressor activity in cats and rats, for increase in capillary
permeability in guinea-pigs and rabbits and for pain production in man.
Table 1 shows the relative potencies P6:P2 on these biological prepara¬
tions. The variations shown in the Table are probably within experimental
variations of the tests and suggest that all the actions of crude mixture are
inherent properties of the pure peptide.
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Actions on smooth muscle
Several isolated smooth-muscle preparations respond to low concentra¬
tions of pure bradykinin. The guinea-pig ileum responds with a slow
contraction to bradykinin 1O-9 and the rat uterus to 10~10. It has been
shown previously that crude bradykinin has an inhibitory effect on certain
types of smooth muscle, particularly those showing rhythmical activity
and a high resting tone. The pure peptide also has this inhibitory action.
On the isolated rat duodenum bradykinin 8 x 10~9 caused only relaxa¬
tion (Fig. 1), whereas with the rabbit duodenum and the rat colon the
response was biphasic, an initial inhibitory action followed by a contraction.
Table 1. Ratios of the relative potency of pure (P6) and crude (P2) bradykinins
in different tests
Vasodilatation Cat skin 365
Depressor action Cat b.p. 480
Rat b.p. 265
Increased capillary permeability Guinea-pig skin 390
Rabbit skin 270
Smooth-muscle contraction Guinea-pig ileum 450
Rat uterus 405
Smooth-muscle relaxation Rat duodenum 225
Bronchoconstriction Guinea-pig 400
Pain production Human blister base 180
Collier, Holgate, Schachter & Shorley (1959) have shown that crude
kinins cause bronchoconstriction in anaesthetized guinea-pigs. In the
present experiments pure bradykinin 0-5 pg injected intravenously into
guinea-pigs caused a bronchoconstriction equal to that caused by the same
dose of histamine. On a molar basis, therefore, bradykinin is about 10 times
more active than histamine when tested in this way. When injections of
bradykinin were made at 5 or 10 min intervals the preparation quickly lost
its sensitivity to bradykinin. An interval of about 15-20 min between
injections of bradykinin was required in order to avoid loss of sensitivity
in this preparation.
Vasodilatation
The vasodilator action of crude plasma kinin has been studied in in¬
vestigations on skin (Lewis, 1958), skeletal muscle and salivary glands
(Hilton & Lewis, 1955). In the present experiments a dose as low as 100 ng
of pure bradykinin caused vasodilatation in the skin of the cat hind limb
compared with 10-20 ng acetylcholine. Figure 2 illustrates the vasodilata¬
tion produced by the pure peptide (P6) compared with that produced by
much larger doses of crude (P2) bradykinin. Therefore, when calculated on a
molar basis, bradykinin is approximately as active as acetylcholine on this
preparation. When compared with histamine on a molar basis bradykinin
is about 10 times more active as a vasodilator.
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Fig. 1. Isolated rat duodenum suspended in a 10 ml. bath containing oxygenated






P2 P6 P2 P6 P2
30 0-27 40 0-16 50
Fig. 2. Venous outflow from skin of hind limb (upper tracing) and arterial blood
pressure (lower tracing). Cat, 2-5 kg, sodium pentobarbitone anaesthesia (40 mg/
kg.). Intra-arterial injections of P2 and P6; doses in /xg. Time marker, 30 sec.
ACTIONS OF PURE BRADYKININ 477
Depressor action
Crude plasma kinin has been shown to lower the arterial blood pressure
on intravenous injection (Rocha e Silva et al. 1949). Pure bradykinin
injected intravenously into both anaesthetized cats and rats also caused
a fall of arterial blood pressure. The threshold dose in the cat was 400 ng/kg.
On a molar basis bradykinin was 10 times less active than acetylcholine
and as active as histamine. The threshold dose in the rat was 150 ng/g.
Increased capillary permeability
The action of increasing capillary permeability was demonstrated for
crude kinins by Holdstock, Mathias & Schachter (1957) and Herxheimer
& Schachter (1959). In the present experiments intradermal injection of
the pure peptide into guinea-pigs and rabbits, previously treated with
Pontamine sky blue, caused an intense local blueing, indicative of increased
capillary permeability (Fig. 3). In both species pure bradykinin increased
capillary permeability in concentrations of 10~9 to 10~8 and therefore on
a molar basis bradykinin was approximately 15 times more active in
increasing permeability than histamine. Accurate comparison was difficult
owing to a qualitative difference between the responses to bradykinin and
those to histamine. This difference was particularly pronounced in the
rabbit, where histamine produced a ring of blueing surrounding a central
area which had been only slightly blued. Bradykinin on the other hand
gave rise to an area of intense blueing. Furthermore, with higher concen¬
trations of histamine (10~4) the area of the response was much greater than
that produced by the highest concentrations (10—s) of bradykinin tested.
Stimulation of pain fibres
Armstrong, Jepson, Keele & Stewart (1957) showed that crude plasma
kinin caused pain when applied to the exposed base of a cantharidin
blister. In addition they claimed that large doses caused not only pain but
also itching, as well as a flare, and a wheal (Armstrong, Keele, Jepson &
Stewart, 1954). In the present experiments with pure bradykinin pain was
produced when concentrations of 10~7 to 10~° were applied to a blister
base, but there was no itching, no flare and no wheal. On a molar basis
pure bradykinin was somewhat less active than 5-hydroxytryptamine,
which was the most potent pain-producing substance in the experimer ts
of Armstrong et al. (1953; 1957). Histamine was usually active at a
concentration of 10 ~6 but the sensation produced by histamine was
different from that produced by bradykinin or 5-hydroxytryptamine.
Histamine caused itching or pricking, whereas bradykinin and 5-hydroxy¬
tryptamine caused a burning sensation. Even when histamine 10 4 was
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applied to the blister base no painful burning sensation resulted. With
concentrations of bradykinin 10~7 to 10~6 the pain was transient; it some¬
times disappeared in less than 1 min. With concentrations of 10~6 to 10~5
pain lasted for 2-3 min.
Repeated administration of bradykinin resulted in a gradual decrease
in the sensitivity of the preparation, as is shown by the following experi¬
ment. Two exposed blister bases in the same subject were each tested at
Fig. 3. Effect of intradermal injections of bradykinin on capillary permeability in
a guinea-pig injected intravenously with Pontamine sky blue (60 mg/kg). The
dark areas represent the areas of blueing 1 hr after the injections. Crude bradykinin
(P2) was injected in doses of (a) 1 mg. (b) 100 fig and (c) 10 fig. Pure bradykinin (P6)
was injected in concentrations of (o) 5 pg/ml., (6) 0-5 /xg/ml. and (c) 0-05 pg/ml.
20 min intervals, one with bradykinin 0*1, TO, TO, 1-0 and 10-0 pg/ml.
and the other with histamine 1-0 pg/ml. The application of bradykinin
0-1 jag/ml. produced a painful burning sensation but the effect of 10 times
this concentration 20 min later was no greater and no longer-lasting.
Subsequent applications of 1 pg, 1 pg and 10 pg/ml. produced no sensa¬
tions. On the other hand, the five histamine applications to the other
blister produced effects without any loss of sensitivity. After a further
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20 min the blister base treated with bradykinin failed to respond even to
500 pg/ml. bradykinin, whereas the blister base which had only received
histamine responded to 0-1 pg/ml. bradykinin with the usual burning
sensation. Finally, both blisters, the one sensitive and the other insensitive
to bradykinin, responded with a strong sensation of pain on application of
5-hydroxytryptamine creatinine sulphate 0-1 pg/ml.
DISCUSSION
All the pharmacological actions attributed to the crude plasma kinins
were found to be inherent properties of the pure peptide, bradykinin. As
a vasodilator substance bradykinin was found to be as active as acetyl¬
choline, the most potent naturally occurring vasodilator substance. In
increasing capillary permeability bradykinin was found to be more active
than the most active substance, histamine. In producing superficial pain
bradykinin was almost as active as 5-hydroxytryptamine.
Isolated smooth muscle preparations are the most sensitive tissues to
bradykinin and are therefore the most commonly used in its detection. The
rat uterus contracts in the presence of 0-1 ng/ml. of bradykinin, which is
therefore about as active as the polypeptide oxytocin on this preparation.
The rat duodenum is relaxed by bradykinin; the concentration necessary
is less than the concentration of adrenaline which is required to relax it.
The action of bradykinin on the blood vessels is to dilate them and to
increase their permeability—this is perhaps its most important action. This
pronounced vasodilator action is consistent with the view that bradykinin
plays an important role in functional vasodilatation (Hilton & Lewis, 1957).
The finding that bradykinin was less active than acetylcholine in lowering
the blood pressure, in spite of the fact that acetylcholine is destroyed in
the blood much more rapidly, suggests that it acts on a part of the vascular
tree different from that on which acetylcholine acts, and which is involved
mainly in local vascular effects.
The differences we observed between bradykiiiin and histamine in their
effects on capillary permeability were similar to those described by Menkin
(1936) between histamine and a mixture of peptides called 'leukotaxine',
and between histamine and crude plasma kinin described by Bhoola &
Schachter (1959).
Thus bradykinin in low concentration produces two of the essential
reactions of the inflammatory response—vasodilatation and increased
capillary permeability. In addition it produces the typical burning
sensation which is experienced in conditions of local tissue injury. Thus
bradykinin may play the role of chemical mediator of the inflammatory
response.
(
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SUMMARY
1. The properties ofpure bradykinin have been examined and compared
quantitatively with those of a crude preparation of bradykinin.
2. The pure peptide was found to have the following actions: vasodilata¬
tion in the skin of the cat's hind limb; depressor action in cats and rats;
increased capillary permeability in guinea-pigs and rabbits; contraction
of isolated guinea-pig ileum and rat uterus; relaxation of rat duodenum;
bronchoconstriction in guinea-pigs; and pain production when applied
to the exposed base of a cantharidin blister in man.
3. It therefore seems likely that all the actions so far attributed to
the crude plasma kinins can be accounted for by this single peptide,
bradykinin.
REFERENCES
Armstrong, D., Dry, R. M. L., Keele, C. A. & Markham, J. W. (1953). Observations on
chemical excitants of cutaneous pain in man. J. Physiol. 120, 326—351.
Armstrong, D., Keele, C. A., Jepson, J. B. & Stewart, J. W. (1954). Development of
pain-producing substance in human plasma. Nature, Lond., 174, 791-792.
Armstrong, D., Jepson, J. B., Keele, C. A. & Stewart, J. W. (1957). Pain-producing
substances in human inflammatory exudates and plasma. J. Physiol. 135, 350-370.
Bhoola, K. D. & Schachter, M. (1959). A comparison of serum kallikrein, bradykinin and
histamine on capillary permeability in the guinea-pig. J. Physiol. 149, 80P.
Collier, H. O. J., Holgate, J. A., Schachter, M. & Shorley, P. G. (1959). An apparent
bronchoconstrictor action of bradykinin and its suppression by some anti-inflammatory
agents. J. Physiol. 149, 54P.
Crawford, T. B. B. & Outschoorn, A. S. (1951). The quantitative separation of adrenaline
and noradrenaline in biological fluids and tissue extracts. Brit. J. Pharmacol. 6, 8-20.
Elliott, D. F., Lewis, G. P. & Horton, E. W. (1960a). The isolation of bradykinin:
A plasma kinin from ox blood. Biochem. J. 74, 15 P.
Elliott, D. F., Lewis, G. P. & Horton, E. W. (19606). The structure of bradykinin.
Biochem. J. (in the Press).
Elliott, D. F., Lewis, G. P. & Horton, E. W. (1960c). The structure of bradykinin:
a plasma kinin from ox blood. Biochemical and Biophysical Research Communications.
New York: Academic Press.
Herxheimer, A. & Schachter, M. (1959). Weal and flare in human skin produced by
histamine and other substances. J. Physiol. 145, 34P.
Hilton, S. M. & Lewis, G. P. (1955). The mechanism of the functional hyperaemia in the
submandibular salivary gland. J. Physiol. 129, 253-271.
Hilton, S. M. & Lewis, G. P. (1957). Functional vasodilatation in the submandibular
salivary gland. Brit. med. Bull. 13, 189-196.
Holdstock, D. J., Mathias, A. P. & Schachter, M. (1957). A comparative study of kinin,
kallidin and bradykinin. Brit. J. Pharmacol. 12, 149-158.
Konzett, H. & Rossler, R. (1940). Versuchsanordnung zu Untersuchungen an der
Bronchialmuskulatur. Arch. exp. Path. Pharmak. 195, 71-74.
Lewis, G. P. (1958). Formation of plasma kinins by plasmin. J. Physiol. 140, 285-300.
Menkin, V. (1936). Studies on inflammation. XII. Mechanism of increased capillary
permeability. A critique of the histamine hypothesis. J. exp. Med. 64, 485—502.
Miles, A. A. & Miles, E. M. (1952). Vascular reactions to histamine, histamine-liberator
and leukotaxine in the skin of guinea-pigs. J. Physiol. 118, 228-257.
Rocha e Silva, M., Beraldo, W. T. & Rosenfeld, G. (1949). Bradykinin, a Irypotensive
and smooth muscle stimulating factor released from plasma globulin by snake venoms
and by trypsin. Amer. J. Physiol. 156, 261-273.
>
[.From the Proceedings of the Physiological Society, 4-5 November i960.]
Journal of Physiology, 155, 13-14 P.
Visceral receptors, pain, bradykinin, and analgesic agents
By C. Braun, F. Guzman, E. W. Horton, R. K. S. Lim and G. D. Potter.
Medical Sciences Research Laboratory, Miles Laboratories, Inc., Elkhart,
Indiana, U.S.A.
Pericapillary non-myelinated fibres and branching varicose terminals
course alongside, but do not end upon, the capillary wall (methylene blue
and silver methods in rat and cat). These pericapillary terminals appear
similar to the free-branching 'pain' receptors in cutaneous epithelium
(Weddell & Pallie, 1954; Lim, 1960).
The perivascular network in larger vessels containing one or more layers
of muscle consists largely of non-myelinated sympathetic efferents, which
disappear after sympathectomy. The remaining fibres are derived from
myelinated axons and are sensory fibres arising from spinal ganglia. Some
of these terminate as pericapillary receptors of the vasa vasorum (and vasa
nervorum).
Intra-arterial injection of KC1 (0-5 ml., 18-75 mg), bradykinin* (0-5 ml.
= 1-2 pg pure bradykinin) or acetylcholine (0-5 ml., 0-5 mg) in the
chloralose dog (80 mg/kg i.v.) evokes a response consisting of vocaliza¬
tion, hyperpnoea and vasomotor change, which disappears on section
of the nerves to the organ or part supplied by the injected vessels.
On the other hand, intravenous and caval injections are without effect.
Intra-arterial injections into the leg after removal of the skin, or into the
splenic, gastric, intestinal or internal carotid arteries, or portal vein, all
give the response.
Excluding KC1 as a general depolarizing agent which may excite axons,
and assuming that the other agents excite receptors (Diamond, 1959),
it is evident that they are capable of exciting both the cutaneous and
the visceral (pericapillary) receptors, which evoke a common response.
In view of the fact that bradykinin is the most effective agent and
produces pain in man (Armstrong, Keele, Jepson & Stewart, 1954),
it may well be one of the agents responsible for the causation of visceral
pain under different conditions of inflammation or internal nociception.
Rocha e Silva & Antonio (1960) report that thermal injury to the rat's
paw liberates bradykinin into the warmed tissues. These observations
support the idea that bradykinin acts as a mediator of inflammatory
changes (Elliott, Horton & Lewis, 1960).
Preliminary tests have shown that the intravenous administration of
sodium acetylsalicylate (ASA) 25-50 mg/kg and A-acetyl-p-aminophenol
* Crude bradykinin used was from a sample kindly provided by Drs D. F. Elliott and
G. P. Lewis and from other batches prepared in this laboratory.
[p. T.o.
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(APAP) 10-20 mg/kg may block the response to bradykinin, etc.,
completely (ASA 4/11, APAP 2/8 dogs), or partially (ASA 5/11, APAP
1/8 dogs), and that morphine sulphate 1-0 mg/kg is the most powerful
blocking agent (6/7 dogs). At these dose levels, the response begins to
recover in 45-60 min.
These observations suggest that if the features of the response, particu¬
larly vocalization, are indicators of visceral pain, the latter may be pro¬
duced by the action of bradykinin on visceral (pericapillary) receptors and
reduced by the action of non-narcotic and narcotic analgesics.
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In 1957, Keele and his co-workers showed that both plasma and inflamma¬
tory exudates after contact with glass cause pain when applied to an exposed
blister base on the human forearm. They compared this "pain-producing
substance" with various pharmacological agents and concluded that it might
be identical with bradykinin but was certainly different from all other known
substances (Armstrong, Jepson, Keele and Stewart, 1957).
When bradykinin, prepared from ox plasma, was isolated (Elliott, Horton
and Lewis, 1960b), the pure peptide was shown to have potent pain-produc¬
ing activity, being active in a threshold concentration of 0.1 tig/vo.\ on the
blister base, the only known substance of greater activity on this preparation
being 5-hydroxytryptamine (Elliott, Horton and Lewis, 1960a). One striking
feature we noticed was the marked tachyphylaxis which developed to pure
bradykinin.
Intra-arterial Injections of Braydkinin
Additional evidence for the action of bradykinin on the peripheral nervous
system came from work on animals. Lim and his colleagues showed that
intra-arterial injection of 1 microgram of bradykinin into lightly anaesthet¬
ized dogs results in vocalization, increased respiration and a transient rise in
biood pressure (Braun, Guzman, Horton, Lim and Potter, 1961; Guzman,
Braun, Lim, Horton and Potter, 1961). These effects are reminiscent of the
pseudaffective response described by Woodworth and Sherrington in the
decerebrate preparation in response to what would in the intact animal have
been a painful stimulus (Woodworth and Sherrington, 1904). This similarity
of response was strongly suggestive that intra-arterial injections of brady¬
kinin were causing pain. Other known algesic agents such as potassium
chloride and acetylcholine also produced this response but were far less active
than bradykinin.
Section of the sensory nerve to the limb or organ under test or ipsilateral
dorsal root ganglionectomy abolished the response whereas sympathectomy
was without effect. The response has been obtained from injections into
the femoral, internal carotid, coronary, splenic and mesenteric arteries and
into the portal vein. Systemic intravenous injection failed to evoke the
response (Guzman, Braun and Lim, 1962).
Histologically, it has been shown that some capillaries in all areas investi¬
gated are accompanied by paravascular nerves which terminate in the
adjacent connective tissue and free branching unmyelinated receptors (Lim,
Liu, Guzman and Braun, 1962). It is postulated that algesic agents such as
bradykinin pass through the capillary wall or are formed in the interstitial
spaces where they act upon these receptors, afferent impulses passing via the
appropriate sensory nerve and dorsal roots.
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This pain-producing action of bradykinin is blocked by non-narcotic
analgesics such as sodium acetylsalicylate and N-acetyl-p-aminophenol when
injected intravenously in the equivalent of therapeutic dosage.
Guinea-pig Bronchoconstriction
Collier and his co-workers have shown that bradykinin-induced broncho¬
constriction in guinea-pigs is also antagonized by the same group of analgesics
(Collier, Holgate, Schachter and Shorley, 1960; Collier and Shorley, 1960).
Two significant features relate these experiments to work on sensory nerve
endings. On both the blister base in man and bronchoconstriction in the
guinea-pig, the response to bradykinin is markedly tachyphylactic. Sec¬
ondly, both bronchoconstriction in guinea-pigs and the pain response in dogs








Acetyl salicylate — + +
Denervation + +
Figure 1. Methods of reducing or abolishing bradykinin response on the human
blister base, the guinea-pig bronchioles and the dog visceral pain receptors.
+ = Effective method of reducing response
This raised the important question—is the guinea-pig bronchoconstriction
a reflex response to bradykinin acting upon afferent nerve endings, the path¬
way being tachyphylactic like the sensory receptors on the blister base and
blocked by aspirin like the vocalization in dogs? Collier has shown that
bradykinin also produces bronchoconstriction in the isolated lungs of the
guinea-pig and we have shown that the spinal, vagotomized guinea-pig also
responds to bradykinin by bronchoconstriction. Thus a pathway involving
the central nervous system seems to be ruled out; however, there is the
possibility that bronchoconstriction is mediated by the equivalent of an
axon reflex within the lungs. There is, however, no evidence for the exist¬
ence of such a pathway.
Intra-epidermal Injections in Man
Intra-epidermal injections of crude bradykinin in man produce pain and
a flare (Harpman and Allen, 1959). Both the flare and the pain were absent
when bradykinin was injected into an area of denervated skin, indicating
that the flare was the result of an axon reflex. The occurrence of a flare has
been confirmed using synthetic bradykinin. 5 micrograms produced a flare
about 5 cm. in diameter and lasting for 5 to 10 minutes.
252 Annals New York Academy of Sciences
Possible Role of Bradykinin
These experiments in man and animals provide clear evidence that brady¬
kinin is a potent algesic agent, but they do not tell us anything about the role
of bradykinin under physiological or pathological conditions. It has been
postulated that bradykinin might be a mediator of the inflammatory response,
accounting for the vasodilatation, increased capillary permeability and pain.
Although its algesic action is undoubted, the ability of bradykinin to account
for inflammatory pain, at least in man, is less certain. One finding which
raised doubts in my mind was the extremely marked tachyphylaxis which
Elliott, Lewis and I observed with pure ox bradykinin. I therefore decided
to re-investigate the actions of bradykinin on the human blister base.
Action of Bradykinin on the Blister Base
The marked tachyphylaxis with synthetic bradykinin was confirmed. The
threshold concentration was 0.1 Mg/ml and doses were applied at 20 minute
intervals (figure 2). It has been shown that increasing the dose interval to
60 minutes does not reduce the speed of onset of tachyphylaxis. Sometimes,
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Figure 2. Tachyphylaxis to bradykinin on the blister base. Ordinate: Intensity of
pain in arbitrary units. Abscissa: Concentration of bradykinin fiig/ml) applied at 20
minute intervals. Pain was assessed every 30 seconds during the period of bradykinin
application.
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applied repeatedly tachyphylaxis to bradykinin did not occur so readily,
but any dose which gave rise to severe pain was always followed by tachy¬
phylaxis. It would seem that doses which cause any appreciable pain are so
unphysiological that tachyphylaxis rapidly ensues. However, with the dilu¬
tions required to avoid tachyphylaxis the response to bradykinin is so feeble
that it is difficult to believe that it can exert a physiological role as an algesic
agent.
Could this tachyphylaxis be due to an accumulation of inactivated brady¬
kinin on the receptor sites? It seems likely as we have heard that bradykinin
is inactivated by a carboxypeptidase and this would result in the same octa-
peptide as brief incubation with chymotrypsin. Chymotrypsin attacks first
the Phe Arg linkage and less readily the Phe Ser linkage (figure 3) (Elliott,
Horton and Lewis, 1960b). Bradykinin solution (10 yug/ml) was incubated
with chymotrypsin (0.1 mg/ml) for 5 minutes and then the reaction was
stopped by boiling. Control samples without chymotrypsin and without
bradykinin were also incubated. The control containing bradykinin produced
intense pain and the usual rapid tachyphylaxis ensued. However the chymo-
tryptic digest had no action on the blister base, nor did it affect the develop¬
ment of tachyphylaxis (figure 4).




Figure 3. The sites of action of chymotrypsin on bradykinin. Primary site of action
indicated by solid arrow, secondary site of action by interrupted arrow.
Comparison of Synthetic Bradykinin and Pain-producing Substance
In contrast to our experience with pure bradykinin, Keele and his co-work¬
ers, in their paper on pain-producing substance made no mention of the
occurrence of tachyphylaxis. I therefore compared the action of glass-
activated human plasma with bradykinin on the blister base. The pain
producing substance was prepared as follows using siliconed glassware
throughout. The plasma was separated from fresh heparinized human blood
by centrifugation. It was acidified with Mo volumes of TV-hydrochloric
acid and incubated at 37° for 10 minutes then neutralized with TV-sodium
bicarbonate solution. This acid-treated plasma was divided into two equal
portions—one of which was shaken with unsiliconed glass beads—the other
was shaken without beads, at 37° C. The appearance of biological activity
was monitored by frequent testing of both samples on the isolated rat duode¬
num. Kinin formation in the tube containing the beads occurred after about
15 minutes at which time no kinin could be detected in the control tube.
Without the beads maximum kinin concentration was reached after about
2 hours. The glass-activated kinin solution was heated to 95° C. and was
used in the pain experiments. In the concentrations used, the initial applica¬
tion produced marked pain with both pain producing substance and brady-
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kinin. Tachyphylaxis developed rapidly with bradykinin but only slowly
with glass-activated kinin even though marked pain was felt during the first
three applications (figure 5). It was concluded that pain-producing sub¬
stance must differ in some way from bradykinin, although parallel assays
have previously revealed no difference between these substances (Gaddum
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Figure 4. Effect of chymotryptic digest of bradykinin on tachyphylaxis. Ordinate:
Intensity of pain in arbitrary units. Abscissa: Applications of bradykinin 10 Aig/ml (B)
and chymotryptic digest (CT + B). Interval between applications 15 minutes. Upper
and lower records represent experiments on two different blister bases. Pain was assessed
every 30 seconds during the period of application.
formation or due to the presence of interfering substances? A sample of
human bradykinin was prepared from human plasma by the same method as
that used to prepare glass-activated kinin but adding trypsin (1 mg/ml final
concentration) instead of glass beads. The trypsin was finally inactivated
by heating to 95° C. This human bradykinin showed the same marked
tachyphylaxis as synthetic bradykinin, indicating that the presence of the
constituents of plasma does not modify the rate of onset of tachyphylaxis.
The incidence of rapid tachyphylaxis appears to depend upon the mode of
kinin formation.
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Figure 5. Tachyphylaxis to pain producing substance and synthetic bradykinin on two
blister bases. Ordinate: Intensity of pain in arbitrary units. Abscissa: Applications of
(a) pain producing substance and (b) bradykinin at 15 minute intervals on two blister
bases. Pain was assessed every 30 seconds during the period of application.
Conclusion
If the nerve endings subserving pain in inflamed tissues behave like those
in the human blister base, release of bradykinin could not account for con¬
tinued pain since the concentration required to produce this would produce
tachyphylaxis. It is possible that the kinin mediator in human inflammation
may be a slightly different peptide from the synthetic nonapeptide—showing
less tachyphylaxis and thus allowing continued severe pain. However,
tachyphylaxis undoubtedly would tend to occur. It is possible that receptors
subserving pain in inflamed tissues differ from those subserving cutaneous
pain, the visceral receptors described by Lim and his colleagues probably
belong to this group. However an alternative explanation is that the
mediator of inflammation does not itself cause the pain but lowers the
threshold for firing of afferent impulses and so renders the area hyperalgesic
to otherwise subthreshold stimuli. It is this action of bradykinin which I
believe deserves further study.
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STUDIES OF THE INFLAMMATORY RESPONSE
OF CELLS AND TISSUES
Bradykinin and the Inflammatory
Response
E. W. HORTON, M. B., Ph.D.*
The purpose of this paper is to examine the evidence in support of the
working hypothesis that bradykinin is a mediator of the inflammatory
response, and to outline what further evidence is required.
Quantitative Aspects
If the changes of the inflammatory response are due to a chemical medi¬
ator produced as a direct consequence of the cell damage, then there should
be some quantitative relationship between the number of cells damaged,
the amount of mediator formed and the extent of the inflammatory changes.
The relationship may not be a simple one, but it must have a quantitative
element which can be measured.
According to the hypothesis under consideration the following sequence
will occur: cell damage; release or activation of plasma kinin forming en¬
zyme; kinin formation; inflammatory response. If the hypothesis is true,
it should be possible to relate the amount of plasma kinin forming enzyme
released to the amount of cell damage. The evidence so far available is not
quantitative enough. It has been shown that heating the skin to above
body temperature results in increased bradykinin in the interstitial fluid
(1, 2), but it would be more convincing if the amount of bradykinin re¬
leased were shown to be in direct proportion to the amount of tissue sub¬
jected to heat treatment. Lewis in describing his interesting experiments
on injury to the dog hind limb has said that the concentration of plasma
kinin forming activity is increased 2 to 8.3 times (3). At present these tech¬
niques are not sufficiently refined to enable us to obtain a quantitative
* Miles-Ames Research Laboratories, Stoke Court, Stoke Poges, Buckingham¬
shire, England.
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relationship between the amount of enzyme formed and the amount of cell
damage.
The second quantitative consideration concerns the ability of the pro¬
posed mediator to reproduce the signs of inflammation when injected or
infused. Elliott et al. (4) showed that pure bradykinin produces vasodila¬
tion, increased capillary permeability and pain and that it is one of the
most active substances known in these respects. These are the effects seen
in the inflammatory response. However, it is not certain that bradykinin
can reproduce the changes of the inflammatory response in the concentra¬
tions in which it occurs in the interstitial fluid during inflammation.
Stores of Mediator
There is no evidence that bradykinin itself is stored in the body. It is
formed from a protein, known as bradykininogen, present in the alpha-2
globulin fraction of blood and interstitial fluid. The evidence so far indi¬
cates that bradykininogen levels in the blood are maintained at a relatively
constant level. It is possible that, if the hypothesis under discussion is true,
a fall in bradykininogen level might be detectable during extensive and
prolonged inflammation unless this is accompanied by an increased syn¬
thesis of bradykininogen. Conversely if some means could be found to
deplete the body of bradykininogen, possibly by blocking its synthesis, it
might prove possible to prevent the inflammatory response to injury. Such
experiments could provide additional evidence in support of the hypothesis.
Inactivating Enzymes
Inflammation in response to local injury is normally localized to the
injured area and its immediate surroundings. Consequently if bradykinin
is a chemical mediator of this response, it is likely that its effects will be
localized by inactivation before it can reach the systemic circulation. We
know that such an enzyme is present in blood and interstitial fluid. Fur¬
thermore an inactivator of kallikrein, the plasma kinin forming enzyme,
has been found in lymph nodes (5). This is interesting in view of Lewis's
finding of increased plasma kinin forming activity in the lymph from in¬
jured areas. One might postulate that the kinins are inactivated by kininase
very soon after their formation, hence the failure to detect kinins in the
lymph as mentioned by Lewis, but that the enzyme; on the other hand, is
not inactivated until it reaches a lymph node. In both cases access of the
active substance to the general circulation would be prevented.
Antagonists
Certain anti-inflammatory agents, notably the salicylates and phenyl¬
butazone have been reported to antagonize some of the pharmacologic
INFLAMMATORY RESPONSE OF CELLS AND TISSUES
actions of bradykinin. The evidence that the bronchoconstrictor action
(6, 7) of bradykinin is blocked by these drugs is convincing, but it is diffi¬
cult to relate this antagonism to the anti-inflammatory actions of these
drugs. What is required is a drug which will block all the pharmacologic
actions of bradykinin specifically. This would be a useful research tool,
and a substance of potential therapeutic value, which could be used to test
the hypothesis that bradykinin is a mediator of the inflammatory response.
Support for the hypothesis would be obtained if the antagonist were equally
effective in blocking inflammatory responses and the actions of injected
bradykinin.
Release of Mediator
A means of inhibiting the plasma kinin forming enzyme, kallikrein, or
inhibiting its activation or release could provide further evidence for or
against the hypothesis. It has been reported that aspirin and phenylbuta¬
zone will antagonize the action of kallikrein both in vivo and in vitro (8).
These observations could not be confirmed by Lewis (9) or in our labora¬
tory. However, if drug inhibition of the enzyme does prove possible the
hypothesis would require that the inflammatory response should also be
inhibited by the drug in similar concentrations.
This summary of the evidence available and evidence required to sub¬
stantiate the claim that bradykinin is a mediator of the inflammatory
response clearly indicates that more experiments, particularly more quan¬
titative experiments, are needed before a verdict can be given.
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AN INCREASE IN BUTANOL-EXTRACTABLE 5-HYDROXY-
TRYPTAMINE IN VENOUS BLOOD DURING REACTIVE
HYPERAEMIA
BY E. W. HORTON*
From the National Institute for Medical Research, Mill Hill, London, N.W.I
(Received 7 June 1963)
Reactive hyperaemia which follows temporary occlusion of the vessel
supplying a tissue has been attributed to the accumulation of metabolic
products during the period of circulatory arrest (Lewis & Grant, 1926).
Either carbon dioxide, lactic acid or one of the adenosine compounds
could be the vasodilator substance concerned.
Frey, Kraut & Werle (1950) suggested that the slight drop in blood pH
which occurs during the period of occlusion might be sufficient to activate
the kallikrein system, and thus lead to the formation ofplasma kinins which
are potent vasodilators. The present investigation was undertaken to test
this hypothesis.
By means of a method of extraction designed to recover kinins quantita¬
tively from whole blood, and by assaying the extracts on the isolated rat
uterus, an attempt was made to estimate the kinin content of blood
collected before and immediately following vascular occlusion of dogs'
hind limbs. In none of the experiments could kinins be detected. On the
other hand, an apparent increase in 5-hydroxytryptamine (5-HT) was
invariably found in extracts of blood from hyperaemic limbs.
METHODS
Extraction of blood. Samples (usually 30 ml.) were collected from the femoral vein via
polythene tubing. The blood ran directly into an equal volume of 0*2 n-HCI saturated
with sodium chloride. The collecting vessel was placed on a two-pan balance and counter¬
poised with tares. Weights corresponding to the amount of blood to be collected were
added to the opposite pan. Blood was collected until the balance needle just reached the
zero mark. The volume was calculated by assuming a specific gravity of 1-060 (see below).
Sodium chloride (1 g/3 ml. blood) was added to ensure complete saturation. After the
addition of an equal volume of n-butanol the mixture was shaken gently by repeated inver¬
sion of the bottle. After centrifugation at 2500 rev/min (1000 g) for 20 min, the butanol
phase was separated by pipetting and stored overnight at —4° C. Little of the hydro¬
chloric acid or sodium chloride pass into the butanol phase. The butanol was extracted
with 0-2 vol. distilled water. The aqueous phase was separated and extracted with 5 vol.
* Present address: Department of Physiology, Medical College of St. Bartholomew's
Hospital, London, E.C.I.
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chloroform to remove traces of butanol. The final aqueous solution, which was approxi¬
mately pH 2, was heated on a boiling water-bath for 10 min to remove traces of chloroform.
It was then neutralized with sodium bicarbonate before testing biologically. Routinely,
the isolated rat uterus was used, but specificity of the method for kinins was from time to
time confirmed by parallel assay on the isolated rat duodenum which relaxes in the presence
of kinins (Horton, 1959).
Recovery experiments. In control experiments bradykinin was added to blood which was
immediately extracted by the method described above. Recoveries, as estimated on the
isolated rat uterus, varied between 83 and 97 % for bradykinin concentrations of 250 ng/ml.
and above. Within the range 10-125 ng/ml. recoveries were lower, varying between 17 and
43%. The minimum concentration of bradykinin which could be detected was 1 ng/ml.
whole blood. These recoveries were low. but as they were reproducible it was considered
justifiable to use this method in an attempt to detect an increase in kin in concentration in
blood.
Estimation of specific gravity of blood. In two experiments the specific gravity of the blood
samples was estimated at the time of collection, by the copper sulphate method (Phillips,
Van Slyke, Dole, Emerson, Hamilton & Archibald, 1945). The specific gravity was always
between 1-058 and 1 *062. The error in assuming a specific gravity of 1 *060 was less than
0-5%.
Preparation of the dog hind limb. Dogs of either sex weighing 11-27 kg were used. They
were anaesthetized with pentobarbitone sodium 45-75 mg/kg injected intravenously. The
trachea was cannulated. All the tissues of one hind limb, except the femoral artery and
femoral vein, were divided at the mid-thigh level, diathermy being used for the soft tissues.
All muscles were doubly ligated before section and the exposed ends of the femur were
filled with plasticine. The femoral vein was cannulated proximally and distally, the two
cannulae being connected by a glass T-piece. To produce reactive hyperaemia both the
femoral artery and femoral vein were occluded with bull-dog clamps. Carotid blood pressure
was recorded with a mercury manometer. The blood pressure tended to fall as the experi¬
ment proceeded because of the removal of the relatively large volume of blood as samples.
Experiments were discontinued if the mean pressure fell below 85 mm Hg.
Measurement of hind-limb blood flow. Blood flow was measured by timing the collection
of the samples with a stop clock.
Isolated rat uterus. Female rats weighing 120-200 g were injected with stilboestrol
(10 /xg/100 g) 18 hr before use. One uterine horn was suspended in a 5 ml. bath containing
de Jalon's solution at 30° C. Doses were added at intervals of 5 min and left in contact
with the tissue for 45-60 sec.
Chymotrypsin inactivation. Chymotrypsin (twice crystalline) was dissolved in de Jalon's
solution and then added to solutions of the extracts, previously adjusted to pH 7-5. The
final concentration of chymotrypsin was 100 /ng/ml. The mixture was incubated at 37° C
for 10 min and then placed in the boiling water-bath for 5 min.
RESULTS
Oxytocic activity of butanol extracts of whole blood following vascular
occlusion
Samples of femoral venous blood were collected before and immediately
after vascular occlusion of dogs' hind limbs. The period of occlusion
varied in different experiments from 5 to 45 min, but was usually 10 min.
Butanol extracts of all the blood samples contained a substance which
caused contraction of the isolated rat uterus. In sixteen samples collected
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immediately after vascular occlusion the concentration of this oxytocic
substance was on average 3-4 times greater than in the control samples.
An experiment in which this characteristic increase after vascular occlu¬
sion occurred is illustrated in Fig. 1. The results of all the experiments
are plotted in Fig. 2. Concentrations of oxytocic substance were expressed
in terms of 5-hydroxytryptamine. The mean value ( + s.e.) for samples
collected after vascular occlusion was 16-1 + 13-6 ng/ml., whereas for the
controls it was 4-7 + 2-5 ng/ml. This difference is statistically significant
(P<0-001).
The butanol extracts caused a contraction not only of the isolated rat
uterus but also of the isolated guinea-pig ileum and the isolated rat duo¬
denum. Unfortimately the sensitivity of these tissues was too low to
5 min 10 min
Fig. 1. Concentrations (ng/ml.) of butanol-extractable 5-HT in venous blood
collected from the isolated hind limb of a dog (No. 4) before and immediately
following vascular occlusion. C = control samples, O = samples collected after 5
and 10 min occlusion. There was a 10-min interval between collection of samples.
allow parallel assays to be carried out. The oxytocic action of the samples
was not affected by the presence of atropine sulphate (0-1 pg/ml.) or by
incubation with chymotrypsin (100 pg/ml.). On the other hand, their
activity like that of 5-hydroxytryptamine, was completely inhibited by
lysergic acid diethylamide (0-1 pg/ml.). These results strongly suggested
that the substance being estimated was 5-hydroxytryptamine, and con¬
sequently all estimates of oxytocic activity have been expressed as ng
5-hydroxytryptamine base/ml. whole blood. On all the tests applied the
active principle in the extracts prepared from control blood was qualita¬
tively identical with that in the extracts from blood collected after vascular
occlusion.
Recovery experiments. The butanol extraction procedure was developed
for the efficient recovery of kinins and was specifically designed to exclude
other naturally-occurring pharmacologically active substances such as
5-HT. It was, therefore, unlikely to be a good method for the estimation
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of 5-HT. This was confirmed experimentally. Recovery experiments in
which 5-HT was added to blood before butanol extraction and was
estimated after butanol extraction on the isolated rat uterus showed that
this method always extracted less than 1 % of the added 5-HT. In view
of this poor recovery and of the probability that the substance being
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Fig. 2. Scatter diagram of the thirty-eight estimates of butanol-extractable 5-HT
in ten dogs. A, #, ■ and ^ represent samples collected after 5, 10, 20 and 45
min vascular occlusion of the hind limb respectively. O indicates control s
collected under resting conditions.
Acetone extraction of whole blood or of plasma, to which 5-HT had been
added, gave variable results, but recoveries were always less than 10%.
A simpler method was tried. Blood samples were allowed to clot and
their 5-HT content was estimated on the isolated rat uterus by adding the
unextracted serum directly to the organ bath. With this method recoveries
of 70-80 % of added 5-HT were obtained. The estimated blood 5-HT
levels fell within the range 135-315 ng/ml. (after correction for 75%
recovery, 180-421 ng/ml., or 1-8-4-2 pg/109 platelets). Since these values
agreed with those found by other workers (Humphrey & Toh, 1954), the
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method was considered to be reliable for estimations of 5-HT. Antagonism
by lysergic acid diethylamide confirmed that more than 95 % of the
activity being estimated was in fact due to 5-HT.
Bloocl levels of 5-hydroxytryptamine following vascular occlusion
With this direct method of estimating 5-HT in serum, the apparent
increase in 5-HT content of blood following vascular occlusion was re¬
investigated. Blood samples collected before and immediately following
a period of vascular occlusion were allowed to clot. The oxytocic activity
of the serum was then estimated on the isolated rat uterus. The mean
activity expressed as 5-HT of eight samples collected after vascular occlu¬
sion was 177 (+ 70) ng/ml., whereas that of the twelve control samples
coco
Fig. 3. Concentrations (ng/ml.) of serum 5-HT (□, left-hand ordinate) and
butanol-extractable 5-HT (■, right-hand ordinate) in venous blood from the
isolated hind limb of dog No. 7 before (C) and immediately following (O) two
10-min periods of vascular occlusion.
was 179 ( + 80) ng/ml. Thus, when a method was used which recovers
most of the 5-HT from blood, no significant difference (P > 0-9) could be
found in its concentration following vascular occlusion. These results were
in marked contrast to those found when the butanol extraction procedure
was used. A direct comparison Avas therefore made.
Parallel estimations by the two methods on the same samples. In each of
these experiments two blood samples were collected, one before and one
immediately after vascular occlusion. Both samples were divided into two
portions, one portion being allowed to clot and the other being extracted
by the butanol procedure. The two sera and the two butanol extracts
were assayed on the isolated rat uterus. In this way parallel estimates by
the two methods were made on one and the same blood sample. Previous
results were confirmed. Estimated by adding crude serum to the organ
bath, the 5-HT content of blood from the occluded limb was no greater
than that of the control blood. On the other hand, the 5-HT content was,
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as usual, considerably greater in the butanol extract of blood from the
occluded limb (Fig. 3). These experiments confirm the conclusion that
only the extractable 5-HT and not the total blood 5-HT is increased in
reactive liyperaemia. On the average butanol-extractable 5-HT in blood
from a non-hyperaemic limb represented only 2-5 % of the total blood
5-HT (compare the two ordinate scales in Fig. 3).
Relation between 5-hydroxytryptamine and rate of hind-limb blood flow
In most experiments the hind-limb blood flow was measured during
collection of the samples, and Table 1 shows how the increase in flow rate
Table 1. Rates of hincl-limb blood flow and blood concentrations of butanol-extractable
5-hydroxytryptamine before and after vascular occlusion
Rate of blood flow Blood 5-HT level
(ml./min) (ng/ml.)
Duration , , , a >
of (a) (b) Increase (c) (d) Increase
Dog Weight occlusion Before After in flow Before After in 5-HT
no. (kg-) (min) occlusion occlusion (a)l(b) occlusion occlusion (c)l(d)
1 11 5 60 144 2-40 3-6 9-4 2-60
2(a) 18 5 38 52 1-37 6-3 12-2 1-93
(b) 10 24 67 2-79 8-1 24-9 2-94
3(a) 14 5 63 71 113 5-6 8-1 1-44
(6) 20 49 41 0-84 5-7 5-4 0-95
4(a) 20 5 71 120 1-69 4-0 15-8 3-98
(b) 10 45 123 2-73 41 28-8 6-96
5(a) 18 10 73 88 1-21 7-0 231 3-33
(b) 10 41 57 1-39 3-2 4-5 1-39
8 17 10 75 78 1-04 2-5 5-6 2-27
9 16 10 41 69 1-68 8-0 58-5 7-34
10 22 10 86 78 0-91 7-2 5-4 0-75
following vascular occlusion compared with the increase in butanol-
extractable 5-HT. In general an increase in flow was associated with a
proportionate increase in 5-HT (the coefficient of correlation, r, = +0-63).
In two experiments (dogs 3(5) and 10), where vascular occlusion was
followed not by reactive hyperaemia but by a slight diminution in blood
flow, the butanol-extractable 5-HT did not increase. These results in¬
dicate that the increase in butanol-extractable 5-HT is related to the
hyperaemia and not merely to the vascular occlusion.
On the other hand, there appeared to be no correlation between absolute
blood-flow rates and amounts of butanol-extractable 5-HT. For example,
the resting blood-flow rates in dog 2(6) and 10 were 24 and 86 ml./min.
whereas the butanol-extractable 5-HT concentrations were 8-1 and 7-2
5-HT AND REACTIVE HYPERAEMIA 107
ng/ml. respectively. Thus a 3-1- times difference in blood flow was associ¬
ated with little difference in 5-HT concentration.
Since there appeared to he an association between 5-HT and reactive
hyperaemia, the effect of 5-HT on blood flow was investigated. Retro¬
grade injections were made via a cannula in the saphenous artery of a hind
limb prepared in the usual way. In doses up to 225 pg (base), injected at
different rates in different experiments, 5-HT had no effect on the rate
of venous outflow from the dog's hind limb. These large doses would
certainly have doubled the 5-HT concentration of the blood. The absence
of any vascular effect is consistent with the finding that reactive hyper¬
aemia is associated, not with changes in total 5-HT concentration, but
with changes in a particular fraction which can be extracted with butanol.
DISCUSSION
Plasma kinins and reactive hyperaemia
Kinins are formed very readily when blood comes into contact with a
foreign surface, particularly glass (Armstrong, Jepson, Keele & Stewart,
1957). Furthermore, kinins, whether they are formed endogenously in the
blood or they are added to it, are rapidly inactivated by a peptidase
(Erdos, Renfrew, Sloane & Wohler, 1963). In order to obtain an estimate
of the kinin content of blood in vivo at a given instant, it is clearly essential
that all enzyme reactions should be stopped at the moment of collecting
the blood sample. Not only must the enzyme reactions be stopped, which
might be achieved by rapid cooling, but they must also be prevented from
recurring during the interval before the biological assay. This can most
conveniently be achieved by enzymic denaturation. In the present in¬
vestigation this was achieved by precipitation with hydrochloric acid.
It is known that when urine is acidified and saturated with sodium
chloride, the kinins can be extracted with butanol (Gomes, 1955; Gaddum
& Horton, 1959). The method has now proved successful with blood.
Recovering by this method averaged 25 % when concentrations of brady-
kinin as low as 10 ng/ml. were estimated in control experiments. Since the
presence of kinins was not detected in samples from hyperaemic limbs, it
may be concluded that concentrations of these substances in dogs' blood
during reactive hyperaemia are certainly less than 10 ng/ml. and probably
less than 1 ng/ml. The failure to demonstrate their presence does not
exclude the possibility that kinins are involved in reactive hyperaemia.
Kinins are potent vasodilator substances and concentrations of less than
1 ng/ml. may be sufficient to produce the increases in blood flow observed
after vascular occlusion. It is possible, therefore, that an increase does
occur but that the method used was not sufficiently sensitive to detect it.
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5-Hydroxytryptamine and, reactive hyperaemia
The identification of the oxytocic substance in the butanol extracts as
5-HT was based upon its biological activity and the effect of specific
antagonists. Although such evidence is not conclusive, all other known
pharmacologically active substances of natural occurrence have been
excluded, with the exception of tryptamine, which is far less active
biologically (Gaddum, 1953).
It is apparent from the results of this investigation that only a small
fraction (about 2-5 %) of total 5-HT can be extracted from whole blood
with butanol, and that it is this fraction, and not the total 5-HT which
is increased in reactive hyperaemia. Humphrey & Toh (1954), after taking
precautions to avoid platelet damage, found the 5-HT concentration of
fresh dog plasma to lie between 2 and 6 ng/ml. In the present investigation
a very similar range (2-5 and 8-1 ng/ml.) has been found for the butanol-
extractable 5-HT concentration of whole blood.
The positive correlation observed between increase in blood flow and
increase in butanol-extractable 5-HT is suggestive that the two changes
are not independent, though the relation does not necessarily imply cause
and effect. Since intra-arterial injections of large doses of 5-HT did not
affect hind-limb blood flow, it seems improbable that 5-HT is the mediator
of the vascular changes observed in reactive hyperaemia.
An alternative role is suggested by the experiments of Kwaan &
McFadzean (1956). They observed that following arterial occlusion in
man the fibrinolytic activity of blood in the occluded limb is increased.
Moreover, they showed that intravenous or paravenous injection of 5-HT
also increases the fibrinolytic activity (Kwaan, Lo & McFadzean, 1957).
This suggests the possibility that vascular occlusion results in the release
of (butanol-extractable) 5-HT from the platelets, and that this 5-HT
activates the fibrinolytic system and so counteracts any tendency of the
blood in the occluded vessels to clot.
SUMMARY
1. Blood collected from dogs' hind limbs during reactive hyperaemia
contained no detectable plasma kinins.
2. An oxytocic substance, closely resembling 5-hydroxytryptamine,
was found in butanol extracts of whole blood. The concentration of this
substance was found to have increased up to seven-fold during reactive
hyperaemia.
3. There was no increase in the total blood 5-hydroxytryptamine of
which the butanol-extractable 5-hydroxytryptamine represents about
2-5%.
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4. There was a positive correlation between increase in butanol-
extractable 5-hydroxytryptamine and increase in blood flow following
vascular occlusion. Intra-arterial injection of up to 225 pg 5-hydroxy¬
tryptamine (base), however, did not affect hind-limb blood flow.
5. It is postulated as a tentative working hypothesis that 5-hydroxy¬
tryptamine is released from platelets during vascular occlusion and that
this may lead to increased fibrinolytic activity of the blood, thus counter¬
acting the tendency for coagulation to occur in the occluded vessel.
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IN URINE; KALLIKREIN AND UROKINASE
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The experiments of the present paper show that urine contains two
enzymes capable of forming plasma kinin; one of these enzymes acts
quickly and is probably identical with kallikrein, the other acts more
slowly and is probably identical with urokinase.
Kallikrein is the name given by Frey & Kraut (1928) to a non-dialysable
depressor substance obtained from urine. This was later shown to be an
enzyme capable of acting on plasma proteins to form a vasodilator and
smooth-muscle-stimulating polypeptide; this plasma kinin was originally
called substance DK (Werle, 1937) and later kallidin (Werle & Berek, 1950).
Urokinase is the name given by Sobel, Mohler, Jones, Dowdy & Guest
(1952) to an activator of plasminogen, the precursor of the proteolytic
enzyme plasmin (Astrup & SterndorfF, 1952). Subsequent work by Lewis &
Work (1957) and Lewis (1958, 1959) has shown that plasmin and its
activators form a plasma kinin when incubated with the pseudoglobulin
fraction of plasma. Urokinase should therefore form plasma kinin by first
activating plasminogen. The question thus arose whether urinary kalli¬
krein and urokinase were identical, both forming kinins by first activating
plasminogen. The results show first a distinct difference in the rate of
plasma kinin formation with the two enzymes. Secondly, the urokinase
was weight-for-weight 300 times more potent in activating plasminogen,
whereas the kallikrein was 40-50 times more potent in producing vaso¬
dilatation and about seven times more potent in contracting the dog's
ileum.
METHODS
Preparation of kallikrein. Pooled male human urine was added to 4 vol. acetone at 4° C.
The precipitate was collected by filtration, dissolved in a small volume of water and dialysed
against running tap water for 48 hr. The dialysed solution was then freeze-dried and stored
at 4° C.
Urokinase was kindly supplied by Dr J. Ploug, of Leo Pharmaceuticals, Copenhagen, and
was prepared by the method of Ploug & Kjeldgaard (1957). The essential steps of this
procedure are adsorption on silica gel, precipitation at pH 1-5, dialysis, and chromato¬
graphy on IRC-50.
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The kallikrein and urokinase extracts were compared in the following tests:
Plasma kinin formation. The enzymes were incubated with a pseudoglobulin solution at
34° C, and samples from the incubated mixture were tested at intervals on the isolated
guinea-pig's ileum suspended in 15 ml. of Mg-free Tyrode solution at 34° C. The pseudo-
globulin was prepared from dog plasma by (NH4)2S04 fractionation: the fraction which
precipitated between 33 and 46 % saturation was dissolved in water, dialysed for 48 hr
against running tap water and freeze-dried. For use the powder was dissolved in 0*9 % NaCl
solution in a volume equal to the original volume of plasma.
Perfusion of dog's skin. Dogs were anaesthetized with pentobarbitone sodium 40 mg/kg.
The two enzyme preparations were injected via the saphenous artery into a patch of skin
prepared as has already been described for cats (Lewis, 1958). The outflow from the saphenous
vein was recorded with a Gaddum drop recorder.
Isolated dog's ileum. The smooth-muscle-stimulating activity of each enzyme preparation
was tested on a 4 cm segment of terminal ileum suspended in a 25 ml. bath of Tyrode
solution at 34° C, containing atropine 10~6.
Activation of plasminogen. When plasminogen is activated plasmin is formed, which is
able to digest casein with the production of free tyrosine, giving rise to absorption in u.-v.
ight at 275 mp. The rate of plasminogen activation can therefore be estimated by mea¬
suring the increase in optical density at 275 m/x.
Plasminogen was prepared from citrated human plasma by the method of Kline (1953);
and goat casein by the method of Mullertz (1955). The incubation mixture contained:
casein (3%, w/v), 3*5 ml., 0*1m phosphate buffer, 3-5 ml.; plasminogen 14 mg, and varying
amounts of either kallikrein or urokinase. The mixture was incubated at 34° C, and 2 ml.
samples were transferred at 0, 10 and 20 min to tubes containing 3 ml. of 1*7 m perchloric
acid. The precipitated proteins were separated by centrifugation and the increase in optical
density of the supernatant at 275 m/x was measured in a Hilger Uvispek absorption
spectrophotometer.
Antiplasmin (antifibrinolysin, 6 u./mg) was a gift from Dr E. C. Loomis of Parke, Davis
and Company.
RESULTS
Rate of formation of plasma kinin. When the two purified enzyme pre¬
parations were incubated with pseudoglobulin it was found that urokinase
was a slow-acting enzyme and that kallikrein was a quick-acting enzyme.
Thus, in the experiment of Fig. 1, on incubation of the kallikrein prepa¬
ration with pseudoglobulin maximum formation of plasma kinin occurred
after 1-5 min (Fig. Id), but when the urokinase was incubated with
pseudoglobulin, maximum formation occurred after 10 min, as is shown in
Fig. 1B.
To distinguish two enzymes by their rate of action is open to the
criticism that the difference is due only to their concentrations. This
criticism does not apply to these results, as is shown by the following
experiment. Various concentrations of the kallikrein (25, 50, 100 and
200 /xg/ml.) and of the urokinase preparation (250, 500 and 1000 /xg/ml.)
were incubated with a standard concentration of pseudoglobulin and the
mixture was tested at various intervals of time. Although the time of
maximum plasma kinin formation occurred later as the concentration of
the kallikrein decreased, the maximum formation took not more than
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10 min (Fig. 2). With the lowest concentration of kallikrein (Fig. 2 D) there
was little or no plasma kinin formation. On the other hand, when urokinase
was similarly incubated with pseudoglobulin in various concentrations,
increasing the urokinase concentration occasionally decreased the time
of maximal formation, although this did not occur before 30 min (Fig. 3).
1 2 3 4 5 6 7 8 9
A
B
I I till I I t
P Ps 1-5 5 10 20 40 £ P
^ Incubation time (min) ^
Fig. 1. Guinea-pig ileum preparation suspended in 15 ml. of Tyrode solution. At P
response to 20 fig of standard plasma kinin, at Ps 0-1 ml. pseudoglobulin solution.
Contractions 3-7 produced by successive 0-1 ml. samples taken from an incubated
mixture of 2 ml. pseudoglobulin solution with 2 mg kallikrein (A), and of 2 ml. of
pseudoglobulin solution with 1 mg of urokinase (B). At E, kallikrein 200 fig (A)
and urokinase 100 fig (B).
It is not possible to make an accurate comparison of the potencies of
urokinase and the urinary kallikrein in forming plasma kinins because
of the differences in the time of formation. But weight-for-weight the
kallikrein preparation was usually more active than the urokinase
preparation.
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The plasma kinin forming activity of human urine can be readily
explained in terms of these two plasma kinin forming enzymes. When
freshly collected human urine (dialysed against running tap water for
4-8 hr) was incubated with pseudoglobulin solution, the mixture developed
smooth-muscle-stimulating activity within 1-5 min, reaching a maximum
/ /
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Fig. 2. Contractions of the isolated guinea-pig ileum produced by successive
samples containing pseudoglobulin solution 0-1 ml. and kallikrein A 200 /rg,
B 100 fig, C 50 fig and D 25 fig, incubated for times shown.
at 5 min. The amount of kinin in the incubation mixture was undi¬
minished after 30 min, despite the presence in pseudoglobulin of an
enzyme which is known to inactivate the kinin (Fig. 4-A). However, when
the experiment was repeated in the presence of the plasmin inhibitor anti-
plasmin (3 mg/ml.), the maximum activity was reached in 5 min, but
subsequently the amount ofkinin decreased and after incubation for 30 min
had fallen considerably (Fig. 4B). These results can be explained by the
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presence in dialysed urine of two enzymes: one a slow-acting plasma kinin
forming enzyme (urokinase) which was inhibited by antiplasmin, and the
other a quick-acting enzyme (kallikrein) which was resistant to antiplasmin.
Perfusion of the dog's skin. Arterial injection of both the kallikrein and
the urokinase preparations caused vasodilatation in the dog's skin. In the
experiment illustrated in Fig. 5, dilatation of about the same order was
obtained with 5 mg of the urokinase preparation and with 125 fj.g of the
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Fig. 3. Contractions of the isolated guinea-pig ileum to a mixture of pseudo-
globulin solution 0*1 ml. and urokinase, A 250 fig, B 500 fig, and C 1000 fig; incu¬
bated for times shown. The mixtures in A and B were not tested at 70 min and
90 min, and the mixture in C was not tested at 30 min.
Isolated dog's intestine. Both the kallikrein and the urokinase prepa¬
ration produced contractions of the isolated dog's ileum. When the two
preparations were compared the kallikrein was not fifty, but only seven,
times as active as the urokinase preparation. There was, in addition, a
qualitative difference in that the contraction due to urokinase was some¬
times steeper than that caused by the kallikrein (Fig. 6). It was observed
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Fig. 4. Contractions of the isolated guinea-pig ileum produced by successive
samples of 0-4 ml. taken from a mixture of dialysed human urine 3 ml. and pseudo-
globulin solution 1 ml. (A ) and from the same mixture with antiplasmin 3 mg/ml.








Fig. 5. Venous outflow from skin of hind limb (upper tracing) and arterial blood
pressure (lower tracing). Dog, 14 kg, sodium pentobarbitone anaesthesia
(40 mg/kg). At (o) 5 mg urokinase and at (6) 125 jig kallikrein injected arterially.
Time, 30 sec.
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that this tissue responded slowly even to very large doses of kallikrein
(5-10 mg).
Plasminogen activation. The results shown in Fig. 7 confirm the fact that
urokinase is a potent activator of plasminogen; on the other hand, kalli¬
krein was about 300 times less active in this respect. The low activity was
not due to the presence in the kallikrein extract of an inhibitory substance,
since it did not inhibit the action of small doses of the urokinase preparation
when mixed with it. In the absence of plasminogen neither the urokinase
preparation nor the kallikrein caused hydrolysis of casein, as measured by
the optical density at 275 mp.
T t f
A B C
Fig. 6. Isolated dog's ileum suspended in 25 ml. of atropinized (10-6) Tyrode
solution. At (A) kallikrein 250 jug and at C 500 jig; at B urokinase 5 mg. The drugs
were in contact with the tissue for 2 min and injections were repeated at 16 min
Fig. 7. Spectrophotometric measurements of the activation of plasminogen to
plasmin by urokinase, Q—Q> in concentrations shown; and by kallikrein,
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DISCUSSION
The present experiments show that human urine contains two enzymes
which form plasma kinins on incubation with pseudoglobulin. They differ
in their rate of kinin formation. One is a relatively quick-acting, the other
a relatively slow-acting enzyme. In the kallikrein preparation from urine
the main activity is due to the quick-acting enzyme, whereas the action of
the urokinase preparation is due to the action of the slow-acting enzyme. (
In these experiments only partially purified urinary extracts have been
used, and the presence of a small amount of the slow-acting enzyme in the
kallikrein, and vice versa, is not excluded.
It is clear from the assays of the two principles on various preparations
that their effects cannot be due to the same active substance. As a vaso¬
dilator kallikrein was 45 times more active than urokinase, but for plasma
kinin formation the activity ratio of kallikrein to urokinase was less than
7. As an activator of plasminogen kallikrein had only l/300th of the
activity of urokinase, but in stimulating the dog's isolated intestine kalli-
krein was about seven times more active.
Since the procedure for extracting kallikrein from urine did not include
any step designed to inactivate the urokinase, it was possible that the
plasminogen-activating action of the kallikrein extract is due to the
presence in it of traces of urokinase. On the other hand, the preparation
of the urokinase involved precipitation at low pH, which would inactivate
most if not all the kallikrein (Frey, Kraut & Werle, 1950).
If small amounts of kallikrein did escape destruction they might be
sufficient to account for the vasodilator action of the urokinase extract.
The finding that the latency and time course of the vasodilatation produced
by the two extracts do not differ might be regarded as evidence in support
of this. Urokinase has a slower action than kallikrein in forming kinins
in vitro\ if it is assumed that the vasodilatation following injections of
these substances is due to the production of kinins in vivo, then urokinase
would be expected to have a slower vasodilator action.
Plasmin, or plasminogen with an activator, will form plasma kinins when
incubated with pseudoglobulin. The formation proceeds slowly and can be
inhibited by antiplasmin (Lewis, 1958). Since urokinase also forms kinins
slowly and since it is a potent activator of plasminogen, it seems likely that
it forms kinins by first activating plasminogen to plasmin. In contrast,
kallikrein forms kinins more quickly and since it has been shown to have
negligible, if any, plasminogen-activating action and is not antagonized by
antiplasmin, it probably acts independently of the plasminogen system. It is
concluded that the two urinary fractions, urokinase and kallikrein, are not
identical but are capable of forming plasma kinins by different mechanisms.
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SUMMARY
1. Partially purified extracts of urokinase and kallikrein have been
compared by parallel assays. Urokinase was 300 times more potent as a
plasminogen activator, whereas kallikrein was 40-50 times more potent as
a vasodilator and 7 times more potent as a smooth-muscle stimulator. It
is concluded that the two active principles are different.
2. Urokinase forms a plasma kinin when incubated with pseudoglobulin.
This reaction proceeds slowly, is inhibited by antiplasmin, and is probably
due to the activation of plasminogen to plasmin.
3. Kallikrein forms plasma kinins more quickly and is thought to act
independently of the plasminogen system.
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Action of Prostaglandin E| on Tissues which
respond to Bradykinin
Prostaglandin E, (9-keto, 11a, 15, dihydroxy-prost-
13-enoic acid, PGEJ was the first of several prostaglandins
to bo isolated by Bergstrom et al.1*2. It is a member of a
chemically now group of vasodilator substances. -Other
naturally occurring vasodilators such as bradykinin, acetyl¬
choline and histamine have effects on several types of
tissue in addition to smooth muscle. For example,
bradykinin increases capillary permeability, produces pain
on application to a blister base and releases adrenaline
from the adrenal medulla3-4. The actions of PGE, on
these and other biological preparations have been investi¬
gated using bradykinin as a standard for comparison. The
results are summarized in Table 1.
The vasodilator activity of PGE, was confirmed on the
flow of blood in the hind-limb of a cat. Like bradykinin,
it increased capillary permeability as shown by intra¬
dermal injection into guinea pigs pre-treatod with Pont-
amine sky blue. A dose of 1 fig (in 0-1 ml.) produced a
maximal effect. The intensity of bluing with PGEt was
loss for a given area of lesion than with bradykinin and
the very intense bluing produced by bradykinin was never
observed with PGEt. Estimates of relative activity were
therefore difficult to make but PGE t was at least 10-100
times less active than bradykinin.
PGEl; unlike bradykinin (0-1 fig/ml.), did not cause
pain on application to human blister bases in concentra¬
tions from 0-1 to 100 fig/ml. Retrograde injections of
bradykinin (2 fig) into the coeliac artery of the 'Nembutal'
anaesthetized cat released the equivalent of 1 gg of adren¬
aline from the adrenal medulla as detected by the dener-
vated nictitating membrane. PGEi did not cause any
detectable adrenaline release (<0-2 fig) in doses up to
20 fig.
Table 1. Threshold Doses or Concentrations of Prostaglandin e,
and Bradykinin required to produce Effects on the Biological
Preparations used in this Investigation
Response Preparation PGEi Bradykinin
Vasodilatation Cat hind limb 200 ng 20-100 ng
Increased capillary
permeability Guinea pig skin 100 ng 1-10 ng
Pain production Human blister base No effect
0-1 jug/ml.(> 100 //g/ml.)
Adrenaline release Cat adrenal medulla No effect
(> 7-5 wg/kg) 0-15 A/g/kg
Reduced air entry Guinea pig lungs No effect
4-10 A<g/kg(> 50 ,ug/kg)
Contraction of Rat uterus 60 ng/ml. 0-5 ncr/ml.
isolated smooth Guinea pig ileum 8 ng/ml. 10 ng/ml.
muscle Rat duodenum (Contraction) (Relaxation)
250 ng/ml. 5 ng/ml.
PGEj also differed from bradykinin in that it did not
reduce air entry into the lungs of the guinea pig as
measured by the Konzett and Rossler method. Like
bradykinin, however, it caused contraction of the isolated
rat uterus and the isolated guinoa pig i leum; it further
contracted the isolated rat duodenum, which is relaxed by
bradykinin.
I thank Prof. S. Bergstrom of the Ivarolinska Institute,
Stockholm, for the prostaglandin Elf and Dr. E. D.
Nicolaidos, of Parke, Davis and Co., Ann Arbor, for
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• The biological activities of prostaglandins El E2, E3 and Fla have been compared.
Prostaglandins E1; E2 and E3 were qualitatively similar; Ex and E2 were about equiactive,
but E3 was less active on all preparations. Prostaglandin Fla was a less potent vasodilator
than Ex on the cat gastrocnemius muscle blood flow and skin blood flow and a less potent
depressor drug on rabbit blood pressure. On the rabbit isolated jejunum Fia was twice
as active as Ei but on the guinea-pig isolated ileum Ex was about forty times more active
than Fia. One qualitative difference between these prostaglandins was observed; on the
rabbit fallopian tube in vivo prostaglandins of the E series decreased both the tone and the
peristalsis of the tube whereas prostaglandin Fia increased tubal tone.
Goldblatt (1'933, 1935) and Euler (1934, 1935a) independently described the
presence of a substance which contracted smooth muscle and lowered blood pressure
and occurred in semen and extracts of prostate glands. The active principle was
given the name " prostaglandin " (Euler, 1935b).
More recently Bergstiom and his colleagues have isolated several different prosta¬
glandins from sheep prostate gland (Bergstrom & Sjovall, 1960a, b; Bergstrom,
Dressier, Ryhage, Samuelsson & Sjovall, 1962), sheep semen (Bergstrom, Krabisch
& Sjovall, 1960), sheep and pig lung (Bergstrom, Dressier, Krabisch, Ryhage &
Sjovall, 1962) and human semen (Bergstrom & Samuelsson, 1962).
Six naturally-occurring prostaglandins have been described. Their structures
have been elucidated by Bergstrom and his co-workers (Bergstrom & Samuelsson,
1962; Bergstrom et al., 1962a, b). The three prostaglandin E's differ only in the
number of double bonds. Reduction of the keto-group in a prostaglandin E can
give two isomeric alcohols (Bergstrom et al., 1962b), those from prostaglandin Ex,
for example, being referred to as F10 and FJ(S (Bergstrom, Ryhage, Samuelsson &
Sjovall, 1963).
In the present investigation the actions of four prostaglandins (Ex, E2, E3 andFla)
(Fig. 1) have been compared on various biological preparations. Some of these
comparisons have been made previously (Bergstrom, Eliasson, Euler & Sjovall,
1959; Euler & Bergstrom, unpublished).
METHODS
Isolated smooth muscle preparations. Segments of various organs were suspended in a 4 ml.
organ-bath. Longitudinal contractions were recorded isotonically with a frontal-writing lever on
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Prostaglandin Et. 11a,15-dihydroxy-9-keto-prost-13-enoic acid
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Prostaglandin E2. lla,15-dihydroxy-9-keto-prost-5,13-dienoic acid
9H H CH2CH:CHCH2CH2 CH2CO2H
CH3CH2CH:CHCH2C CH:CHH fH
Prostaglandin Es. 1 la,15-dihydroxy-9-keto-prost-5,13,17-trienoic acid
OH H CH2 CH2 CH2 CH2 CH2 CH2 C02H
CHj CH2CH2CH2CH2C CH:CHh fH
H
HO "OH
Prostaglandin Fla. 9a,lla,15-trihydroxy-prost-13-enoic acid
Fig. 1. Formulae of the four naturally-occurring prostaglandins studied in this investigation.
a smoked drum, or isometrically with a force-displacement transducer (Grass FT.03) and an ink-
writing polygraph. A dose-cycle of 4 to 6 min was used with 45 to 90 sec contact time.
Guinea-pig ileum. Terminal ileum, from guinea-pigs weighing 200 to 400 g, was suspended in
Tyrode solution at 37° C, gassed with air.
Rabbit jejunum. Proximal jejunum, from rabbits weighing 1.5 to 2.5 kg, was suspended in Tyrode
solution at 35 to 36° C, gassed with air.
Hamster colon. The ascending colon, from hamsters weighing 100 to 200 g, was suspended in
de Jalon solution at 35 to 36° C, gassed with air.
Rat uterus. A segment of uterine horn, from rats weighing 150 to 250 g which had been injected
subcutaneously, 18 hr previously, with stilboestrol (100 pg), was suspended in de Jalon solution
at 32° C, gassed with air.
Pithed rat blood pressure. Rats, weighing 200 to 350 g, were anaesthetized with ether and pithed
by passing a strong wire through the orbit and down the cerebrospinal axis. Artificial ventilation
was maintained by a Palmer small-animal respiration pump. Blood pressure was recorded from
a carotid artery via a cannula connected to a Statham P23A transducer. Injections were made
into a jugular or femoral vein.
Cat gastrocnemius muscle bloodflow. Cats, weighing 2.5 to 5 kg, were anaesthetized with sodium
pentobarbitone (40 mg/kg) injected intraperitoneally. The trachea, a carotid artery and a jugular
vein were cannulated. Blood pressure was recorded by a mercury manometer. The femoral
vessels were ligated beyond the branches to the gastrocnemius muscle. All other branches and
tributaries proximal to this level were ligated, and the artery supplying the gracilis muscle was
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cannulated with fine polyethylene tubing connected to a three-way tap for retrograde intra-arterial
injections. Blood flow was maintained by stimulation of the sciatic nerve (3 to 4 V, 0.2 msec
duration, 6 shocks/min). Heparin (1,000 U/kg) was injected intravenously and further doses of
500 U/kg were given every 2 hr. Venous outflow was recorded by passing blood from the femoral
vein through a Palmer drop-chamber connected to a Gaddum drop-recorder or Thorp impulse-
counter, or through a Grass drop-chamber connected to a Grass polygraph, the blood being
returned into the jugular vein.
Cat hind-limb skin blood flow. The preparation was identical to that used for recording gastro¬
cnemius muscle blood flow, except that the femoral artery and vein were ligated immediately distal
to the saphenous vessels, which were left intact.
Fallopian tubal tone and peristalsis. Rabbits, weighing 1.5 to 3 kg, were anaesthetized with
intraperitoneal urethane (175 mg/kg). The trachea was cannulated. A jugular vein was cannulated
for intravenous injections. Blood pressure was recorded from a carotid artery with a Statham
transducer. The abdomen was opened with a mid-line incision, the alimentary viscera were
displaced to one side and a fallopian tube was identified. A polyethylene cannula was inserted
into the uterine end of the tube through an incision in the uterine horn and tied in position, taking
care not to occlude tubal blood supply. The cannula was attached to a Statham transducer P23AC,
the side-limb of which was connected via polyethylene tubing to a 20 ml. syringe placed in a Palmer
slow-injection apparatus.
The perfusion system from syringe to cannula contained Tyrode solution. An inflow rate of
27 /xl./min was usually adequate to stimulate peristalsis, which was recorded with a suitable pen-
writer.
Prostaglandins E2, E3 and Fla were assayed by bracketing against prostaglandin
Ei on eight different biological preparations. The activities expressed relative to
prostaglandin Ex (=1) are shown in Table 1. The threshold doses of prostaglandin
Ej are shown in Table 2.
Isolated smooth muscle preparations. Each of the four prostaglandins contracted
smooth muscle. In general, prostaglandin E2 was slightly more active, and prosta¬
glandin E3 rather less active, than Ei. Prostaglandin Fia was twice as active as Ex
on the rabbit jejunum (Fig. 2) but about forty times less active on the guinea-pig
ileum (Fig. 3). The guinea-pig ileum, rabbit jejunum and hamster colon were
Table 1
BIOLOGICAL ACTIVITY OF PROSTAGLANDINS E2, E3 AND F1Q RELATIVE TO
PROSTAGLANDIN Ex
Figures represent mean activity (±standard errors) relative to prostaglandin Ex (=1). Numbers
of assays are shown in parentheses. * In four of five preparations prostaglandin F,a increased
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Table 2
THRESHOLD DOSES OF PROSTAGLANDIN E,






Cat gastrocnemius muscle blood flow



















Fig. 2. Contractions of rabbit isolated jejunum, suspended in a 4 ml. organ-bath containing Tyrode
solution. Contractions were recorded isometrically with a Grass force-displacement transducer







Fig. 3. Contractions of guinea-pig isolated ileum. Records as for Fig. 2.
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about equally sensitive to prostaglandin Ei, responding to a concentration of 8 to
12 ng/ml.
Blood pressure and blood flow measurements. Prostaglandins Ei and E2 were
equiactive in lowering the rabbit blood pressure, and produced a threshold effect in
concentrations of 600 ng/kg, but prostaglandin E3 was less active. Prostaglandin
F,« was fifteen to twenty times less potent than E, on the blood pressure. Similarly,
on the cat gastrocnemius muscle blood flow and the cat skin blood flow prostaglandins
Ei and E2 were equiactive, but E3 and Fm were less active (Fig. 4).
(min)















Fig. 4. Cat 3.7 kg, anaesthetized with sodium pentobarbitone (40 mg/kg). Uppermost trace,
venous outflow from gastrocnemius muscle recorded with a Thorp impulse counter; middle
trace, arterial blood pressure; lowest trace, event marker. Ei, E2 and E3=prostaglandins Et,
E2 and E3 respectively.
Fallopian tubal tone andperistalsis. Prostaglandin Ei, in doses as low as 800 ng/kg.
reduced the tone of the rabbit fallopian tube in vivo and diminished its peristalsis
(Horton, Main & Thompson, 1963). Similar effects were seen with prostaglandins
E2 and E3, E2 being equiactive with Ei and E3 being about half as active. In contrast,
prostaglandin Fia in doses of 5/ug/kg increased the tone of the fallopian tubes in
four of the five rabbits tested (Fig. 5). In the remaining animal 5 pg/kg of Fia
caused a transient reduction in tone and in peristalsis.
DISCUSSION
Prostaglandins Ex, E2 and E3 differ chemically only in their degree of unsaturation,
having one, two and three double bonds respectively (Fig. 1). Biologically, they were
qualitatively similar and the ratios of activity were very similar on different prepara¬
tions. In general prostaglandin E2 was either equiactive to or slightly more active
than Ej, whereas prostaglandin E3, which has a double bond in the terminal pentyl
group (Bergstrom et al., 1962b), was less active than Ei and E2 on all preparations,
On the rabbit jejunum and guinea-pig ileum the ratios are in fairly good agreement












(20 iig) (4 /ig)
5. Records of rabbit blood pressure (upper traces) and intraluminal pressure in a fallopian
tube (lower traces), (a), (b) and (c) represent three different experiments. E1; E2, E3 and Fia=
prostaglandins Ei, E2, E3 and F,a respectively.
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with those of Euler & Bergstrom (unpublished), but on the rabbit blood pressure
Euler & Bergstrom reported that E2 was definitely less active than Ei, whereas in our
experiments there was no difference.
Prostaglandin Fia has a hydroxyl substituent in the cyclopentane ring instead of
the keto-group of prostaglandin Ei. This structural difference has a more profound
effect on biological activity than the degree of unsaturation. The ratio of activity
of Fto Ei varied greatly from one preparation to another. For example, on the
rabbit jejunum Fia was twice as active as Ei, but on the guinea-pig ileum it was forty
times less active. Bergstrom et al. (1959) found similar ratios for Ei and Fia on
these tissues. They also reported that Fia had no depressor activity in doses up to
10 /xg in the rabbit, in contrast to Ei which was a potent depressor substance. We
found that each of these prostaglandins lowered rabbit blood pressure although the
threshold dose for Fw (5 /xg/kg) was approximately ten times that for Ex. It seems
probable that the maximum doses of Fxa used by Bergstrom et al. (1959) were just
subthreshold.
It is clear that none of the preparations we have tested are suitable for distinguishing
between prostaglandins Ex, E2 and E3 by parallel biological assay. On the other
hand, prostaglandin Fw might easily be distinguished from prostaglandins of the E
series by parallel assays on the rabbit jejunum and guinea-pig ileum. The index
of discrimination (Gaddum, 1955) between Ex and Fxa using these two tissues would
be about 100. Similarly, such a combination of tissues might be used to estimate
the amounts of Ei and Fia in a mixture using Euler's (1948) method, as already
suggested by Bergstrom et al. (1959).
Asplund (1947) reported that prostaglandin inhibits tubal peristalsis in the rabbit.
This observation has been confirmed using pure prostaglandin Ex (Horton et al.,
1963). In the present investigation prostaglandins E2 and E„ like Ex, also inhibited
tubal tone and peristalsis, but prostaglandin Fia had the opposite effect, an increase
in tubal tone being observed.
Prostaglandins are present in high concentrations in human semen. It has been
suggested that they may aid conception by relaxing the smooth muscle of the fallopian
tubes, thus allowing easier access of sperm to an ovum (Asplund, 1947). The
relaxant effect of the prostaglandin E's on the rabbit fallopian tubes agrees with this
hypothesis, but the stimulant action of prostaglandin Fn does not. It is possible
that under physiological conditions prostaglandin Fxa does not reach the tubes, or
at least not in sufficiently high concentration to affect their tone, and that the inhibitory
effect of prostaglandins Ex and Ea, which are more potent, is the predominant
physiological response.
We are very grateful to Professor S. Bergstrom for gifts of the pure prostaglandins.
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In a previous investigation we compared the biological activities of four prostaglandins,
Els Ea, E3 and Fla (Horton & Main, 1963). Prostaglandins of the E series were qualita¬
tively very similar in their effects and their ratios of activity were approximately constant on
all the biological preparations tested. In contrast, the biological activity of prostaglandin
Fla relative to Et varied widely on different preparations, and on one, the rabbit fallopian









Prostaglandin Ei: I I a.l 5-dihydroxy-9-oxo-prost-l 3-enoic acid
Fig. 1. Formulae of prostaglandin F,a and prostaglandin E,
In this investigation we have compared a fifth prostaglandin, F2(i (Fig. 1), directly with
prostaglandin Ex on eight smooth muscle preparations selected for their known sensitivity
to Ei. We have found that, on preparations which are inhibited by prostaglandins, F2„ is
always less active than Ej, but that, on preparations which are contracted, F2Q is usually
more active than Ex. These findings are of interest since F2a is the prostaglandin which
predominates in several tissues (Bergstrom, 1964).
METHODS
Smooth muscle preparations in vitro
Segments of various organs were suspended in a 4- or 10-ml. organ-bath. Longitudinal contractions
were recorded either isotonically with a frontal-writing lever on a smoked drum, or isometrically with a
* Present address: Department of Physiology, Medical College of St. Bartholomew's hospital,
Charterhouse Square, London, E.C.l.
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force-displacement transducer and an ink-writing polygraph. A dose cycle of 4 to 6 min with a contact
time of 45 to 90 sec was used for all preparations except the cat trachea.
Rabbit jejunum. Proximal jejunum, from rabbits weighing 2 to 3 kg, was suspended in Tyrode solution
at 35 to 36° C, gassed with air.
Guinea-pig ileum. Terminal ileum, from guinea-pigs weighing 200 to 450 g, was suspended in Tyrode
solution at 37° C, gassed with air.
Hamster colon. The ascending colon, from hamsters weighing 100 to 200 g, was suspended in de Jalon
solution at 35 to 36° C, gassed with air.
Cat trachea. Tracheas were obtained from cats which had been anaesthetized with sodium pento¬
barbitone, and which had been used for other experiments. Two or three rings of trachea were tied
together with the muscle in alignment; the cartilage was removed. The preparations were suspended in
Krebs-Henseleit solution at 37° C, gassed with 95% oxygen and 5% carbon dioxide.
Rat uterus. Segments of uterus from rats weighing 150 to 250 g, which had been injected subcutaneously
with stilboestrol (100 nS) 18 hr previously, were suspended in de Jalon at 32° C, gassed with air.
Smooth muscle preparations in vivo
Rabbit blood pressure and fallopian tube intraluminal pressure. Rabbits weighing 2 to 3 kg were anaes¬
thetized with urethane (1.75 g/kg) injected intraperitoneally. Arterial blood pressure and fallopian tube
intraluminal pressure were recorded with pressure transducers as described previously (Horton & Main,
1963).
Cat gastrocnemius muscle blood flow. In one cat weighing 3.4 kg gastrocnemius muscle blood flow was
recorded as described previously (Horton & Main, 1963). Prostaglandins were injected intra-arterially.
RESULTS
In all experiments the relative activity of the two prostaglandins was estimated by
bracketing. Threshold doses quoted for prostaglandin F2a are approximate. The results
are summarized in Table 1.
Table 1
APPROXIMATE THRESHOLD DOSES OF PROSTAGLANDIN F2a AND ITS BIOLOGICAL
ACTIVITY RELATIVE TO PROSTAGLANDIN Ea
In three out of four experiments prostaglandin F2a increased the tone of the fallopian tubes, in contrast





(ng/ml. in vitro) Relative activity, between
Preparation Response (/*g/kg in vivo) F2a to Ei F 2a and Ei Tot;
Rabbit jejunum Contraction 0-25-1 26 (5-100) 5 7
Guinea-pig ileum Contraction 10-50 0-55 (0-015-3) 3 7
Hamster colon Contraction 1-5 3-5 (1-8) 0 5
Cat trachea Relaxation 50-1,000 0-03 (0-0025-0-05) 0 4
Rat uterus Contraction 25-50 8 (5-15) 0 4
Rabbit fallopian
tube Contraction 1-3-5 — 3 4
Rabbit blood pres¬
sure Depression 0-7-2-5 0-11 (0-08-0-2) 3 4
Cat gastrocnemius
muscle blood flow Vasodilatation <0-05 0 1
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Intestinal smooth muscle
The rabbit isolated jejunum contracted in response to prostaglandin F2a in concentrations
of 0.25 ng/ml. In five out of seven experiments there was a qualitative difference in the
responses to prostaglandin F2a and prostaglandin Ex. The contraction due to prostaglandin
F2a was slower in onset and reached a maximum more slowly than the contraction to
prostaglandin Ex (Fig. 2). This qualitative difference made meaningful quantitative com-
/ ■ / >S»
?$/ I
• • '—'
F2a El I min
Fig. 2. Isotonic responses of isolated rabbit jejunum preparation suspended in 4-ml. organ-bath containing
Tyrode solution. F2a=prostaglandin F2„, 4 ng/ml.; Ex=prostaglandin Elf 20 ng/ml.
parisons difficult. Prostaglandin F2a was always more active than prostaglandin Ex, the
amount varying from 5- to 100-times with different intestines. The biggest differences were
found in preparations which were less sensitive than usual to prostaglandin Ex although the
sensitivity to prostaglandin F2a was normal. The reason for this discrepancy is unexplained.
It could not be accounted for by deterioration in the prostaglandin solutions because
freshly prepared solutions were also less active on these less sensitive preparations.
A similar qualitative difference between the prostaglandins was sometimes observed
(three out of seven experiments) on the guinea-pig isolated ileum. On this preparation the
ratio of activity of Ex to F2„ was even more variable than on the rabbit jejunum. On
average, prostaglandin Ej was slightly more active but the relative activities varied from
0.015 to 3.0 on different preparations.
No qualitative differences in the stimulant action of the two prostaglandins were observed
on the hamster isolated colon. In four out of five experiments prostaglandin F2a was more
active than Ej, in the remaining experiment they were equiactive.
I min
Fig. 3. Isometric responses of cat isolated trachea, suspended in 4-ml. organ-bath containing Krebs-
Henseleit solution. At the dots acetylcholine (12.5 ng/ml.) was added. F2a=prostaglandin F2a,
0.75 fig/ml.; E1=prostaglandin E„ 1.9 ng/ml.; W=wash.
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Respiratory smooth muscle
The cat isolated tracheal chain has little or no inherent tone; inhibitory responses are
therefore difficult to detect. If a contraction of the preparation is produced by acetyl¬
choline, prostaglandins can be shown to have inhibitory effects (Main, 1964). Using this
technique, we have shown that, like prostaglandin E1; F2a also inhibits this preparation.
The activity of prostaglandin F2a was, however, only about one-thirtieth of that of Ex
(Fig. 3). In view of the small amounts of prostaglandin F2a available, comparisons were
not made on other preparations of respiratory smooth muscle which are affected by
prostaglandin Ex (Main, 1964).
Reproductive smooth muscle
Both prostaglandins contracted the isolated uterus of the rat, prostaglandin F2a being
more active than The threshold concentration of prostaglandin F,a was about 25 ng/ml.
The rabbit fallopian tube in vivo, which is relaxed by small doses of prostaglandin Ea, was
I min
Fig. 4. Record of rabbit (2.8 kg) blood pressure (B.P., upper trace) and fallopian tube intraluminal pressure
(lower trace). F2a= prostaglandin F2a, 10 //g; Ei=prostaglandin Ei, 2 and 1 fig at first and second
injections respectively.
contracted by prostaglandin F^, in three out of four experiments (Fig. 4). In the fourth
experiment prostaglandin F2a produced a short-lasting relaxation. Prostaglandin F2a was
much less active than Ex on this preparation, the threshold dose being about 5 jug/kg.
Vascular smooth muscle
On intravenous injection into the anaesthetized rabbit both prostaglandins caused a fall
in arterial blood pressure. Prostaglandin F2a was about one-tenth as active as prostaglandin
Ej. In three out of four experiments prostaglandin F2a produced a more gradual and more
prolonged fall of pressure than occurred with prostaglandin E, (Fig. 4). In one experiment
on the cat gastrocnemius muscle blood flow, prostaglandin F2a was shown to have vaso¬
dilator activity, but it was less active than prostaglandin E2. In view of this low activity
and of the need to conserve supplies of prostaglandin F2tI no further blood flow experiments
were carried out.
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DISCUSSION
Prostaglandins E1( E2 and E3 differ chemically only in their degree of unsaturation and
have very similar biological activities; E3 is usually the least potent (Horton & Main, 1963;
Bergstrom & Euler, 1963; Horton, 1964; Main, 1964). On the other hand, prostaglandin
Fla, which can be formed by the reduction of the oxo substituent in the cyclopentane ring
of prostaglandin E1; differs more significantly from prostaglandins of the E series (Horton &
Main, 1963). It could be predicted that the introduction of a second double bond in the
prostaglandin Flct molecule would have a similar effect upon its biological activity as a
change from prostaglandin Ex to prostaglandin E2, and that, in view of the similarity of
Ej and E2, the two prostaglandin Fs would also have very similar activity. How far is
this prediction substantiated by the experimental findings ? In our previous investigation
we estimated the relative activities of E2 to Ex and of Fla to Ex; the expected relative activities
of F2a to Ej can therefore be calculated. The general trend of the predictions is supported
Table 2
BIOLOGICAL ACTIVITY OF PROSTAGLANDIN Fsa RELATIVE TO PROSTAGLANDIN E,
Results predicted from previous studies are compared with observed results. * Prostaglandin Fia and
F2a increased the tone of the fallopian tubes in contrast to prostaglandins of the E series which caused
relaxation
Relative biological activity
Observed Observed Predicted Observed Calculated
Preparation E2/Ex Fja/Ei F2a/Ei F 2a/Ei F2a/Fia
Rabbit jejunum 1-5 2-2 3-3 26 12
Guinea-pig ileum 1-6 0-02 0-03 0-55 27
Hamster colon 2-8 0-26 0-73 3-5 13
Cat trachea 1-0 0-002 0-002 0-03 15
Rat uterus 1-1 0-9 1-0 8 9
Rabbit fallopian tube 0-9 * * * *
Rabbit blood pressure 1-0 0-08 0-08 0-1 1-25
Cat gastrocnemius
muscle blood flow 0-8 0-2 0-16 <0-05 0-3
by the experimental results (Table 2). Thus F2a has weak inhibitory actions on cat isolated
trachea and on vascular smooth muscle, while on the rabbit fallopian tube prostaglandin
F2a, like Fla but unlike E1? increases intraluminal pressure. However, on all tissues (except
vascular smooth muscle) the activity of F2a was some ten times greater than predicted.
The reason for this apparent discrepancy cannot be explained. Anggard & Bergstrom
(1963) also found that F2a is more potent than FltI but they made no direct comparison.
We have been able to confirm other observations of Anggard & Bergstrom (1963), namely
that the rabbit isolated duodenum or jejunum is very sensitive to F2„ and that F2a is not a
very potent depressor substance but that like other prostaglandins it does increase blood
flow through skeletal muscle. We were unable to confirm that the rat isolated uterus will
respond to F2a in concentrations as low as 1 ng/ml. although it is more active than other
prostaglandins on this preparation. It is possible that the exact stage in the oestrous cycle
is critical for such high sensitivity.
One important reason for comparing the activities of different prostaglandins is to
establish which tissue is most suitable for the assay of a particular prostaglandin and
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which pair of tissues might be used to distinguish between two prostaglandins or to estimate
their concentrations in a mixture. Biological methods of estimation are more sensitive than
any known chemical methods and are the only means of assaying the minute quantities
found in small amounts of tissue. We have previously concluded that no combination of
biological preparations yet known will distinguish between the three prostaglandin Es but
that Fla and Ej could be distinguished by parallel assays on rabbit jejunum and guinea-pig
ileum (Horton & Main, 1963) or rabbit jejunum and cat trachea (Main, 1964). The rabbit
jejunum and cat trachea could also be used to distinguish between the prostaglandin Es
and prostaglandin F2„ (index of discrimination=800). It is doubtful whether any pair of
the tissues tested in this investigation would enable us to distinguish between prostaglandin
Fla and prostaglandin F2«. A combination of, say, guinea-pig ileum and rabbit blood pres¬
sure might provide a high enough index of discrimination. However, the rabbit blood
pressure is too insensitive for use as a routine assay method where only nanograms of
prostaglandins may be present in the sample to be assayed.
In addition to a qualitative difference in the response of the rabbit fallopian tube, F^
and Ej differed in the type of response on the rabbit blood pressure and certain types of
isolated intestinal smooth muscle. On both rabbit blood pressure and rabbit isolated
jejunum the responses to F2a were usually slower in onset and took longer to reach a
maximum than the responses to Ex. Similar differences were not observed between
prostaglandin Fla and prostaglandin Ex in our previous investigation, but Bergstrom,
Eliasson, Euler & Sjovall (1959) did report that the response to Fla was slower than that to
Ej. It is unlikely that the slower response is due to conversion of prostaglandin F23 to E.>
since F2a is active at lower concentrations than E». Possibly it is related to the ease with
which this compound is transported to the active site.
One of the most interesting features which has emerged from this investigation is the
contrast in potency of prostaglandin F2a as an inhibitor and as a stimulator of smooth
muscle. It had already become apparent from our previous work (Horton & Main, 1963;
Main, 1964) that Fla is less potent than Ex on smooth muscle which is inhibited and the
present results suggest that this is a general property of prostaglandin Fs. In some respects
the difference is similar to that existing between adrenaline and noradrenaline. Prostaglan¬
din Ej, like adrenaline, is potent on tissues which are inhibited, whereas both catechol
amines and both prostaglandins are potent as stimulators. It is perhaps premature to
speculate about two kinds of prostaglandin receptor.
Information about the distribution of the different prostaglandins in different tissues is
still incomplete. Prostaglandin F2a appears to be more widely distributed than the others;
it has been isolated from lung, brain, iris, semen and menstrual fluid. In view of its presence
in lung and brain it is of interest that it is considerably less active than the corresponding
prostaglandin E in relaxing respiratory smooth muscle and in causing stupor and sedation
(Horton & Main, 1965). If prostaglandins are concerned in the control of smooth muscle
tone in the lungs (Main, 1964), it would seem likely that prostaglandin E3 rather than
prostaglandin F2a would be of more immediate physiological importance. Possibly prosta¬
glandin F2a in lung and brain represents a tissue store of prostaglandin which is either a
relatively inactive metabolite of prostaglandin E2 or a precursor which exerts physiological
effects only after conversion to prostaglandin E2.
476 E. W. HORTON and I. H. M. MAIN
SUMMARY
1. The biological activities of four prostaglandins have previously been reported; in
the present paper the activity of a fifth prostaglandin, F2a, is compared with prostaglandin
Ex on smooth muscle preparations.
2. Both prostaglandins contract intestinal smooth muscle of the rabbit, hamster and
guinea-pig in vitro. Responses of the rabbit jejunum to prostaglandin F2a are usually slower
in onset and more prolonged than those to prostaglandin Ex.
3. Both prostaglandins inhibit acetylcholine-induced contractions of the cat isolated
tracheal chain, but F2a has only one-thirtieth of the activity of Ex.
4. The rat isolated uterus is contracted by both prostaglandins, but is more sensitive to
F2a. On the other hand, the rabbit fallopian tube in vivo, which is relaxed by small doses of
prostaglandin Ex, is contracted by F2a.
5. Both prostaglandins increase blood flow through skeletal muscle in the cat and lower
arterial blood pressure; F2„ is less potent in this respect than Ex.
6. It is concluded that prostaglandin F2a is a less potent inhibitor of smooth muscle than
prostaglandin Ex, but that, on smooth muscle preparations which are contracted, F2a is
often more active than Ex.
We are indebted to Professor Sune Bergstrom of the Karolinska Institute for pure samples of the
prostaglandins.
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THE RELATIONSHIP BETWEEN THE
CHEMICAL STRUCTURE
OF PROSTAGLANDINS AND THEIR
BIOLOGICAL ACTIVITY
By E. W. HORTON and I. H. M. MAIN
INTRODUCTION
The term 'prostaglandin' was introduced by Euler in 1935 to describe a
lipid-soluble substance present in human seminal plasma, which contracts
isolated smooth muscle and lowers arterial blood pressure and which
differs from all other known naturally occurring substances. In 1962,
Bergstrom and his colleagues at the Karolinska Institute reported the iso¬
lation of six prostaglandins from various animal tissues (see Horton, 1965, for
references). In view of this it became important to know whether and how
the prostaglandins differ from each other in their biological properties.
We were very fortunate in obtaining samples of five prostaglandins from
Professor Bergstrom and Dr Samuelsson and we are greatly indebted to
them for supplying us with them at a time when only very small quantities
had been isolated. One of the most significant recent advances in this field
was the observation made independently by two groups of workers that
the prostaglandin E's are biosynthesized from the essential fatty acids
(Bergstrom, Danielsson & Samuelsson, 1964; Dorp, Beerthuis, Nugteren &
Vonkeman, 1964). Furthermore, the same tissue enzyme systems can
form 'unnatural' prostaglandins when incubated with analogues of the
essential fatty acids. We have studied one of these, wor-prostaglandin E1;
very kindly supplied by Dr van Dorp, and also the precursors of pro¬
staglandins Ex and E2, fos-homo-y-linolenic acid and arachidonic acid
respectively.
METHODS
The methods used in this investigation have been described fully in our
previous papers (Horton & Main, 1963; Horton, 1964; Main, 1964; Horton
& Main, 1965 a-c).
RESULTS
Effects on biological activity of increasing the degree of
unsaturation of the prostaglandin E molecule
The prostaglandin E's differ from each other only in their degree of
unsaturation having one, two and three double bonds (Fig. 1). We have
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compared them on eleven biological preparations, and on all of these the
responses to the three prostaglandins were qualitatively very similar. They
all produced a contraction of the rat uterus, guinea-pig ileum, rabbit







Fig. i. Formulae of prostaglandins Ej, E2 and E3.
cat vascular smooth muscle and rabbit oviduct smooth muscle. They all
lowered the arterial blood pressure of the anaesthetized rabbit and had a
sedative-like action in young chicks. On injection into the cerebral
ventricles of the unanaesthetized cat, E2 and E3 (like Ex) produced a state
of catatonic stupor but there were insufficient experiments for an estimate
of their relative potencies to be made.
The activities of E2 and E3 relative to Ex did not vary greatly from one
preparation to another (Table i). E2 was a little more active than E2 on the
Table i. Biological activity of prostaglandins E2 and E3
relative to prostaglandm E1 (= i)
Preparation Response E2/EJ EJE,
Rat uterus Contraction i"i 0-3
Guinea-pig ileum Contraction i-6 0-2
Rabbit jejunum Contraction i'5 I-o
Hamster colon Contraction 2-8 0-2
Cat trachea Relaxation IO 0-2
Rabbit oviduct in vivo Inhibition Q'9 o-4
Rabbit blood pressure Depression i-o °'3
Cat muscle blood flow Vasodilatation o-8 o*5
Cat skin blood flow Vasodilatation 09 0'2
Chick Sedation °'7 °*3
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guinea-pig ileum, rabbit jejunum and hamster colon and rather less active
in producing sedation in the chick and as a vasodilator in the cat. Allowing
for variation in the response of tissues, it is unlikely that the biological
activities of E2 and Ex differ very significantly. On the other hand E3 had
only one fifth to one half of the activity of Ex except on the isolated rabbit
jejunum on which they were equi-active.
Effects on biological activity of reduction of the 9 oxo
substituent to a cis-hydroxyl
Prostaglandin F's differ from the corresponding E's by the presence of a
hydroxyl substituent in the 9 position instead of an oxo (Fig. 2). In the





Fig. 2. Formulae of prostaglandins Flct and F2„.
On comparing E's and F's biologically several qualitative differences were
observed. Whereas E's inhibit smooth muscle of the rabbit oviduct, Fla
and F2ct both increase oviduct smooth muscle tone. The difference between
F2ct and E1 is illustrated in Fig. 3. The threshold dose of F for producing
an increase in oviduct tone is five to ten times greater than the threshold
dose for E for producing a decrease in tone.
Another qualitative difference in the biological actions of F's and E's is
seen on intravenous injection in the unanaesthetized chick. The E's pro¬
duce a condition resembling sedation, but Flct and F2a both cause con¬
traction of the extensor muscles of the legs and back. This action is not on
the skeletal muscle but on the spinal cord (Horton & Main, 1965 c).
Although catatonic stupor occurs in cats following injections of Ex into
the cerebral ventricles, no such effects are seen after F2a even in doses up
to 10 times the effective dose of E1. It is not known whether this is a
qualitative difference or merely a difference in sensitivity; higher doses of
F2ii might have been effective.
32 E. W. HORTON AND I. H. M. MAIN
On the isolated rabbit jejunum and guinea-pig ileum which contract in
response to both E's and F's, it was often observed that the onset of the
contraction was quicker and that the maximum height of the response was
reached more quickly after E than after F. This difference was particularly
marked when we compared F2et with Ej.




Fig. 3. Record of urethanized rabbit blood pressure (upper trace) and oviduct intra¬
luminal pressure (lower trace). F2o. = prostaglandin. F2a and E, = prostaglandin E,,
injected intravenously (doses in fig).
Table 2. Biological activity of prostaglandin F's relative
to prostaglandin E's (= 1)
Preparation Response Fia/Ex
Fga/Eg










Rabbit blood pressure Depression 0*08
o*i
Cat muscle blood flow Vasodilatation 0*2
< o*o6
Estimates of the relative activities of E's and F's on various preparations
are shown in Table 2. There is a large variation between different prepara¬
tions. On the rabbit jejunum F's are more active than E's, but on the
guinea-pig ileum and the cat tracheal chain preparations E's are more
active than F's.
Effects on biological activity of changing the configuration
of the 9 hydroxyI from cis to trans
When a prostaglandin E is reduced at the 9 position, two stereoisomers are
formed, Fa and F^, the hydroxyls at 9 and 11 being cis and trans respec¬
tively (Fig. 4). Only the cis isomers have been isolated from natural
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sources. We compared the biological activities of Fla and F1/5 prepared
chemically from E, and kindly supplied by Dr D. A. van Dorp.
On the five different preparations on which we were able to obtain
responses with F1/?, its effects were qualitatively similar to those of Flct.
Fla varied from 4 times (cat trachea) to 30 times (rabbit jejunum) more
active than F1/? (Table 3).
oh
oh
Fig. 4. Formulae to illustrate the difference between
the a and /? isomers of prostaglandin Flf F2 or F3.
Table 3. Biological activity ofprostaglandin Fla relative
to prostaglandin
Preparation Response Fia/Ftf
Rat uterus Contraction 24
Guinea-pig ileum Contraction 20
Rabbit jejunum Contraction 3°
Rat fundus Contraction 9
Cat trachea Relaxation 4
Rabbit oviduct in vivo Contraction > S
Rabbit blood pressure Depression > 5
Effects on biological activity of shortening the carboxylated side chain
ofprostaglandin E1 by one methylene group
On ten different biological preparations wor-prostaglandin Ej (Fig. 5)
produced responses which were qualitatively similar to those of Ex. Nor-E1
was between a tenth and a third as active as Ex on most preparations, but
on the isolated rat uterus the two compounds were about equi-active
(Table 4). They were also of the same order of potency in producing
catatonia on injection into the cerebral ventricles of cats, but the number of
observationswas too few to permit a reliable quantitative estimate to be made.
3 P&F




Fig. 5. Formulae of prostaglandin Ei and nor-prostaglandin E,.
Table 4. Biological activity of nor-prostaglandin E1 relative
to prostaglandin El{ = 1)
Preparation Response Nor-EJE1
Rat uterus Contraction i-o
Guinea-pig ileum Contraction 01
Rabbit jejunum Contraction 03
Rat fundus Contraction 02
Cat trachea Relaxation O-I
Rabbit oviduct in vivo Inhibition o-i
Rabbit blood pressure Depression 01
Chick Sedation 01
Spinal chick Potentiation of 01
crossed extensor
reflex
Biological activities of the precursors of the prostaglandins
bis-homo-y-linolenic acid and arachidonic acid
Zhs-homo-y-linolenic acid and arachidonic acid (Fig. 6) were compared
with Ex on eleven biological preparations. They produced effects which
were often qualitatively similar to those of Ex, but except on two of the
preparations they were of a very different order of activity. Bij-homo-y-
linolenic acid and arachidonic acid like Ex contracted the rabbit jejunum,
guinea-pig ileum, rat uterus and rat fundus. In one experiment fcr-homo-y-
linolenic acid caused a slight inhibition of cat tracheal smooth muscle, and
in one out of three experiments it produced a slight inhibition of rabbit
oviduct smooth muscle. The essential fatty acids in doses of 200 or 400 pg\
chick produced some sedation—an effect equivalent to that produced by
o-5-i-o/tg of Ex.
Neither fek-homo-y-linolenic acid nor arachidonic acid produced cata¬
tonic stupor in cats nor increases in skeletal muscle blood flow. On the
human blister base preparation, both essential fatty acids produced a
sensation of pain in a concentration of 50 /ig/ml or more. A response to Ex,
100 yg/ml, could just be detected—higher concentrations were not tested.
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Dakhil & Vogt (1962) have shown that some of the smooth-muscle
stimulating activity of unsaturated long-chain fatty acids, but not that of
the prostaglandins is due to the formation of peroxides. We have not
excluded the possibility that the effects of fc-homo-y-linolenic acid and








Fig. 6. Formulae of prostaglandin E1; fo's-homo-y-linolenic acid and arachidonic acid.
Table 5. Biological activity of bis-homo-y-linolenic acid and
arachidonic acid relative to prostaglandin E1{= 1)
Bis-homo-
Preparation Response y-1 /Ex Arach./Ei
Rat uterus Contraction 0'06 0-03
Guinea-pig ileum Contraction 0-003 0-003
Rabbit jejunum Contraction o-i 0-17
Rat fundus Contraction 0-03 0-015
Cat trachea Relaxation 0-004 < 0*002
Rabbit oviduct in vivo Inhibition O-OI o-oi
Rabbit blood pressure Depression 0-005 0-003
Cat muscle blood flow Vasodilatation < o-oi < O-OI
Chick Sedation 0-0025 0-0025
Cat Catatonic stupor < O-IO < 0-125
Human blister base Pain 2 2
our solutions were kept under nitrogen, but later they came into contact
with air intermittently over a period of several months. There was no
appreciable change in biological activity after this contact with air. It
seems likely that if peroxidation occurred it was already complete at the
time of the first biological tests. Whether or not the biological activity was
due to peroxides or to the acids themselves, it is certain that these substances
are far less active than the prostaglandins on most biological preparations
which we investigated (Table 5).
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SUMMARY AND CONCLUSIONS
Seven prostaglandins have been studied. The four with an oxo substituent
at the 9 position have qualitatively similar biological properties irrespective
of other changes in the molecule such as degree of unsaturation or chain
length.
Similarly, the three prostaglandins with a hydroxyl substituent at the
9 position were qualitatively very similar and could easily be distinguished
as a group from the 9-0x0 compounds. This division on biological grounds
corresponds to the classification already made into E's and F's on the basis
of their partition between ether and a phosphate buffer.
Pzk-homo-y-linolenic acid and arachidonic acid have weak prostaglandin
E-like actions, but it is uncertain whether these actions are due to the acids
or their peroxides.
Parallel bioassay on the rabbit jejunum and cat trachea will readily
distinguish between an E and an F, but no combination of tissues yet
found will distinguish between individual E's (or F's).
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Dorp: In the biosynthesis of homologues such as the nor-PGE1; con¬
tamination with endogenous prostaglandins should be avoided. Therefore
it is desirable to use an enzyme which is free of endogenous prostaglandin,
and that can be done by working with centrifugates and not homogenates.
Anggard : I should like to ask Dr Horton how the cats reacted when the
prostaglandin was injected intravenously.
Horton : In the intact cat there is some diminution of activity with rather
large intravenous doses of prostaglandin Ex. In the decerebrate cat there is
a marked potentiation of decerebrate rigidity after intravenous prosta¬
glandin and in the spinal cat there is also an increase in muscle tension and
a potentiation of the spinal reflexes.
Anggard: Prostaglandins of the E type are metabolised very quickly,
and the half-life of i jug of prostaglandin Ex would probably not exceed
i or 2 min.
Vogt: Atropine reduces some responses to prostaglandins. This may in¬
dicate an effect on cholinergic nerve endings. Further, the separation of lipid-
soluble acids from amines and peptides by extraction with organic solvents
may not be complete; some amines may stick to the acids. We realized
this when we acetylated lipid-soluble acids in order to prove the presence
of hydroxy groups. The acetylated compounds produced strong contrac¬
tions which could be blocked by atropine, and were probably caused by
acetylcholine formed from contaminating choline.
Clitheroe: As you mentioned, Dr Ambache, the reduced activity of
ricinelaidic acid as compared with ricinoleic acid can be associated with
the trans double bond. This causes the hydrocarbon chain with the hydroxyl
group attached to it to move away from the carboxylic acid group. Similarly
one would expect lower activity with 12-hydroxy-stearic acid. In pro¬
staglandins the double bond at position 13 similarly tends to bring the rest
of the hydrocarbon chain with a hydroxyl group on it towards the acid end
of the molecule. I wonder whether these structural similarities could be
possibly associated with a receptor site containing at least three possible
points of access.
editor's note
The term izs-homo-y-linolenic acid is used in this Memoir for all-cA
eicosa-8,n,i4-trienoic acid, as suggested by Dorp (p. 75).
Separatum EXPERIENTIA 21, 113 (1965)
Birkhauser Verlag, Basel (Schweiz)
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Biological Activities of Pure Prostaglandins
By E. W. Horton
Department of Physiology, Medical College of St. Bartholomew's Hospital, London (England)
Prostaglandin was the name given by Euler in 1935
to a substance in extracts of human semen which con¬
tracts isolated smooth muscle and lowers arterial blood
pressure, and which differs from all other known
naturally-occurring substances1-4. Using prostaglan-
din-containing extracts of various degrees of purity,
Euler and others investigated its biological actions.
These results were the subject of a comprehensive re¬
view by Eliasson in 19596. About that time Berg¬
strom et al. announced the isolation of prostaglan¬
din6-7, and soon these workers were able to elucidate
its chemical structure8. It became apparent that pro¬
staglandin was not a single substance but a family of
closely-related compounds. Six of these have now been
isolated from natural sources, including semen9-11,
vesicular glands7-12-13, menstrual fluid14, lung13-15,
brain16, thymus17 and iris18 (Table I). Chemically, the
prostaglandins are hydroxy unsaturated C20 fatty
acids, five of the carbon atoms forming a cyclopentane
ring (Figure). Prostaglandin E's have oxo and hydroxy
substituents in the ring whereas the prostaglandin F's
have two hydroxy substituents. The three E's (and
three F's) differ from each other only in their degree of
unsaturation (Figure).
The object of the present paper is to review the work
which has been done using prostaglandins known to be
20 19 18 17 16 15 14 13 7 6 5 4 3 2 1
ch3ch2ch2ch2ch2ch2ch2ch2^ ,h ,ch2ch2ch2ch2ch2ch2co2h
Prostanoic acid10
Prostaglandin Ex = 11a, 15-dihydroxy-9-oxo-prost-13-enoic acid8.
Prostaglandin E2 = 11a, 15-dihydroxy-9-oxo-prost-5, 13-dienoic
acid12.
Prostaglandin E3 = 11a, 15-dihydroxy-9-oxo-prost-5, 13, 17-trienoic
acid19.
Prostaglandin Fia = 9a, 11a, 15-trihydroxy-prost-13-enoic acid8.
Prostaglandin F2a = 9a, 11a, 15-trihydroxy-prost-5, 13-dienoic
acid15.
Prostaglandin F3Ce = 9a, 11a, 15-trihydroxy-prost-5, 13, 17-trienoic
acid19.
The formulae of six prostaglandins and of the parent acid, pro-
<;tnnnir arid whirh hat not hrrn itolatrd from natural tonrr.rt.
Table I. Distribution of prostaglandins. Prostaglandins have been
isolated in pure form from the sources indicated below. The figures
refer to concentrations in jug/g (yMg/ml in the case of semen). + indi¬
cates that the compound has been isolated from that source, but the
amount present is unknown; — indicates that the evidence suggests
that the prostaglandin is not present
Tissue
Prostaglandin
E, E2 E3 F1(
Reference
Semen (human) 20 20 22 3 5 9, 10
Semen (sheep) + 11
Vesicular gland + + + (+) - - 7, 12, 13
(sheep)
Menstrual fluid + + 14
(human)
Lung (human) 4- 13
Lung (monkey) + 13
Lung (ox) 4- 4- 13
Lung (pig) 4- 15
Lung (sheep) - + -(+) 0.5 (+) 13, 15
Lung (guinea-pig) + 13
Brain (ox) 0.3 16
Thymus (calf) 0.8 13, 17
Iris (sheep) 4 18
1 M. W. Goldblatt, Chem. Ind. 52, 1056 (1933).
2 U. S. von Euler, Arch. exp. Path. Pharmak. 175, 78 (1934).
3 M. W. Goldblatt, J. Physiol. (Lond.) 84, 208 (1935).
4 U. S. von Euler, Klin. Wschr. 33, 1182 (1935).
5 R. Eliasson, Acta physiol. scand. 46, Suppl. 158 (1959).
6 S. Bergstrom and J. Sjovall, Acta chem. scand. 11, 1086 (1957).
7 S. Rergstrom and J. Sjovall, Acta chem. scand. 14, 1701 (1960).
8 S. Bergstrom, R. Ryhage, B. Samuelsson, and J. Sjovall,
Acta chem. scand. 16, 501 (1962).
9 S. Bergstrom and B. Samuelsson, J. biol. Chem. 237, PC3005
(1962).
10 B. Samuelsson, J. biol. Chem. 238, 3229 (1963).
11 S. Bergstrom, L. Krabisch, and J. Sjovall, Acta chem. scand.
14, 1706 (1960).
12 S. Bergstrom, F. Dressler, R. Ryhage, B. Samuelsson, and
J. Sjovall, Ark. Kemi 19, 563 (1962).
13 S. Bergstrom, Sixth International Congress of Biochemistry,
New York (1964), Pre-circulated Abstracts, p. 559.
14 G. Eglinton, R. A. Raphael, G. N. Smith, W. J. Hall, and
V. R. Pickles, Nature (Lond.) 200, 960 (1963).
15 S. Bergstrom, F. Dressler, L. Krabisch, R. Ryhage, and J.
Sjovall, Ark. Kemi 20, 63 (1962).
16 B. Samuelsson, Biochim. biophys. Acta 84, 218 (1964).
17 S. Bergstrom and B. Samuelsson, Acta chem. scand. 17, 282
(1963).
18 E. AnggArd and B. Samuelsson, Biochem. Pharmacol. 13, 281
(1964).
19 B. Samuelsson, J. Am. chem. Soc. 85, 1878 (1963).
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chemically pure. No attempt has been made to include
results obtained with impure preparations.
Actions on reproductive smooth muscle. Smooth
muscle from the female reproductive tract of all species
so far investigated responds to prostaglandin. Rat and
guinea-pig uteri are contracted by prostaglandins E1;
E2, E3, Fla and F2a20-24, an<i ln addition to a direct
stimulant action on guinea-pig myometrium pro¬
staglandin E2 potentiates subsequent responses to
other oxytocic substances24. In vitro, the non-pregnant
uterus of the rabbit shows little or no response to
prostaglandin Ex, but contracts in response to pro¬
staglandin Flct20; in vivo, spontaneous contractions of
the rabbit uterus are inhibited by prostaglandin Ex25.
Similar inhibitory effects of prostaglandin Ex have
been observed on contractions of the cervix in the
anaesthetized rabbit, but the part of the reproductive
tract in this species most sensitive to prostaglandin is
the oviduct smooth muscle23-26. Prostaglandins Ex, E2
and E3 injected intravenouslj- reduce the tone and con¬
tractions of the oviduct, but prostaglandins Fla and
F2a usually have the opposite effect, although higher
doses of these compounds are required22-27.
The suggestion28 that prostaglandins from semen
are absorbed from the vagina into the circulation and
thence act upon the reproductive tract smooth muscle
receives some support from the finding that prosta¬
glandin Ex is absorbed from the rabbit vagina26. Al¬
though this is unlikely to be a physiological mecha¬
nism in the rabbit in view of the. absence of pro¬
staglandin from rabbit semen, nevertheless it is of
great interest that prostaglandin can reach the circu¬
lation in this way and it would seem to justify an in¬
vestigation in humans to determine whether a similar
process operates after coitus. This could equally well
be investigated in sheep, since ram semen, like that of
humans, contains prostaglandin. Horton, Main and
Thompson, however, have shown23 that injections and
infusions of prostaglandin in anaesthetized ewes pro¬
duce detectable changes in the intraluminal pressure of
the oviduct only in amounts greatly in excess of those
present in a single ejaculate of ram semen29. These ob¬
servations do not exclude the possibility that seminal
prostaglandin acts locally upon vaginal or cervical
smooth muscle.. Nor do they exclude the possibility
that circulating prostaglandin has a more subtle and
less easily recordable effect which is of physiological
importance. If this is so, the demonstration that a
prostaglandin has an effect on the muscle tone of the
oviduct of a species may be irrelevant to the question
of a physiological mechanism.
These points should be borne in mind when consider¬
ing results obtained on tissues of the human female
reproductive tract in vitro. Bygdeman and Eliasson30
showed that isolated myometrial strips from non¬
pregnant females are inhibited by prostaglandins Ex,
E2 and E3. Prostaglandins FXa and F2a usually cause
contraction but are rather inactive. Pickles and
Hall31 obtained similar results, but their preparations
were more sensitive to prostaglandin F2a (contracting
in the approximate range of 2 to 20 ng/ml), and the
responses they obtained with prostaglandin E2 were
sometimes stimulant and sometimes inhibitory. Hu¬
man Fallopian tubes in vitro are contracted by pro¬
staglandin Ex at their uterine ends but elsewhere are
relaxed like the uterus itself28.
Although Sandberg, Ingelman-Sundberg and
Ryden28 postulate that prostaglandin is absorbed
from the posterior fornix and transported to the uterus
and tubes, a simple calculation indicates that the con¬
centrations likely to be achieved by such a process
would be low. For example, assuming that 5 ml of
semen containing 70 /ug of prostaglandin/ml (Table I)
is deposited in the vagina of a woman with a blood
volume of 5 1, then the maximum concentration of
prostaglandin which could be achieved in the circula¬
tion would be 70 ng/ml. In order to act upon tissues the
prostaglandin would have to pass into the interstitial
fluid and so further dilution would occur. This calcu¬
lation assumes that all the prostaglandin would be ab¬
sorbed before any had been lost by excretion or inac-
tivation, yet we know that prostaglandin is removed
from the blood during its passage through the heart
and lungs, and that it is excreted in the urine (see be¬
low). The problem of whether or not prostaglandin is
absorbed from the vagina in physiologically significant
amounts will probably have to be solved by experi¬
ments on human subjects.
Little is known about the actions of prostaglandins
on smooth muscle of the male reproductive tract.
Adrenaline induced contractions of the vas deferens of
the rabbit both in vivo and in vitro are inhibited by
prostaglandin Ex32, but the absence of prostaglandin
from the semen and male reproductive tract organs of
the rabbit suggests that this effect is of no physio¬
logical significance.
20 S. Bergstrom, R. Eliasson, U. S. von Euler, and J. Sjovall,
Acta physiol. scand. 45, 133 (1959).
21 E. W. Horton, Nature (Lond.) 200, 892 (1963).
22 E. W. Horton and I. H. M. Main, Brit. J. Pharmacol. 21, 182
(1963).
23 E. AnggArd and S. Bergstrom, Acta physiol. scand. 58, 1 (1963).
24 W. J. Hall and V. R. Pickles, J. Physiol. (Lond.) 169, 90 P
(1963).
25 E. W. Horton, I. H. M. Main, and C. J. Thompson, to be pub¬
lished.
26 E. W. Horton, I. H. M. Main, and C. J. Thompson, J. Physiol.
(Lond.) 168, 54 P (1963).
27 E. W. Horton and I. H. M. Main, to be published.
28 F. Sandberg, A. Ingelman-Sundberg, and G. Ryden, Acta
obstet. gynec. scand. 42, 269 (1963).
29 E. W. Horton and C. J. Thompson, Brit. J. Pharmacol. 22, 183
(1964).
30 M. Bygdeman and R. Eliasson, Med. exp. 9, 409 (1963).
31 V. R. Pickles and W. J. Hall, J. Reprod. Fertil. 6, 315 (1963).
32 S. W. Holmes, E. W. Horton, and I. H. M. Main, Brit. J. Phar¬
macol. 21, 538 (1963).
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Actions on respiratory smooth muscle. Main33 has
shown that prostaglandins inhibit respiratory smooth
muscle. In experiments on isolated tracheal chains
from cats, monkeys, rabbits, guinea-pigs, ferrets, pigs
and sheep, prostaglandin Ej inhibited contractions
produced by adding acetylcholine to the organ bath.
On preparations which possessed inherent tone the in¬
hibitory action of prostaglandin could be detected
without the prior addition of a stimulant drug. The
cat isolated tracheal chain was the most sensitive of all
the preparations, sometimes responding to as little as
1 ng of prostaglandin Ej/ml. On this tissue prostaglan¬
din E2 is equi-active with E,, but E3 has l/5 and Fla
only 1/600 of the activity of Ej. More recently, Horton
and Main27 have shown that prostaglandin F2a is also
less active on the cat isolated trachea, having about
1/30 of the activity of Ej, but even at high concentra¬
tions the response to prostaglandin F2a is always in¬
hibition. Anggard and Bergstrom had previously re¬
ported very weak contractions of cat, rabbit and
guinea-pig tracheal chains at rather high concentra¬
tions of prostaglandin F2ct (2.5 //g/ml); prostaglandin
F2a had no effect on isolated bronchial chains from cats
in concentrations up to 2.5 //g/ml23.
When the peripheral stump of the vagus nerve is
stimulated in the neck or when histamine is injected
intravenously, bronchial resistance is increased in
anaesthetized rabbits and guinea-pigs as measured by
the Konzett and Rossler method. This increased bron¬
chial resistance, or perhaps more accurately 'increased
resistance to inflation', is partially antagonized by
prostaglandin Ex injected intravenously in doses of 0.1
/tg/kg (guinea-pig) and 1.6 //g/kg (rabbit)33. The in¬
hibitory action of prostaglandin E3 on bronchial re¬
sistance in the guinea-pig cannot be demonstrated un¬
less bronchial tone is first increased by vagal stimula¬
tion or a bronchoconstrictor drug21'33, but in the rab¬
bit there is sometimes a decrease in the normal level
of bronchial resistance following an injection of pro¬
staglandin Ex. In the cat both prostaglandin Ej (0.3
ytig/kg)33 and prostaglandin F2c( (15 //g/kg)23 increase
resistance to inflation.
Although prostaglandin E's are more potent in¬
hibitors of smooth muscle than prostaglandin F's,
F2ct is the prostaglandin which occurs most commonly
in the lungs (Table I). Perhaps prostaglandin F2a is
stored as a less active precursor of prostaglandin E2
which is the compound of more immediate physio¬
logical importance.
Actions on the cardiovascular system. Prostaglandins
lower systemic arterial blood pressure when injected
intravenously, the E's being more potent than the
p's 2o, 22,23,27,34 part at least of this depressor action of
the prostaglandins is due to vasodilatation; blood flow
through skeletal muscle in the cat is increased by intra¬
arterial injection of prostaglandins Ej, E2, E3, Flct and
F2lI22'23'27. Intravenous infusions of prostaglandin Ej
in two healthy human subjects caused some reduction
in cardiac output accompanied by slight tachycardia35,
suggesting that decreased cardiac output may be con¬
tributory to the depressor action. Tachycardia was
also observed in the cat following an intravenous in¬
jection of prostaglandin Ej33, but intravenous pro¬
staglandin F2a in the cat produces a bradycardia which
is abolished by atropine26. Prostaglandin Ej has no
effect on the isometric contractions of the sponta¬
neously beating isolated guinea-pig atria, nor does it
affect the positive inotropic responses of this prepara¬
tion to catechol amines32.
During the period following injection of prostaglan¬
din E1 intravenously or intra-arterially, the pressor
and vasoconstrictor responses to angiotensin, vaso¬
pressin, adrenaline and noradrenaline are reduced32.
This is not due to a simple algebraic summation of op¬
posite effects but appears to represent a decreased
responsiveness of the vascular smooth muscle to vaso¬
constrictor substances for some time after exposure to
prostaglandin.
Unlike several naturally-occurring vasodilator sub¬
stances (for example bradykinin, histamine and
acetylcholine), prostaglandin Ex does not release
adrenaline from the adrenal medulla when injected
close-arterially21. Prostaglandin Et also has only a
weak action in increasing capillary permeability21.
The effects of prostaglandins on blood vessels are of
doubtful physiological significance. It is improbable
that prostaglandins would be released as local metabo¬
lites in functional hyperaemia, other more potent vaso¬
dilators being readily available in larger amounts. The
vasodilator potency of the most active prostaglandins,
namely Ex and E2, is certainly less than that of brady¬
kinin for example21. If prostaglandins ever circulate in
the blood under physiological conditions, it seems
likely that they would do so at concentrations con¬
siderably lower than those necessary to produce a
depressor effect (compare the concentrations of vaso¬
pressin necessary to produce antidiuresis and vaso¬
constriction).
Actions on intestinal smooth muscle. Isolated seg¬
ments of intestinal smooth muscle of most species in¬
vestigated contract in response to low concentrations
of the prostaglandins, the rabbit isolated duodenum
and jejunum respond to 0.25 ng prostaglandin F2a/ml
for example23-27. This type of preparation has therefore
been widely used for the estimation of prostaglandin.
Other sensitive tissues include the guinea-pig ileum,
hamster colon, chicken jejunum, chicken rectal caecum
and rat jejunum5'20-23'27'34. In contrast to tissues on
33 i. H. M. Main, Brit. J. Pharmacol. 22, 511 (1964).
34 S. Bergstrom and U. S. von Euler, Acta physiol. scand. 59,
493 (1963).
35 S. Bergstrom, H. Duner, U. S. von Euler, B. Pernow, and
J. Sjovall, Acta physiol. scand. 45, 145 (1959).
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which prostaglandins exert an inhibitory effect where
prostaglandin E's are more potent than the F series,
these intestinal preparations are often more sensitive
to the prostaglandin F's. Whether prostaglandins have
any local role in the control of intestinal movements
which are independent of innervation is a problem
which awaits further study.
Actions on the nervous system. Injections of prosta¬
glandins Ej, E2 and E3 in doses of 10 to 60 fig into the
cerebral ventricles of unanaesthetized cats are followed
after a latent period of 20 min or more by signs of
sedation and catatonic stupor36. The stupor lasts for
several hours and the cat shows diminished sponta¬
neous activity for up to 48 h after the injection. On
the other hand, the righting reflex is always present
and when the cat is disturbed its movements are brisk
and show no evidence of ataxia. In marked contrast,
prostaglandin F2a, the only prostaglandin so far found
in tissues of the central nervous system16, produces no
detectable changes in cats following injections into
the ventricles in doses equal to or higher than those of
prostaglandin Ej necessary to produce pronounced
catatonia37. The catatonia and stupor are therefore
not due to some non-specific physico-chemical effect
of long-chain fatty acids since a simple reduction of
the oxo group in the prostaglandin E molecule aboli¬
shes (or lessens) its activity.
Using an iontophoretic technique for applying sub¬
stances to single cells, Krnjevic (personal communi¬
cation) detected no significant effect of prostaglandin
E-l on 18 cortical neurones in two cats. There was no
excitation of quiescent cells, no excitation or depression
of spontaneously active cells, no effect on glutamate
firing, no change in response of cholinoceptive cells to
firing by acetylcholine and no change in the effective¬
ness of y-aminobutyrate as a depressant of glutamate
firing.
Some rather transient sedation is the only effect
seen following intravenous injection of prostaglandin
E-l (20 /<g/kg) in cats. A decrease in spontaneous ac¬
tivity of mice lasting for about 1 h is observed follow¬
ing intravenous or subcutaneous injections (unpub¬
lished observations). In the young chick, which is be¬
lieved to lack a blood brain barrier, prostaglandins are
particularly active on the central nervous system.
Prostaglandins Ej, E2 and E3 in doses as low as 1 /<g
injected intravenously cause sedation with cessation
of spontaneous movements, closure of the eyes and,
in higher doses, loss of righting reflexes30. In contrast,
prostaglandin F2;x produces not sedation but a postural
defect. The limbs extend or abduct often to extreme
degrees, but the legs appear not to be paralysed37. All
these effects are temporary; the chicks recover com¬
pletely after 10 min to 2 h depending upon the dose.
Little work has been reported on the actions of
prostaglandins on the peripheral nervous system.
Prostaglandin Ej in concentrations from 0.1 to 100
jug/ml when applied to exposed blister bases on the
human forearm did not give rise to any sensation of
pain or itch21. Bradykinin (0.1 fig/ml) and 5-hydroxy-
tryptamine (0.01 fig/ml) were effective in producing
a sensation of pain on these preparations.
Part of the stimulant action of prostaglandin Ej on
the guinea-pig isolated ileum appears to be mediated
by a nervous pathway since the response is partially
antagonized by atropine (0.01 /rg/ml) (unpublished
observations). Contractions of the cat nictitating
membrane produced by pre-ganglionic cervical sym¬
pathetic nerve stimulation were unaffected by pro¬
staglandin El injected either intravenously or into the
common carotid artery, although relaxations of the
membrane after cessation of stimulation were more
rapid in the period immediately following prostaglan¬
din administration32. There was no evidence in these
experiments to suggest that ganglionic transmission is
affected by circulating prostaglandin but experiments
using more refined techniques are needed in order to
be certain of this.
Actions on adipose tissue. Rat epididymal fat pads
incubated in vitro release glycerol and fatty acids into
the medium in response to catechol amines, cortico-
trophin, glucagon and thyroid stimulating hormone.
The presence of prostaglandin Ej in concentrations of
20 ng/ml or more inhibits the lipolysis induced by
these agents38. Although prostaglandin Ex suppresses
adrenaline-induced activation of lipase, it does not
affect adrenaline-induced activation of phosphorylase,
an enzyme also present in adipose tissue. Bergstrom,
Carlson and Oro 39 in experiments on anaesthetized
dogs have shown that prostaglandins ~E1, E2 and E3 are
very potent also in vivo in inhibiting catechol amine-
induced lipolysis, although prostaglandin Flct is inac¬
tive, at least in doses similar to those of the E's. Doses
which were effective in lowering plasma free fatty acid
levels also produced a slight fall in blood pressure but
the effect on the fatty acids was more prolonged. In¬
creases in blood glucose due to injections of adrenaline
were only moderately inhibited by prostaglandin Ex.
In contrast to these results in dogs, prostaglandin Ej
infusion in human subjects increases the arterial level
of free fatty acids and does not counteract the rise in
free fatty acids produced by noradrenaline13.
Actions on micro-organisms. Long-chain fatty acids
inhibit the growth of certain bacteria and yeasts, and
the presence of such substances accounts for the anti¬
bacterial activity of human sebaceous secretions40.
36 E. W. Horton, Brit. J. Pharmacol. 22, 189 (1964).
37 E. W. Horton and I. H. M. Main, submitted for publication to
Int. J. Neuropharmacol. (1964).
38 D. Steinberg, M. Vaughan, P. J. Nestel, and S. Bergstrom,
Biochem. Pharmacol. 12, 764 (1963).
39 S. Bergstrom, L. A. Carlson, and L. Oro, Acta physiol. scand.
60, 170 (1964).
40 J. M. L. Burtensiiaw, J. Hygiene (Lond.) 42, 184 (1942).
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Holmes41 has recently shown that prostaglandin E^
although a long-chain fatty acid, does not have an
inhibitory action on the growth of micro-organisms in
vitro in concentrations up to 1 mg/ml, whereas un-
decenoic, lauric and ricinoleic acids were inhibitory
against some or all of the organisms tested. These ob¬
servations would seem to exclude the possibility that
prostaglandins provide some form of chemical defense
mechanism in the tissues in which they occur.
Metabolism of prostaglandin Ev Intra-aortic infu¬
sions of prostaglandin Ex inhibit noradrenaline-induced
fat mobilization in dogs more effectively than intra¬
venous infusions, suggesting that prostaglandins are
either taken up or inactivated by the lungs (and/or
heart)39. Similar differences have been observed in
ewes25. Samuelsson42 has reported that when tritium-
labelled prostaglandin Ex is injected subcutaneously in
rats, most of the radioactivity appears in the urine
and about a one fifth in the faeces.
Miscellaneous observations (unpublished). In the
water-loaded ethanol-anaesthetized rat43, prostaglan¬
din Ex injected intravenously decreased urine flow but
only in doses which lowered arterial blood pressure.
The rats responded to 0.01 milliunits of vasopressin,
but these antidiuretic responses were unaffected by
previous administration of prostaglandin Et in doses
which produce a slight depressor response. This con¬
trasts with the observation24 that prostaglandin E2
potentiates oxytocic responses to vasopressin in vitro,
and with the observation that pressor responses to
vasopressin are temporarily abolished after prostaglan¬
din Ej32.
The presence of high concentrations of prostaglan¬
din in human semen (Table I) does not appear to be
essential for sperm motility. Two equal portions of a
freshly collected sample of human semen were centri-
fuged and the deposited sperms were re-suspended in
artificial seminal plasma. One plasma contained pro¬
staglandin Et (100 ^g/ml), the other contained no
prostaglandin. The total number of motile sperms in
the two aliquots was not significantly different even
after three such washings when the % motility was
still 75% of the initial figure.
The beating of cilia of the epithelium lining the rab¬
bit trachea was not affected by the presence of pro¬
staglandin Ej (10 /<g/ml) as measured by observing the
rate of movement of foreign particles under the micro¬
scope. The movement of the particles could be blocked
by atropine and the rate increased by eserine.
Discussion. The concept that the significance of
prostaglandin is confined to the reproductive tract is
no longer tenable. Prostaglandins are widely distri¬
buted throughout the body and they have an equally
wide range of biological activities; indeed all organs
from which prostaglandins have been isolated contain
some cells (in addition to vascular smooth muscle)
which respond to their presence. The thymus may be
an exception to this generalization.
The idea that prostaglandins are hormones which
circulate and act upon a variety of tissues is also diffi¬
cult to accept on the present evidence. Prostaglandin
Ej, for example, inhibits the tone of vascular, respira¬
tory and reproductive smooth muscle, inhibits the
mobilization of fats and, if the dose is adequate, de¬
presses central nervous activities. Under what circum¬
stances would such a combination of diverse effects
be likely to occur ? It is conceivable, of course, that
prostaglandins circulate in concentrations lower than
those required to produce the effects described above
and that the truly physiological responses to these low
concentrations remain to be elucidated.
Another possibility is that prostaglandins act
locally, perhaps intracellularly as coenzymes. For ex¬
ample, the prostaglandin E's and F's may function in
pairs, the conversion of an F to an E providing two
hydrogen atoms for a hydrogenase system and vice
versa. Some observations are difficult to explain on
this hypothesis. If a prostaglandin E acting as a
hydrogen acceptor relaxes smooth muscle then the
corresponding F acting as a hydrogen donor might be
expected to have the opposite action to E or possibly
no action, but not to have the same effect as occurs
with respiratory and vascular smooth muscle.
The position may be analogous to that of the
adrenal corticosteroids. Many biologically-active ste¬
roids have been isolated from the adrenal cortex but
only a few are actually secreted, the remainder being
precursors in the biosynthetic pathway. If the pro¬
staglandins are similar in this respect, then the F's
must be considered as less active precursors of com¬
pounds of greater physiological significance (the cor¬
responding E's). It is the F's which are predominantly
stored in many tissues. According to this hypothesis
F2a in lung is functionally important only as a pre¬
cursor of E2, which possibly has some role in the con¬
trol of respiratory smooth muscle tone. In the brain
prostaglandin E2, having been formed in small amounts
from F2a, may act upon a similar biochemical pathway
in nervous tissue. The dramatic effects seen on intra-
cerebroventricular injection of the E's could be inter¬
preted as due to the presence of a great excess of a
compound which is normally present in only minute
quantities. On the other hand F2a, although it is the
compound normally present in larger amounts, is less
active and therefore has no effect on intraventricular
injection. Furthermore, the rate of conversion of
to E2 is probably too slow for any detectable effects
41 S. W. Holmes, to be published.
42 B. Samuelsson, Sixth International Congress of Biochemistry,
New York (1964), Pre-circulated Abstracts, p. 593.
43 G. W. Bisset, Brit. J. Pharmacol. 18, 405 (1962).
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due to increased E2 to be observed following an injec¬
tion of F3a.
The idea that F is a less active precursor of E is, to
some extent, supported by the findings in semen. If
the E's are the physiologically important compounds,
then it is to be expected that E's and not F's would be
secreted by the seminal vesicles. In this instance the
semen is not a storehouse for prostaglandin (like lung
and brain) but a secretion which must contain its
prostaglandins in an already active state. Both human
and sheep semen contain predominantly prostaglan¬
din E's (Table I).
Table II shows the relative activities of prostaglan¬
din E's and F's on seventeen biological preparations.
On those which are inhibited by prostaglandins, E's
are always more potent than F's, but on tissues which
are stimulated the ratios of activity are more variable,
the two prostaglandins tending often to be equi-
active. It is of interest in this connection to compare
these effects with those of adrenaline and noradrena¬
line. In general, adrenaline (like prostaglandin E's) has
more potent inhibitory actions but both catecholamines
(and both prostaglandins) are very active on tissues
Table II. Relative biological activities of prostaglandins E's and F's
on various preparations. An asterisk indicates that the figure was
calculated from results obtained from two sources
Biological
preparation
Response Ei/Fia E2/F2a Reference
Cat isolated Inhibition 500 30* 33, 27
trachea
Guinea-pig Contraction 45, 43 20, 22
isolated ileum
Chicken jejunum Contraction 40 20
Cow isolated Contraction >30 20
iris
Rabbit B.P. Depressor >20, 13 20, 22
Chick Sedation > 15* 36, 37
Rat isolated Contraction 12 20
jejunum
Cat Stupor >6* 36, 37
Cat skeletal muscle Dilatation 4.5 22
blood vessels
Hamster isolated Contraction 4.2 22
colon
G.P. isolated Contraction 3 20
uterus
Fat mobilization Inhibition >2 33
Chicken rectal Contraction 1.8 20
caecum
Rat isolated Contraction 0.5, 1.0 20, 22
uterus
Rabbit isolated Contraction 0.6, 0.45 20, 22
jejunum
Rabbit isolated Contraction <0.5 20
uterus
Rabbit oviduct Inhibition (Prostaglandin 22, 27
in vivo F's contract)
which are stimulated. A further point of similarity may
be that in both cases a more potent inhibitor (adrena¬
line and prostaglandin E) is formed in the tissues from
a less potent inhibitor (noradrenaline and prostaglan¬
din F). The inhibitory and excitatory effects of pro¬
staglandins, like those of the catecholamines, may
each have a physiological importance at different sites.
Most of these speculations are based upon insufficient
and incomplete evidence. Our knowledge of the distri¬
bution, metabolism and actions of the prostaglandins
is still fragmentary and certainly does not allow any
but the most tentative conclusions to be drawn at the
time of writing. The functional significance of the
prostaglandins still eludes us.
Resume. Les prostaglandines sont des acides gras
non satures existant a l'etat naturel et contenant un
anneau de cyclopentane; elles ne different les unes des
autres que par leur degre de non-saturation et la pre¬
sence dans 1'anneau d'un substituant oxo (prostaglan-
dine E) ou hydroxy (prostaglandine F). Les pro¬
staglandines ayant une ou deux liaisons doubles sont
plus actives au point de vue biologique que les pro¬
staglandines ayant trois liaisons doubles. La reduction
du groupe oxo a un effet prononce sur l'activite bio¬
logique. C'est ainsi que les prostaglandines F inhibent
moins que les prostaglandines E le muscle lisse vascu¬
lare, respiratoire et reproducteur et la mobilisation
des lipides et causent une sedation et une stupeur moins
fortes chez les animaux non anesthesies. D'autre part,
le muscle lisse qui est contracte par les prostaglandines,
comme par exemple l'intestin du lapin, est souvent
plus sensible aux F qu'aux E. Les prostaglandines F
abondent dans les tissues animaux et on suggere
qu'elles sont peut-etre les precurseurs des E plus ac¬
tives dans certains organes, par exemple le poumon et
le cerveau.
On discute le role physiologique eventuel des pro¬
staglandines. II est, pense-t-on, peu probable que leur
importance fonctionnelle soit limitee a la physiologie
de la reproduction, bien que cette fonction puisse etre
importante. On postule que si les prostaglandines cir-
culent sous forme d'hormones, elles le font dans des
concentrations plus faibles que celles qui affectent la
pression arterielle. Alternativement, les prostaglan¬
dines peuvent agir localement, peut-etre a l'interieur
des cellules sous forme de co-enzymes. Par exemple,
les prostaglandines E et F peuvent fonctionner par
paires, la conversion d'une F en E fournissant deux
atomes d'hydrogene par systeme d'hydrogenase et
vice versa. L'abondance des prostaglandines et la diver-
site de leurs effets biologiques suggerent certainement
qu'elles jouent un role general de cet ordre dont 1'im-
portance est fondamentale.
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By acid ether extraction and thin-layer chromatography, prostaglandins have been
separated from biologically active compounds of other chemical groups. The
technique does not, however, separate different prostaglandins from each other. The
biological activity of the eluates was estimated on the rabbit isolated jejunum and
the hamster isolated colon preparations in terms of prostaglandin Ei; the concentra¬
tions (thus expressed) of prostaglandin in human semen ranged from 24 to 783 /<g/ml.
with a mean of 226 «g/ml. No prostaglandins (minimal detectable concentration,
0-5 pg/g) could be detected in the male reproductive organs of several species of
laboratory animal.
Bergstrom and his co-workers have isolated and determined the structure of
six prostaglandins (Bergstrom, Ryhage, Samuelsson & Sjovall, 1962), all of which
occur in human semen (Samuelsson, 1963). One or more prostaglandins have also
been isolated from sheep prostate glands (Bergstrom & Sjovall, 1960a,b ; Bergstrom,
Dressier, Ryhage, Samuelsson & Sjovall, 1962), sheep semen (Bergstrom, Krabisch
& Sjovall, 1960), sheep and pig lung (Bergstrom, Dressier, Krabisch, Ryhage &
Sjovall, 1962), calf thymus (Bergstrom & Samuelsson, 1963) and human menstrual
fluid (Eglinton, Raphael, Smith, Hall & Pickles, 1963).
In this paper a method is described for the extraction of prostaglandins from
tissues and for their separation from biologically active substances of other groups
by thin-layer chromatography. After elution, prostaglandin activity was assayed
in parallel on the rabbit isolated jejunum and the hamster isolated colon preparations
in terms of pure prostaglandin Et. A preliminary report of this method has been
published (Horton & Thompson, 1963).
METHODS
Collection of semen. Human semen was obtained from fertility clinics through the kind
•co-operation of Dr D. F. Hawkins of University College Hospital, London. Ejaculates were
poured into a bottle containing 50 ml. of 0.2 M-phthalate buffer (pH 4) and 500 ml. of diethyl
ether. The pooled samples so collected were extracted at two-weekly intervals. Ram semen,
•collected out of season by electro-ejaculation, was kindly provided by Dr H. M. Dott of the
Agricultural Research Council's Unit of Reproductive Physiology, Cambridge. Rabbit
semen was collected by the method of Macirone & Walton (1938).
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Extraction of semen. The samples of human semen were extracted three-times with 250 ml.
of diethyl ether. The pooled ether phases were evaporated to dryness on a rotary film
evaporator. The residue was weighed and then dissolved in a mixture of methanol and chloro¬
form (1:1). Ram and rabbit semen in phthalate buffer were extracted with ether in a similar
way.
Extraction of tissues from the male reproductive tract. The seminal vesicles and prostate
glands from rabbits, guinea-pigs, hamsters, rats and mice, and the bulb of the penis of the
cat and the testis of the ferret were removed from freshly killed animals. The tissues were
weighed and then ground up in 0.1 M-phthalate buffer (pH 4). After three extractions with
two volumes of ether, the pooled ether phases were evaporated to dryness and the residue
was dissolved in the chloroform: methanol mixture and chromatographed as described for the
semen extracts.
Thin-layer chromatography of extracts. A Desaga Thin Layer Spreader was used to prepare
a layer of Silica Gel G (Merck), 250 my. thick. The plates were then dried in an oven at
120° C for 30 min. The solutions in methanol: chloroform mixture, volumes of 5, 10 and
20 pi., were spotted on to a 10x20 cm marker plate, with the origin 1.5 cm from the bottom
edge. The developing solvent was a mixture of diethyl ether, petroleum ether (60 to 80° C
boiling range), glacial acetic acid and methanol (50:40:5:5), and it was allowed to run to a
line 10 cm from the origin. The spots were located under ultra-violet light after spraying with
fluorescein and contrasting with bromine vapour. They were then sprayed with 50% sulphuric
acid and heated for 15 to 30 min to provide additional confirmation. Pure prostaglandin Ei
was used as a marker. Preparative plates (20 x 20 cm) were run under identical conditions to
the marker plates, and the solution in methanol: chloroform mixture was applied at 5 mm
intervals. Between 1 and 3 mg of residue were applied to the plate. After development, the
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Fig. 1. (a) Isotonic contractions of a rabbit's isolated jejunum preparation in a 5 ml. organ-bath
containing atropinized (1 /xg/'ml.) Tyrode solution at 36° C. Responses are shown to the
standard prostaglandin Ej (Std, 800 ng) and to the eluates (diluted 1 in 20, 0.2 ml. samples,
Ell, etc.) from the four zones of a preparative thin-layer chromatogram of an ether-extract of
human semen, (b) A tracing of the corresponding marker plate on which 5 and 10 pi. of extract
of human semen and of pure prostaglandin Ej were chromatographed. The origin is on the
left and the solvent front on the right of the diagram. The spots on the marker plate were
identified under ultra-violet light after treating the plate as described in Methods.






appropriate zones of silica gel, as indicated by the marker plate and shown in Fig. 1, were
scraped off. Elution was carried out by shaking the silica gel with methanol. After filtering
off the silica gel with a sintered glass funnel, the methanol was removed on a rotary film
evaporator and the dry residue taken up in 1 ml. of water for biological assay.
Biological assays. Eluates from the chromatograms of human semen extracts were always
assayed in parallel on both rabbit jejunum and hamster colon preparations. Eluates from
chromatograms of other tissue extracts were assayed on one preparation only. All estimations
are expressed in terms of pure prostaglandin Ei on the basis of bracketing assays.
Rabbit isolated jejunum. A 3 to 4 cm segment from the duodeno-jejunal region of the
small intestine was removed from rabbits which had been stunned by a blow on the head and
killed by exsanguination. The tissue was suspended in a 4 ml. organ-bath containing aerated
Tyrode solution at 35 to 36° C. A dose cycle of 3 to 5 min was used with 45 to 90 sec
contact. Isotonic contractions were recorded on a smoked drum using a frontal writing point
lever, with a tension of 1 to 1.5 g and a five-fold magnification.
Hamster isolated colon. A 3 to 5 cm segment of the ascending colon was removed from
hamsters, which had been killed by a blow on the head. The procedure was identical to that
described for the rabbit jejunum, except that the tension applied was 0.6 to 0.8 g.
RESULTS
Thin-layer chromatography of extracts of human semen. Numerous solvent
mixtures were tested as developing solvents in an attempt to separate the
prostaglandins from other lipid constituents of human semen by thin-layer chromato¬
graphy. When the mixture (diethyl ether: petroleum ether: glacial acetic acid:
methanol) was used several spots separated, as shown by ultra-violet light. When
pure prostaglandin was run in parallel in this solvent system, it had an RF value
of about 0.25, which corresponded to the position of a discrete spot on the
chromatogram of the seminal extracts. On the basis of the chromatographic distri¬
bution of the components of the seminal extracts, four zones were marked out on
the plates (Fig. 1). The first zone, from 0.5 cm below to 1.25 cm above the origin,
contained those substances which moved little, if at all, from the origin. The
second zone (from 1.25 to 3 cm) contained the prostaglandins. The third zone
(from 3 to 6 cm) contained other lipid components of the seminal extracts, and the
fourth zone (from 6 to 10 cm) represented the remainder of the plate up to the solvent
front which, in the case of the seminal extracts, usually contained no substances.
After developing the preparative plates, the four zones were scraped off and eluted
separately. Almost all biological activity of the ether extracts of semen was found
in zone 2, which corresponded to the position of the prostaglandin E( spot.
The biological activity of residues which had not been chromatographed varied
between 84 and 120% of the activity of the corresponding eluate from zone 2.
This variation is within the limits of error of the biological assay.
Concentration of prostaglandin in human semen. Two aliquots of each extract
were chromatographed on two preparative plates on different days. The eluates
from all zones of both plates were assayed on both the rabbit jejunum and the
hamster colon preparations. Four separate estimates of the biological activity of
the zone of the chromatogram corresponding to the prostaglandin spot were therefore
obtained for each sample. In general there was reasonable agreement between
the results of the assays (Table 1). The concentration of prostaglandin in fourteen
186 E. W. HORTON and C. J. THOMPSON
Table 1
CONCENTRATION OF PROSTAGLANDIN IN FOURTEEN POOLED SAMPLES OF
HUMAN SEMEN
All samples were run on two thin-layer chromatograms and the zones corresponding to the position
of prostaglandin HL were eluted and assayed using prostaglandin Et as standard. The four results
so obtained and the means are given
Weight of Prostaglandin Ex-equivalent
Volume residue f/xg/ml. semen)
of semen extracted by
(ml.) ether (mg) Rabbit jejunum Hamster colon Mean
4-0 18 320, 212 471, 529 383
13-5 270 796, 844 746 783
49-4 134 111, 109 111, 109 110
52 98 32, 41 16, 21 27
3 33 313, 104 835, 42 324
33 183 11, 21 21, 42 24
13 240 47, 30 47, 26 37
10 275 88, 70 88, 70 79
24 195 466, 391 466, 520 461
2-6 32 133, 190 133, 190 162
2-0 322 164, 261 164, 164 188
49 847 192, 240 480, 360 318
29 204 111, 74 37, 37 65
7-0 91 204, 382 115, 130 208
Total means 213 240 226
pooled samples of human semen, in terms of prostaglandin E,, ranged from 24 to
783 /rg/ml. with a mean of 226 ,«g/ml.
Concentration of prostaglandin in other tissues and tissue fluids. Sheep semen
contained 7.3 ,"g/ml. of prostaglandin Ex-equivalent and rabbit semen (six samples)
less than 0.5 «g/ml. In none of the following tissues could prostaglandin be
detected (minimal detectable concentration, 0.5 jug/g); the seminal vesicles and
prostate glands of rabbits, guinea-pigs, hamsters, rats and mice, the ferret testis and
the bulb of the penis of the cat.
DISCUSSION
Previous estimates of the concentration of prostaglandin in human semen were
expressed in terms of arbitrary standards (Asplund, 1947 ; Eliasson, 1959 ; Hawkins
& Labrum, 1961). Since then prostaglandin EL has been isolated in pure form
(Bergstrom & Sjovall, 1960b), and it has therefore been possible, in the present
investigation, to express the concentrations as prostaglandin Ex-equivalents in jug/ml.
The original standard of Euler has been compared directly with pure prostaglandin
E, and, on the rabbit isolated jejunum at least, it contains the prostaglandin E^
equivalent of 4.5 ug/Euler's unit (BergstrOm, Eliasson, Euler & Sjovall, 1959).
Asplund (1947) used this standard for his assays of prostaglandin in human semen,
while Eliasson used a standard which was 1.5-times more active. No direct
comparison was made between the standard used by Hawkins & Labrum (1961) and
either Euler's standard or pure prostaglandin Et. However, Hawkins & Labrum
state that the rabbit isolated jejunum and the guinea-pig isolated ileum preparations
respond with small contractions to 0.0005 U/ml. of their standard. Since these
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preparations usually respond to a threshold concentration of 8 to 12 ng/ml. (Horton
& Main, 1963), the standard of Hawkins & Labrum must have contained the equiva¬
lent of about 20 /ug of prostaglandin Ej/U. Using these calculated conversion factors,
the results of the various workers can be expressed in terms of prostaglandin
E^equivalents in /rg/ml. The results are summarized in Table 2. There is
remarkably good agreement between the results of the four investigations.
Table 2
COMPARISON OF THE ESTIMATED CONCENTRATIONS OF PROSTAGLANDIN IN
HUMAN SEMEN REPORTED BY FOUR GROUPS OF INVESTIGATORS
The results of previous workers have been converted to prostaglandin Ej-equivalents (/u.g/ml. of




of 1 unit No. of
Reference (Fg/U) Mean Range samples Origin of samples
Asplund (1947) 4-5 37 <20->90 155 Individual ejaculates from
fertility clinics
Eliasson (1959) 6-75 81 10-203 16 Individual ejaculates from
sixteen infertile patients
187 74-405 13 Individual ejaculates from
three healthy subjects
Hawkins & Labrum 20 122 34-448 50 individual ejaculates from
(1961) fertility clinics
Present investigation — 226 24-783 14 Pooled samples from
fertility clinics
Each sample assayed in the present investigation represented a mixture of
ejaculates from several individuals all attending fertility clinics. Eliasson (1959)
and Hawkins & Labrum (1961) have produced some evidence that subfertile males
may have low seminal prostaglandin levels. The contribution from subfertile
individuals to the samples collected is unknown, but all the individuals must be
regarded as potentially infertile and some probably were so, and the proportion is
likely to have varied from one sample to another. This could partly account for
the wide range of concentrations.
In agreement with previous workers (Euler, 1936 ; Bergstrom et al„ 1960), we
found that sheep semen contains prostaglandin, though in lower concentrations than
does human semen. Our estimate may not present a normal value because the
semen was collected by an artificial procedure from rams outside the reproductive
season. Rabbit semen and the tissues of the male reproductive tract from the various
species investigated contained less than 0.5 Mg/g of prostaglandin. These findings
also confirm previous reports that prostaglandins are either absent or present only
in low concentrations in these tissues (Euler, 1937 ; Eliasson, 1959).
The present method has the advantage that the presence of biologically active
substances of a non-lipid nature (for example, choline, histamine, adrenaline and
bradykinin) in the final eluates can definitely be excluded. Even if these substances
passed into the ether phase during extraction, they would not move from the origin
when the chromatogram developed with the solvent mixture used in these experi¬
ments. It is likely that most of the activity in the final eluates was due to prosta¬
glandins. However, the method does have the disadvantage that a separate estimate
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of the concentrations of the different prostaglandins is not possible. When this
investigation was begun the chemical identity of the prostaglandins in human semen
was unknown. Later prostaglandin Ex was isolated from semen (Bergstrom &
Samuelsson, 1962). More recently the presence in semen of the five other prosta¬
glandins has been reported (Samuelsson, 1963). Clearly the next step must be the
development of a method for the separate estimation of these six prostaglandins.
We thank Professor S. Bergstrom for kindly supplying the pure prostaglandin Ei used in
this investigation.
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Prostaglandins are widely distributed in animal tissues (Bergstrom,
1964; Samuelsson, 1964), but they are found in particularly high concen¬
trations in human and ram semen (Bergstrom, Krabisch & Sjovall, 1960;
Eliasson, 1959; Hawkins & Labrum, 1961; Horton & Thompson, 1964;
Samuelsson, 1963). It has been suggested that the physiological signifi¬
cance of these high concentrations may be related to the effects which
prostaglandins have on female reproductive smooth muscle. Uterine and
oviduct smooth muscle is contracted or relaxed by prostaglandins, the
effect depending upon the species and upon the type of prostaglandin
(Anggard & Bergstrom, 1963; Bergstrom, Eliasson, von Euler & Sjovall,
1959; Bygdeman & Eliasson, 1963; Hall & Pickles, 1963; Horton & Main,
1963, 1965; Pickles & Hall, 1963; Sandberg, Ingelman-Sundberg & Ryden,
1963). As a result of coitus in humans and sheep a high local concentration
of prostaglandin will occur in the upper vagina; it is likely therefore that
this prostaglandin has a direct effect on smooth muscle of the cervix.
Effects of prostaglandins on oviduct smooth muscle on the other hand are
less likely to be due to such a local action. It has been postulated that
prostaglandins are absorbed from the vagina into the systemic circulation
and so reach the oviducts in addition to other parts of the female re¬
productive tract. By this means prostaglandins may aid sperm transport
and so increase the chances of conception (Asplund, 1947; Horton, Main &
Thompson, 1963; Sandberg et al. 1963). The present investigation was
undertaken to test first whether prostaglandin can be absorbed from the
vagina and secondly whether the amounts reaching the circulation in this
way are sufficient to affect the tone of the oviduct.
We have shown that prostaglandin can be absorbed from the rabbit
* Present address: Department of Physiology, Medical College of St Bartholomew's
Hospital, Charterhouse Square, London, E.C. 1.
f Present address: The Medical Professorial Unit, St Bartholomew's Hospital, West
Smithfield, London, E.C. 1.
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vagina, but that the intravaginal concentrations necessary to produce
detectable effects on intra-luminal pressure of the oviduct are greatly in
excess of those which occur in the rabbit under physiological conditions.
We have also shown that the amount of prostaglandin Ej in ram semen
(about 10 /ig/ejaculate) is insufficient when injected systematically in ewes
to affect oviduct intra-luminal pressure. We conclude that although it is
possible for prostaglandin to reach the circulation from the vagina, the
physiological significance of the low concentrations likely to be thus
achieved has still to be determined.
METHODS
Experiments on anaesthetized rabbits. Female rabbits (2—3-5 kg) were anaesthetized with
urethane (1-75 g/kg) injected intraperitoneally. The trachea was cannulated. An external
jugular vein was cannulated for intravenous injections. Blood pressure was recorded from a
carotid artery with a Statham transducer. The abdomen was opened with a mid-line incision,
and an oviduct was identified. A polyethylene cannula was inserted via an incision in the
uterine horn through the utero-tubal junction and into the uterine end of the oviduct. It
was tied in position taking care not to occlude blood vessels supplying the oviduct. The
cannula was attached to a Statham transducer the side limb of which was connected via
polyethylene tubing to a syringe placed in a Palmer slow injection apparatus. The infusion
system from syringe to cannula contained Tyrode solution and an inflow rate of 27 or
54 /d./min was used. Intra-luminal pressure was recorded with a Grass ink-writing poly¬
graph. The Tyrode solution escaped from the infundibular end of the oviduct into the
peritoneal cavity.
For recording intra-luminal pressure of the uterine horn an incision was made at the
cervical end of the horn and a cannula was inserted towards the oviduct. A second incision
was made in the horn to allow the Tyrode to escape. With rates of infusion of 54-216 /d./min
spontaneous contractions of the uterine horn were observed. These were always less frequent
and more prolonged than those of the oviduct. In some experiments tension of the uterine
horn was recorded isometrically with a Grass force-displacement transducer. The vaginal end
of the horn was attached by a thread to a fixed point and the oviduct end to the transducer;
the lumen of the horn was not perfused in these experiments.
In order to record the intra-luminal pressure of the cervix a cannula was inserted through
an incision at the cervical end of one uterine horn so that its tip lay in the cervical canal. The
vagina was opened to expose the external os and so allow the perfusing Tyrode solution to
escape freely. Intra-luminal pressure was recorded by the same method as used for the
oviduct and uterine horn; the rate of infusion was adjusted until contractions of the
cervix were obtained. These were similar in frequency and magnitude to those of the uterine
horn.
Intravaginal administration of prostaglandin to anaesthetized rabbits. A polyethylene can¬
nula was introduced into the vagina so that its tip lay about 2 cm from the cervix; it was
tied in position internally by a ligature which was passed around the wall of the vagina
taking care not to occlude any of the vaginal blood vessels. The uterus was tied off to prevent
fluid from passing from the vagina to the uterine lumen. Solutions were administered and
withdrawn by means of a syringe attached to a soft polyethylene catheter which was passed
down the vaginal cannula until its tip lay in the lumen of the vagina.
Experiment on an unanaesthetized rabbit. In one rabbit an oviduct was cannulated
aseptically under pentobarbitone sodium anaesthesia in the usual way. The cannula was
brought to the surface via a skin incision on the back of the neck. The abdominal wound was
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sutured and the animal allowed to recover. On the following day records of oviduct intra¬
luminal pressure in the unanaesthetized rabbit were obtained by attaching the cannula to a
Statham pressure transducer and perfusing with Tyrode as described above.
Experiments on anaesthetized ewes. Adult non-pregnant ewes weighing from 39 to 92 kg
wore anaesthetized with pentobarbitone sodium injected via an external jugular vein. The
dose administered initially to induce anaesthesia varied from 27 to 48 mg/kg in different
experiments. The trachea was cannulated immediately. Anaesthesia was maintained by
intravenous injections of further small doses of pentobarbitone sodium at intervals varying
from 15 to 60 min.
An external jugular vein was cannulated for intravenous injections and a common carotid
artery was cannulated for recording arterial blood pressure with a Statham pressure trans¬
ducer. A fine polyethylene catheter was inserted through a small incision in the right
femoral artery and passed retrogradely so that its tip lay either in the thoracic or in the
upper abdominal aorta. The exact position of the catheter was verified at the end of the
experiment. Intra-aortic injections were made through this catheter. Infusions were made
from syringes placed in a Palmer slow injection apparatus.
The intra-luminal pressure of an oviduct was measured with a Statham pressure trans¬
ducer by the technique described above for similar recordings in rabbits. The Tyrode solution
was infused through the lumen of the oviduct at 54 or 108 /d./min.
Hormonal pre-treatment of ewes. The first two ewes were not pre-treated with hormones
and in view of the time of year (March/April) they were unlikely to have been in oestrus. The
third ewe was pre-treated with stilboestrol, 1 mg/day injected subcutaneously on 4 alternate
days for a week before the experiment. The remaining four ewes were pre-treated by the
regime described by Gordon (1963) which is designed to bring about the onset of oestrus.
Progesterone 50 mg (in olive oil) was injected intramuscularly on days 1, 4 and 7. Pregnant
mare's serum (750 units) was injected intramuscularly on day 9 or 10 and the experiment
was performed 2 days later. Tests were not carried out to confirm whether oestrus had in
fact occurred. Receptivity of the ewe to the ram is probably the most reliable indication
but facilities for carrying out such a test were not readily available at the time of this
investigation.
Experiments on isolated oviducts. Rabbit oviducts were taken from freshly killed animals,
ewe oviducts were taken from ewes which had been used for in vivo experiments. All were
placed in Tyrode solution. Ewe oviducts were stored at 4°C until use. A complete oviduct
was suspended in a 10 ml. organ bath containing Tyrode solution at 37°C. Intra-luminal
pressure was recorded with a Statham transducer using the same method as that described
for the in vivo experiments. The Tyrode solution was infused at 54 or 108 /tl./min and
escaped from the infundibular end into the organ bath.
Drugs. Drugs and materials used were pentobarbitone sodium (Nembutal, Abbott
Laboratories), adrenaline hydrochloride (B.D.H.), acetylcholine bromide (B.D.H.) and
progesterone (B.D.H.). We are grateful to Professor S. Bergstrom of the Karolinska Institute
for supplies of prostaglandins Et and Fla, to Dr H. M. Dott of the A.R.C. Institute of Animal
Reproductive Physiology, Cambridge for the ram semen and to Dr E. D. Nicolaides of the
Parke Davis Company, Ann Arbor for synthetic bradykinin.
Preparation and standardization of seminal prostaglandin. Human semen was obtained
from fertility clinics through the kind co-operation of Dr D. E. Hawkins of University
College Hospital, London. Ejaculates were pooled in 0'2 M-phthalate buffer (pH 4) and
extracted with diethyl ether as described previously (Horton & Thompson, 1964). The ether
phase was evaporated to dryness and the residue was taken up in a small volume of saline.
This concentrated solution of prostaglandin was standardized on the rabbit isolated jejunum
against pure prostaglandin Ej. All quantities of this extract are expressed in terms of pg of
prostaglandin E, equivalent. In the text it is referred to as the crude prostaglandin mixture.
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RESULTS
Actions of prostaglandin E1 on female reproductive tract
smooth muscle in the rabbit
In rabbits anaesthetized with urethane, prostaglandin E, injected in¬
travenously in doses of 0-5 /tg/'kg or more lowered the intra-luminal pressure
and reduced the size and frequency of spontaneous contractions of the
oviducts. In rabbits which had been pre-treated with stilboestrol the
oviduct was more sensitive sometimes responding to as little as 0-03 //,g
prostaglandin Ex/kg. Spontaneous contractions of the uterine horn and







Fig. 1. Rabbit, 2-5 kg, anaesthetized with urethane (1-75 g/kg) injected intra-
peritoneally. Records of intra-luminal pressure of the oviduct (upper trace), uterine
horn (middle trace) and cervix (lower trace). PGEi = prostaglandin Ex (6 fig)
injected intravenously.
temporarily abolished. The inhibitory effect on the uterine horn was not
always seen but there was never any evidence of uterine contraction
following prostaglandin Ex. The oviducts were the most sensitive and most
consistent in their response to prostaglandin Ex, whereas the uterine horn
was the least sensitive of the three parts of the female reproductive tract
investigated (Fig. 1). Inhibition of oviduct smooth muscle tone was there¬
fore used for detecting the presence of prostaglandin Ex in the blood
supplying the female reproductive organs following intravaginal admini¬
stration. Before proceeding to this experiment, however, it was necessary
to show that inhibition of the oviducts following an intravenous injection
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of prostaglandin Ex was a direct action, and not an indirect one, secondary
to changes in blood pressure or to a reflex mediated via the central nervous
system.
Evidence that prostaglandin E1 exerts a direct effect
on the rabbit oviducts
Evidence in favour of a direct action of prostaglandin Ex on the rabbit
oviducts was obtained by experiments on anaesthetized animals, on pithed









Fig. 2. Babbit, 2-3 kg, anaesthetized with urethane (1-75 g/kg) injected intra-
peritoneally. Becords of oviduct intra-luminal pressure (upper trace) and arterial
blood pressure (lower trace). PGEX = prostaglandin Ex (5 fig); BK = bradykinin
(2 fig) injected intravenously.
PGE,
25 fjg 1 min
J20 |
Fig. 3. Rabbit, 2-6 kg, pithed under ether. Records of oviduct intra-luminal
pressure (upper trace) and arterial blood pressure (lower trace). PGEX = prosta¬
glandin Ex (25 /tg) injected intravenously.
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inhibit oviduct tone invariably cause a simultaneous fall of arterial blood
pressure in the rabbit (Horton & Main, 1963). It could therefore be argued
that the effect on the oviduct was secondary to the depressor response.
When acetylcholine or bradykinin was injected intravenously in doses
equi-depressor to those of prostaglandin Et no inhibitory effect on the
oviducts was seen, although bradykinin sometimes caused a transient
increase in tone (Fig. 2). Furthermore, in the rabbit, which had had its
central nervous system entirely destroyed by pithing, prostaglandin Ex
caused the usual inhibition of the oviducts although the already very low
blood pressure was not lowered further (Fig. 3). A fall of blood pressure
alone is therefore insufficient to produce changes in tubal tone.
The isolated oviduct of the rabbit suspended in Tyrode solution pos¬
sessed little inherent tone. However, when adrenaline was added to the
bath, the tone increased and was maintained even after the organ bath had
been washed out. This tone was reduced by the addition of prostaglandin
E-l in a similar manner to the effect observed in vivo (Fig. 4). These ex¬
periments suggest that prostaglandin E1 exerts its inhibitory effect directly
upon the oviducts.
PG Adr PG PG
4 2 4 4
Fig. 4. Rabbit isolated oviduct suspended in a 4 ml. bath containing aerated Tyrode
solution at 35°. Record of intra-luminal pressure. PG = crude prostaglandin
mixture; Adr = adrenaline; doses in jug. Adrenaline had been added to the bath
producing a rise in oviduct tone before the first dose of prostaglandin was added.
In one experiment on an unanaesthetized rabbit prostaglandin E^ ( .12 jug)
injected intravenously inhibited spontaneous muscular contractions of the
oviduct. The duration and intensity of the inhibition were very similar to
those observed in the anaesthetized preparation.
Absorption of prostaglandin from the rabbit vagina
One or 2 ml. of prostaglandin solution (50-400 /tg/ml.) was administered
intravaginally to ten anaesthetized rabbits. After a latent period of
2-10 min varying from one experiment to another the intra-luminal
pressure of the oviduct and the arterial blood pressure began to fall.
Contractions of the oviduct became less frequent and of smaller magnitude.
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In the experiment illustrated in Fig. 5 the intra-luminal pressure of the
oviduct fell from approximately 14 to 4 mm Hg and the frequency of con¬
tractions fell from 10 to 0-5/min. These effects were long lasting. On washing
the vagina with saline both the arterial blood pressure and the intra¬
luminal pressure and frequency of contractions of the oviduct slowly
returned to normal.
PG 1 min
Fig. 5. Rabbit, 3'7 kg, anaesthetized with urethane (1-75 g/kg) injected intra-
peritoneally. Record of intra-luminal pressure of an oviduct. Between a and 6
there was a 5 min interval and between b and c an 8 min interval. PG = crude
prostaglandin mixture (400 fig in 1 ml. saline) administered intravaginally. The
vagina was washed out 34 min later (between b and c). Figures on the trace indicate
time in minutes after PG administration and wash-out, respectively.
The threshold concentration of prostaglandin Et which produced an effect
on intravaginal administration was approximately 50 yg/ml. With lower
concentrations falls in oviduct tone could not with certainty be distinguished
from spontaneous variations in tone. The crude prostaglandin mixture was
used for most of the intravaginal administrations in order to conserve
supplies of the pure material. The results were confirmed with pure
prostaglandin Ej in similar dose ranges.
Actions of prostaglandin on the oviduct smooth
muscle of the anaesthetized ewe
Intra-luminal pressure of an oviduct was recorded in five anaesthetized
ewes. Prostaglandin solutions (both the crude prostaglandin mixture and
pure prostaglandin Et) injected either intravenously or intra-aortically
produced changes in intra-luminal pressure. The direction of the change
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varied; in three ewes there was an increase in intra-luminal pressure, in two
a decrease (compare Figs. 6 and 7). In any one animal the response to
prostaglandin was always qualitatively the same throughout the experi¬
ment and a similar response was usually obtained subsequently with the
isolated oviduct from that animal. There was no obvious correlation
between the type of response and either the time of year or the hormonal














Fig. 6. Ewe (No. 5), 40 kg, anaesthetized with pentobarbitone sodium injected
intravenously. In each panel upper trace is a record of oviduct intra-luminal
pressure and lower trace arterial blood pressure. PG = crude prostaglandin mix¬
ture (in jig) injected intravenously (i.v.) or intra-aortically (i.a.); Sal. = saline;
Adr = adrenaline; U.S. = ram semen.
or decrease in tone, did not vary much from one ewe to another (Table 1);
approximate thresholds for intra-aortic doses ranged from 0-4 to 2-5 /tg/kg,
effective intravenous doses were substantially higher (Fig. 6) and so to
conserve prostaglandin supplies the intra-aortic route was generally used.
In two ewes (Nos. 5 and 6) prostaglandin was infused intra-aortically
in an attempt to mimic more closely the effects of circulating prostaglandins.
Infusion rates of 0-7 and 2-2 //g/kg/min respectively had no effect on the
intra-luminal pressure of the oviduct, whereas 1-4 and 4-3 /{g/kg/min
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produced a moderate sized response. In all these experiments a fall in
arterial blood pressure was observed. Moreover, the threshold for the















Fig. 7. Ewe (No. 6), 39 kg, anaesthetized with pentobarbitone sodium injected
intravenously. Records of oviduct intra-luminal pressure (upper trace) and arterial
blood pressure (lower trace). PGEjl = prostaglandin Ej (in fig); Sal = saline (ml.);
Adr = adrenaline (fig)- All injected intra-aortically.
Although the crude prostaglandin mixture was generally used, pure
prostaglandin E, always produced similar effects. Figure 7 illustrates the
rise in intra-luminal pressure of the oviduct accompanied by a fall in blood
pressure which followed the intra-aortic injection of 100 jig of prostaglandin
Ex. In this ewe the crude prostaglandin mixture also increased intra¬
luminal pressure.
Effect of ram semen on the anaesthetized ewe
In two ewes (Nos. 4 and 5) the effect of injecting ram semen intra-
vascularly was observed. In ewe No. 4, 1 ml. of ram semen injected
intra-aortically caused a slight rise in arterial blood pressure but no change
in the response of the tone of the left oviduct. Later in the experiment the
intra-luminal pressure of the right oviduct was recorded and in this case
1 ml. of ram semen injected intra-aortically caused a slight transient
increase in tubal tone similar to the effect seen with prostaglandin itself.
This second injection did not affect arterial blood pressure. In ewe
No. 5 1 ml. of a fresh batch of ram semen injected intra-aortically caused
a slight fall in blood pressure but did not affect tubal tone (Fig. 66). The
same amount injected into the external jugular vein caused a fall followed




Table1.Effectsndeffectivedos fprostaglan inthin ra-lnminalpr surft viducts tdivitro
EweWt.Hormonal no.(kg)pre-treatment 155None 292None 356Stilboestrol
Monthf expt. March April April
andontherterialbl opressureinew s Oviductinsitu Effective intra-aortic Responsedose*(/<g/kg)
476Progesterone+P.M.s.May 540Progesterone+P.m.s.Nove ber 639Progesterone+P.m.s.November 7
Contraction Relaxation Contraction Relaxation (preceded bytransient contraction) Contraction
0-4-1-7 0-9-2-1 1-0-4-0 1-0-5-0 2-5-5-0
Intra-aortic infusion (jKg/kg/min)
0-7noeffect 1*4relaxation 1-4relaxation
Approximate threshold depressoroses .(̂g/kg)°n intra-aortic injection 0-2 0-9 <0-7 0-7/tg/kg/min (intra-aortic infusion)
2-2noeffect/^g/kg/min 4-3contraction(intra-aortic 4-3contractioninfusio )
Oviductinitro
Response Relaxation(some¬ timespreceded bycontraction) Contraction Relaxation (afterlatent period) Noeffect Relaxation Relaxation (sometimes contraction) Relaxation
Effective concentrations* (ng/ml.) 300-400 800 100-200 >1000 2-5-40 (prostaglandinEx) 100-4000
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Effect of prostaglandin on the isolated oviduct of the ewe
The isolated oviduct of the ewe unlike that of the rabbit showed
spontaneous contractions. In four ewes the response of the isolated
oviduct to the crude prostaglandin mixture resembled that of the same
tube in situ. In ewe No. 4, no responses to prostaglandin could be obtained
in vitro although it had responded to prostaglandin in situ, and it showed
the usual increase in tone when adrenaline was added to the organ bath.
The concentrations required to produce a threshold effect in vitro ranged
from 2-5 to 800 ng/ml. in those preparations which responded to prosta¬
glandin. The preparations which relaxed tended to be more sensitive than







Fig. 8. Ewe (No. 1) isolated oviduct suspended in a 10 ml. bath containing Tyrode
solution at 35°. Record of oviduct intra-luminal pressure. PGFla = prostaglandin
Fla; PGEj_ = prostaglandin Ex; doses in ftg. W, organ bath washed out.
On an oviduct taken from ewe No. 1 prostaglandin Ej (250 to 1000 ng/ml.)
like the crude prostaglandin mixture caused a reduction in tubal tone.
Prostaglandin Fla (1000 ng/ml.) had no effect on this preparation (Fig. 8).
DISCUSSION
The object of the experiments described in this paper was to test the
hypothesis that seminal prostaglandin can be absorbed from the vagina
into the circulation in amounts sufficient to affect smooth muscle tone of
the oviduct. Prostaglandin Ej, injected intravenously in the anaesthetized
rabbit inhibits smooth muscle tone in all parts of the female reproductive
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that, on the oviduct at least, this is a direct action and is not due to
changes of blood pressure or to effects mediated via the central nervous
system.
Our assertion that prostaglandin can be absorbed from the vagina into
the circulation is based upon the following evidence. When a solution of
prostaglandin was introduced into the vagina there was a fall in systemic
arterial blood pressure and a fall in oviduct intra-luminal pressure very
similar to that observed following an intravenous injection. Moreover, the
effects following intravaginal administration occurred after a latent period
and were more gradual in onset than those seen following a single intra¬
venous injection. Such a time lag fits in with the concept of gradual
absorption. It might be argued that the effect on the oviduct was mediated
in some way by the reproductive tract itself. In all experiments the lumen
of the uterus was tied off in at least one place between the vagina and the
oviduct so that prostaglandin could not reach the oviduct via the lumen;
furthermore, in several experiments the same effects were observed when
the oviduct was completely isolated from the remainder of the reproductive
tract by dividing the ipsilateral uterine horn between ligatures. The effects
on the oviduct could therefore not have been due to a locally mediated
reflex of either neurogenic or myogenic origin. It would also be difficult to
explain the blood-pressure changes on a basis of a local action of prosta¬
glandin on the reproductive tract. If it is accepted that these effects are
due to circulating prostaglandins and it is further accepted that the
prostaglandins act directly upon the oviduct or structures intimately
associated with it—a nerve plexus, for example—then it must be concluded
that prostaglandin can be absorbed from the rabbit vagina into the
circulation in amounts sufficient to alter the tone of the oviduct. On the
other hand this is unlikely to be a physiological mechanism in the rabbit.
Several workers have now shown conclusively that rabbit semen, like the
semen of many other laboratory animals but unlike that of man and the
ram, is very low in prostaglandin. The amounts present (if any) are cer¬
tainly too small to affect the tone of the oviduct even ifall the prostaglandin
were absorbed immediately into the circulation. In fact we have shown that
freshly collected rabbit ejaculates on intravenous injection in the rabbit
have no detectable effect on the oviduct. Nevertheless, the demonstration
that vaginal absorption of prostaglandin can occur is of interest. Unless
conditions in the human female and in the ewe are very different from those
in the rabbit some absorption of seminal prostaglandin is to be expected
following coitus in these species.
Our next step was to investigate a species whose semen was rich in
prostaglandin. As prostaglandin E-, has been isolated from ram semen, the
ewe was selected for these experiments. We were able to show that oviduct
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intra-luminal pressure could be measured by the same method as that used
in the rabbit. On the other hand the effects of prostaglandin varied from
one animal to another. In spite of this qualitative difference, the sig¬
nificance of which is unknown, the sensitivity to prostaglandin varied very
little. The most striking feature, however, of this part of the investigation
was the large amount of prostaglandin necessary to elicit changes in
oviduct intra-luminal pressure. Even when intra-aortic injections were
made, the amount of prostaglandin which produced a threshold effect on
the oviduct of the ewe was 40 fig or about 4 times the total amount present
in a single ram ejaculate. When the smaller effectiveness of intravenous
administration and still more of intravaginal administration is taken into
account it is clearly impossible for absorption from the vagina in the ewe
to give rise to concentrations sufficient to affect tubal tone. In view of this
result and because of the technical difficulties to be overcome and of the
relative scarcity of prostaglandin, vaginal absorption in the ewe was not
investigated. We did, however, show that the intra-aortic injection of ram
semen (which contained 10 fig prostaglandin/ml.) did not affect the oviduct
or even the arterial blood pressure to any significant degree.
These results disprove our original hypothesis. They do not exclude the
possibility that prostaglandin is absorbed from the vagina following coitus
in sheep but the blood prostaglandin levels likely to be achieved would be
far too small to affect smooth muscle tone of the oviduct. Possibly prosta¬
glandins so absorbed may fulfil some other role. It is conceivable that in
the unanaesthetized ewe the oviduct is far more sensitive than in the
animal under pentobarbitone although this was not the case in the
rabbit where sensitivities were of the same order whether the animal was
unanaesthetized or under urethane or pentobarbitone. One major snag
to the concept of prostaglandins acting as circulating hormones is their
potent vasodilator activity. All effects so far reported in the intact animal
following systemic injection of prostaglandin have been accompanied by
a fall in blood pressure. While that is not to say that there is a cause and
effect relation between the one and the other, nevertheless, we consider it
unlikely that such effects would under physiological conditions be mediated
by a hormone which at the same time lowered arterial blood pressure
appreciably.
We conclude then that seminal prostaglandin may be absorbed from the
vagina but that the amounts reaching the circulation in this way are too
small to affect the tone of the oviduct smooth muscle. Our experiments do
not, of course, exclude the possibility that prostaglandins in the semen act
locally upon the cervix and the uterus itself from within the lumen of the
reproductive tract.
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SUMMARY
1. Spontaneous contractions of the oviduct, uterine horn and cervix of
the anaesthetized rabbit are inhibited by prostaglandin Ex injected
intravenously.
2. The action on the oviduct is direct; it is not mediated via the central
nervous system nor is it secondary to changes in blood pressure.
3. When prostaglandin solutions in concentrations of 50 /ig/ml. or more
are administered intravaginally in rabbits, absorption into the circulation
occurs in amounts sufficient to reduce the tone of the oviduct.
4. Intra-aortic injections of prostaglandin lowered oviduct intra¬
luminal pressure in two ewes but raised it in three other ewes. In any one
animal responses remained qualitatively similar throughout the experiment
and a similar response was usually obtained subsequently with the isolated
oviduct from that animal.
5. Freshly collected ejaculates of ram semen injected intra-aortically
had little or no effect upon the intra-luminal pressure of the oviduct.
6. It is concluded that although prostaglandin can be absorbed from the
vagina (of the rabbit) the amounts of prostaglandin in both rabbit and
sheep semen are too small to have any significant effect upon oviduct
smooth muscle even if complete and rapid vaginal absorption of seminal
prostaglandin were to occur.
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Prostaglandins E1( E2 and E3, injected into the cerebral ventricles of unanaesthetized
cats, produced sedation, stupor and signs of catatonia. The threshold dose was 3 ng/kg.
Slight sedation was also observed following an intravenous injection, but a dose of 20
/ig/kg was required. In chicks, intravenous injections of prostaglandins (10 to 400 fig/kg)
caused respiratory depression, profound sedation, loss of normal posture and, with the
higher doses, loss of the righting reflex.
Brain extracts contain biologically active lipid-soluble substances (Ambache &
Reynolds, 1960, 1961 ; Kirschner & Vogt, 1961 ; Toh, 1963), most of which stimu¬
late smooth muscle. The chemical structure of many of these substances is unknown
but their biological and physicochemical properties somewhat resemble those of the
prostaglandins (see Horton & Main, 1963, for references to early history and formulae
of these substances). It was therefore of interest to know whether prostaglandins
have any actions on the central nervous system. In the present experiments prosta¬
glandins of the E series produced stupor and prolonged sedation when injected
into the cerebral ventricles of cats and sedation when injected intravenously into
chicks. The prostaglandins of the E series have been isolated and their structure
elucidated in Bergstrom's laboratory in Stockholm (Bergstrom & Sjovall, 1960;
Bergstrom, Dressier, Ryhage, Samuelsson & Sjovall, 1962 ; Bergstrom, Ryhage,
Samuelsson & Sjovall, 1962 ; Samuelsson, 1963).
METHODS
Injections into the cerebral ventricles ofcats. Collison cannulae (C. F. Palmer, Ltd.) were implanted
with sterile conditions into the lateral ventricles of six female adult cats, weighing 2.5 to 3 kg and
anaesthetized with pentobarbitone sodium (40 mg/kg), as described by Feldberg & Sherwood (1953).
After an interval of not less than 1 week, injections were made through the cannula without anaes¬
thesia. Prostaglandin E, was dissolved in sterile 0.9% saline by the addition of solid sodium bicar¬
bonate. Neutral solutions warmed to 37° C were injected slowly under aseptic conditions in volumes
of 0.1 or 0.2 ml. and washed in with 0.1 ml. of 0.9% saline. The cats were observed continuously
for 2 to 8 hr and intermittently for 48 to 72 hr.
In four cats weighing 1.8 to 3.3 kg, prostaglandin E3 was injected intravenously without anaes¬
thesia through the superficial vein of the foreleg.
Intravenous injections into chicks. Two- to five-day-old chicks weighing 40 to 50 g were used and the
injections were made into the right external jugular vein in volumes of not less than 0.1 ml. and not
more than 0.5 ml.
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RESULTS
Injections into the cerebral ventricles of cats. The intraventricular injection of 7 to
20 /xg/kg of prostaglandin Ex was followed within 5 to 20 min by sedation and stupor.
Spontaneous movement decreased and the cat would sit in a corner of its cage or,
if allowed its freedom, would seek out a dark recess usually under a bench, where
it would continue to sit for hours, if undisturbed. The cat assumed a characteristic
posture with head forward and slightly lowered ; the eyes were closed. The cat showed
little interest in its surroundings, it did not resent being picked up and it showed no
signs of affection. When taken up and set free, it tended to retire quickly to its former
sheltered position. Its movements were not impaired but rapid and fully co-ordinated.
The cat failed to respond to a sudden loud noise or to a bright flash of light. On
the other hand, when pressure was applied to a foot-pad the limb was rapidly with¬
drawn but there was no vocalization, indeed the cats were invariably silent. To a few
stimuli, there was a sluggish response ; for example on the introduction of another
cat into the room, the eyes slowly opened, the ears pricked up and the head moved in
the appropriate direction.
Sometimes there were definite signs of catatonia. This was a late feature which
occurred after a latency of at least 40 min and developed gradually. When fully
developed, the cat could be placed across the rungs of an inverted stool and would
remain in such an unnatural position without moving for periods up to 90 min. In
contrast, uninjected cats could not be induced to adopt such a position at all. The
catatonic signs lasted up to 4 hr, sedation and stupor up to 24 hr, and even at 48 hr
there was sometimes reduced spontaneous activity. The threshold dose which pro¬
duced sedation and stupor was approximately 3 /xg/kg and the effect lasted 4 to 8 hr.
Another effect of the injection of prostaglandin Er was moderate dilatation of the
pupils lasting 3 to 4 hr ; the pupillary reflexes were, however, normal. There was no
evidence of any loss of function of any cranial or spinal nerves. There was no obvious
change in respiratory or cardiac rates ; no salivation, lachrymation, vomiting,
defaecation or micturition occurred. There was no hyperphagia, indeed cats which
had been starved for 24 hr before the injection showed no interest in food during the
stupor due to prostaglandin. The injection caused no scratching or other movements.
In one cat prostaglandin E2 (12 /xg/kg) and in another cat prostaglandin E3 (12 /xg/kg)
were injected intraventricularly. Sedation, stupor and catatonia developed and the
effects resembled those seen following an intraventricular injection of 7 /xg/kg of
prostaglandin Ei.
In control experiments intraventricular injections of neutral 0.9% saline were
followed by transient slight diminution in spontaneous activity.
Intravenous injections into cats. When injected intravenously into unanaesthetized
cats in doses up to 10 /xg/kg, no effects were detected with prostaglandin Ex. In doses
of 20 /xg/kg the only effect was a reduction in spontaneous activity lasting about 2 hr.
The effect was less than that following an intraventricular injection of 3 /xg/kg of
prostaglandin Ex.
Intravenous injections into chicks. Immediately following an intravenous injection
of prostaglandin E1; E2 or E3 in doses from 10 to 400 /xg/kg there was a great reduction
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in respiratory rate—sometimes the rate decreased from 60 to 15 breaths/min. In
addition there was profound sedation but no signs of catatonia. The chick lay on its
side and, with the higher doses (50 to 200 /xg/kg of prostaglandin E,), the righting
reflex was lost. There was little spontaneous movement, but in a few chicks during
the first 3 min after the injection short-lasting convulsive movements of the legs and
wings occurred. The duration of sedation depended upon the dose injected. When
sedation subsided the chick slowly resumed its normal posture. The righting reflex
was first restored, the chick remaining in a squatting position with its eyes closed.
The respiratory rate had by then returned to normal. Gradually the chick resumed
the standing posture and finally it would begin to chirp and move about the cage.
During the period of sedation the chicks were invariably silent even when pressure
was applied to a toe, although this produced immediate withdrawal of the limb.
There was no loss of the corneal reflex and, when the standing posture had been re¬
gained, there was no abnormality of gait or lack of co-ordination. Control injections
of 0.5 ml. of 0.9% saline produced no detectable changes.
With prostaglandin the effects of 10 /xg/kg lasted about 5 min and those of
200 /xg/'kg about 75 min. When an estimate of the relative activities of the three
prostaglandins was made by measuring the time between injection and the recovery
or normal posture, prostaglandin Et was 1.5-times more active than E2 and 4-times
more active than E3.
DISCUSSION
The effects following an intraventricular injection of the prostaglandins E resemble
the late effects of intraventricular injection of physostigmine, dyflos, acetylcholine or
bulbocapnine seen by Feldberg & Sherwood (1954, 1955). These authors describe the
posture of a cat after intraventricular physostigmine as sitting "hunched up without
movement ; its eyes half shut or shut and its head slightly inclined forward" ; this
description could be used equally for cats injected with prostaglandin. The catatonic
stupor produced by the four drugs used by Feldberg & Sherwood, however, was
preceded by signs of pronounced excitation—vigorous scratching, licking and washing
movements followed by reflex hyperexcitability and tremor. None of these excitatory
effects was observed with the prostaglandins.
The effects of intraventricular prostaglandin could be mimicked, but to a small
degree only, by intravenous injection of a relatively large dose. Such a dose injected
intravenously into anaesthetized cats would cause a substantial fall in blood pressure
(Holmes, Horton & Main, 1963), and therefore the possibility cannot be excluded that
part of the short-lived sedative effect seen on intravenous injection is secondary to this
fall of blood pressure. The effects following intraventricular injection, however, cannot
be explained in this way, since by the intraventricular route much smaller doses were
effective than on intravenous injection, and the effects were not only sedation but also
stupor and catatonia.
As the effects of intravenous prostaglandins in the 2- to 5-day-old chick somewhat
resemble those seen in cats on intraventricular injection and are not typical signs of
circulatory failure, they also appear to be central nervous effects. Prostaglandins will
reach the brain from the blood stream as, in these young chicks, the blood-brain
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barrier has not yet developed. It is of interest to note that the relative central depress¬
ant activities of the three prostaglandins in chicks were similar to those found in
smooth muscle preparations (Horton & Main, 1963).
Ambache & Reynolds (1960, 1961) found a smooth muscle stimulating substance
in rabbit brain which they were unable to distinguish from irin, a hydroxy unsaturated
fatty acid extracted from the iris. Kirschner & Vogt (1961) prepared three biologically
active fractions from horse, rabbit and guinea-pig brains ; two were identified as
lysophosphatidic acid and ganglioside respectively, but the third fraction was believed
to consist of unsaturated fatty acids. Similarly, Toh (1963) separated three fractions
from cat and dog brain extracts ; the third fraction (Toh's substance C) behaved like
an unsaturated fatty acid. Ramwell & Shaw (1963) have found an oxytocic ether-
soluble acid in brain superfusates. Whether any of these biologically active fatty
acids are prostaglandins is unknown. It is significant, however, that Bergstrom and his
colleagues (Bergstrom, Dressier, Krabisch, Ryhage & Sjovall, 1962) were unable to
detect any prostaglandin in sheep brain whereas other sheep tissues which they
extracted all contained either prostaglandin or prostaglandin-like material. The
demonstration of the central actions of prostaglandin described in this paper perhaps
justifies a renewed search for it in the central nervous system.
I wish to thank Professor S. Bergstrom for very kindly supplying the pure prostaglandins used in
this investigation.
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DIFFERENCES IN THE EFFECTS OF PROSTAGLANDIN F2a,
A CONSTITUENT OF CEREBRAL TISSUE, AND
PROSTAGLANDIN E,ON CONSCIOUS CATS AND CHICKS
E. W. Horton* and I. H. M. Main*
Miles-Ames Research Laboratories, Stoke Poges, Buckinghamshire
Summary—Prostaglandin Fm, a normal constituent of ox brain, produced no obvious effects
when injected into the cerebral ventricles of four unanaesthetized cats in doses of 15-100 pg
per animal. In contrast the closely related prostaglandin Ex produced marked sedation and
stupor in doses of 20 pg per animal in each of these animals confirming the results obtained
previously with this compound. In twenty chicks, intravenous injections of prostaglandin
F2a (25-450 pg/kg) caused extension of the limbs and sometimes extension of the neck,
followed by a tendency of the limbs to abduct. In lower doses (5-25 pg/kg) abduction
of the limbs was the only change observed. Unlike prostaglandin prostaglandin F2a caused
no respiratory depression and little or no sedation in these doses.
INTRODUCTION
Prostaglandins Ex, E2 and E3 produce catatonic stupor in cats when injected into the
cerebral ventricles while in young chicks they produce sedation when injected intravenously
(Horton, 1964). Samuelsson (1964) has now isolated prostaglandin from ox brain.
In view of this, it was of interest to know whether prostaglandin Ga had effects on the
central nervous system similar to those reported for the prostaglandin £'s.
We have found that prostaglandin Ga has no effect when injected into the cerebral
ventricles of cats in doses equal to or greater than those required to produce stupor with
prostaglandin Ev On the other hand in chicks both prostaglandins were active in similar
doses but the effects produced were qualitatively different. Whereas prostaglandin E1
produced sedation, prostaglandin Ga caused extension and abduction of the limbs without
sedation.
The chemical relationships between prostaglandin F2a and the prostaglandin E's are
shown in Fig. 1. The three prostaglandin E's differ only in the number of double bonds.
Reduction of the oxo-group in a prostaglandin E yields two isomeric alcohols, those from
prostaglandin E2, for example, being referred to as prostaglandin Fia and F2(3. The a-
but not the P-isomers occur naturally (Bergstrom et at., 1962a; Bergstrom et al., 1962b;
Samuelsson, 1963).
METHODS
Injections into the cerebral ventricles of cats
Cannulae were implanted under sterile conditions into the lateral ventricles of six adult
male cats, weighing 3 -0 to 4 -6 kg and anaesthetized with pentobarbitone sodium (40 mg/kg),
*Present Address: Department of Physiology, Medical College of St. Bartholomew's Hospital, Charter¬
house Square, London, E.C. 1.
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Fig. 1. Formulae of prostaglandin F 2a and the three prostaglandin E's.
as described by Feldberg and Sherwood (1953). After an interval of not less than 1 week,
injections were made through the cannula without anaesthesia. The prostaglandins were
dissolved in water by the addition of solid sodium bicarbonate and diluted with 0-9%
saline. Neutral solutions were injected in volumes of 0-1 or 0-2 ml and washed in with
0 1 ml of 0-9% saline. The cats were observed for about 8 hr after an injection.
Intravenous injection into chicks
Two to five-day-old chicks weighing 35-50g were used. Injections were made into the
right external jugular vein in volumes of not less than 0-1 ml and not more than 0-5 ml.
The chicks were observed until about 1 hr after recovery of normal posture.
RESULTS
Injections into the cerebral ventricles of unanaesthetized cats
In cats intracerebro-ventricular injection of prostaglandin E1 in the dose range 10-60 /xg
per animal produces a stuporose condition previously described in detail (Horton, 1964).
In order to compare prostaglandin F2a with prostaglandin Elt the sensitivity of six adult
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male cats to prostaglandin Et was first tested by injecting 20 ftg per animal into the cerebral
ventricles. At this dose level, all the cats became stuporose; they sat with their eyes closed
or partially closed apparently disinterested in their surroundings. Three showed signs of
catatonia. This was diagnosed either when a limb remained in positions in which it was
placed or if the cat could be put in abnormal postures (Fig. 2a). Such postures were some¬
times retained for periods up to an hour or more.
The four cats which showed the most marked responses to prostaglandin Et were
injected after an interval of a week or more, with prostaglandin in doses of 15, 20, 60
and 100 pg respectively. Prostaglandin in these doses, produced no obvious effect.
The cats showed no signs of sedation but remained alert and interested in their surround¬
ings (Fig. 2b). There was no stupor and no catatonia. Our observations are summarized
in Table 1.
table 1. Effects of prostaglandins E1 and Fia injected into the cerebral ventricles of
unanaesthetized cats













1 3-1 20 Stupor+ +
No catatonia
20 Friendly, playful and alert
as in pre-injection period.
2 3-3 20 Stupor + +
Catatonia +
60 No difference from pre-
injection control period.
3 3-0 20 Stupor +
No catatonia
4 3-2 20 Stupor +
No catatonia
5 4-6 20 Stupor + + +
Catatonia + + +
15 Alert, no evidence of stupor
or catatonia.
6 3-2 20 Stupor + +
Catatonia +
100 No difference from pre-
injection control period.*
*In this cat prostaglandin Ex (20 pg) injected intraventricularly 1 hr after the prostaglandin Fm caused
catatonic stupor.
Intravenous injections into chicks
Twenty chicks were injected with prostaglandin Fia in doses ranging from 2-7 to 450
Pg/kg, and fourteen other chicks were injected with prostaglandin E1 (10 to 2000 pg/kg)
to confirm previous observations with this compound.
In doses from 25 to 450 pg/kg prostaglandin Fu caused an immediate and extreme
extension of the limbs with some dorsiflexion of the neck (Fig. 3a). These effects lasted for
from 2 to 10 min. During this period the chick was unable to stand and often it was
unable to right itself when placed on its back. When the chick was supported under its
body the limbs did not remain extended but were partially flexed. The chick's limbs were
unable to support the weight of its body, but the limbs could be moved when support
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was provided. There was little or no sedation and there was no depression of respiration;
the eyes were open throughout. When the chick regained the standing posture the legs
tended to separate until gradually the chick's abdomen came to rest on the bench with its
legs in full abduction. This tendency for the legs to abduct lasted for up to 30 min from
the time of injection. With the lower dose range (5-25 /xg/kg) this was the only effect
observed with prostaglandin F2a (Fig. 3b). The threshold dose was about 5 /xg/kg.
In contrast, prostaglandin E1 caused an initial marked but transient slowing of the
respiratory rate followed within 30 sec of the injection, by sedation; the righting reflex
was lost at the higher dose levels (Fig. 3c and 3d). In three chicks very high doses (1, 1 and
2 mg/kg) of prostaglandin Ex were injected. The effects were pronounced and lasted
for 1J, H and 2£ hours respectively. All the chicks recovered. The threshold dose of
prostaglandin Ex was about 10 /xg/kg. The effects of 5 /xg/kg could not be distinguished
from those following an injection of an equal volume of saline.
No permanent changes were observed following injection of either of the prostaglandins.
DISCUSSION
The presence in brain of lipid-soluble substances of unknown chemical structure but
with biological activity similar to the prostaglandins led to the discovery that the pure
prostaglandin E's have potent central nervous activity (Horton, 1964). Shortly after that
investigation was completed, Samuelsson (1964) reported the isolation of prostaglandin
E2a from ox brain. Since prostaglandin FZa, and not the prostaglandin £"s tested by
Horton (1964), appears to be the natural prostaglandin of brain it was of great interest to
know whether it had the same central nervous activities. This investigation shows that
it does not. In cats known to respond well to prostaglandin Et, injection of prostaglandin
into the cerebral ventricles produced no effects. This does not exclude the possibility
that higher doses might have been effective. The negative result is, however, of great
value since it effectively disposes of the criticism that effects produced by intracerebro-
ventricular injection of these fatty acids are due merely to non-specific physical or physico-
chemical changes within the ventricles. Whereas the degree of unsaturation of the molecule
makes little difference to the central nervous activity of the prostaglandin E's (Horton,
1964), we have now shown that reduction of the oxo substituent of prostaglandin E2 to
form prostaglandin F2a abolishes the ability of the compound to produce sedation and
stupor in cats, at least within the same dose range. This finding indicates that a high
degree of chemical specificity is necessary for the production of these effects.
The qualitative difference in actions of the prostaglandin E's and prostaglandin E2a
in chicks to some extent confirms the differences seen in cats. Whereas the prostaglandin
E's produce sedation in chicks somewhat resembling the effects seen in cats but without
catatonic stupor, prostaglandin produced little or no sedation in chicks even in doses
as high as 450 /xg/kg. Quite different effects were observed. With these higher doses the
limbs were extended fully but not rigidly. The responses of the chicks to prostaglandins
E1 and F2a superficially resembled those to curare and decamethonium (Buttle and
Zaimis, 1949). Prostaglandins did not however cause a paralysis since active movement
of the limbs was always possible. During the sedation due to prostaglandin E1 pressure
applied to a toe was followed by rapid withdrawal of the limb, while in the chick whose legs
were extended following prostaglandin F-2a the legs could be flexed when the chick was held
by its body. These effects of prostaglandin F2a were presumably due to an action on some
Fig. 2(a). (Cat No. 5) 4 -6 kg photographed 1 hr after an injection into the cerebral ventricles
of prostaglandin Ex 20 ^g. There was a 13-day interval between the two injections.
.pi. 2b
Fig. 2(b). Cat (No. 5) 4-6 kg photographed 1 hr after an injection into the cerebral ventricles
of prostaglandin F2a 15 fig. There was a 13-day interval between the two injections.
f.pl. 2a
Fig. 3. (a) Chick 40g photographed 1 min after an intravenous injection of 4 pg of prosta¬
glandin Fw.
(b) Same chick 22 min later
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component of the systems controlling posture. The site of this action remains to be
elucidated.
Little is yet known about the distribution of the different prostaglandins in the brain
of different species. On the assumption, however, that prostaglandin is a normal
constituent of human brain it is of interest to speculate that a derangement of its meta¬
bolism might account for certain mental disorders. For example, if prostaglandin F2a in
brain is normally formed by reduction of prostaglandin E2, inhibition or absence of the
enzyme system necessary for this conversion might lead to an accumulation of prosta¬
glandin E2 in cerebral tissue and so might produce a condition of catatonic stupor similar
to that seen in cats (Horton, 1964). Such a defect could account for some cases of catatonia
in man.
Resume—La prostaglandin F2a, coniposante normale du cerveau de boeuf, par injection
intraventriculaire dans le cerveau de quatre chats non anesthesies, n'entraine pas d'effet
notable aux doses de 15-100 pg/animal.
Inversement, la prostaglandine Eu compose tres voisin, engendre a la dose de 20 pg/animal,
une sedation marquee et de la stupeur chez chacun des animaux. Ces resultats confirment
les donnees obtenues precedemment avec cette substance.
Chez vingt poussins, l'administration intraveineuse de prostaglandine F2a (25-450 pg/kg)
determine I'extension des membres et dans certains cas du cou, suivie d'une tendance 41'abduc-
tion pour les membres. A des doses plus faibles (5-25 pg/kg) seule apparait l'abduction
des membres.
Contrairement a la prostaglandine Eu la prostaglandine Fia ne provoque aucune
depression respiratoire et, aux doses mentionnees, peu ou pas de sedation.
Zusammenfassung—Prostaglandin F 2a, ein normaler Bestandteil des Ochsen-Gehirns, hatte
keine offensichtliche Wirkiing, wenn die Impfung in die Gehirnhohlen (cerebrale Ventrikel)
von vier unbetaubten Katzen in Dosen von 15-100 pg/pro Tier vorgenommen wiirde. 1m
Gegensatz dazu verursachte das eng verwandte prostaglandin Ex auffallende Beruhigung
und Betaubung in Dosen von 20 pg in jedem dieser Tiere und bestatigte die Ergebnisse die
schon friiher mit dieser chemischen Substanz erzielt wurden. Die intravenose Einspritzung
von prostaglandin F2a (25^150 pg/kg) verursachte in sehr jungen Hiinchen eine Streckung der
Glieder und manchmal eine Streckung des Nackens, gefolgt von einer Neigung der Glieder
sich vom Korper wegzubewegen (Abduktion). In kleineren Dosen (5-25 pg/kg) wurde nur
die Wegbewegung der Glieder vom Korper (Abduktion) beobachtet. Im Gegensatz zu
prostaglandin Ex, verursachte prostaglandin Fm in diesen Dosen kein Sinken der Atmung
und wenig oder keine Beruhigung.
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(c) Chick 39g photographed 1 min after an intravenous injection of 2 pg of prosta¬
glandin Et.
(d) Same chick 30 min later.
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component of the systems controlling posture. The site of this action remains to be
elucidated.
Little is yet known about the distribution of the different prostaglandins in the brain
of different species. On the assumption, however, that prostaglandin ?2a is a normal
constituent of human brain it is of interest to speculate that a derangement of its meta¬
bolism might account for certain mental disorders. For example, if prostaglandin F,a in
brain is normally formed by reduction of prostaglandin E2, inhibition or absence of the
enzyme system necessary for this conversion might lead to an accumulation of prosta¬
glandin E2 in cerebral tissue and so might produce a condition of catatonic stupor similar
to that seen in cats (Horton, 1964). Such a defect could account for some cases of catatonia
in man.
Resume—La prostaglandine F2a, composante normale du cerveau de boeuf, par injection
intraventriculaire dans le cerveau de quatre chats non anesthesies, n'entraine pas d'effet
notable aux doses de 15-100 pg/animal.
Inversement, la prostaglandine Eu compose tres voisin, engendre a la dose de 20 pg/animal,
une sedation marquee et de la stupeur chez chacun des animaux. Ces resultats confirment
les donnees obtenues precedemment avec cette substance.
Chez vingt poussins, l'administration intraveineuse de prostaglandine F2a (25-450 pg/kg)
determine l'extension des membres et dans certains cas du cou, suivie d'une tendance a l'abduc-
tion pour les membres. A des doses plus faibles (5-25 pg/kg) seule apparait l'abduction
des membres.
Contrairement a la prostaglandine Ex, la prostaglandine F2a ne provoque aucune
depression respiratoire et, aux doses mentionnees, peu ou pas de sedation.
Zusammenfassung—Prostaglandin F 2a, ein normaler Bestandteil des Ochsen-Gehirns, hatte
keine offensichtliche Wirkiing, wenn die Impfung in die Gehirnhohlen (cerebrale Ventrikel)
von vier unbetaubten Katzen in Dosen von 15-100 pg/pro Tier vorgenommen wiirde. Im
Gegensatz dazu verursachte das eng verwandte prostaglandin E1 auffallende Beruhigung
und Betaubung in Dosen von 20 pg in jedeni dieser Tiere und bestatigte die Ergebnisse die
schon friiher mit dieser chemischen Substanz erzielt wurden. Die intravenose Einspritzung
von prostaglandin F2a (25-450 pg/kg) verursachte in sehr jungen Hiinchen eine Streckung der
Glieder und manchmal eine Streckung des Nackens, gefolgt von einer Neigung der Glieder
sich vom Korper wegzubewegen (Abduktion). In kleineren Dosen (5-25 pg/kg) wurde nur
die Wegbewegung der Glieder vom Korper (Abduktion) beobachtet. Im Gegensatz zu
prostaglandin Elt verursachte prostaglandin F2a in diesen Dosen kein Sinken der Atmung
und wenig oder keine Beruhigung.
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Tritiated prostaglandin E1 has been administered to cats <
*
and chicks by a variety of routes and its fate studied. After
injection into the lateral cerebral ventricle, the carotid and
vertebral arteries and the aorta in cats, very little
radioactivity was recovered from the central nervous system,
Similar results were obtained when the prostaglandin was given
intravenously and intra-arterially to chicks. The results
IV
of this study confirm work in other species and suggest that
prostaglandin exerts its central pharmacological actions in
extremely small concentrations.
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Pharmacological actions of prostaglandin on the central
I
nervous system have been demonstrated in cats by injection into
the cerebral ventricles (1 & 2), by intravenous injection (3),
by micro-iontophoretic application (4) and by close-arterial
inj'ection to the/ spinal cord (5). Although only relatively
small doses are required to produce these effects in cats and
also on intravenous inj'ection in young chicks (1, 2 & 3), it
has been shown in other species (rats, mice and sheep) that
little or no tritium-labelled prostaglandin reaches the central
nervous system following intravenous inj'ection <(6, 7 & 8).
In this investigation tritiated prostaglandin E. has been
injected into cats and chicks by various routes in doses known
to produce central nervous effects. The results show that little
of the tritiated prostaglandin E^ is present in the brain or
spinal cord when these pharmacological effects are observed.
Methods
Injections into the cerebral ventricles of conscious cats
Collison cannulae were implanted into the lateral ventricles
of three cats under pentobarbitone sodium (40mg/kg) anaesthesia
(9). After an interval of not less than five days injections
were made through the cannula without anaesthesia. Prostaglandin E^
was dissolved in 0.9% saline. Injections were always of 0.2ml and
were washed in with a further 0.1ml saline. After a pre-
, 1
determined time the animals were anaesthetized with intravenous
» *
thiopentone sodium and killed by exsanguination (during
anaesthesia the brain was exposed and immediately after death
tissue and fluid samples were taken for assay). The brain was
divided into various anatomical regions which were extracted
separately (see Table 1).
Injection into the left vertebral artery
A cat was anaesthetised with pentobarbitone sodium
(40mg/kg i.p.). The chest was opened and the animal was
artificially ventilated. The left internal mammary artery was
. -t
cannulated for retrograde 'injection into the vertebral artery and
the left brachial artery was tied off. A thread was placed
around the superior vena cava ready for occlusion and both
external jugular veins were cannulated for collection of blood
from the head. Prostaglandin in saline was injected slowly
into the internal mammary artery, the superior vena cava being
« ■ •, i »
occluded at the start of the injection. The animal was
<
exsanguinated through both external jugular veins. The brain
was removed immediately after death.
V; ••• ,-■•{ , .-'v. •! " •• ■■ • ••• ■ . ... • . ' : •:
Injection into the left common Carotid artery 1 , ,
A similar injection procedure was followed except that the
left lingual artery was cannulated for retrograde injection.
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In.iection into the abdominal aorta
In a third cat under pentobarbitone anaesthesia, the
renal, superior mesenteric, inferior mesenteric and splenic
blood vessels were ligated. The intestines, pancreas and
spleen were removed. The aorta and inferior vena cava were
i *
ligated at their distal ends and the left renal artery was
cannulated for retrograde injection into the aorta. Prostaglandin
E^ in saline was injected over a period of one minute into the
renal artery. Two minutes after the start of injection the
aorta was cannulated and the animal exsanguinated. The
* ■ V.".
spinal cord (LI to CI) and liver were removed immediately
after death.
Intravenous injection into chicks
Two to three-day-old chichs (35-45g) were used. Injections
were made into the right external jugular vein in a volume of
0.5ml. The chicks were killed by decapitation, 1 to 2 minutes,
after injection. The brain, liver and remaining carcass
. ; i -
wore extracted separately.
Intra-arterial injection into chickens
Chickens (800 - 850g) were anaesthetized with anaesthetic
ether and their common carotid arteries were exposed. Injections
of prostaglandin dissolved in 0.25 to 0.75ml of saline were made
into the right carotid. The chickens were killed by decapitation
30 seconds after injection and their brains removed.
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Preparation of samples for assay
y
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Tissue samples were macerated in 96% ethanol and were allowed
»
to stand for 2 hours. The samples were then centrifuged and the
supernatant removed. The residue was washed with a further
aliquot of 96% ethanol and re-centrifuged. The combined
. i
supernatants wer e taken to dryness under reduced pressure at
50°C. The residue was taken up in either 12ml methanol or the
minimum quantity permitting complete solution, which ever was
the greater. Blood samples were diluted with an equal volume
of N/1q hydrochloric acid and partitioned twice with an equal
volume of ethyl acetate (10). The combined organic phases
were taken to dryness and the residue was taken up in 12ml
methanol. Cerebrospinal fluid samples were evaporated to
dryness and the residues dissolved in 12ml methanol.
Estimation of tritium in extracts «
This was carried out in a Packard Tricarb liquid
scintillation counter using the internal standard technique.
4ml of the methanolic tissue extracts were always used with
1
10ml of a scintillator solution of the following composition:
2,5 - bis - [5* - t - butyl - benzoxazolyl (2*) ] - thiophene
(CIBA), 7g; toluene, 600ml; methylcellosolve; 400ml; naphthalene;
80g. All results are expressed as the mean of at least three
ten minutes counts. The tritiated prostaglandin used in this
study had an activity of 138 x 10 d.p.m./mg.
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Artificial cerebrospinal fluid
The artificial cerebrospinal fluid was of the following
composition: MgSO^, 205mgj CaCl2, 120mg; KC1, 210mg; NaHCO^,
2.3gj NaCl, 7.38g; made up to 1 litre with water.
-I';:'} |i'H * - :;.0V" . \
Results
'
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Injections into the lateral cerebral ventricle of
unanaesthetized cats
A mixture containing equal parts tritiated and unlabelled
prostaglandin was used in this study. The total dose
injected into the lateral ventricle of each unanaesthetized cat
was 50f(£ prostaglandin contained in 0.2ml saline.
In the first experiment;where the injection was made into
the left lateral ventricle, decreased motor activity was observed
20 minutes after injection and after 1 hour there was definite
signs of stupor and some catatonia. One hour and 45 minutes
after injection, the catatonia and stupor were still increasing.
The animal was then anaesthetized and its ventricular system
was perfused with 10ml of artificial cerebrospinal fluid, the
perfusate being removed through a needle placed in the cisterna
magna. The animal was exsanguinated and the brain , liver and
gall bladder and kidneys dissected out. All these tissues were
extracted and their tritium content estimated. These are
summarized in Table 1. The largest amount was found in the liver.
•
.. «'
The kidneys and cerebrospinal fluid contained appreciable amounts
but the brain contained very small quantities. This was
distributed throughout all the regions (cortical, grey and white
matter, caudate nucleus, hippocampus, thalamus, hypothalamus,
midbrain, cerebellum, medulla and pons). It is of interest to
note that when the liver extract was partitioned between
aqueous pH3 and ethyl acetate nearly all the radioactivity went
into the aqueous phase which indicated that the tritium was no
longer incorporated into prostaglandin but was in the form of
a less acidic, water soluble compound which is probably a
metabolite.
In the second experiment a similar procedure was followed
but the animal was anaesthetized and exsanguinated 5 minutes
after injection into the left lateral ventricle. No signs of
stupor or catatonia had developed in that time. Similar results
to those of the first experiment (Table l) were obtained with
lr ' I' '"i.
higher levels in the cerebrospinal fluid. Even five minutes
" "■**• j-. ' - -J • • • • * ■./ ;
after injection into the ventricular system appreciable aounts
of radioactivity were recovered from the liver.
:
A ■' i »
In the third cat the injection was made into the right
lateral ventricle. Catatonia developed very rapidly and was
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marked 20 minutes after injection. After 35 minutes the animal
was anaesthetized and exsanguinated. In this experiment the
ventricular system was not perfused but any pools of cerebrospinal
fluid found during the dissection were removed and each tissue
sample was washed with saline to remove any activity present in
the cerebrospinal fluid adhering to the tissue surface, but little
activity was present in the washings. Similar results were
obtained (Table 1).
K '•
Intra-arterial injections into anaesthetized cats
In the first experiment lOpg of tritiated prostaglandin
was injected retrogradely into the left internal mammary artery so
that it should have passed up the left vertebral artery to the
brain. One minute blood samples were taken from the jugular veins
until the animal died during the sixth minute after the start
of the injection. The brain was removed immediately after death.
No area of the brain (forebrain, midbrain, cerebellum, medulla
and pons) contained radioactivity equivalent to as much as
O.lpg prostaglandin and one quarter of the injected activity was
found in the blood, the majority coming out in the first 3 minutes.
i
When lOp.g of tritiated prostaglandh was injected
retrogradely via the left lingual artery similar results were
obtained. Approximately one quarter of the injected activity
was recovered from the blood collected during 5 minutes
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exsanguination and no part of the brain contained activity
equivalent to as much as O.lgg prostaglandin E^.
When a similar retrograde injection of lOpg was made into
the left renal artery, which should have enabled the prostaglandin
to reach the spinal cord, 10% of the injected activity was
recovered from the li minute blood samples taken from the aorta.
The spinal cord (lumbar and sacral regions) was found to
contain activity equivalent to less than O.lug prostaglandin E^.
About 10% of the injected activity was recovered from the liver,
indicating that not all the hepatic blood vessels had been
occluded.
Intravenous Injection into chicks
2ug of tritiated prostaglandin E^ was injected into each of
three chicks which all showed marked sedation within 90 seconds
of injection. The chicks were killed at the time of peak effort
which varied from 1 to 2 minutes. The brain of each chick was
assayed separately and their livers were pooled for assay aa were
the rest of their carcasses. The three brains contained 1.7%>
0.8% and 0.1% respectively of the activity injected. The livers
contained 5% and the remaining carcasses 85% of the injected
activity.
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Intra-arterial injection in chickens
After lug of tritiated prostaglandin E^ was injected into
the right common carotid artery of half-grown chicken, 2% 'of the
injected activity was present in its brain. A similar result
was obtained when 3t'g of tritiated prostaglandin was injected
into a second chicken. When 5ug unlabelled prostaglandin
was injected into the right external jugular vein of an
unanaesthetized chicken, pharmacological effects, loss of the






The results obtained in this study support Samuelsson's
findings in other species that very little radioactivity is found
in the central nervous system after intravenous or subcutaneous
administration of tritiated prostaglandin E^ (6, 7 & 8).
Prostaglandin E^ appears to have little difficulty in
crossing the cerebrospinal fluid-blood barrier, since 5 minutes
after injection into the lateral ventricle appreciable quantities
of activity were found in the liver. Whether this is due to
*
uptake through the blood vessels of the choroid plexus or
I «
whether the prostaglandin is transported rapidly through the brain
tissue and thence to the cerebral capillaries is unknown. However,
from present evidence it appears that by whatever route
-14-
prostaglandin E^ is administered relatively little is taken up by
r J
the central nervous system of either the cat or the chick. The
midbrain, medulla and pons consistently contained higher quantities
of radioactivity after intraventricular injection than other
regions. The uptake by these areas is unlikely to be an artefact
resulting from contamination of the tissue with cerebrospinal fluid
adhering to the surface, as negligible activity was detected in the
washings when the pieces of tissue were washed after dissection.
The dose of prostaglandin employed in each experiment
was shown to be sufficient to produce central; pharmacological
effects. Thus it would seem that only minute amounts of
prostaglandin E^ are required to produce these pharmacological
effects on the central nervous system.
The prostaglandin used in this study was tritiated on
so it is improbable that any active metabolite could be
present without radioactivity. The possibility that the central
effects observed could be due to a peripheral action of
prostaglandin E^ modifying afferent Impulses to the brain can be
discounted as very much higher doses are required to produce
*
effects when the drug is given intravenously rather than into the
lateral ventricle.
The finding that the radioactivity present in the liver
of the cat killed 105 minutes after intraventricular injection
-15-
behaved in a different manner from prostaglandin E^ in the
i i ' » •'
-• ; - • . , ' ■; ■ ' ,'■■■
hydrochloric acid-ethyl acetate solvent partition is of interest.
All the known immediate metabolites of prostaglandin would
behave in a similar manner to the parent compound in this
partition system. Thus it would seem that the activity present
in the liver is a simpler, less acidic and water soluble compound;
this confirms the results of Samuelsson (6) in the rat after
subcutaneous administration of labelled prostaglandin E^.
The experiments described in this paper extend SamuelssonTs
observations to the cat and the chick, the species in which
i
prostaglandin E^ has been shown to have actions on the central
nervous system. They further show that even when prostaglandin E^
is injected more directly towards the central nervous system, only
small amounts can be detected in the brain and spinal cord.
Furthermore, in the young chick, originally selected for studying
central effects of prostaglandin because it is said to lack
a blood brain barrier, only minute amounts of prostaglandin E.
^could be detected in the brain following intravenous injections
■f. I
of pharmacologically effective doses.
-16-
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Distribution of prostaglandin after the injection of 50ug
into the lateral ventricles of cats.
The content of each area is given in p.g followed by the




Cerebrum 1.89 (98) 2.92 (132)
Midbrain 0.10 (100) 0.30 (321)
Cerebellum 0.18 (55) 0.70 (194)
Medulla & pons 0.25 (125) 0.64 (256)
Spinal cord -
f ' - V. *
Liver & gall bladder 19.42 0.92
Kidney 1.08 <0.2
Lungs














[From the Proceedings of the Physiological Society, 26-27 March 1965]
Journal of Physiology, 179, 18-20P
Actions of prostaglandins on the spinal cord of the chick
By E. W. Horton* and I. H. M. Main. The Department of Physiology, The
Medical College of St Bartholomew's Hospital, Charterhouse Square, London,
B.C. 1
In unanaesthetized chicks the intravenous injection of prostaglandin
F2a (25 yg/kg or more) causes extension of the legs lasting several minutes
(Horton & Main, 1965). Experiments have now been made to localize the
site of this action. In chicks anaesthetized with chloralose, prostaglandin
E2c£ (30-100 /tg/kg) injected intravenously increased gastrocnemius
muscle tension, recorded isometrically; the effect was abolished by
denervation of the muscle. Prostaglandin F2ct had no effect on contractions
of gastrocnemius muscle produced by stimulation of the ipsilateral
sciatic nerve. These results suggest that prostaglandin F2a acts centrally
not peripherally. Since increases in gastrocnemius muscle tension following
intravenous injections of prostaglandin F2a (40 yg/kg) were also observed
in spinal chicks (Fig. 1), it is concluded that the effect seen in the un¬
anaesthetized chick is either wholly or partly due to an action of prosta¬
glandin F2a on the spinal cord.
We have also observed in the spinal chick that reflex contractions of the
gastrocnemius muscle in response to stimulation of the central stump of the
contralateral sciatic nerve are potentiated by prostaglandin F2a, in doses
(1-5-7 [ig/kg) too low to affect muscle tension in the absence of stimulation.
This action of prostaglandin F2a resembles that of strychnine (Fig. 1), and
the two substances are about equally potent on this preparation. Since
prostaglandin F2a has been isolated from the central nervous system
(Samuelsson, 1964), this high potency on spinal reflexes is of some interest.
Prostaglandin Fx also potentiated the crossed extensor reflex in the
spinal chick in doses of 1-5-5 /tg/kg. This result was unexpected since in
the chloralosed chick prostaglandin Ex inhibits (whereas prostaglandin
F2a potentiates) the crossed extensor reflex, and in the unanaesthetized
chick prostaglandin E1; unlike prostaglandin F2a, causes sedation and
no increase in muscle tension (Horton, 1964).
In both the chloralosed and the spinal preparation, prostaglandin F2a
caused a rise and prostaglandin Et a fall in arterial blood pressure, but
these changes were insufficient to account for the central nervous effects.
The pressor response to prostaglandin F2ci was not abolished by either
hexamethonium (10 mg/kg) or phenoxybenzamine (1 mg/kg).
Effects of prostaglandins on the spinal chick will be demonstrated. The
























Fig. 1. Spinal chick (decapitated weight 45 g). Upper trace: gastrocnemius
muscle tension recorded isometrically. Lower trace: arterial blood pressure (in
this trace artifacts occurred due to slight movement of the cannula at the time of
each stimulation). Reflex contractions of gastrocnemius muscle were elicited by
5 V pulses of 25 msec duration. F2c( = prostaglandin FSil; Et = prostaglandin E2
and Str. = strychnine hydrochloride, all injections into the right external jugular
3
chick is anaesthetized with ethyl chloride and ether, the cord is sectioned
between C2 and C4 and the chick is decapitated. Arterial blood pressure
is recorded from the left sciatic artery with a Sanborn pressure transducer.
Tension of the right gastrocnemius muscle is recorded isometrically with
a Grass force-displacement transducer (FT. 03). The central stump of the
left sciatic nerve is stimulated once every 10 sec with 5 V pulses of 25 msec
duration.
We thank Professor S. Bergstrom and Dr B. Samuelsson of the Karolinska Institute for
supplies of prostaglandins E, and E2,„ and Dr D. A. van Dorp of the Unilever Research
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FURTHER OBSERVATIONS ON THE CENTRAL
NERVOUS ACTIONS OF PROSTAGLANDINS F2a AND E,
With an Addendum on the Effects of Prostaglandins Ei and F2q
on Systemic Arterial Blood Pressure in Chicks
BY
E. W. HORTON* AND I. H. M. MAIN*
From the Department of Physiology, Medical College of St. Bartholomew's Hospital, London
(Received March 29, 1967)
We have previously reported that prostaglandins E1; E2 and E3 produce catatonic stupor
in the cat and sedation in the chick (Horton, 1964), and that prostaglandin F2a, the only
prostaglandin so far isolated from the brain (Samuelsson, 1964), does not have these
central actions (Horton & Main, 1965a). On the other hand, on intravenous injection
in the young chick, prostaglandin F2„ causes dorsiflexion of the neck and extension of
the legs, effects which could be either central or peripheral (Horton & Main, 1965a). It
seemed likely that extension of the legs would be conducive to quantitative measurement
and this was therefore used as the starting point for further investigation. From
experiments reported in this paper, it is concluded that the prostaglandins act upon
the spinal cord of cats and chicks. In view of the identification of prostaglandins in
central nervous tissues of these species reported in the following paper (Horton &
Main, 1967), the possibility that some of these actions may reflect a physiological role
of the prostaglandins in the central nervous system must be considered.
Some of the experiments reported here have been demonstrated to the Physiological
Society (Horton & Main, 1965b).
METHODS
Experiments on chicks
Chicks of either sex, aged from 2 days to 9 weeks old and weighing from 35 g to 1.3 kg, were
anaesthetized with chloralose (60 to 80 mg/kg) or urethane (1.5 to 2 g/kg except in the preliminary
experiments described under " Results,") injected intraperitoneally or, for spinal cord transection,
with ethyl chloride or an ethyl chloride-diethyl ether mixture. The trachea was cannulated in
all experiments and prostaglandins were injected via a cannula inserted into the right external
jugular vein. Blood pressure was recorded from the left ischiadic artery via a polyethylene cannula
connected to a Sanborn pressure transducer, using a Sanborn polygraph.
Mid-cervical cord transection was performed as follows. After cannulation of the trachea and
right external jugular vein, the common carotid arteries, which lie deep and immediately in front
of the vertebral column, were divided between ligatures. Two strong ligatures were passed round
the vertebral column at about the level of the second and sixth cervical vertebrae respectively, and
a third ligature was passed round the remaining tissues of the neck excluding the tracheal and
jugular cannulae. The ligatures were tied and the cord sectioned between the two ligatures around
* Present address: Department of Pharmacology, The School of Pharmacy, Brunswick Square.
London W.C.I.
CNS ACTIONS OF PROSTAGLANDINS 569
the vertebral column at about the level of the fourth cervical vertebra. The head was then
removed and subsequently weighed. The chick was artificially ventilated by a Palmer small animal
respiration pump with a frequency of 36 or 48/min and delivering a volume of 2 ml./50 g chick.
Muscle tension was recorded isometrically from the freed tendon of a gastrocnemius muscle using
a force-displacement transducer (Grass FT.03, 0-200 g springs). The limb was fixed to a cork
board by pins inserted through the lower femur and tibia. Muscle contractions were elicited either
by stimulating the cut peripheral stump of the ipsilateral sciatic nerve or, reflexly, by stimulating
the cut central stump of the contralateral sciatic nerve maximally (5 V square wave pulses, 1-25
msec duration, 0.05-0.5/sec). Lower eyelid tension was recorded by a thread attached to the centre
of the lid margin ; in these experiments the head was immobilized. Body temperature was main¬
tained by means of a heated operating table and an overhead warming lamp. In some but not all
experiments, rectal temperature was recorded using a small thermometer.
The cerebral hemispheres were exposed by removing the overlying thin cartilaginous area of
skull with fine scissors. The dura was then incised on both sides, avoiding the midline from which
bleeding occurred readily. The spinal cord was exposed from the mid-thoracic to the lumbar region.
Exposure of the lower lumbar region proved difficult owing to the anatomical arrangement of the
avian pelvis.
Experiments on cats
Cats of either sex weighing 0.75 to 5.1 kg were either anaesthetized with chloralose (80 mg/kg
injected intraperitoneally or intravenously), decerebrated at the inter-collicular level or spinalized at
the level of the second cervical vertebra (with destruction of the brain) under ethyl chloride-ether
anaesthesia. Spinal cats were artificially ventilated. Blood pressure was recorded from a carotid
artery using a Sanborn pressure transducer. Intravenous injections were made into an external
jugular vein.
Close-arterial injection to the gastrocnemius muscle. The artery supplying the gracilis muscle was
cannulated with fine polyethylene tubing connected to a three-way tap. Retrograde injections were
made into the femoral artery.
Recording of muscle tension. Muscle tension was recorded isometrically from the freed tendons
of hind limb muscles (gastrocnemius, quadriceps and hamstring) using force-displacement trans¬
ducers (Grass FT.03, 0-2 kg springs). Contractions of the gastrocnemius muscle were elicited by
stimulating the cut peripheral stump of the ipsilateral sciatic nerve (5 V square wave pulses, 1 msec
duration), or by direct stimulation of the muscle (20-50 V pulses, 1 msec duration) through silver
wire electrodes looped round each end of the muscle. Crossed extensor reflexes were elicited from
the gastrocnemius or quadriceps muscles by stimulating the cut central stump of the contralateral
sciatic nerve either with single stimuli (5 V pulses, 0.1-1 msec duration) or with trains of stimuli
at 20/sec lasting 5-10 sec. The patellar reflex was elicited by an electrically operated Palmer
knee-jerk hammer.
Inhibition of the crossed extensor reflexes recorded from the quadriceps muscle was achieved by
stretching the ipsilateral hamstring muscle, the tendon of which was connected to a force-
displacement transducer. By moving the transducer through a standard distance a constant stretch
could be repeatedly applied to the muscle.
Chronic denervation of the gastrocnemius muscle. The cat was anaesthetized with pentobarbitone
(40 mg/kg injected intraperitoneally). Under aseptic conditions a sciatic nerve was located via
a small skin incision on the posterior surface of the limb. A segment of nerve 1 in. long was
removed, the wound closed and the cat allowed to recover. Responses of the denervated muscle
were investigated 3 weeks later.
Spinal cord exposure. In decerebrate or spinal cats the spinal cord was exposed dorsally from
L4 to S3. The dura was incised and reflected. In some experiments exposure was carried out
under ether anaesthesia before spinalization to reduce reflex excitability. Cotton wool impregnated
with a warm solution of the substance under investigation was applied to the exposed surface.
Hind limb de-afferentation. The dorsal roots from L4 to S3 on one side were cut. This abolished
the crossed extensor reflex elicited by stimulating the central stump of the cut sciatic nerve on the
side of the de-afferentation but not that elicited by stimulating the cut sciatic nerve centrally on
the contralateral side.
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RESULTS
The site of action of prostaglandin if, in chicks
Effects ofprostaglandin F.,„ on anaesthetized chicks
Preliminary experiments were made to determine whether F2u would produce extension
of the legs in the anaesthetized chick as we had observed previously in the unanaesthetized
chick (Horton & Main, 1965a).
Prostaglandin F2„ (40 ug/kg) was injected intravenously in 6 two-day old chicks. Two
chicks had been injected intraperitoneally with 0.9% sodium chloride solution, 2 with
urethane (1.25 g/kg) and 2 with urethane (2.25 g/kg). In the unanaesthetized control
chicks, F2a caused extension of the legs lasting between 1 and 2 min, accompanied by
dorsiflexion of the head and neck. The eyes were wide open. This was followed by
a period during which the chick could stand with legs abducted. In the chicks lightly
anaesthetized with urethane (1.25 g/kg), in which the righting reflex was absent and the
eyes were shut but the withdrawal reflex to toe pinching was present, dorsiflexion of the
neck and extension of the legs were observed following the intravenous injection of F,„;
the eyes opened during the period when the legs were extended. In the chicks more
deeply anaesthetized with urethane (2.25 mg/kg), the withdrawal reflex was absent and the
intravenous injection of F2„ had no effect.
These results showed that it would be possible to use the anaesthetized chick to locate
the site of action of F2,„ provided that the anaesthesia was not too deep.
I min
r i«
Fig. 1. Chicken (550 g) anaesthetized with urethane (1.7 g/kg). Record of gastrocnemius muscle
tension recorded isometrically. Response to prostaglandin Fsa (1 ug) injected intravenously.
Effects ofprostaglandin F2„ on gastrocnemius muscle tension
In chicks anaesthetized with urethane or chloralose, F2„ increased gastrocnemius muscle
tension measured isometrically (Fig. 1). The increase in tension was similar in onset
and duration to the extension of the legs observed in unanaesthetized chicks. The con¬
traction began 10 to 30 sec after the injection and lasted up to 10 min. There was no
obvious decrease in sensitivity to F2„ (on a weight basis) with age. The sensitivity to
F2, was similar in chicks anaesthetized with either urethane or chloralose. In 9 chicks
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the lowest effective dose of F2n ranged from 2 to 100 ^g/kg. However, tachyphylaxis to
successive doses of F2n often developed, especially when the interval between doses was
short. Assessment of threshold doses was therefore difficult.
The increase in gastrocnemius muscle tension in response to F2a was accompanied
often by defaecation and sometimes by opening of the eyes. The latter effect is illustrated
in Fig. 2. In this experiment tension of the lower eyelid was recorded isometrically and







Fig. 2. Chick (85 g) anaesthetized with urethane (2.0 g/kg). Upper trace: systemic arterial blood
pressure. Middle trace: lower eyelid muscle tension. Lower trace: gastrocnemius muscle
tension. Responses to prostaglandin F2a (5 /<g) injected intravenously.
Effects ofprostaglandin Fin on systemic arterial blood pressure
In 4 chicks anaesthetized with urethane, in which gastrocnemius muscle tension
and ischiadic arterial blood pressure were recorded simultaneously, increases in gastro¬
cnemius muscle tension following an intravenous injection of F2tt were accompanied by
changes in blood pressure which varied from one chick to another; in one chick there
was a rise, in a second a fall and in the other 2 chicks a rise followed by a fall in blood
pressure. In view of this it seems unlikely that either a rise or a fall of blood pressure
could have been the cause of the increase in gastrocnemius muscle tension produced by
F2„. Furthermore, similar rises or falls in blood pressure produced by injecting adrenaline
or acetylcholine did not alter gastrocnemius muscle tension.
Effect of mid-cervical cord transection on the response to prostaglandin F,,a
In 8 chicks whose spinal cord had been sectioned in the mid-cervical region (decapitated
weight 31-71 g), F,„ in doses of 9 to 166 y-gjkg, given intravenously, increased gastro¬
cnemius muscle tension,
u
572 E. W. HORTON and I. H. M. MAIN
Effect of acute denervation on the response to prostaglandin F2a
In one unanaesthetized chick the left sciatic nerve was sectioned after infiltration of
the overlying skin with amethocaine. Fifteen minutes after section an intravenous
injection of Fa„ (330 pg/kg) resulted in the usual dorsiflexion of the neck accompanied
by extension of the right (innervated) limb. There was no extension of the left (denervated)
limb.
In the anaesthetized or spinal chick F2a also failed to produce a contraction if the gastroc¬
nemius muscle was acutely denervated. In the experiment on a spinal chick illustrated




5 ftg S fig 2 tig
Fig. 3. Spinal chick (decapitated weight 32 g). Gastrocnemius muscle tension recorded isometrically
(upper trace: left leg; lower trace: right leg). Responses to prostaglandin Fir, (5 /ig) and
decamethonium iodide (CIO, 2 /»g) injected intravenously. Between the first and second panel
the left sciatic nerve was cut. There was an interval of 60 min between each injection.
was recorded. F2a (156 pg/'kg) injected intravenously increased the tension of b®th the
left and the right gastrocnemius muscles. After the left sciatic nerve had teen sectioned
the same dose of F2a increased the tension of the right gastrocnemius muscle only. To
avoid tachyphylaxis the interval between doses was 1 hr. Blood pressure was not
recorded in this experiment since cannulation of an ischiadic artery would have interfered
with the limb blood flow and in the 2-day old chick no satisfactory alternative artery was
available for cannulation. Adrenaline (16 Kg/kg) was injected intravenously midway
between the doses of F2a to ensure that the blood pressure was maintained. After
denervation decamethonium iodide (63 pg/kg) contracted both gastrocnemius muscles
indicating that the denervated gastrocnemius muscle was still capable of contracting in
response to drugs injected intravenously.
These experiments show that the response of the gastrocnemius muscle to F2a is not
due to a direct action on the muscle or an action on the neuromuscular junction.
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The site of action ofprostaglandins F2a and E1 in decerebrate and spinal cats
Experiments on decerebrate cats
Although in the unanaesthetized cat prostaglandin F2a injected either intravenously
(15 ptg/kg) or into the cerebral ventricles (15-100 ^g) has no obvious effect, it was observed
that in the decerebrate cat F2a injected intravenously increases gastrocnemius muscle
tension as it does in the intact and spinal chick. However, in the decerebrate cat, unlike
in the chick, Ex also increases gastrocnemius muscle tension on intravenous injection.
These actions are illustrated in Fig. 4. In 3 decerebrate cats the approximate threshold
dose of F2a was 5 to 7 ng/kg and in 7 decerebrate cats the approximate threshold dose
of Ej ranged from 5 to 15 ng/kg. In 2 cats Et in doses of 8 and 17 (xg/kg failed to increase
gastrocnemius muscle tension, although the fall in arterial blood pressure was the same as
in the other cats. Tachyphylaxis to Ej sometimes developed.
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Fig. 4. Decerebrate cat (3.4 kg). Upper trace: carotid blood pressure. Lower trace:
gastrocnemius muscle tension. Responses to intravenous injections of prostaglandin Ei (50 jug)
and prostaglandin F2a (25 ,«g).
The interval between the injection and the onset of contraction varied from 25 to 100 sec.
Sometimes the contractions of the gastrocnemius muscle were accompanied by arching
of the back, extension of the forelimbs and on two occasions walking movements.
Decerebrate rigidity was potentiated. Ex and F2a always caused a fall in systemic arterial
blood pressure sometimes accompanied by an increase in ventilation rate. There was
no obvious correlation between the magnitude of the depressor response and the con¬
traction of the gastrocnemius muscle. Larger depressor responses produced by intra¬
venous injection of acetylcholine (10 ng/kg) had no effect on gastrocnemius muscle tension.
In view of the apparent similarity in response of the gastrocnemius muscle in the decere¬
brate cat to Ej and F2a, and because of the shortage of F2a, subsequent studies on the
site of this action of the prostaglandins in the cat were carried out with Ex.
In the decerebrate cat acute denervation of the gastrocnemius muscle prevented the
increase in tension following an intravenous injection of Ej. On close-arterial injection
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into a hind limb in doses similar to those effective by the intravenous route, Ex had no
effect on gastrocnemius muscle tension. Higher intra-arterial doses sometimes increased
tension but only after a longer latent period than after intravenous injection, and the
response was bilateral. These results show that the increased gastrocnemius muscle
tension following intravenous injection of Ex in the decerebrate cat is not due to an action
on skeletal muscle or the neuromuscular junction.
Experiments on spinal eats
In 3 spinal cats Ex in threshold doses ranging from 5 to 40 ^g kg increased gastrocnemius
muscle tension, the time course of the contraction being similar to that in the decerebrate
cat. In 3 other spinal cats Ex in doses from 16 to 58 ixg/kg had no effect on gastrocnemius
muscle tension.
The response of the gastrocnemius muscle to Ex in the spinal cat was abolished by
denervation of the muscle but not by dorsal root (L4 to S3) section. Close-arterial
injections of into the hind limb of the spinal cat, in doses similar to those effective by
the intravenous route, had no effect on gastrocnemius muscle tension, thus confirming
the findings in decerebrate cats that this is not a peripheral action of prostaglandin Ex.
In one experiment a direct action of Ej on the spinal cord was demonstrated by topical
application. An increase in gastrocnemius muscle tension occurred when Ex (500 gg/ml.)
was applied to the dorsal surface of the lumbar (L6-7) cord. This effect could be elicited
repeatedly. Application of saline had no effect. Concentrations of 100 gg/'ml. or less
of Ex had no effect.
Action ofprostaglandin E1 on skeletal muscle
The experiments show that the increase in gastrocnemius muscle tension is not due to
an action of Et on the muscle itself. In higher doses Ej injected close-arterially to the
muscle had an inhibitory effect on muscle twitches. In a spinal cat Ej (29 jj-g/'kg) injected
close-arterially inhibited contractions of the gastrocnemius muscle in response to electrical
stimulation of the sciatic nerve. In another experiment, on a chloralosed cat, contractures
of the chronically denervated gastrocnemius muscle in response to close-arterial injections
of acetylcholine (0.18 fxg/kg) were also inhibited by Ex (23 y.g kg) injected close-arterially.
This effect lasted throughout the remainder of the experiment. On the other hand,
contractions due to direct electrical stimulation were not significantly affected (Fig. 5).
Effects ofprostaglandins F2a and E1 on spinal reflexes in cats and chicks
During the experiments described above a crossed extensor reflex was sometimes elicited
as a test of the integrity of the spinal cord. It was observed that prostaglandins usually
potentiated this reflex in both the chick and the cat. This action of prostaglandins on
spinal reflexes has been investigated further and the results are described below.
Spinal chicks
In some of the early experiments on spinal chicks no crossed extensor reflex could be
elicited, while in other experiments the reflex appeared only after an interval of 30-60 min.
In later experiments, an intravenous injection of 0.9% sodium chloride solution or
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Fig. 5. Cat (2.2 kg) anaesthetized with chloralose (80 mg/kg). Upper trace: carotid arterial blood
pressure. Lower traces: muscle tension recorded from a chronically denervated gastrocnemius
muscle ; twitches were elicited by direct electrical stimulation of the muscle ; contractures were
elicited by close-arterial injection of acetylcholine (0.4 ,«g) as indicated by the dots. The interval
between (a) and (b) was 12 min. Effects of prostaglandin Ei (50 /tg) injected close-arterially.
adrenaline (5-10 ng/kg) was given immediately after section of the spinal cord, and in
these experiments reflexes were present from the outset.
In the spinal chick, reflex contractions of the gastrocnemius muscle in response to
stimulating the central stump of the cut contralateral sciatic nerve were potentiated by
F2a in doses too low to affect muscle tension in the absence of stimulation. The poten¬
tiation began 5-10 sec after the injection, reached a maximum within 30-60 sec and
usually lasted 3-30 min according to the dose injected. The crossed extensor reflex was
elicited in 16 spinal chicks weighing from 42 to 141 g. In every case F2„, in doses ranging
from 2 to 150 gg/kg potentiated the response. With the higher doses of F2a, a contraction
of the gastrocnemius muscle was observed in addition to the potentiation of spinal reflexes
(Fig. 6), and tachyphylaxis to both responses frequently occurred.
Prostaglandin Ej also potentiated the crossed extensor reflex in spinal chicks in threshold
doses (1.5 to 5 ng/kg) similar to those of F2„. Higher doses of Ei caused transient
potentiation of reflexes and convulsive movements of the chick, but this was followed
by inhibition of the reflex possibly due to the lowering of blood pressure. Unless
adrenaline was injected to restore the blood pressure, death often occurred after these
higher doses of Ej in the spinal chick.
When gastrocnemius muscle twitches were elicited by stimulation of the intact ipsilateral
sciatic nerve, intravenous injections of F2a and Ej did not affect the size of the muscle
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Fig. 6. Spinal chick (decapitated weight 44 g). Upper trace: gastrocnemius muscle tension, crossed
extensor reflex twitches were elicited by electrical stimulation of the contralateral sciatic nerve.
Lower trace: systemic arterial blood pressure. Response to prostaglandin F>a (2 /j$) injected
intravenously.
mmHg
twitches, either in doses which potentiated spinal reflexes or even in doses (of F,„) high
enough to cause contraction of the ipsilateral gastrocnemius muscle. These results
indicate that the potentiation by prostaglandin of the crossed extensor reflex is central
not peripheral.
The action of F2„ and Ex on the crossed extensor reflex of the spinal chick resembled
strychnine. No valid comparison of potency of prostaglandins and strychnine could be
made since the dose-response curves were not parallel. The threshold dose of strychnine
was usually of the order of 10 p-g/kg. The maximum potentiation which could be achieved
with higher doses of strychnine was greater than that which could be produced with the
prostaglandins, and the effect of strychnine lasted longer.
Anaesthetized chicks
The crossed extensor reflex could be elicited readily in chicks anaesthetized with
chloralose but not in chicks lightly anaesthetized with urethane. Furthermore, small doses
of urethane (0.2 g/kg) reduced or abolished the crossed extensor reflex in chloralosed chicks.
In 9 experiments on chloralosed chicks from 2 days to 9 weeks old weighing 35 g-
1.25 kg, F2a, in doses ranging from 4-15 [j-g/kg, potentiated the crossed extensor reflex.
In chloralosed chicks Ex either had no effect or inhibited the crossed extensor reflex in
doses (1-8 ;zg/kg) similar to those which potentiated the reflex in the spinal chick.
Neither E1; nor F2(i, when applied topically to the dorsal surface of the lumbar region
of the spinal cord, had any effect on the crossed extensor reflexes. In one experiment Ej
(100 ug'ml.) had no effect whereas strychnine (100 ug/ml.) caused marked potentiation.
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Topical application of Ex (50-100 pg/ml.) to the exposed cerebral hemispheres had little
or no effect on the reflex in the chloralosed chick except in one experiment in which the
reflex was reduced by Ej (100 pg/ml.). The possibility that this action may not have been
a local one but was secondary to absorption into the systemic circulation cannot be
entirely excluded. The effect was accompanied by a slight fall in arterial blood pressure.
Decerebrate and spinal cats
Prostaglandin Ex potentiated the crossed extensor reflex in decerebrate and spinal cats
in doses of 1-20 pg/kg and 10-32 pg/kg respectively. Figure 7 shows an experiment on a
spinal cat in which Ej caused a potentiation of the crossed extensor reflex which lasted
30 min. Sometimes potentiation of the reflex was preceded by a slight inhibition which
coincided with the maximum lowering of the blood pressure (20-30 sec.). Prostaglandin
Ej had no detectable effect on the patellar reflex, in doses which potentiated the crossed




Fig. 7. Spinal cat (3.1 kg). Upper trace: carotid arterial blood pressure. Middle trace: left quadri¬
ceps muscle tension, patellar reflex twitches. Lower trace: right gastrocnemius muscle tension,
twitches were elicited by stimulating the contralateral sciatic nerve. Effect of prostaglandin
Ei (20 fig), injected intravenously.
Since Ej did not potentiate the twitches of the gastrocnemius muscle in response to
ipsilateral nerve stimulation, it is concluded that the potentiation of spinal reflexes in the
cat is due to an action on the spinal cord. This could be due to facilitation of the firing
of motor neurones. Such an action could be either by direct facilitation, or by inhibiting
pre- or post-synaptic inhibitory mechanisms. A few experiments were carried out on
spinal cats in an attempt to find out which mechanism might be responsible.
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In one experiment, the crossed extensor reflex, recorded from the left quadriceps muscle,
was elicited by repetitive stimulation of the contralateral sciatic nerve for periods of 10 sec
at 1 min intervals. A constant stretch applied to the left hamstring muscle during each
reflex response resulted in marked inhibition. Ej (30 gg/kg) potentiated the crossed
extensor reflex but did not affect the degree of inhibition. The tension developed in
the hamstring muscle during stretching was also increased by Ej.
In another experiment inhibition of the crossed extensor reflex by electrical stimulation
of the ipsilateral peroneal nerve was unaffected by Ex.
These results suggest but do not prove that reflex potentiation of Ei does not result
from inhibition of inhibitory mechanisms.
Topical application of Ex to the spinal cord of spinal cats, in concentrations of 20-
100 gg/ml. did not affect spinal reflexes. In one experiment referred to above contraction
of the gastrocnemius muscles and potentiation of crossed extensor reflexes followed the
application of higher concentrations of Ex (500 ug ml.) to the dorsal surface of the cord
in the L6-L7 region.
DISCUSSION
Evidence that prostaglandin F2a acts on the spinal cord of the chick
Our experiments confirm that extension of the legs observed in the chick after an intra¬
venous injection of F2a (Horton & Main, 1965a) is due to contraction of the extensor muscles
such as the gastrocnemius muscle. By recording the increase in tension of this muscle
we have been able to locate the site of this action of F2a. Since the response to F2„ is
abolished by acute denervation of the muscle, it must be centrally mediated. Since it is
readily elicited in the decapitated chick the brain cannot be necessary for the mediation
of this effect, nor can it be a reflex response mediated by pathways which depend upon
the integrity of the brain stem. Reflex contraction of the gastrocnemius muscle due to
F2„ acting upon spinal afferent nerves is unlikely because under light urethane anaesthesia
electrical stimulation of the cut central stump of the sciatic nerve failed to elicit reflex
contractions of the contralateral gastrocnemius muscle whereas F2a injected intravenously
did produce a contraction of the muscle. It is, therefore, concluded that F2a increases
gastrocnemius muscle tension by an action on neurones within the chick spinal cord.
Confirmation of this conclusion by topical application of F2a to the exposed spinal cord
has not yet been obtained, possibly because the concentrations applied were too small.
Potentiation by F2„ of the crossed extensor reflex in the chloralosed and spinal chick is
compatible with an excitatory or facilitatory action on spinal cord neurones or of inhibition
of inhibitory pathways.
Although F2a acts upon the spinal cord of the chick, the possibility that it also acts on
the brain cannot be excluded.
Evidence that prostaglandin E1 acts on the spinal cord of the cat
Increases in gastrocnemius muscle tension in the spinal cat in response to intravenous
injections of Ex could not be imitated by injecting the prostaglandin close-arterially to
the muscle. Furthermore, acute denervation of the muscle abolished the response to
intravenous Ex showing that the action of the prostaglandin cannot be upon the skeletal
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muscle or the neuromuscular junction, but must be centrally mediated. Reflex contrac¬
tions of the gastrocnemius muscle mediated via the brain could not of course account for
the positive responses obtained in the spinal animal, but reflex contractions due to Et
acting upon spinal afferent nerves are not excluded. A direct action of Ex on the cord
is more likely, because, in one experiment, contractions of the gastrocnemius muscle were,
elicited by topical application of Ej to the spinal cord. We conclude that prostaglandin
Ej in the cat, like F2a in the chick, can increase gastrocnemius muscle tension by an
action on the spinal cord.
Since the effect of Ex was observed equally on both gastrocnemius muscles after uni¬
lateral section of the dorsal roots, it could not be due to facilitation of y-motoneurone
firing alone. We conclude that Ei facilitates the firing of a-motoneurones either directly
or indirectly. The facilitation is probably due to stimulation of excitatory pathways
since inhibition of inhibitory pathways was not observed after prostaglandin administration.
This problem must be investigated further using electrophysiological techniques.
Responses to Ex observed in the decerebrate cat could be accounted for by an action
on the spinal cord. The question of whether Ej also excites hind-brain descending
facilitatory pathways remains unsettled, though Avanzino, Bradley & Wolstencroft (1966)
have shown that medullary reticulospinal neurones respond to prostaglandins applied
iontophoretically and that the predominant response is excitation. Increases in gastroc¬
nemius muscle tension in response to Ex were obtained more readily in the decerebrate
than the spinal animal. Whether this could be explained on the basis of additional
contributions from the stimulation of descending facilitatory pathways which have their
origin in the hind-brain is a matter for further experiment.
The evidence concerning the site of action of F,„ in the cat is incomplete. Certainly
F2„ had a similar action to Ex on the decerebrate cat and it may be supposed that it also
exerts its effect partly, at least, on the spinal cord. Avanzino et al. (1966) showed that
F2„ fires off reticulospinal neurones in the medulla and Duda & McPherson (personal
communication) have observed that F2<J has actions on the spinal reflexes in the chloralosed
cat, when injected into the abdominal aorta.
Our experiments on reflexes in both the spinal chick and the spinal cat support the
conclusion that prostaglandins have facilitatory action on the firing of a-motoneurones,
though the inhibitory action of Ex on the crossed extensor reflex in the chloralosed chick
is suggestive that prostaglandins may also be inhibitory or excite inhibitory pathways
in certain circumstances. These observations have received some support from the
recent experiments of Duda & McPherson (personal communication) on the chloralosed
cat using electrophysiological recording techniques.
Possible physiological implications of these results are discussed more fully in the
following paper.
SUMMARY
1. Prostaglandin F2a on intravenous injection in chicks increases gastrocnemius muscle
tension. Experiments were made to locate its site of action.
2. The effect was observed in the decapitated chick but was abolished by denervation
of the muscle. It could be elicited in the urethanized chick in which reflex contractions
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were blocked. It is concluded that the site of this action of F2a in the chick is upon the
spinal cord.
3. In spinal cats prostaglandin Ej injected intravenously increased gastrocnemius
muscle tension also by an action on the spinal cord. The effect was abolished by dener¬
vation of the muscle but not by dorsal root section. Close-arterial injection of Ex to
the gastrocnemius muscle did not elicit a contraction but did inhibit muscle twitches and
acetylcholine-induced contractures. In one experiment prostaglandin Ej applied topically
to the spinal cord induced a contraction of the gastrocnemius muscle.
4. Decerebrate rigidity in the cat was potentiated by prostaglandins F2„ and Ex.
5. Crossed extensor reflexes were potentiated by prostaglandin F2a in the spinal chick
and by Ex in the spinal cat. The patellar reflex in the spinal cat was little affected by
prostaglandin Ex. In the chloralosed chick F2„ potentiated but Ej inhibited the crossed
extensor reflex.
This work was supported by grants from the Medical Research Council. We are grateful to
Professor S. Bergstrom and Dr. B. Samuelsson, of the Karolinska Institute, and to Dr. D. A. van Dorp,
of the Unilever Research Laboratories for supplies of prostaglandins.
ADDENDUM
Effects ofprostaglandins E1 and F.,a on systemic arterial blood pressure in chicks
During experiments on chicks described in this paper, arterial blood pressure was
usually monitored. In all preparations Ex had a depressor effect. In spinal preparations
F2(i had a pressor effect but in anaesthetized chicks the response to F2„ was more variable;
sometimes pressor, sometimes depressor, and sometimes biphasic (pressor followed by
depressor). The results are summarized in Table 1.
The pressor action of F2a in spinal chicks was not abolished by phenoxybenzamine
(10 mg/kg) which abolished responses to noradrenaline nor by hexamethonium (10 mg/kg)
or pronethalol (10 mg/kg).
Table 1
ACTIONS OF PROSTAGLANDINS ON THE ARTERIAL BLOOD PRESSURE OF
ANAESTHETIZED AND SPINAL CHICKS
Number of experiments
Arterial blood pressure response
Preparation Prostaglandin Total Pressor Fressor-depressor Depressor
Spinal F2a 14 14 0 0
El 9 0 0 9
Chloralose F2a 14 8 5 1
anaesthesia Ex 8 0 0 8
Urethane F 2a 10 3 4 3
anaesthesia Ex 15 0 0 15
All anaesthetized F 2a 24 11 9 4
chicks Ex 23 0 0 23
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In 3 experiments on the isolated chicken heart perfused by the method of Langendorff,
F2a had no action on the force or rate of contraction in doses higher than those which
had a pressor action on intravenous injection in the spinal chick. In 2 experiments Ex
(25 and 50 ug) injected into the perfusion fluid increased the force of contraction but
smaller doses had no effect.
The results suggest that the pressor action of F2a is not mediated by the sympathetic
nervous system and does not result from a direct action on the heart.
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SUMMARY
1. Experiments, using electrophysiological recording techniques, were
carried out to confirm the report that prostaglandins affect spinal reflexes
irtoat.
2. Ventral root potentials evoked by stimulation of the ipsilateral
dorsal root were recorded. Those with a lateift period corresponding to a
monosynaptic pathway were used primarily in this investigation.
3. Prostaglandin 10, (.'W>-17*8 //g/kg) injected into the aorta reduced the
amplitude of monosynaptic responses in six out of ten cats. The effect
began 15 min after injection and lasted over 3 hr. In one cat 10, caused
potentiation of the reflex and in three cats there was no effect.
4. Prostaglandin (2-4-3-5 /(g/kg) inhibited the monosynaptic re¬
sponse in four cats but in one of these a subsequent large dose (19-6/<g/g/kg)
greatly potentiated the reflex.
ft. Prostaglandin Faa (1*4-17-8//g/kg) injected into the aorta was fol¬
lowed by significant but variable changes in monosynaptic response. In
one experiment an intravenous injection (DOdi//g/kg) was followed by a
long-lasting potentiation of the reflex response.
fl. It is concluded that prostaglandins, two of which have previously
been identified in cat brain extracts, have pronounced and long-lasting
effects on monosynaptic spinal reflexes.
INTRODUCTION
Prostaglandins have been shown to have pharmacological actions on the
brain and spinal cord (Morton, 19(14; Morton & Main, I9G5; Avan/.ino,
* IVoaont Addrms: Inn! itu1o uf Normal and PuUtolngioul I'hyHiolotfy, Slovak Academy of
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Bradley & Wolstencroft, 1906; Horton & Main, 1 907a; Holmes & Horton
1968a). In the present investigation, the actions of three prostaglandins
have been studied on spinal reflexes by intra-arterial injection close to the
spinal cord.
METHODS
Twenty-two cats weighing between 2-8 and 4-0 kg were used. Anaesthesia was induced
with a mixture of halothane ('Fluothano' I.C.I., £• of Goldman's vaporizer scale) in nitrous
oxide (3-0 l./min) and oxygen (0*3 l./min), and maintained with chloralose (70 mg/kg)
injected intravenously. To avoid the need for additional anaesthetic during the hours of
observation, an additional dose (25 mg/kg) of chloralose was given 4-6 hr after the first
dose when the dissection was complete but beforo observations were made.
The trachea was cannulatod in all experiments. Blood pressure was recorded from a
carotid using a polyethylene catheter connected to a pressure transducer (Stathain model
no. P23DH) and then through a carrier amplifier to a potentiometrie pen recorder.
The spinal cord was exposed dorsally in the lumbar region and the dura opened. Keflex
responses recorded from a ventral root, wore evoked by stimulation of the ipsilatend dorsal
root of I ho same lumbar segment. Both ventral and dorsal roots were out peripherally.
The recordings wore obtained from platinum electrodes under liquid paraffin maintained
at a temperature of 36-38° C. The dorsal roots were stimulated and the responses recorded
by methods previously described (Evans & McPerson, 1958; 1959).
To attain higher concentrations of the prostaglandins in the spinal cord, the solution was
injected intra-arterially. A fine nylon catheter was inserted into the aorta via a renal artery
with its tip just below the origins of the renal arteries; it was tied at the insertion point in
the renal artery. During the administration of prostaglandins the most distal part of the
aorta was occluded with an elastic loop placed around the aorta and in order to prevent
injected prostaglandins from passing into the blood vessels of the hincl limbs. Other branches
of the aorta were not occluded. The aortic occlusion lasted throughout the administration of
the prostaglandins and ended approximately 20 sec after tho injection was completed.
Throughout tho oporative procedures a mixture of 5 % (w/v) dextrose and 0-9 % (w/v)
saline (Evans Medical Ltd.) was infused intravenously at a rate of about 0*5-1 ml./min.
The urinary bladder was kept empty throughout all experiments by means of an indwelling
catheter.
Prostaglandin Ei is lla,15-dihydroxy-9-oxo-prost-13-enoic acid. Tho material used,
except in three experiments, was 99 % pure specially prepared and kindly supplied by Dr
D. A. van Dorp of tho Unilever Research Laboratories, Vleardingen, The Netherlands.
Prostaglandin Flo(, 9a,lla,15-trihydroxy-prost-13-enoic acid was also supplied by Dr D. A.
van Dorp. Prostaglandin F2a,9a,lla,15-trihydroxy-prost-5,13-dienoic acid was kindly
supplied by Dr John E. Pike of the Upjohn Company, Kalamazoo, U.S.A.
RESULTS
Occlusion of tho aorta lasting 1-2 min raised systemic arterial blood
pressure and in about lialf the experiments increased the amplitude of the
monosynaptic reliex responses. After the end of occlusion, reflex responses
returned to their pre-occlusion levels within 4-6 min. Such an effect is
illustrated in Fig. 1. The potentiation was significant (P < 0-01) for the
first 2 min after the start of occlusion. When prostaglandins were injected
during the occlusion similar short-lived potentiation was observed. This is
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illustrated in Fig. 2. In this experiment the initial potentiation can he
attributed to the occlusion because it was already maximal when the
prostaglandin was injected.
Prostaglandins lowered arterial blood pressure but even in the largest
doses used, the depressor effect lasted less than 20 min.
Effect of prostaglandin Ex on monosynaptic reflexes. Prostaglandin Ex








C 1 2 3 4 S
Minutos
Fig. 1. Tho offcct of aortic occlusion on tho amplitudo of a monosynaptic redox.
C = control (pre-ooclusion) valuo of tho responso. During the first minute tho
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Fig. 2. Monosynaptic redox responses before, during and immediately after aortic
occlusion and injection of prostaglandin 10, into the aorta (at Ft!). The occlusion
was roleasod 20 sec after the injection. Ordinate: amplitude of the response in
arbitrary units. Abscissa: time in min.
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often cats (Fig. 3; Table 1). The effect began between 15 and 30 min after
injection into the aorta and lasted at least 3 hr. In three experiments there
was no significant change in reflex responses with doses of 3-3, 3-5 and
15-6 /ig/kg during the period of observation following in jection (1|, 2 and
3 hr respectively). Tn one experiment the reflex response was potentiated
following the injection of prostaglandin Ex (1-5 /<g/kg).
Miuutoa
Fig. 3. Results of ton experiments (soo Table 1) showing the effect of prostaglandin
Ej injected into the aorta on monosynaptic reflex responses. Changes during the
first 20 min which might bo attributable to aorta occlusion or to vascular effects
have not been plotted. Ordinato: % cliango in amplitude of the response. Abscissa:
time in min aftor the injection.
The effect, of prostaglandin F, (3-5 //g/kg) in reducing the size of the
monosynaptic redox responses is shown in more detail in Fig. 4. The reduc¬
tion in amplitude started 15 min after injection of prostaglandin Ex and at
that time the arterial blood pressure had already returned to its previous
level. The reflex responses even 4 hr after the injection were less than 50]%
of the pre-injection control values. In this experiment there was no signi¬
ficant change in the size of a polysynaptic reflex response over the 4 hr
period (Fig. 4).
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EJJrd of prostaglandin Fu on spinal rejlexe# In four oats, prostaglandin
"la (2-4-iM)/tg/kg) caused a reduction in monosynaptic responses (Fig. 5;
Table 2). These effects lasted up to .'5 hr. In one experiment (No. 4)
Table 1. Weight of cats and dosages of prostaglandin Ej, used





No. Sox (kg) (/<S) /'-g/kg
1* Male 3-0 1-2 0-4
3-7 1-2
74) 2-3
2* Female 441 04) F5
il Female 2'H 104) 3-5
4 Female 2-8 100 3-5
5 Fomalo 2-8 10-0 3-5
0 Female 2-8 10-0 3-5
7* Female 30 10-0 3-3
8 Female 2-8 10-0 3-5
20 0 7-1
9 Female 3-2 50-0 15-6
10 Female 2-8 504) 17-8
* 95 % pure prostaglandin E, was used in these experiments. In tho remaining experiments
99 % pure prostaglandin Ej was used.
Minutes
Fig. 4. Tho effect of prostaglandin E, (10 /eg) injected into tho aorta on mono¬
synaptic reflex responses. Samples of the action potentials at 2, 10, 50, 60 and
120 min after the injection are illustrated. Ordinate: % change in amplitude of
monosynaptic reflex response. Abscissa: time in min (log scale) after the injection.
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prostaglandin Fla (3-5 /tg/kg) caused a small decrease in response over a
3 hr period. A subsequent injection of Fla (19-6/tg/kg) in this cat was
followed by a very significant potentiation of the response reaching a
peak after 90 min. This potentiation lasted over 3 hr (Fig. 6). In other
experiment (No. 1) a diminution in monosynaptic responses was accom¬
panied by a large increase in polysynaptic response (Fig. 5).
MinulKN
Fig. 5. KohuIIm of four experiments (Table 5!) showing tho effects of prostaglandin
F, on monosynaptic reflex responses and one polysynaptic reflex responso
(Expt. no. 1, interrupted line). In Expt. no. 4, tho effect of 10 /tg prostaglandin Ela
(4a) and a subsequent dose of 55 /tg (46) over 3 hr later is illustrated. Ordinate: %
change in amplitude of reflex responses. Abscissa: time in min after the injection.
Effect of prostaglandin FZa on spinal reflexes. In seven out of eight cats
prostaglandin F2a (1-4-30-3/tg/kg) caused a significant change in the
monosynaptic reflex response within 30 min of the injection. Five of these
experiments are illustrated in Fig. 7; Table 3. In three of these there was
potentiation and in two inhibition 30 min after injection. Changes in
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response were still significant (P < 0-001) 2.) In* later, though in four of the
five experiments the direction of the ehongo was opposite to tlud. at 30 inin.
The results of the remaining three experiments in which larger (loses of
prostaglandin F.,a were used, are shown in Fig. 8. In one experiment
(cat no. 7) F2a (17-8 //g/kg) caused a great diminution in monosynaptic
responses. In another cat (No. 0) the same dose had no effect over a 3 hr
log time
Fig. 6. The results of experiment four from Fig. 5 shown in greater detail. The open
circles represent reflox responses measured over a 3 hr period following an intra-
aortic injection of 10 /tg prostaglandin Fla. The filled circles "represent reflex re¬
sponses measured later in the same cat aftor an injection of 55 /tg prostaglandin
Fla. Ordinate: % change in amplitude of reflex response. Abscissa: time in min
after tho injections (log scale).






No. Sox (kg) (/(g) /'g/kg
1 Malo 3-3 5-0 1-5
8-0 2-4
2 Malo 2-8 100 3-5
3 Female 2-8 10-0 3-5
4 Female 2-8 100 3-5
05-0 23-2
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period. In a third cat (No. 8), F2a (30-3 //g/kg) wan injected intravenously
and in this experiment there was a potentiation of the monosynaptic
response lasting over 3 lir.
1 2 3 4 5 10 20 30 45 60 90 120150180
log timo
Fig. 7. Roaulta of fivo experiments (Table 3) showing tho offoct of prostaglandin F2CI
(1'4-3'f) /tg/kg) on monosynaptic redox responses. Tho filled circlos represent
responses which were significantly difforcnt (P < 0-01) from thoso of t.ho control
periods. Ordinate: % change in amplitude of reflex response. Abscissa: timo in
min after tho injection (log scale).
log timo
Fig. 8. Results of throo experiments (Table 3) showing the effects of prostaglandin
F2a (l7'8-30-3 /tg/kg) on monosynaptic reflex responses. In Exp. 8 the drug was
injected intravenously. Ordinate: % chango in monosynaptic reflex responses.
Abscissa: time in min after injection (log scale).
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No. Sox (kg) (/<£) /ig/kg
1 9 2-7 40 1-4
0 9 3-4 104) 2-9
3 9 3-3 104) 3-0
4 9 2-9 104) 3-4
f> 9 2-H 104) 3-5
li 9 2-H 50-0 17-H
7 9 2-H 1)0-0 17-H
S 9 2-H Hf>-0 30-3
DISCUSSION
The results of this investigation confirm previous reports that prosta¬
glandins have central nervous actions (Horton, 1964; Morton & Main,
1965; 1967 a; Avanzino et al. 1966). There are, however, apparent differences
in detail which require discussion.
Effect of cardiovascular changes on spinal reflexes. During the intra¬
arterial injection of prostaglandins, the lower abdominal aorta was oc¬
cluded in an attempt to direct more of the prostaglandin towards the
spinal cord. This intra-arterial technique was based upon that described
by Bulbring, Burn & Skoglung (1948) and by Homstedt & Skoglund (1953).
The occlusion itself produced facilitation of the monosynaptic reflex re¬
sponse, lasting not more than 6 min. The actions of prostaglandins were
slower in onset and far longer-lasting; they could thus be distinguished
easily from the effects of occlusion. Effects observed within 5 min of
prostaglandin injection and aortic occlusion should be disregarded.
Prostaglandins, particularly E1, are vasodilators, and usually lowered
arterial blood pressure following injection. Even with the highest doses
injected, the blood pressure had returned to its pre-injection level within
20 min in all experiments and usually the depressor effect was of far
shorter duration. It is clear that the changes in spinal reflexes have an
entirely different time of onset and duration than the depressor response.
Actions of prostaglandin h\. In six out often experiments prostaglandin
Ej caused a lasting and pronounced diminution in monosynaptic reflex
responses. In seven experiments the prostaglandin Ex was 99 % pure and
in five ofthese, there was inhibition of the reflex. The only experiment in
which E, facilitated the reflex was with a rather less pure (95%) form of
E, but the number of experiments is too few to permit the conclusion that
this result was due to an impurity in the prostaglandin.
These results in the chloralosed cat contrast with those of Horton &
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Main (1967a) in the spinal oat, in which the patellar reflex was unaffected
by Ej injected intravenously. It may be that the negative results of
Horton & Main (1967a) correspond to the three negative results obtained
in this investigation. There are, however, other possible explanations. In
the present, experiments the brain of the eat was intact and so it is con¬
ceivable, especially in view of the slow onset of the effects, and even though
the prostaglandin was injected towards the spinal cord, that E, was
acting not on spinal neurones but on supraspinal centres with descending
pathways which impinge on the neurones of the spinal monosynaptic
reflex arc.
A second possibility is that E, blocks, at the spinal level, descending
faeilitatory pathways which impinge upon the motoneurone. An inhibitory
action on the reflex would then only he revealed when these descending
pathways and their (supraspinal) centres were intact,. Such an action
might ho expected to inhibit, both monosynaptic, and polysynaptic path¬
ways. Although lew measurements of polysynaptic reflexes were made, Ej
certainly did not, affect the response in one experiment in which the
monosynaptic reflex was inhibited.
There is an interesting parallel between the contrasting results in
chloralosed and spinal cats and the results in chloralosed and spinal chicks.
The crossed extensor reflex in the chloralosed chick is inhibited by Ex
whereas in the spinal (decapitated) chick the reflex is potentiated by Ex
(Horton & Main, 1967a). A similar explanation of the differences may
apply in the two species.
The throe negat ive results may have been due to insullieient dosage but
the one instance of potentiation is less readily explained. A van/,inn ct al.
(1966) reported qualitative differences in the response of different brain
stem neurones, but qualitative differences were never found in spinal cats
by Horton & Main (1967a).
Actions of prostaglandins Flot and FZx. The actions of Fla in general
resembled those of Ex on monosynaptic reflexes, but in one experiment
facilitation of the reflex was observed. This experiment is of some interest
because a small dose of Fla caused a slight but significant reduction in
reflex response lasting 21 hr. At that point an additional larger dose was
administered which caused potentiation lasting a further 9 hr.
The actions of F2a are more difficult to understand. Either potentiation
or inhibition of the reflex occurred in the first 30 min following injection;
these changes were highly significant when compared with the small
variation in control responses. The variation in the responses from sig¬
nificant potentiation to significant inhibition in the remaining 21- hr
seems to be a characteristic response to F2a. Fluctuations of this magnitude
were never observed in control experiments nor were they observed in
12 P. DVDA AND OTHERS
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Central nervous actions of the prostaglandins and their
identification in the brain and spinal cord
By E. W. Horton and I. H. M. Main
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Observations on unanaesthetized cats and chicks
In unanaesthetized cats prostaglandins E1; E2 and E3 injected into the cerebral
ventricles in doses of 10 to 60 pg produce stupor usually accompanied by
catatonia. These effects are not observed after intravenous injection of prosta¬
glandin Et or prostaglandin F2a, nor do they occur following intraventricular
injection of F2(Z (Table 1). During the stupor which lasted sometimes for 24 hr or
more, the cats showed diminished spontaneous activity and a lack of interest in
their surroundings, but there was no impairment of movement and no analgesia
or anaesthesia. Catatonia was diagnosed when the cat could be placed in
abnormal postures (Fig. 1), or when a limb could be displayed by the observer
into an abnormal position which was retained for several seconds or even
minutes, before the limb was slowly returned to a more natural position.
On intravenous injection in 2-8 day-old chicks E1; E2 and E3 (10-200 /rg/kg)
produce sedation with loss of the righting reflex in higher doses, whereas Fl£X
and F2ct (25-450 ^g/kg) produce extension of the neck and legs without any
signs of sedation (Fig. 2) (4, 5, 7).
Localisation of the site of action of FZa in the chick
and in the spinal cat
The extension of the legs observed after F2(X could be measured in the anaesthe¬
tized chick. In chicks lightly anaesthetized with chloralose or urethane an










Stupor Catatonia Stupor Catatonia
1 20 + + _ 20
2 20 + + + 60
3 20 + + + + 15
4 20 + + + 100
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Fig. 1. Cat 2.6 kg photographed in
a catatonic posture 75 min. after an
injection into the cerebral ventricles
of prostaglandin E3, 30 /<g. This po¬
sture was maintained for 8 min. be¬
fore the cat climbed slowly down.
intravenous injection of F2ct (2 fig/kg) was followed by an increase in tension of
the gastrocnemius muscle (Fig. 3). The effect could not be obtained in deeply
anaesthetized chicks suggesting that it was mediated via the central nervous
system. Similar responses were obtained with F2ce in the decapitated chick
Fig. 2. Chick 39 g photographed 1 min after an intravenous injection of prostaglandin F,a, 4//g.
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Fig. 3. Chicken 550 g anaesthetized with urethane (1.7 g/kg). Effect of 1 //g of prostaglandin
F2ct injected intravenously on gastrocnemius muscle tension recorded isometrically. (Horton
and Main, British Journal of Pharmacology. In the press.)
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spinalized in the mid-cervical region, indicating that the brain is not necessary
for the mediation of this effect. The response was abolished by acute denerva¬
tion of the gastrocnemius muscle showing that F2a does not produce its effect by
an action on the neuromuscular junction or on the skeletal muscle itself (Fig. 4).
Similar effects were observed with both F2a (5-30 ^wg/kg) and Ex (5-50 //g/kg)
in the decerebrate and spinal cat (Fig. 5). The contraction of the gastrocnemius
muscle in response to intravenous prostaglandins was abolished by cutting
the sciatic nerve but not by cutting the dorsal roots. When Ex was injected
close-arterially to the muscle either in the innervated, acutely denervated or
F2t- f2*. c 10
5/9 5pg 2/g
Fig. 4. Decapitated chick (32 g) spinalized in the mid cervical region. Gastrocnemius muscle
tension recorded isometrically (upper tracing left leg, lower tracing right leg). Responses to
intravenous injections of prostaglandin F2a (5 //g) and decaniethonium iodide (2 /«g). Between
the first and second panel the left sciatic nerve was cut. There was an interval of 60 min. before
each injection. (Horton and Main, British Journal of Pharmacology. In the press.)
LEFT SCIATIC NERVE
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chronically denervated preparation, contraction of the gastrocnemius did not
occur. From these experiments it is concluded that F2a in the chick and both Et
and F2a in the cat produce contraction of the gastrocnemius by an action on the
spinal cord, and since contraction can be elicited in the de-afferentated prepara¬
tion it is possibly due to facilitation of a-motoneurones.
Fig. 5. Decerebrate cat (3.4 kg). Upper trace carotid arterial blood pressure, lower trace
gastrocnemius muscle tension. Responses to intravenous injections of prostaglandin
(50 /<g) and prostaglandin F2a (25 /(g). (Horton and Main, British Journal of Pharmacology.
In the press.)
Actions ofprostaglandins on spinal reflexes
In the spinal chick and spinal cat crossed extensor reflexes are potentiated by
intravenous injections of F2a and Ex (Figs. 6 and 7). The effect was observed
tmin
GASTROC.M.
Fig. 6. Decapitated chick (44 g) with a mid cervical spinal transection. Upper trace gastrocne¬
mius muscle tension, muscle twitches were elicited by electrical stimulation of the contralateral
sciatic nerve; lower trace systemic arterial blood pressure. Responses to prostaglandin F2a
(2 /(g) injected intravenously. (Horton and Main, British Journal of Pharmacology. In the
press.)




Fig. 7. Spinal cat (2.4 kg). Upper trace gastrocnemius muscle tension, muscle twitches were
elicited by electrical stimulation of the central stump of the contralateral sciatic nerve. Lower
trace carotid arterial blood pressure. (Horton and Main, British Journal of Pharmacology. In
the press.)
following smaller doses than those necessary to produce contraction of the
gastrocnemius and was more prolonged. The monosynaptic patellar reflex in the
cat was sometimes potentiated by Ex.
Abolition of tremor by prostaglandins
In the lightly anaesthetized chick (urethane) or cat (pentobarbitone, with intact
brain) Ex (3 /tg/kg) injected intravenously reduced gastrocnemius muscle tension
and abolished tremor or shivering which is commonly observed during the
recovery from these anaesthetics in these species (Fig. 8). This is in marked
contrast to the increase in gastrocnemius tension observed in the spinal and
decerebrate cat. In the chick the abolition of tremor also occurred when Ex was
applied to the cerebral hemispheres suggesting an action on higher centres.
However, pentobarbitone tremor in the cat could not be abolished by injection
of Ex (30 /ng) into the cerebral ventricles but only by intravenous injection.
Actions ofprostaglandins on systemic arterial blood pressure
In the spinal chick F2(Z (2 ^g/kg) had a pressor effect (Fig. 6), but in chicks
anaesthetized and with intact brains F2ct had a depressor effect sometimes
preceded by a transient pressor phase. Ex was depressor in both types ofprepara¬
tion. The pressor effect of F2a in spinal chicks was not abolished by hexa-
methonium or phenoxybenzamine, and therefore does not appear to be mediated
via the sympathetic nervous system.
17 — 679780 Nobel Symposium, 2




Fig. 8. Cat 3.2 kg anaesthetized with sodium pentobarbitone. Upper trace: gastrocnemius
muscle tension. Lower trace: carotid arterial blood pressure. Responses to prostaglandin E,:
(20 fig) injected intravenously. (Horton and Main, British Journal of Pharmacology. In the
press.)
Identification ofprostaglandins in central nervous tissues
In 1964 Samuelsson (11) announced the isolation of F,a from ox brain. We have
used his procedure in order to identify the prostaglandins in cat brain, chicken
brain and chicken spinal cord. On silicic acid chromatography peaks of bio¬
logically-active material corresponding to prostaglandins E and F were found
with all three extracts (Figs. 9 and 10). Fractions from each peak were separa¬
tely pooled and purified further on silica gel plates using the AI solvent system
Fig. 9. Chromatography of an extract of cat fore brain on a 2 g. column of silicic acid. Elution
rate 0.8-1.0 ml/min. 10 ml fractions collected. Ordinate: biological activity assayed on the
rabbit jejunum in terms of Fla. Abscissa: fraction number. (Horton and Main, British Journal
of Pharmacology. In the press.)
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Fig. 10. Chromatography of pooled chicken brain extracts-details as Fig. 9. (Horton and Main,
British Journal of Pharmacology. In the press.)
of Green and Samuelsson (3). Further evidence about the types ofprostaglandin
present was obtained by thin layer chromatography on AgN03-impregnated
plates and by parallel biological assays on several tissues (Table 2). By this
means we have shown that cat forebrain (supra-collicular) contains F2a, and an
unidentified E, and that both chicken brain and chicken spinal cord contain
F2a and E2 (8).
Discussion and conclusions
Our pharmacological experiments indicate that prostaglandins act at various
sites in the central nervous system. That these actions are upon the neurones
themselves is suggested by the results of Avanzino, Bradley and Wolstencroft
(1, 2), who have shown that prostaglandins can excite (or sometimes inhibit)
central neurones on micro-iontophoretic application. Although we have found
prostaglandins in the brain of the cat and the chicken we have no evidence that
they are actually in the neurones—they might for example be in the glial cells.
Table 2. Parallel biological assays ofmaterial elutedfrom zone 2 ofa thin layer chroma-
togram (AI solvent system) of cat brain extract in terms ofprostaglandin Da and Er.
Preparation Fia E,
Guinea pig ileum 1.0 1
Rat fundus 1.0 3
Cat trachea 1.0 3
Jird colon 0.6 9
Rat uterus 0.4 75
Rabbit jejunum 1.2 94
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The observation of Ramwell and Shaw (9, 10) that prostaglandins are released
from the somato-sensory cortex of the cat on sensory nerve stimulation is
suggestive however of a neuronal origin. Taken together these observations
might be thought to support the hypothesis that the prostaglandins are central
nervous transmitters but they could equally be modulators of such transmitters.
For example, prostaglandins could be released from the depolarized post
synaptic membrane temporarily preventing either further release or action of
the transmitter. Investigations into the cellular and subcellular distribution of
prostaglandins in the central nervous system may help in solving this problem.
E. W. Horton is grateful to the Medical Research Council for grants in support of this
work. I. H. M. Main is grateful to the Wellcome Trust for a travel grant. Prostaglandins
were kindly supplied by Professor S. Bergstrom, Dr. B. Samuelsson and Dr. D. A. van
Dorp.
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Brain extracts from several species contain biologically active lipids whose physico-
chemical properties resemble those of the prostaglandins. Ambache reported the presence
in rabbit brain of a smooth muscle-stimulating unsaturated hydroxy fatty acid (Ambache
& Reynolds, I960, 1961; Ambache, Reynolds & Whiting, 1963). Kirschner & Vogt
(1961) prepared chloroform-methanol extracts of horse brain and separated three biologic¬
ally active fractions, one of which consisted of unsaturated fatty acids. Toh (1963)
prepared an extract of dog and cat brain, the biological activity of which was due to
unsaturated fatty acids. The biological activity of these extracts may have been due, at
least in part, to prostaglandins. A prostaglandin has so far been isolated from the brain
of only one species, the ox (Samuelsson, 1964), though Coceani & Wolfe (1965) have
reported the presence of a prostaglandin-like substance in cat brain using Samuelsson's
extraction procedure.
In view of the pharmacological actions of prostaglandins on the central nervous system
of cats and chicks (Horton, 1964; Horton & Main, 1965a & b, 1966a, 1967a), we have
attempted in this investigation to identify prostaglandins in central nervous tissues of
these species. Preliminary reports of this work have been published (Horton & Main,
1966b, 1967b, and c).
METHODS
Chemical Procedures
Collection and ethanol extraction of cat brain
Adult cats of both sexes were anaesthetized with ethyl chloride and ether. All brain tissue above
the intercollicular level was removed by classical decerebration technique. The tissue was weighed
and either stored at about —10° C for subsequent homogenization or homogenized immediately
with a pestle and mortar in 96% aqueous ethanol and sand. The homogenate was stirred for 4 hr
at room temperature in 96% aqueous ethanol (4 ml./g of tissue). The mixture was filtered or
centrifuged or both, and the residue was re-extracted with 0.5 vol. 96% aqueous ethanol. The
combined aqueous ethanol filtrates or supernatants were evaporated to dryness under reduced
pressure at 40-45° C using a rotary evaporator. The dried residue was stored at —20° C.
Collection and ethanol extraction of chicken brain and spinal cord
Adult chickens (Gallus domesticus) of both sexes were exsanguinated by section of the large
blood vessels in the neck. Whole brains and spinal cords were dissected out immediately and
* Present address: Department of Pharmacology, The School of Pharmacy, Brunswick Square,
London, W.C.I.













































Outline of the extraction procedure used for the identification of prostaglandins in brain.
zone 4
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weighed. The ethanol extraction procedure was the same as that used for cat brain ; the chicken
brains and spinal cords were extracted separately. The dried residues were stored at —20' C.
The subsequent extraction procedure was that described by Samuelsson (1964) and was the same
for cat brain, chicken brain and chicken spinal cord (Fig. 1).
Silicic acid chromatography
The dried residue from the ethanol extraction was dissolved in an equal volume of ethyl acetate
and 0.1 N hydrochloric acid. After separation the acid aqueous phase was re-extracted with 1 vol.
ethyl acetate. The combined ethyl acetate phases were concentrated to a smaller volume on a
rotary evaporator. The ethyl acetate was extracted twice with 1 vol. pH 8 phosphate buffer solu¬
tion. The aqueous phases were pooled and acidified to pH 3 by drop-wise addition of concentrated
hydrochloric acid. The acid aqueous solution was then extracted twice with ethyl acetate. The
ethyl acetate phases were pooled and evaporated to dryness. The residue was partitioned between
equal volumes of 67% aqueous ethanol and light petroleum (B.P. 40-60° C). The aqueous ethanol
was evaporated to dryness and subsequently chromatographed on a column of silicic acid.
Silicic acid chromatography
Two grammes silicic acid (Bio-Rad Laboratories, Calif.) was activated by heating for 1 hr at
115° C before use. It was washed twice with heavy petroleum (B.P. 60-80° C) and then suspended
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in an ethyl acetate : benzene (30:70) mixture. Columns 80 mm in length and of cross-sectional
diameter 8 mm reducing to 4 mm were prepared. The dried residue from the solvent partition
procedure or a mixture of purified prostaglandins was dissolved in 1 ml. ethyl acetate: benzene
(30:70) and applied to the column drop-wise with a Pasteur pipette. The flask was washed three
times with ethyl acetate: benzene and the washings applied to the column.
The column was developed with increasing concentrations of ethyl acetate in benzene. Ten or
20 ml. fractions were collected under reduced pressure with a flow rate of 0.8 to 1.2 ml./min. The
fractions were evaporated to dryness immediately after they had been collected and the residues
were dissolved in distilled water for assay on the rabbit isolated jejunum. Approximate estimates
of the biological activity in each fraction were made as soon as possible after collection, thus
monitoring the progress of the chromatography and allowing changes in eluant to be made at
appropriate times.
The concentrations of ethyl acetate in benzene used to develop the column were 30, 40, 60, 80
and 100% (v/v), followed finally by 100% methanol to remove the most polar substances from the
column. All fracticns were assayed more accurately at the end of the experiment and those
with biological activity were stored frozen for further investigations.
Thin layer chromatography
Plates of dimensions 200x50 mm coated with Silica Gel G (E. Merck) were used throughout. In
some preparative experiments the silica gel was 0.5 mm in thickness but a thickness of 0.25 mm was
otherwise routinely used. Silica gel plates impregnated with 4% silver nitrate were prepared by
suspending the silica gel (30 g) in a 2% solution of silver nitrate (60 ml.). The plates were activated
in an oven at 115-120° C for 1 hr and stored over self-indicating silica gel until used. A strip
approximately 3 mm in width was removed from each edge of the silica gel before use. Prosta¬
glandins and brain extracts were dissolved in methanol and applied to the plate with a Agla
microsyringe using a length of narrow bore polyethylene tubing (capacity 30 pi.) attached to the
syringe needle.
Solvent systems used were the AI and All systems described by Green & Samuelsson (1964). The
A1 system contains benzene: dioxane: acetic acid 20:20:1, and the All system contains the less
polar (upper) phase of a mixture of ethyl acetate: acetic acid: methanol: 2,2,4-trimethylpentane: water
110:30:35:10:100 which had been allowed to equilibrate for 2 hr. All solvents except dioxane were
redistilled before use.
Cylindrical glass developing tanks of internal diameter 6 cm and of height 21.5 cm were used.
The walls were lined with Whatman No. 1 filter paper impregnated with the solvent mixture. The
tanks were sealed with glass lids using silicone grease. Marker plates using pure prostaglandin
solutions were prepared by spotting on volumes of not more than 30 /zl. of stock (methanol) solutions
of the prostaglandins (0.1 or 1.0 mg/ml.). With preparative plates a series of spots (or a continuous
band) of the extract dissolved in methanol was applied to the origin. Preparative and marker plates
were run simultaneously in the same tank.
Plates were usually developed until the solvent had reached between 11 and 14 cm from the
origin. The position of the solvent front was marked on remoung the plate from the tank. The
plates were dried and marker plates were sprayed with 10% phoaphomolybdic acid in ethanol. On
heating at 100° C for 10 min grey-blue spots developed on a greenish-yellow background, showing
the position of the prostaglandins. About 1 pg of prostaglandin Fia and about 10 pg of prosta¬
glandins Ei and E2 could be detected by this method.
Preparative plates were divided into zones corresponding to the Rf values of prostaglandins on
the marker plate. With the AI system zones corresponding to prostaglandins E and F were
separated ; with the All systems the prostaglandin E fraction was further separated in to Ei, E2
and E3, and the prostaglandin F fraction into Fia, F*.*, and F3a. Due to shortage of material, marker
plates could not be run routinely with F3Q:. The position of F3o: on the preparative plate was
therefore calculated from the observed Rf value of Fia on the marker plate using the relative Rf
values of Fi« and F3« reported by Green & Samuelsson (1964). In a control experiment Fia was
applied to a preparative plate and the predicted F3« zone contained all the biological activity. The
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position of the E3 and F3a zones were also calculated since these prostaglandins were not available
for chromatography.
The separated zones were shaken with 3 or 5 ml. methanol and centrifuged. The deposit was
re-extracted with methanol and the combined methanol extracts evaporated to dryness. The
residue was dissolved in either 0.9% sodium chloride solution or Tyrode solution so that the Ag+
ions were precipitated as AgCl. This precipitate did not interfere with assays on the rabbit jejunum.
In some cases the dried residue from the methanol extraction of these AgNC>3 plates was dissolved
in 0.1N HC1 (which precipitated the Ag+) and extracted with ethyl acetate. The ethyl acetate was
evaporated to dryness, and the residue dissolved in saline or Tyrode solution for assay.
Preparation of F2ct from E>
Reduction of E2 by sodium borohydride to yield Fs^ and F^-j was carried out as described by
Bergstrom, Krabisch, Samuelsson & Sjovall (1962).
Sodium borohydride 1 mg was added to a solution of 400 pg E2 in 1 ml. methanol at 0° C. The
mixture was allowed to stand for 20 min at 0° C and then for 20 min at room temperature. Ten
millilitres of 0.1N HC1 were then added and the aqueous phase was extracted twice with ether. The
combined ether extracts were washed with water and taken to dryness.
The residue was dissolved in methanol and chromatographed on silica gel in the AI solvent
system. About 5% of the extract was applied to a marker plate which, after development, was
sprayed with phosphomolybdic acid and heated. Two spots appeared, one (Rf 0.32) corresponding
to F2a and the other (Rf 0.25) to F2/5. The remainder of the extract was applied to a preparative
plate which, after development, was divided into zones corresponding to Fa^ and F2p- The zones
were eluted with methanol and taken to dryness. The material from the Foa zone was rechroma to-
graphed in the AI solvent system to eliminate traces of F2j which were present. The biologically
active material in the F2o; zone from this second chromatogram was standardized on the isolated
rabbit jejunum and guinea-pig ileum against pure F2a-
Biological preparations
Biological assays
The rabbit isolated jejunum was used routinely for the estimation of biological activity in the
various fractions, using prostaglandins Ei and Fur as the standards for comparison. The concentra¬
tions of prostaglandins in brain was calculated from the relative activities previously determined
(Table 1).
Table 1
BIOLOGICAL ACTIVITY OF PROSTAGLANDINS E2, Es, Fia and F2„ RELATIVE TO
PROSTAGLANDIN Ei ON RABBIT ISOLATED JEJUNUM
(data from Horton & Main, 1963, 1965, 1966)
E2 E3 Fia F 2a
1-5 1-0 2-2 26
Smooth muscle preparations in vitro
Segments of various organs were suspended in a 4 ml. or 10 ml. organ-bath. Longitudinal contrac¬
tions were recorded either isotonically with a frontal-writing lever on a smoked drum, or isometrically
with a force-displacement transducer (Grass F.T.03) on a Sanborn polygraph. A dose cycle of 4
to 6 min with a contact time of 45-90 sec was used for all preparations except the cat trachea.
Rabbit jejunum
Proximal jejunum, from rabbits weighing 1-3 kg, was suspended in Tyrode solution at 37° C,
gassed with air or 5% carbon dioxide in oxygen.
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Guinea-pig ileum
Terminal ileum from guinea-pigs weighing 200-400 g was suspended in Tyrode solution at 37° C,
gassed with air or 5% carbon dioxide in oxygen.
Rat uterus
A segment of a uterine horn from rats weighing 150-250 g which had been injected subcutaneously,
18 hr previously, with stilboestrol (100 pg), was suspended in de Jalon solution at 30° C, gassed with
air.
Jird colon
Segments of ascending colon from Meriones weighing 100-150 g were suspended in Tyrode solu¬
tion at 37° C, gassed with air.
Rat fundus
Longitudinal strips of the fundus from rats weighing 200-350 g. were prepared as described by
Vane (1957) and suspended in Tyrode solution at 37° C, gassed vigorously with oxygen.
Cat trachea
Tracheas were obtained from cats which had been used for other experiments. Two or three
rings of trachea were tied together with the muscle in alignment; the cartilage was removed. The
preparations were suspended in Krebs-Henseleit solution at 37° C, gassed with 5% carbon dioxide in
oxygen. The inhibitory action of a prostaglandin was demonstrated by adding it to the organ bath
either 30 sec before a dose of acetylcholine, or after acetylcholine had produced a sustained con¬
traction (Main, 1964).
Spinal chick preparation
The technique is described in the preceding paper (Horton & Main, 1967a).
RESULTS
Identification ofprostaglandins in chicken brain
Solvent extraction and partition
Ethanolic extracts of 115 g chicken brain contracted the isolated rabbit jejunum. On
partition between ethyl acetate and water at different pHs as described under Methods
(Fig. 1) the biologically active material behaved like an acidic lipid. On partition between
67% aqueous ethanol and petroleum ether (B.P. 40-60 °) the biological activity was recovered
from the aqueous ethanol phase. From the results of previous workers (Samuelsson,
1963; Bergstrom & Samuelsson, 1963) these results are compatible with the biological
activity being due to prostaglandins.
Silicic acid chromatography
The next stage was chromatography on a silicic acid column to purify the extract further
and also to separate prostaglandins E from F. According to Samuelsson (1963) Es
and Fs are eluted with concentrations of 60% and 80% ethyl acetate in benzene, respec¬
tively. Control experiments were first carried out using 10-20 ,ug of pure E]^ and Fla.
In these experiments both types of prostaglandins were eluted with 60% ethyl acetate
and none with 80% ethyl acetate. However, by using 40°0 ethyl acetate in benzene E
could be eluted first, while F was eluted by 60% ethyl acetate in benzene as shown in Fig. 2.
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n
% ethyl acetate in benzene
Fig. 2. Chromatography of a mixture of prostaglandins Ei (10 pg) and Fia (20 pg) on a 2 g column
of silicic acid. Elution rate 0.8-1 ml./min. 10 ml. fractions collected. Ordinate: biological
activity assayed on the rabbit jejunum in terms of prostaglandin Ei (open circles) and Fia (closed
circles). Abscissa: upper line, fraction number ; lower line, nature of eluant.
In this experiment the recoveries of Ex and Fla applied to the column were 90% and 98%
respectively. The identity of the prostaglandins was confirmed by parallel biological
assay. Furthermore in experiments in which prostaglandin E2 was chromatographed
alone, all the biological activity was eluted with 40% ethyl acetate.
The chicken brain extract obtained from the solvent partition procedure described
above was chromatographed on a silicic acid column. The result is shown in Fig. 3.
Apart from a small initial peak of activity (=2-2 pg Fla), there was one peak eluted with
40% ethyl acetate in benzene corresponding to prostaglandins E ( = 19 pg Ej) and another
peak eluted with 60% ethyl acetate in benzene corresponding to prostaglandins F
Fig. 3. Chromatography of chicken brain extract on a 2 g column of silicic acid. Elution rate
1-1.2 ml./min. 20 ml. fractions collected. Ordinate: biological activity assayed on the rabbit
jejunum in terms of prostaglandin Fia. Abscissa: upper line, fraction number ; lower line,
nature of eluant.
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( = 12-1 ng Fla). Considerable biological activity ( = 16 pg Flu) was eluted with methanol,
but this did not correspond to either a prostaglandin E or F.
Thin layer chromatography in the AI solvent system
The material in fractions 7-10 (pool 1) and 16-20 (pool 2) was further purified by thin
layer chromatography in the AI solvent system. On chromatography of pool 1, 97%
of the biological activity was recovered from zone 3 which corresponded to prostaglandins
E on the marker plate (Fig. 4). On chromatography of pool 2, 90% of the activity was
recovered from zone 2 of the chromatogram corresponding to prostaglandins F. The
% biological activity found in the various zones of the chromatogram as assayed on the
rabbit isolated jejunum is shown in Table 2.
(o) (b)














Eia Ej Brain extract
Fig. 4. Thin layer chromatography of chicken brain extract (pool 1, Fig. 3) in the AI solvent system,
ta) marker plate, spotted with prostaglandins Fia and Ei and sprayed with phosphomolybdic acid,
(b) preparative plate, spotted with brain extract, divided into zones.
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Table 2
PERCENTAGE BIOLOGICAL ACTIVITY FOUND IN THE ZONES OF PREPARATIVE THIN
LAYER CHROMATOGRAMS OF CHICKEN BRAIN (POOLS 1 AND 2) DEVELOPED IN THE A1
SOLVENT SYSTEM AND ASSAYED ON THE RABBIT JEJUNUM IN TERMS OF E, (POOL 1)
AND Fla (POOL 2)
% of total biological activity
Position recovered from plate
Zone Mean of pure
No. Rf prostaglandins Pool 1 Pool 2
1 Origin 0-75 7-0
2 0-32 Fa 0-75 90-0 (=5 jugFia)
3 0-44 E 97-0 (=22-5 Mg Ed <2-0
4 <1-1 <2-0
5 Front <0-5 <2-0
Thin layer chromatography in the All solvent system
The material from the active zones corresponding to prostaglandins E and F was
further chromatographed on silver nitrate-impregnated plates in the All solvent system.
The results of chromatography of zone 3 (prostaglandins E from the plate run in the
AI system) are shown in Table 3. Most of the biological activity as assayed on the
Table 3
PERCENTAGE BIOLOGICAL ACTIVITY FOUND IN THE ZONES OF A PREPARATIVE THIN
LAYER CHROMATOGRAM OF CHICKEN BRAIN (POOL 1, ZONE 3, PROSTAGLANDINS E
FROM THE PLATE RUN IN AI, TABLE 2) DEVELOPED IN THE All SOLVENT SYSTEM AND
ASSAYED IN PARALLEL ON THE RABBIT JEJUNUM AND GUINEA-PIG ILEUM IN TERMS
OF PROSTAGLANDIN Ex
% of total biological activity
Position recovered from plate
Zone of pure
No. Rf prostaglandins Rabbit jejunum Guinea-pig ileum
1 Origin <1 <2
2 *(0-31) E, 1 <2
3 ■— 2 <1
4 0-62 e2 92 (=25 mg Efi 89 (=7 Mg e0
5 ■—. 2 <2
6 0-79 e, I <2
7 Front <1 <2
* Rf value calculated as described in Methods.
isolated rabbit jejunum and guinea-pig ileum was recovered from zone 4 corresponding
to E2. Traces of activity were detected in the " neutral " zones adjoining E2 but there
was no significant activity in any other zone (Fig. 5). The E2 zone was assayed on three
isolated tissues in terms of Ej and Fla as shown in Table 4.
The results of the parallel assays confirm that the activity is prostaglandin E-like, it
could not be due to a prostaglandin F. The differences between estimates of biological
activity (in terms of Ex) on these three tissues may be attributed partly to biological error
in the assays and partly to differences in the relative activities of E2 to Et on these
preparations (Horton & Main, 1963).
The results of chromatography of the zone 2 (prostaglandins F from the plate run
in the AI system) are shown in Table 5.



















Fig. 5. Thin layer chromatography of chicken brain extract (zone 3, Fig. 4) in the All solvent
system, (a) marker plate, spotted with prostaglandin Ei and E2 and sprayed with phospho-
molybdic acid, (b) preparative plate, spotted with brain extract divided into zones.
Table 4
CHICKEN BRAIN EXTRACT. PARALLEL BIOLOGICAL ASSAYS OF THE MATERIAL ELUTED
FROM ZONE 4 OF THE THIN LAYER PLATE DEVELOPED IN THE All SOLVENT SYSTEM
(TABLE 3)
Each figure represents the result of one estimation
Biological activity
Preparation /'g E, equivalent g Fia equivalent
Rabbit jejunum 25, 25 8, 5
Rat fundus 12 96
Guinea-pig ileum 7 87
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Table 5
PERCENTAGE BIOLOGICAL ACTIVITY FOUND IN THE ZONES OF A THIN LAYER PLATE
(PREPARATIVE THIN LAYER CHROMATOGRAM OF CHICKEN BRAIN POOL 2, ZONE 2,
FROM THE PLATE RUN IN AI SEE TABLE 2) DEVELOPED IN THE All SOLVENT SYSTEM
AND ASSAYED ON THE RABBIT JEJUNUM IN TERMS OF PROSTAGLANDIN Fla
Position % of total
Zone of pure biological activity
No. Rf prostaglandins recovered from plate
1 Origin <5
2 (0-22) F3a <5
3 — <5
4 (0-47) F 2 a 67 (=0-75 ng Fla)
5 <5





Of the total activity 67% were recovered from zone 4, corresponding to F2„. A small
amount of activity was also present in zone 6, which corresponded to Fln.
The F2a zone was assayed on two isolated tissues in terms of F1(I as shown in Table 6.
The results are compatible with the activity being due to prostaglandin F2„. The activity
could not be due to any of the prostaglandins E.
Table 6
CHICKEN BRAIN EXTRACT. PARALLEL BIOLOGICAL ASSAYS OF THE MATERIAL ELUTED
FROM ZONE 4 OF THE THIN LAYER PLATE DEVELOPED IN THE All SOLVENT SYSTEM
(TABLE 5)
Each figure represents the result of one estimation.
Biological activity
Preparation /ig Fla equivalent ^g Ej equivalent
Rabbit jejunum 0-75, 1-0 3-8,3-0
Rat fundus 0-9 O il
Concentration ofprostaglandins in chicken brain
Although these experiments were primarily designed to identify prostaglandins, some
indication of the concentration of prostaglandins E2 and F2a in chicken brain were obtained
from the results of silicic acid chromatography (Fig. 3). Pool 1 (prostaglandins E) con¬
tained biological activity on the rabbit jejunum equivalent to 19 ,ug Ej. The amount of
E2 recovered from the column was therefore about 13 ;j.g (relative activity of E2 to E1=l"5,
Table 1). The concentration of E2 in chicken brain was therefore of the order of 100 ng/g
wet weight. Pool 2 (prostaglandins F) contained biological activity equivalent to 1 gg F2„
(relative activity of F2a to Fla=12, Horton & Main, 1965c, Table 1). The concentration
of F2„ in chicken brain was therefore of the order of 10 ng/g wet weight of tissue.
Identification ofprostaglandins in chicken spinal cord
Silicic acid chromatography
Chicken spinal cord (35.7 g) was extracted with ethanol and partitioned as described
under Methods. The resultant extract which contained biologically active material as
assayed on the rabbit isolated jejunum was chromatographed on a silicic acid column.
There were peaks of biological activity corresponding to prostaglandins E (pool 1)
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(=2.2 ng Ej) and prostaglandins F (pool 2) (=4.5 p.g FlQ). A third peak of activity was
eluted with methanol.
Thin layer chromatography in the AJ solvent system
Pool 1 and pool 2 were chromatographed separately on thin layer plates in the A1
solvent system. The results are shown in Table 7.
Table 7
PERCENTAGE BIOLOGICAL ACTIVITY FOUND IN THE ZONES OF PREPARATIVE THIN
LAYER CHROMATOGRAMS OF CHICKEN SPINAL CORD DEVELOPED IN THE AI SOLVENT
SYSTEM AND ASSAYED ON THE RABBIT JEJUNUM IN TERMS OF PROSTAGLANDIN Ex
(POOL 1) AND PROSTAGLANDIN Fla (POOL 2)
% of total biological activity
Position recovered from plate
Zone of pure
No. Rf prostaglandins Fool 1 Fool 2
1 Origin 4 11
2 0-3 ' Fa 4 64 (=3 /*g Fla)
3 0-4 E 88 (=20 /rg Ex) 15
4 — <2 <5
5 Front <2 <5
Most of the activity in pool 1 was recovered from zone 3 corresponding to prostaglandins
E and most of the activity in pool 2 was recovered from zone 2 corresponding to prostag¬
landins F, though there was a small amount in the adjacent zones.
Thin layer chromatography in the All solvent system
The material from the active zones corresponding to prostaglandins E and F was further
chromatographed on silver nitrate-impregnated plates in the All solvent system. The
results of the two chromatograms are shown in Table 8.
Most of the biological activity of pool 1 zone 3 (prostaglandins E from the plate run
in the AI solvent system) was recovered from zone 4 of the silver nitrate-impregnated
plate corresponding to prostaglandin E2. There was no significant activity in the zones
corresponding to E3 (zone 2) or Ej (zone 6).
Table 8
PERCENTAGE BIOLOGICAL ACTIVITY FOUND IN THE ZONES OF PREPARATIVE THIN
LAYER CHROMATOGRAMS OF CHICKEN SPINAL CORD (POOL 1, ZONE 3, AND POOL 2,
ZONE 2, FROM THE PLATES RUN IN AI, TABLE 7) DEVELOPED IN THE All SOLVENT
SYSTEM AND ASSAYED ON THE RABBIT JEJUNUM IN TERMS OF PROSTAGLANDIN Ex
(POOL 1) AND PROSTAGLANDIN Fla (POOL 2)
% of total biological activity recovered from plate
Zone • ■ "
No.
Rf
Pool 1 zone 3
Rf
Pool 2 zone 2
1 Origin <4 Origin 18
2 (0-34) e3 <4 (0-21) F3a <9
3 — <8 — <9
4 (0-67) E2 62 (=4 ,ig Ej) (0-45) F2a 46 (=0-5
5 — 15 — <9
6 0-77 Ex <4 0-58 Fsa <9
7 Front <4 Front
PROSTAGLANDINS IN CNS 593
Most of the biological activity of pool 2 zone 2 (prostaglandins F from the plate run
in the AI solvent system) was recovered from zone 4 of the silver nitrate-impregnated
plate corresponding to prostaglandin F2„. Activity was also present at the origin but
not in the zones corresponding to Fla or F3„.
The activity in the E, and F2a zones was assayed in parallel on different isolated tissues
and the results are shown in Table 9. The results are compatible with the activity in
these zones being due to E2 and F2Q respectively.
Table 9
CHICKEN SPINAL CORD EXTRACT. PARALLEL BIOLOGICAL ASSAYS OF THE MATERIAL
ELUTED FROM THE E2 AND F„a ZONES OF THE CHROMATOGRAMS DEVELOPED IN THE
AH SOLVENT SYSTEM (TABLE 8)
Biological activity
. Ratio of
E, zone F2a zone activity
Preparation (/ig Ex equiv.) O'g Flaequiv.) Fi/E,.a
Rabbit jejunum 4-0 0-5 6-7
Rat fundus 2-0 0-6 0-9
Guinea-pig ileum 1-6 Not tested <0-1
Concentration ofprostaglandins in chicken spinal cord
By assaying the biological activity eluted from the silicic acid column, chicken spinal
cord is estimated to contain of the order of 400 ng E2/g and 10 ng F2a/g tissue wet weight.
Identification ofprostaglandins in cat brain
Silicic acid chromatography
Cat forebrains obtained by decerebration were extracted with ethanol and partitioned
as described under Methods. The resultant extract was chromatographed on a silicic
acid column. The result is illustrated in Fig. 6. There were peaks of biological activity
Fig. 6. Chromatography of an extract of cat brain on a 2 g column of silicic acid. Elution rate
0.8-1 ml./min. 10 ml fractions collected. Ordinate: biological activity assayed on the rabbit
jejunum in terms of prostaglandin Fla. Abscissa: upper line, fraction number; lower line,
nature of eluant.
594 E. W. HORTON and I. H. M. MAIN
Thin layer chromatography in the AI solvent system
Pool 1 (fraction 9) was chromatographed on a thin layer plate in the AI solvent system.
Most of the activity was present in zone 3 corresponding to prostaglandins E. Pool 2
(fractions 13-18) was chromatographed on a thin layer plate in the AI solvent system
(Table 10). At least 96% of the activity was present in zone 2 corresponding to
prostaglandins F.
Table 10
PERCENTAGE BIOLOGICAL ACTIVITY FOUND IN ZONES OF A PREPARATIVE THIN LAYER
CHROMATOGRAM OF CAT BRAIN (POOL 2) DEVELOPED IN THE AI SOLVENT SYSTEM
AND ASSAYED ON THE RABBIT JEJUNUM IN TERMS OF PROSTAGLANDIN FIa
Position % of total biological
Zone of pure activity recovered
No. Rf prostaglandins from plate
1 Origin 3
2 0-31 Fa 96 (=10 jug Fla)




PERCENTAGE BIOLOGICAL ACTIVITY FOUND IN THE ZONES OF A PREPARATIVE THIN
LAYER CHROMATOGRAM OF CAT BRAIN (POOL 1, ZONE 3 FROM THE PLATE RUN IN THE
AI SOLVENT SYSTEM) DEVELOPED IN THE All SOLVENT SYSTEM AND ASSAYED IN
PARALLEL ON THE RABBIT ISOLATED JEJUNUM AND RAT FUNDUS PREPARATIONS






































44 (=0-38 Mg Ex)
<9
Table 12
PERCENTAGE BIOLOGICAL ACTIVITY FOUND IN ZONES OF A PREPARATIVE THIN LAYER
CHROMATOGRAM OF CAT BRAIN (POOL 2, ZONE 2 FROM CHROMATOGRAM SHOWN IN
TABLE 10) DEVELOPED IN THE All SOLVENT SYSTEM AND ASSAYED ON THE RABBIT
JEJUNUM IN TERMS OF PROSTAGLANDIN Fla
Biological activity was found in all zones of the plates even those beyond the solvent front. Figures in
the Table are obtained by subtracting the value of this non-specific activity from the total activity in each zone
Position % of total biological
Zone of pure activity recovered
No. Rf prostaglandins from plate
1 0
2 (0-21) E: a 0
3 17
4 (0-45) F 2a 69
5 9
6 0-59 Fia 5
7 0
8 Front 0
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Thin layer chromatography in the All solvent system
The material from the active zones corresponding to prostaglandins E and F was
chromatographed on silver nitrate impregnated plates in the All solvent system. The
biological activity in each zone was assayed and the results are shown in Tables 11 and 12.
When assayed on the rabbit jejunum, significant activity of the prostaglandins E con¬
taining extract was found in zones 2 and 6 corresponding to E3 and Ej respectively. No
significant activity was present in zone 4 (E2) or the zones adjacent to it. When assayed
on the rat fundus, activity was present only in zone 6, corresponding to E1 (Table 11).
Most of the activity of the prostaglandins F containing extract corresponded to F2„
(zone 4) but a small amount of activity was present in zone 6 corresponding to Fla. The
" neutral" zones 3 and 5 also contained activity suggesting that, on the preparative plate,
the brain F2a spot had extended to the adjacent zones. However, the possibility that a
small quantity of Fla was present cannot be excluded.
Parallel biological assays
The material from zone 6 (prostaglandin Ex) of the All plate of the prostaglandin E
extract was assayed on three isolated smooth muscle preparations. The results shown in
Table 13, are compatible with the biological activity in zone 6 being due to prostaglandin Ex.
Table 13
CAT BRAIN EXTRACT (POOL 1). PARALLEL BIOLOGICAL ASSAYS CF THE MATERIAL
ELUTED FROM ZONE 6 OF A THIN LAYER PLATE DEVELOPED IN THE All SOLVENT
SYSTEM (SEE TABLE 11), IN TERMS OF Ej AND Fla
Biological activity
Preparation gg Ei equivalent gg Fia equivalent
Rabbit jejunum 0-2
Rat fundus 0-38 0-38
Cat trachea 0-2 8
The material from zone 4 (prostaglandin F2„) of the All plate of the prostaglandin F
containing extract was assayed on the rabbit jejunum and rat fundus in terms of prostag¬
landins F1h and Ej. The results 0-85 and 1-75 gg Fln and 2.1 and 0.14 gg Ej respectively
were in agreement with its identification as a prostaglandin F.
An aliquot of the active material in zone 2 (prostaglandins F) from the thin layer chroma-
togram shown in Table 10 was assayed on six isolated smooth muscle preparations using
Fla and Ej as standards. The results are shown in Table 14. The activity in terms of
Table 14
CAT BRAIN EXTRACT (POOL 2). PARALLEL BIOLOGICAL ASSAYS OF AN ALIQUOT OF TH E
MATERIAL ELUTED FROM ZONE 2 OF THE THIN LAYER PLATE DEVELOPED IN THE A I
SOLVENT SYSTEM (TABLE 10) EXPRESSED IN TERMS OF Fla AND E,
Biological activity Ratio of
•-— activity
Preparation Fla (gg) Ei (gg) FialP-i
Rabbit jejunum 3-8 9-4 2-5
Guinea-pig ileum 3-1 0-1 0 04
Rat fundus 3-0 0-3 0-1
Cat trachea 3 0 0-3 01
Jird colon 1-7 0-9 0-5
Rat uterus 1-3 7-5 6-0
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Fla ranged from 1.3 fig on the rat uterus to 3.8 pg on the rabbit jejunum, thus the greatest
index of discrimination between cat brain extract and Fla was about 3. In contrast, the
activity in terms of E1 ranged from 0.1 pg on the guinea-pig ileum to 9.4 pg on the rabbit
jejunum, an index of discrimination of 94. These results are compatible with the activity
being due to a prostaglandin F, and confirm that it could not be due to a prostaglandin E.
A further aliquot of this material was compared with pure F2CI on the arterial blood
pressure and crossed extensor reflex of the spinal chick. The intravenous injection of
0.1 fxg prostaglandin F2a caused a rise in blood pressure and potentiated the crossed
extensor reflex. An amount of brain extract, equivalent to 0.1 pg F2a as assayed on the
rabbit jejunum, caused a similar rise in blood pressure and potentiation of the crossed
extensor reflex as shown in Fig. 7.
I min
i 1
F,„ Cat brain F
01 ng 01 ml.
(=0-1 /xgF2CI on rabbit jejunum)
Fig. 7. Spinal chick (decapitated weight 38 g). Blood pressure and crossed extensor reflex. Upper
trace: arterial blood pressure. Lower trace: gastrocnemius muscle tension, twitches were elicited
by electrical stimulation of the contralateral sciatic nerve. Responses to prostaglandin F»a
(0.1 /<g) and cat brain extracted (pool 2, zone 2 from AI plate, 0.1 ml.sO.l pg F2« on rabbit
jejunum) injected intravenously. There was an interval of 25 min between injections.
Concentration oj prostaglandins in cat forebrain
Brain tissue, 17 g, removed at decerebration from one cat was extracted and chromato-
graphed, with similar results to those obtained with pooled cat brains. From the silicic
acid column peaks of biological activity corresponding to 0.09 pg prostaglandins Ej and
1.6 fag prostaglandins Fla were eluted.
On the basis of this experiment cat brain was estimated to contain of the order of
10 ng F2a/g and 5 ng E1;/g wet weight of tissue.
DISCUSSION
Brain extracts contain acidic lipid-soluble substances which stimulate smooth muscle
(Ambache & Reynolds, 1960, 1961; Kirschner & Vogt, 1961; Ambache et al., 1963;
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Toh, 1963). One of these substances has been isolated from ox brain and identified as
prostaglandin F2a by chromatographic and mass spectrographic analysis (Samuelsson,
1964). Chemical identification, although desirable, is not always possible with the
minute quantities of prostaglandins found in small samples of animal tissues. Further¬
more, if the compound to be identified is already of known chemical structure and is
available in pure form for comparison with the extracted material, such absolute confirma¬
tion of its identity may be unnecessary. The question thus arises as to how much and
what kind of data are required before a claim to have identified a prostaglandin can be
justified. The problem is complicated because there are many different prostaglandins
with rather similar biological properties. In the present investigation the following
criteria have been used for the identification of a prostaglandin (1) on solvent partition
between water (at pH 3 and pH 8) and an organic solvent such as ether or ethylacetate,
the unknown should behave like an acidic lipid; (2) on silicic acid chromatography the
unknown should have a similar retention volume to one of the known prostaglandins;
(3) on thin layer chromatography in the AI and All (and possibly other) solvent systems
of Green and Samuelsson (1964), the Rf value should correspond to a known prostag¬
landin; (4) on parallel biological assay there should be quantitative agreement on two or
more tissues. Unequivocal evidence of a negative kind can be obtained from such an
approach. Thus it may well be possible to conclude with confidence that an isolated
substance is not, say, prostaglandin Ej because of its different chromatographic behaviour
and the lack of agreement between the parallel assays. On the other hand, agreement
between the behaviour of the isolated substance and a particular prostaglandin in all
these respects does not provide conclusive evidence. It may be permissible to conclude
that the chemical and biological properties of the substance are compatible with its
identification as, say, prostaglandin F2„ but there must always be some element of doubt.
Nevertheless the more data of this kind that are accumulated the greater the probability
that the identification is correct.
In this investigation solvent partition indicated that the substances extracted from brain
and spinal cord were polar acidic lipids. On silicic acid chromatography peaks of bio¬
logical activity were eluted corresponding to the retention volumes of prostaglandins E
and F in control experiments. It should be noted that prostaglandins E and F were
eluted with 40 and 60% ethylacetate in benzene respectively, whereas others have used
60 and 80% (Samuelsson, 1964; Coceani & Wolfe, 1965). This may have been due to
a different source of silicic acid. Other more polar substances which stimulate the rabbit
jejunum were eluted with methanol, but no attempt has been made to identify them.
They are possibly hydroperoxides of unsaturated fatty acids.
Confirmation that prostaglandins E and F were present in the extract was obtained by
thin layer chromatography in the AI solvent system of Green and Samuelsson (1964),
which separates the E's from the F„'s and F^'s. Biological activity in the two peaks from
the silicic acid column behaved like prostaglandins E and F„ respectively. In most
experiments location of the prostaglandins depended upon biological assay of the eluates
of appropriate zones of the thin layer plate, but in one experiment, in which cat brain
extract was chromatographed in the AI solvent system and the plate was sprayed with
phosphomolybdic acid, a spot appeared which corresponded exactly to F„. Further
evidence that the activity was due to prostaglandins E and F was obtained from the results
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of parallel biological assay on smooth muscle preparations. Since there is no way of
distinguishing between the different prostaglandins E and F by parallel biological
assay, final identification was based on chromatographic behaviour on thin layer plates
of silica gel impregnated with silver nitrate developed in the All solvent system, which
separates prostaglandins according to their degree of unsaturation.
From the combination of chromatographic and biological evidence it is concluded
that cat forebrain contains prostaglandin F2„ and a prostaglandin E, tentatively identified
as Fj. Evidence for the presence of E3 was equivocal (Table 10). There may also be some
Flu present but no E2, or F3u could be detected. Both brain and spinal cord of the chicken
contained substances which behaved chromatographically and biologically like prostag¬
landins E2 and F2u, the presence of detectable quantities of E1; E3 and F3„,was excluded,
but there may have been some F1(i in the chicken brain.
The primary object of this investigation was to identify prostaglandins in tissues, not to
estimate the amounts present. However, the concentration of F2a in cat fore-brain and
of F2a and E2 in chicken brain and spinal cord has been estimated from the biological
activity in the E and F peaks of the silicic acid chromatograms. Since F2a and E2 were
not normally used as prostaglandin standards in the bioassay of fractions from the silicic
acid columns, the relative biological activities of the mono- and di-unsaturated F's and
E's on the rabbit jejunum (Horton & Main, 1963, 1966a) have been used in the calculation.
By this means F2a was estimated to be present in cat fore-brain, chicken brain and chicken
spinal cord in concentrations of about 10 ng'g wet weight of tissue. The concentration
of Ex in cat fore-brain was about 5 ng/g; in contrast, the concentration of E2 in chicken
brain and chicken spinal cord was relatively high, 100 ng/g and 400 ng/g respectively.
In calculating these figures, no account was taken of losses during the extraction pro¬
cedure before silicic acid chromatography; hence, the concentrations of prostaglandins
in these tissues may be higher than estimated. It is unlikely, however, that extraction
losses could account for the large difference between the estimated concentration of F2a
in cat fore-brain, chicken brain and chicken spinal cord (10 ng/g) and that found by
Samuelsson (1964) in whole ox brain (300 ng/g). This discrepancy could be due to species
variation in the concentration of prostaglandin in the central nervous system or it could
also be due to differences in the concentrations of prostaglandins in different parts of the
central nervous system. For example, a high concentration of prostaglandins E in the
hind brain could account for the differences between cat fore-brain and chicken whole
brain. This receives some support from the finding that chicken spinal cord contains
even higher concentrations of prostaglandin E2. It is not certain whether any or all of
the hind-brain was included in Samuelsson's experiments or whether a similar uneven
distribution of prostaglandins E could account for the absence of prostaglandins E in
his extracts. It is of interest that Ambache, Brummer, Rose & Whiting (1966) reported
that rabbit cerebral hemispheres contain mainly prostaglandins F2„ with some E2.
If prostaglandins are unevenly distributed in the central nervous system this would
suggest that they have a role in the specialized function of the region where their concen¬
tration is highest. Further investigations must be carried out to determine the regional
distribution of prostaglandins in the central nervous system. It is also important to
discover whether, for example, such prostaglandins represent a pool with a constant
rate of turnover, or a store which may be released in response to a specific stimulus.
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In preceding papers (Horton, 1964; Horton & Main, 1965a, 1967a) pharmacological
actions of prostaglandins on the central nervous system of the cat and the chicken have
been demonstrated. The identification of prostaglandins in the central nervous system
of these species raises the possibility that these actions may reflect a physiological role,
though the precise nature of such a role is unknown.
One possibility is that prostaglandins act as chemical transmitters of nerve impulses
and evidence related to this hypothesis will be discussed briefly.
Although prostaglandins are present in brain and spinal cord it has not yet been estab¬
lished whether they are located in neurones or, for example, in glial cells. Investigations
into the cellular and subcellular distribution of prostaglandins in the central nervous
system are required to solve this problem.
That the pharmacological actions of prostaglandins on the central nervous system may
be due to a direct action on neurones is suggested by the results of Avanzino, Bradley &
Wolstencroft (1966a, b). Prostaglandins Ej, E2 and F2a applied ionotophoretically in
very small amounts, had an excitatory or inhibitory action on the frequency of firing of
reticulo-spinal neurones in the decerebrate cat, though desensitization, specific for the
prostaglandin applied, was frequently observed. In contrast, prostaglandin Ex had no
effect when applied iontophoretically to cortical neurones in the chloralosed cat (Krnjevic,
1965) suggesting either that there are marked regional differences in sensitivity to pro¬
staglandins, or that anaesthesia blocks the effect.
Release of prostaglandins from the central nervous system has been demonstrated
(Ramwell & Shaw, 1963a and b, 1966; Ramwell, Shaw & Jessup, 1966; Ramwell, 1967).
On direct electrical stimulation, transcallosal stimulation or stimulation of the contra¬
lateral superficial radial nerve, prostaglandins (and acetylcholine) were detected in super-
fusates of the cat somatosensory cortex. Similarly, electrical stimulation of the frog hind
limbs caused increased release of prostaglandins into spinal cord perfusates. Prostag¬
landins (or prostaglandin-like substances) have been detected in superfusates of cat cere¬
bellum (Coceani & Wolfe, 1965) and in fluid perfused through the cerebroventricular
system of cats (Feldberg & Myers, 1965, 1966) though in these situations a direct relation¬
ship between output of prostaglandins and neuronal activity was not clearly demonstrated.
These results do not exclude the possibility that prostaglandins may be central trans¬
mitters. However, evidence has recently been presented that, on nerve stimulation,
prostaglandins are released in association with the classical chemical transmitters from
several tissues outside the central nervous system including the rat diaphragm (Ramwell,
Shaw & Kucharski, 1965), rat adipose tissue (Shaw, 1966), cat adrenal gland (Ramwell,
Shaw, Douglas & Poisner, 1966), and dog spleen (Davies, Horton & Withrington, 1967).
These results suggest that prostaglandins are not transmitters but may rather be modulators
of transmission. Prostaglandins are not released from the rat diaphragm preparation
by direct electrical stimulation of the muscle or from the isolated phrenic nerve, but they
are released from the intact preparation on nerve stimulation even after muscle twitches
have been blocked by d-tubocurarine (Ramwell et ah, 1965). Prostaglandins are released
from adipose tissue either by nerve stimulation or by adding catecholamines to the incuba¬
tion medium. Moreover, the amount of prostaglandins released is sufficient to inhibit
the concomitant mobilization of free fatty acids from the tissue (Shaw, 1966). These
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results raise the possibility that prostaglandins may modulate transmitter action by a local
negative feed-back mechanism—for example, the action of the transmitter on the post¬
synaptic membrane may release prostaglandins which may inhibit further release or
action of the transmitter.
Prostaglandins have potent inhibitory actions on hormone-induced lipolysis in adipose
tissue (Steinberg, Vaughan, Nestel & Bergstrom, 1963) and on the hormone-induced
increase in permeability of the isolated toad bladder (Orloff, Handler & Bergstrem, 1965).
The concept that prostaglandins are modulators of chemical transmitters at nerve endings
could, therefore, be extended to include an action on true hormones throughout the body.
There is evidence that the common factor in the mechanism of action of many hormones
is the activation of the adenyl cyclase system which converts adenosine triphosphate
(ATP) to 3,5-adenosine mono-phosphate (3,5-AMP) which in turn activates other enzyme
systems to produce, for example, lipolysis or increased permeability (Sutherland, 0ye &
Butcher, 1965). Since, in these situations, prostaglandins do not prevent the action of
3,5-AMP, the action of prostaglandins may be to prevent the activation of adenyl cyclase.
Whether the miscellaneous biological actions of prostaglandins can be rationalized in
terms of a fundamental action on the adenyl cyclase system cannot be decided from existing
evidence. It is of interest to note, however, that the brain forms 3,5-AMP in response
to catecholamines (Sutherland et at., 1965).
It is concluded that prostaglandins may have a role in the central nervous system,
possibly as modulators of the actions not only of chemical transmitters released from
nerve endings but also of other local or true hormones released in the central nervous
system or reaching it from the systemic circulation. That this modulator action is not
confined to the central nervous system but may be of importance throughout the body
does not diminish its significance in the central nervous system.
Human seminal plasma contains by far the highest concentration of prostaglandins in
any tissue yet examined. It is known that these prostaglandins are absorbed from the
vagina after coitus and circulate in the bloodstream as hormones acting on female repro¬
ductive tract smooth muscle. It is tempting to speculate that the function of prostag¬
landins in human reproduction may also involve a hormonal action on the brain, possibly
on those centres which control sexual behaviour.
SUMMARY
1. The object of the investigation was to identify the prostaglandins present in the
central nervous system of the cat and the chicken.
2. On the basis of their behaviour on solvent partition, silicic acid column chromato¬
graphy, thin layer chromatography and on biological preparations prostaglandins F2a
and Ej have been identified in cat brain (supracollicular) and prostaglandins E2 and F2„
in chicken brain and spinal cord.
3. The concentration of prostaglandin F2a in the three tissues was approximately
10 ng 'g whereas the concentrations of prostaglandin E2 in the chicken brain and spinal
cord were about 100 ng/g and 400 ng/g respectively.
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4. The physiological significance of the prostaglandins in the central nervous system
is discussed in the light of the known pharmacological actions.
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A link between prostaglandins and the central nervous system
has been established by three kinds of experimental evidence.
These are:- (1) prostaglandins are natural constituents of the
brain and spinal cord, (Sainuelsson, 1964; Coceani & Wolfe, 196 55
Ambache, Brummer, Rose & Whiting, 1966; Horton & Main, 1966a,
1967a,cbd); (2) prostaglandins are released from the central nervous
system spontaneously and in response to electrical or chemical
stimulation (Ramwoll h Shaw, 196.5, 1966; Ramwall, Shaw & Jessup,
1966; Coceani & Wolfe, 1965; Feldberg & Myers, 1966) and (3)
prostaglandins on injection have powerful central nervous actions
(Horton, 1964; Horton & Main, 1965abb, 1967b,c&d; Avanzino, Bradley
& Wolstencroft, 1966). This paper describes experiments which
extend these three lines of investigation.
Occurrence of prostaglandins in the central nervous system
Prostaglandins have now been identified in brain tissue
from seven species. In every animal F2a has been found, but the
presence of F- , E0 and E1 is more variable. It may well be1.0C 1
that the concentrations of these prostaglandins in some species
are too low to permit their detection in the amounts of tissue
extracted. For example, there is strongly suggestive evidence
for the presence of a prostaglandin E in mouse brain but more
definite identification could not be made with the amounts of
brain used (Holmes &1 Horton, 1968b). Different regions of the
-2-
oentral nervoua system contain prostaglandin E^, Eg> and Fg
and their concentrations do not vary greatly from one region
to another (Holmes & Horton, 1967). Now each of those prosta¬
glandins has its own independent biosynthetic and metabolic
pathway (Bergstrom & Samuelsson, 1965); they are not known to be
precursors or metabolites of each other. If the hypothesis that
prostaglandins are central nervous transmitters is true, then it
may be predicted that, in the dog, four types of "prostanergic"
neurone, each releasing a different prostaglandin, are widely and
fairly evenly distributed throughout the central nervous system.
If prostaglandins are chemical transmitters at central
synapses, it should be possible to demonstrate their presence in
the nerve ending fraction of brain homogenates. Such evidence has
been obtained using rat cerebral cortex (Kataoka, Ramwell & Jessup,
1967). In our experiments on rabbit brain between 80 and 90% of
the brain prostaglandins were recovered from the high-speed super¬
natant. The amounts in the particulate fraction were small and so
far positive identification of prostaglandins in the nerve ending
fraction of rabbit whole brain has not been possible (Hopkin,
Horton & Whittaker, 1967), but our results are not incompatible
with the occurrence of prostaglandins in synaptosomes.
Release of prostaglandins from the central nervous system
We have perfused the cerebral ventricular system of chloralosed
dogs from the lateral ventricle of the cisterna magna. We have
-3-
identified four prostaglandins, E^, E^, and F^a in the
perfusates by their behaviour on solvent partition, chroma¬
tography and biological assay. This result suggests that the
prostaglandin-like substances in perfusates of the cat described
by Feldberg & Myers (1966) are likely to be prostaglandins.
Pharmacological Actions of the Prostaglandins on the brain and
Spinal Cord
Prostaglandin F2^ injected intravenously in young chicks
causes contraction of extensor muscles which is abolished by
denervation of the muscle. There is a simultaneous potentiation
of the crossed extensor reflex, which outlasts the muscular
contracture (Horton if Main, 1965afrb, 1967b,c&d). A similar
response has been observed in the decerebrate cat with both
prostaglandin F2a and E^ and this also occurs after spinal
transection at the C2 level. On the basis of this and other
evidence it is concluded that prostaglandin F^^^ and prostaglandin
have actions on spinal neurones in the chick and cat
respectively.
Electrophysiological techniques have now been used to show
that prostaglandins E^, Fj and F^^ have potent and long-lasting
effects on monosynaptic pathways in the catfs spinal cord (Duda,
Horton if McPherson, 1968). For example, prostaglandin E^ in six
cats caused marked reduction in size of evoked ventral root
—i..
-4-
potentials, which had a latent period corresponding to that of a
monosynaptic pathway. The effects lasted over 3 hours. Such a
prolonged duration of action is reminiscent of the effect of
prostaglandin E on injection into the cerebral ventricles of cats.




In the unanaethetized chick prostaglandin E. injected
X
intravenously causes sedation with loss of the righting reflex
(Horton, 1964). This "sedative" action of prostaglandin E< bas
been investigated further in mice using tests known to be
sensitive to substances of the sedative-tranquillizer group (Holmes |
& Horton, 1968b).
On subcutaneous or intravenous injection in mice prosta-
I
glandin E. (ling/kg) caused diminished spontaneous activity '
1if
lasting about 30 minutes,during which ptosis and the passing of
several liquid faeces were observed. These effects were not seen
with prostaglandin F£a (lmg/kg).
In most of these tests on mice where prostaglandin E^ was
active, it was more potent than chlorpr-omazine. In many respects
the effects of E^ and reserpine were similar, although the latter
showed little anticonvulsant activity. The effects of E^ were
quicker in onset but shorter lasting than those of reserpine.
Both prostaglandin (0.5 - 1 mg/kg) and prostaglandin
-5-
(lmg/kg) increased hexobarbitone "sleeping" time in mice. At the
lmg/kg dose level prostaglandin antagonized convulsions due
to leptazol (lOOmg/kg) and maximal electro-shock, only slightly
reduced strychnine (lmg/kg) convulsions but did not affect
picrotoxin (lOmg/kg) convulsions. On the other hand, prostaglandin
^2a ^ am* ^ ms/kg) potentiated the action of threshold convulsant
doses of leptazol. Prostaglandin E^ (Img/kg) produced some motor
inco-ordination as tested on the rotarod. It had some activity in
antagonizing the writhing or stretching induced in mice by intra¬
peritoneal acetylcholine, though no analgesic activity when tested
by pressure applied to the tail. Prostaglandin E^ (lmg/kg) did
not antagonize the circling movements or Straub tail phenomenon
induced in mice by morphine.
The ptosis produced by prostaglandin E^ was prevented by pre-
treating the mice with imipramine (20mg/kg). In this respect
the effect was similar to that of reserpine. However, iproniazid
(150mg/kg) failed to prevent E^ - induced ptosis.
These preliminary results in mice confirm and extend the
observations made with chicks, namely that prostaglandins in the E
series have a powerful "sedative-tranquillizer" action. The
potentiation of leptazol convulsions by F2a may be due to its known
action on motor pathways in the spinal cord.
In view of the small doses required to produce these central
-6-
effects, it is of interest that in both the cat and the chick
little specific activity can be detected in the brain or spinal
cord following intravascular injection of tritiated prostaglandin
in cats and chicks, (Holmes & Horton, 1968a). Even on
injection into the cerebral ventricles little of the prostaglandin
E^ inj'ected could be recovered from brain tissue removed at the
time of maximal pharmacological response. Hansson & Samuelsson,
(1965) using mice, had also reported that very little tritiated
prostaglandin E. reached the brain of mice following subcutaneous
injection.
Concluding Remarks
It is now well established that prostaglandins are normal
constituents of brain and spinal cord and that they are released
from these organs both spontaneously and in response to nerve
stimulation. The occurrence of prostaglandins in the non-
cholinergic nerve ending fraction of rat cortex is suggestive
evidence that these substances may be central transmitters. If
so, the regional distribution in dog brain shows that such
prostanergic neurones must be of wide distribution and possible of
four types. When it is considered that only traces of an injected
dose reach the central nervous system, the central nervous actions
of prostaglandins must be considered of quite considerable potency.
In general it seems that prostaglandin E^ in three species has
a sedative-tranquillizer action provided that the brain is intact
though stimulant actions on motor pathways are revealed in the
cat and the chick when the brain has been destroyed. The action
of F2a appears to be chiefly a facilitatory one on motor pathways.
The only hint of a sedative action is its potentiation of
hexobarbitone sleeping time in mice. Thus potentiated the
crossed extensor reflex in the chick (whether the brain is intact
or not), it often potentiates monosynaptic reflexes in the cat,
and it potentiates the convulsant action of leptazol.
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SUMMARY
1. Experiments were carried out to determine whether the prosta¬
glandins, which have been identified as natural constituents of the brain,
are widely distributed or concentrated in special regions of the central
nervous system.
2. Prostaglandins Eu Ea, Fla and F2ahave been identified in dog brain
using solvent partition, column and thin layer chromatographic and
bioassay techniques.
3. Each of these prostaglandins is distributed throughout all regions of
the central nervous system investigated (cortex, hippocampus, caudate
nucleus, hypothalamus, cerebellum, medulla and pons, cortical white
matter and spinal cord).
4. This distribution suggests that the role of prostaglandins in the
central nervous system is not confined to any specific region.
INTRODUCTION
Prostaglandins have been isolated from central nervous tissue of ox, cat,
chicken and rabbit (Samuelsson, 1964; Coceani & Wolfe, 1965; Ambache,
Brummer, Rose & Whiting, 1966; Horton & Main, 1967a). It is not known
whether the prostaglandins are concentrated in certain regions of the brain
suggesting a special role for a specific prostaglandin in the region where it is
concentrated, or whether they are more widely distributed. Studies of the
regional distribution in the central nervous system of other naturally
occurring substances have helped to elucidate their possible physiological
significance (Feldberg & Vogt, 1948; Amin, Crawford & Gaddum, 1954;
Vogt, 1954; Adam, 1961).
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prostaglandins in Hlianol extracts of (central nervoiiB tissue from the dog.
The significance of this distribution, which is rather uniform throughout
the central nervous system, is discussed. A preliminary report of some of
this work has already been made (Holmes & Morton, 1907).
METHODS
Removal of tissue samples. A series of nineteen elogs (seventeen greyhounds and two
labradors) ranging in weight from 20 to 32 kg was used. The dogs were anaesthetized with
pentobarbitone sodium (40 mg/kg) injected intraperitonoally. The trachea ami femoral vein
were cannulatod and a catheter was passed up the femoral artery into Ihe aorta. The dog
was exsanguinated via the arterial cather. During exsanguination the skin and muscle wore
reflected from the upper part of the cranium and the skull was trephined bilaterally. The
trephine holes wore extended by nibbling away the adjoining skull, the dura mater was
opened and when exsanguination was complete the brain was divided'from the spinal cord
and removed as quickly as possible. The required areas of central nervous tissue were
dissected out, weighed, chopped and placed in four volumes (w/v) of ice-cold 96% aqueous
ethanol as quickly as possible. The time from death until the tissue was placed in ethanol
varied from 2 to 10 min; to ensure that a longer period did not elapse only four areas wore
taken from any one dog. When small quantities of tissue, such as the hypothalamus, were
taken the tissue from two dogs was combined.
Extraction procedure. The dissected tissue was macerated for 30 min in 96 % ethanol taking
care to avoid heating above 45° C. The macerate was then allowed to stand for 2 hr at room
temperature with occasional stirring. The pH was then adjusted to 3 with concentrated
hydrochloric acid and the macerate was left to stand for a further 2 hr. It was then filtered
under reduced prossure, the residue being resuspended in a further four volumes (w/v) of
96% ethanol and re-filtered. The combined ethanol filtrates were taken to dryness, at 45° C
using a rotary evaporator, and the residue was subject to a solvent partition system similar
to that described by Horton & Main (1967a) which is summarized in Fig. 1. An emulsified
area often occurred at the interface in these partitions and this was always taken with the
phase containing the prostaglandins until the last partition when the interface was cleared
by centrifugation.
Column chromatography. Silicic acid (Bio-Had Laboratories, minus 325 mesh) columns
were prepared in the following manner: Silicic acid (10 g for 18 mm i.d. columns, 3g for
10 mm i.d. columns) was activated by heating for 1 hr at 110° C. It was then suspended in
light petroleum, placed in a glass column and washed with more light petroleum to removo
impurities. The column was then washed with 30% ethyl acetate in benzene. If the extract
to be chromatographed was from more than 10 g tissuo, 18 mm i.d. columns were used, if
from less than 10 g, 10 mm i.d. columns were used. The columns were eluted under reduced
pressure at a rate of approximately 1 cm fall/min.
Tho residue from the 67 % ethanol phase of the solvent partition system shown in Fig. I
was taken up in 1 ml. ethyl acetate and 2 ml. benzene and loaded on to tho column with a
Pasteur pipetto. This was followed by two 0-5 ml. ethyl acetate washes and finally by 2 ml.
benzene. The column was run in 30% ethyl acetate in benzene which was used to rinse the
flask containing the sample before being passed through the column. Unless this rather
complox loading procedure was followed it was found that considerable biological activity
was not transferred from tho flask to the column. Ethyl acetate (30%) was run through tho
column until the eluto was colourless. The column was then run in ascending concentrations
of ethyl acetate in benzene and was finally eluted with 100% methanol. Tho eluato from a
column was monitored for biological activity on the rat fundus strip and/ or rabbit jejunum
throughout.
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Thin layer chronuilriigruphy. Glass plates (29 x 5 cm) woro covered with a 0-25 mta layer
ot' Silica Gol G (Merck) containing 2% silver nitrate. The plates were allowed to dry and
were activated by heating to 110° (J Ibr 30 mill. The activated plates were stored in a
desiccator over self-indient ing silica gel. I'nro prostaglandins and tissue extracts were dis¬
solved in methanol and applied to the thin layer plates wit h an Agla micromotor syringe.
The thin layer plates were developed in Green & Samuels,son's (1964) ATI system which
separated prostaglandin I'd from E.> from E3 and FJa from I'Y.t from F3<x and were normally
run to 12 cm. Marker plates loaded with pore prostaglandins wore always run at the same
time as preparative plates and were visualized by spraying with 19% phosphnmolybdic
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Fig. 1. Outline of extraction proceduro.
were relatively small only marker plates loaded with prostaglandin Et or Fla were normally
run and the RF values for prostaglandins E2, E3, F2( and Fa, were determined by extra¬
polation from the literature (Green & Samuelsson, 1964). Preparative plates were divided
into zones corresponding to the positions of prostaglandins E3, E2 and E3 or Fla, F3l and
F3a. A blank zone near the solvent front, of similar sizo to the prostaglandin zones, was
always taken so that correction could bo made for any biological activity exhibited by the
silica gel in subsequent, bioassay. Tho zones were scraped off the thin layer plates and
extracted by shaking with 5 ml. methanol, the mixture being contrifugod and the super¬
natant removed. Tho residue was rosuspondod in 2-5 ml. methanol and ro-centrifuged.
The combined methanol supernatants woro evaporated to dryness and tho residue taken up
in I N-HC1, This took any silver present out of solution as insoluble silvor chloride and tho
prostaglandins woro extracted from the aqueous phaso by a two stage solvent partition with
an equal volume of ethyl acotato. The combined organic phases woro ovaporated to dryness
and tho residue was takon up in a small volume of either water or Tyrode solution and
stored at — 20° C until t.hoy woro assayed.
Recovery experiments. Recovery experiments wero carried out at the end of the study when
a supply of tritiatod prostaglandin E, became available. Tritiatod prostaglandin E3 (19 /ig)
was added to tho othanol maoerato of cerebral cortical tissue and its recovery was deter¬
mined at various stages of the extraction procedure using a Packard Tricarb liquid scintil¬
lation counter. At tho end of silicic acid column chromatography a recovery of 40 -45% was
obtained from tho appropriate eluato and most of tho loss occurred in tho pH 8 buffer—
ethyl acetato solvent partition system. Similar recoveries wore obtained in earlier studies
using unlabelled prostaglandin E, when activity was determined by bioassay.
If 5 fig of tritiatod prostaglandin E, was run in the AIT solvent in thin layer chromato¬
graphy a recovery of about 89% was obtained from the appropriate zone after removal of
silver. However, if 9-5 fig was similarly treated tho recovery fell to about 65%.
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Diological assays, smooth muscle, preparations in vitro. Segments of
various organs were suspended in a 4 or 10 ml. organ-bath and longitudinal
contractions were recorded isotonically with a frontal-writing lever on a
smoked drum. A dose cycle of 3-5 min with a contact time of 45 sec-2-5
mill was employed for all preparations. All estimates of content were made
by bracketing with pure prostaglandins.
Rat fundus. Longitudinal strips from the fundus of rats weighing 150-
300 g were prepared as described by Vane (1957) and suspended in Tyrode
solution at 37° C vigorously gassed with oxygen.
Rabbit jejunum. Proximal jejunum from rabbits weighing 0-75-3 kg was
suspended in Tyrode solution at 37° 0 gassed with air.
Guinea-pig ileum. Terminal ileum from guinea-pigs weighing 200-400 g
was suspended in Tyrode solution at 37° (! gassed with air.
Rut uterus. A uterine horn from dioestrous rats weighing 150-300 g was
opened longitudinally along the line of the mesenteric blood vessels and
suspended in de Jalon solution at 22° 0 gassed with air.
RESULTS
Identification of prostaglandins in whole dog brain. Whole dog brain
(95 g) was extracted and partitioned as described under Methods. The
extract was then ehromatographed on a silicic acid column, the eluates
being assayed for biological activity on the rut fundus and rabbit jejunum
(Pig. 2). Pour peaks of activity were elided. The material in the first peak
elided with 30% ethyl acetate in benzene, and in the last peak, eluted
with 100% methanol, was discarded. The second and third peaks of
biological activity corresponded to the elution times of prostaglandins P
and prostaglandins F respectively.
The material in the pooled fractions of the second peak were chromato-
graphed on a thin layer of AgN03 impregnated silica gel and developed in
the All solvent system simultaneously with a prostaglandin Ej marker
plate. When the preparative plate was zoned and eluted (Fig. 3) biological
activity was found in the zones corresponding to prostaglandins E, and E2.
The material in the P., zone behaved in a similar manner to pure pro¬
staglandin Et w lion assayed on the rat fundus and guinea-pig ileum ; 480 ng
Ej on the rat fundus and 570 ng E, on the guinea-pig ileum. The zone
corresponding to prostaglandin E2 gave a content of 950 ng E2 when assayed
on the mt fundus and 890 ng E2 on the guinea-pig ileum.
When the fractions corresponding to the third peak of activity (80%
ethyl acetate) from the silicic acid column were similarly treated it was
found that the zones on the preparative plate corresponding to the Rb.
values of prostaglandins Fla and F2a both contained biological activity.
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Fig. 2. Silicic acid column chromatography of the extract of 95 g dog brain. 10 g
silicic acid column. Ordinate: biological activity in jig in terms of prostaglandin
on the rat fundus strip and Fla on the rabbit jejunum. Abscissa: upperline, ml.

















Fig. 3. Thin layer chromatography of dog brain extract (second peak, Fig. 2) in
the All solvent system, (a) Marker plato sprayed with 10% phosphomolybdic
acid; (b) preparative plate divided into zones.
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Estimates of the content were 500 ng (rabbit jejunum) and 590 ng
(rat uterus) and of the F2ct content 390 ng (rabbit jejunum) and 480 ng
(rat uterus).
No activity was detectable in the prostaglandin E3 or zones when
assayed on any of the biological preparations employed nor was there
significant biological activity in other zones.
Although this experiment was carried out primarily to obtain a quali¬
tative identification of the prostaglandins, it is apparent that the four
prostaglandins are found in similar concentrations in dog brain (Ej,
35 ng/g; E2, 62ng/g; Flct, f>3ng/g; F2ct, 56ng/g; all uncorrected for
recoveries).
Distribution of four prostaglandins in dog central nervous system. Using
similar techniques to those employed for (lie identification of prosta¬
glandins in whole dog brain it was found that prostaglandins 10,, I02, Fla
ami all occurred in each area of the central nervous system examined.
All four prostaglandins occurred in similar concentrations throughout the
central nervous system. In each experiment various areas were compared
with cerebral cortical grey matter from the same dog or pair of dogs and
the results are expressed in terms of total prostaglandin E's and total F's
eluted from silicic acid columns (Table 1). The presence of each of the four
prostaglandins found in whole dog brain was confirmed in each area st udied
by further purification on thin layer chromatography in the All system
and bioassay.
Tn order to check that the anaesthetic (pentobarbitone sodium)
employed did not affect the prostaglandin levels within the brain, one dog
was anaesthetized with a completely different kind of anaesthetic, tribro-
niocthanol (Avertin-Winthrop Laboratories). It was found that its cortex
contained 184 ng/g prostaglandin F, equivalent of prostaglandin 10 and
204 ng/g Fla equivalent of prostaglandins F; the cortex of a dog anaesthe¬
tized with pentobarbitone sodium at the same time contained 185 ng/g
prostaglandin E, equivalent and 164 ng/g Fla equivalent respectively,
DISCUSSION
The identification of a specific prostaglandin in extracts of dog central
nervous tissue was based upon its behaving in a similar manner to the pure
prostaglandin in the solvent partition system, silicic acid column and thin
layer chromatography and parallel biological assay.
In the solvent partition system described in the methods section the
67 % ethanol would contain the polar acidic lipids including prostaglandins
from the original extract.
When the 67 % ethanol residue was subjected to silicic acid column
Table1.Distributionofprostoglandinsnthece traln rvoussystemofthd g.T talprost glandinsEexpressedint msofjdtotalprostaglandinsFintermsfFl .Allvaluesruncorrectedforcoveryandrxpressedt msfng/gtis ue Area...Cortex Expt.EF 110294 2116190 39658 42294 522-5100 620-5124 763100 886126 968100 1085238 111163S9 12132132 13185164 14337151 Mean104147
Cortical
Hippo-CaudateHypo-M dullawhiteSpinalcampusnucleusthalamusCer bellum-j-ponsmatterco d 26-5192
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chromatography it was found that the prostaglandins E were separated
from the prostaglandins F and both were separated from other biologically
active material in the extract (Fig. 2). When the column was eluted with
methanol considerable non-prostaglandin biological activity came off the
column. No attempt was made to identify further this activity but Morton
& Main (1967a) reported similar activity when they passed their chick and
cat central nervous tissue extracts through silicic acid columns; in the
case of the dog the activity was far greater when assayed on the rabbit
jejunum rather than the rat fundus.
When the zones from the thin layer plates run in the All solvent
system (Green & Samuelsson, 1964) were assayed in parallel on two
different tissues against the appropriate pure prostaglandin and a similar
potency was obtained on both tissues; it would seem reasonable to con¬
clude that a specific, prostaglandin was present in the original ext ract.
Although, in view of the small amounts present, no chemical charac¬
terization of prostaglandins was attempted, sufficient evidence is pre
set I fed to conclude that the substances identified are prostaglandins.
The identification of prostaglandins by a combination of chromato¬
graphy and bioassay has been discussed fully by Morton & Main (1967a).
The results of the recovery experiments carried out with tritiated
prostaglandin E, indicate that better recoveries might be obtained if a
buffer somewhat more alkaline than pH 8 was employed in the solvent
partition although care must be taken not to promote the formation of
prostaglandins 15 from the prostaglandins E.
The distribution of I lie four prostaglandins found in whole dog brain was
found to be remarkably constant, and the only areas to show any real
difference from the cortex were the medulla and pons which exhibited
consistently low values for their total prostaglandins 10. Also the cortical
white matter possible had a low content of prostaglandins 10 and this lifs
in wit h the work of Coceani & Wolfe (1966) who found that white matter
contained approximately one fifth the concentration of prostaglandins
found in the whole cerebrum from ox brain. The variation in content of
both prostaglandins E and F in the areas studied, apart from the two cases
mentioned above, were almost certainly due to variation between dogs
rather than areas. This is indicated when the ranges of the various estima¬
tions are studied.
Both Samuelsson (1964) and Horton & Main (1967a) used a further step
in their identification procedure. After silicic acid column chromatography
they subjected both the prostaglandins E and F peaks to thin layer
chromatography in the AI system (Green & Samuelsson, 1964) before pro¬
ceeding to the All system. Whilst this does provide a further piece of
evidence for the identificaton of a specific prostaglandin in an extract it was
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found that silicic acid column chromatography efficiently separated the
prostaglandins E from the F's and no improvement in performance in the
All system was observed if thin layer chromatography in the A I system
was carried out first. On the basis of this, chromatography in the AI
system was omitted.
Prostaglandins have been shown to be released into the perfused cerebral
ventricular system of the dog (S. W. Holmes & E. W. Horton, unpublished).
There is also evidence for the release of prostaglandin-! ike substances from
the inferior and anterior horns of the lateral ventricles and the third
ventricle in cats (Feldherg & Myers, 1966). Super litsafes of cat somato¬
sensory and cerebellar cortex have also been shown to contain prosta¬
glandins (Itamwell A Shaw, 19(1(1; (foecani <V Wolfe, 1965). Their release
from the frog perfused spinal cord has also been demonstrated (I'amwell)
Shaw & Jessup, 19(1(1). The level of release of prostaglandins from t he cat
somatosensory cortex and frog spinal cord has been shown to be affected
by afferent stimuli.
When one considers the occurrence, release and profound pharmacological
effects of prostaglandins in the central nervous system it would seem
reasonable to postulate a transmitter function for the compounds at
central synapses. Choline acetylase, noradrenaline, histamine, 5-hydroxy-
tryptamine and dopamine among other substances concerned with chemical
transmission in the nervous system are concentrated in specific regions
(Feldberg & Vogt, 1948; Amin et al. 1954; Vogt, 1954; Bertler & Rosengren,
1959; Adam, 1961). Such concentration may be considered a criterion for a
substance's possible role as a transmitter at central nervous synapses. The
even distribution of all four prostaglandins found in whole dog brain then
makes a transmitter function improbable. Furthermore, although these
four prostaglandins are very closely related chemically, it has been shown
that each has its own biosynthetic pathway (Samuelsson, 1967). This would
necessitate postulating the presence of four different types of neurone,
each releasing a different prostaglandin^distributed throughout the central
nervous system.
It has been demonstrated that prostaglandins are released in association
with known chemical transmitters in response to nerve stimulation at a
variety of synapses outside the central nervous system. These sites in¬
clude the rat diaphragm (Ramwell, Shaw & Kucharski, 1965) rat adipose
tissue (Shaw, 1966), cat, adrenal gland (Ramwell, Shaw, Douglas &
Poisner, 1966) and dog spleen (Davics, Morton & Withrington, 1967). At
these sites prostaglandins do not fulfil the criteria of a transmitter,
although they may well be involved in the transmission mechanism as is
suggested by their known pharmacological actions on the central nervous
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system (Horton, 1964; Horton & Main, 1965; 19676; Avanzino, Bradley
& Wolstencroft, 1966).
It is concluded that, on the basis of the evidence at present available,
the four prostaglandins identified in dog central nervous tissue probably
fulfil some function other than that of transmitters although they may be
involved in neural mechanisms. Their release in response to nerve stimu¬
lation as sites outside the central nervous system suggest that their
function may be widespread, in relation to neural mechanisms, and not
confined to the central nervous system.
This work was supported by grants from the Medical Research Council. We are grateful
to Dr D. A. van Dorp, of the Unilevor Rosearch Laboratories and Dr J. E. Piko, of the
Upjohn Company for supplies of pure prostaglandins and to the former for the sample of
tritiatod prostaglandin E2.
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Prostaglandin Content of Particulate
and Supernatant Fractions of Rabbit
Brain Homogenates
Whole rabbit brains were homogenized in 0-32 molar
sucrose solution, and subcellular fractions were prepared
by centrifugatioh by the method of Gray and Whittaker1.
Prostaglandins were extracted from the homogenates and
from the various fractions by solvent partition and further
purified by chromatography2.
Extracts of rabbit brain homogenatos showed prosta-
glandin-like activity when assayed biologically on the rat
isolated fundal strip preparation. On silicic acid column
chromatography, two main peaks of biological activity
were detected, corresponding to the elution rate of pure
prostaglandins E and F respectively. On thin-layer
chromatography using plates of silica gel impregnated
with silver nitrate, zones corresponding to prostaglandins
E2 and F2a contained more than 90 per cent of the
biological activity, confirming the report of Ambache,
Brummer, Rose and Whiting3. The homogenates were
estimated to contain 500 ng prostaglandin F2a and 75 ng
prostaglandin E2/g of brain tissue. When the brain was
macerated or homogenized in 96 per cent aqueous ethanol
instead of sucrose, similar amounts of prostaglandins were
recovered. There was no evidence in our experimental
conditions for inactivation or new synthesis in the sucrose
homogenates as reported by other workers4.
In each of four experiments the final supernatant after
centrifuging at 100,000(/ (4° C for 2 h) contained between
80 and 90 per cent of the total prostaglandin activity of
the homogenates. Substances with chromatographic and
biological properties identical to prostaglandins E2 and
F2a were identified in the supernatant fraction, which
also contained 80 per cent of the total potassium present
in the whole homogenate.
The combined particulate fractions also contained the
two prostaglandins. Between 5 and 10 per cent of the
biological activity of the whole homogenate was in the
fraction P2 which, according to electron microscopic
evidence1, would contain mitochondria and nerve endings.
Because the amounts of prostaglandin in the P2 fraction
were so small, further fractionation by sucrose gradient
technique has not so far been feasible. The remainder of
the prostaglandin-like activity of the particulate fraction
was distributed between PI (nuclei and cell debris), P3
(microsomes) and P4 (ribosomes and post-microsomal
fractions).
The combined particulate fraction was treated in three
ways in an attempt to release any bound prostaglandin.
One sample was frozen and thawed ten times, another
was incubated at pH 3 and 60° C for 1 h, and a third
sample was suspended in water before extraction with
ethyl acetate at pH 3. None yielded any additional
prostaglandin.
As a control, the succinate dehydrogenase contents of
tire particulate and supernatant fractions were compared
with those of the original homogenate. All the enzyme
activity of the homogenate was recovered from the
particulate fraction.
It is unlikely that the prostaglandin content of the
particulate fractions was the result of contamination by
supernatant, because washing with sucrose and recentri-
fugation did not reduce the amount recovered. But the
possibility that the prostaglandin recovered from the
supernatant originated from a very labile store in one of
the particulate fractions cannot be excluded.
Our results differ from those of Kataoka, Ramwell and
Jessup5, who located 30-40 per cent of the prostaglandins
in rat cerebral cortex in nerve ending fractions. The results
from both laboratories point to a wide distribution of
prostaglandins throughout subcellular compartments.
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Prostaglandins are released when the sympathetic nerves supplying the rat epididymal
fat pad in vitro are stimulated (Shaw, 1966). It is not yet known whether this is a general
phenomenon associated with adrenergic nerve stimulation but the experiments described
in this paper show that prostaglandin E2 is released when the splenic nerve is stimulated.
A preliminary account of this work has already been published (Davies, Horton &
Withrington, 1967).
In the investigation reported here we collected venous blood samples from the perfused
dog's spleen in order to detect any prostaglandin release when the splenic nerve was
stimulated. A large increase in prostaglandin E2 output was found.
METHODS
Blood-perfused dog spleen. An isolated spleen was perfused with blood from the femoral artery
of a second (donor) dog using the technique described in the following paper (Davies & Withrington,
1968). The splenic venous blood was returned to the femoral vein of the donor except during the
collection of a sample, when it was diverted out of a side arm. During the collection of a sample,
blood from a reservoir was pumped into the donor. Electrodes were placed on the splenic nerve and
the spleen was bathed in liquid paraffin at 37° C. The nerve was stimulated with 50 V pulses of
0.5 msec duration at 10/sec.
Extraction procedures. The procedures are outlined in Fig. 1. Blood was either collected in a
measuring cylinder and added to 4 vol. ice cold 96% aqueous ethanol, or added to the ethanol
directly from the collecting cannula. The mixture was shaken and filtered. The residue was
re-extracted with 4 vol. 96% aqueous ethanol. The combined aqueous ethanol filtrates were
evaporated to dryness. The dried residue was dissolved in a mixture of equal volumes of ethyl
acetate and water at pH 3. After separation, the acid acqueous phase was re-extracted with
1 vol. ethyl acetate. The combined ethyl acetate phases were concentrated to smaller volume and
extracted twice with an equal volume of phosphate buffer solution pH 8. The aqueous phases were
pooled, acidified to pH 3 by addition of HC1, and re-extracted twice with an equal volume of ethyl
acetate. The ethyl acetate phases were pooled and evaporated to dryness.
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Fig. 1. Extraction and identification of prostaglandins.
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The residue was partitioned between equal volumes of 67% aqueous ethanol and heavy petroleum
(b.p. 60o-80° C). The aqueous ethanol was evaporated to dryness and chromatographed on silicic
acid columns (1-3 g) using the procedure described by Horton & Main (1967). Thin-layer plates of
dimensions 200x50 mm or 200x200 mm coated with Silica Gel G (E. Merck) 0.25 mm thick were
prepared and used as previously described in detail (Horton & Main, 1967). The AI and All solvent
systems were described by Green & Samuelsson (1964).
Biological assays. The rat fundus was used routinely for the estimation of biological activity in
the various fractions obtained during the extraction procedure. With all smooth muscle preparations
contractions were recorded on a smoked drum using a frontal writing lever.
Rat fundus. A fundal strip was prepared and suspended in a 10 ml. bath containing oxygenated
Tyrode solution. Doses were in contact with the tissue for 1.5-2 min and a cycle of 6-8 min
was used.
Rabbit jejunum. Proximal jejunum, from rabbits weighing 1-3 kg, was suspended in a 4 ml. bath
containing Tyrode solution at 37° C and gassed with air. A dose cycle of 4-5 min with 45-90 sec
contact was used.
Guinea-pig ileum. Terminal ileum from guinea-pigs weighing 150-600 g was suspended in a
4 ml. bath containing Tyrode solution at 37° 7 and gassed with air. A dose cycle of 5 min with
1 min contact was used.
Cat tracheal chain. A chain of three tracheal segments was suspended in Krebs-Henseleit solution
at 37° C and gassed with 5% COa-95% Os. Contractions were elicited by adding acetylcholine to
the bath and the assay was performed by comparing the inhibitory action of the unknown extract
with that of prostaglandin E2 (Horton & Main, 1967).
Occurrence of prostaglandin-like substances in splenic venous blood
In a preliminary experiment samples of plasma were acidified with HC1 and partitioned
with an equal volume of ethyl acetate. After two such extractions, the combined
ethyl acetate phases were evaporated to dryness. The residue was dissolved in water
and assayed on the rat fundus.
The sample collected during and after electrical stimulation of the splenic nerves (300
stimuli at 10/sec) contained the equivalent of 35 ng prostaglandin Eh/ml. plasma, whereas
the control samples did not contain any detectable prostaglandin. After phenoxv-
benzamine, administered in a dose (5 mg) sufficient to block the contraction of the spleen
to nerve stimulation, the output of prostaglandin-like material in response to nerve
stimulation was abolished, whereas the output of noradrenaline was increased (Table 1).
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A similar increase in prostaglandin-like activity was found in four out of five dogs
investigated. In a sixth dog sufficient prostaglandin E2 for identification was extracted
from the blood collected during stimulation.
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Identification of prostaglandin E2
Splenic venous blood (46 ml.) collected during and after nerve stimulation was extracted
by the solvent partition procedure outlined in Fig. 1. The material was chromatographed
on a silicic acid column and the eluates were assayed for biological activity on the
isolated rat fundus. Several peaks of activity were found (Fig. 2), the one eluted with
40% ethyl acetate corresponding to the prostaglandins E as found in other experiments
(Horton & Main, 1967 ; Holmes & Horton, 1967). The material from the " prostaglandin
E " peak was purified further by thin-layer chromatography on silica gel plates using the
AI solvent system of Green & Samuelsson (1964). About one-third of the biological
activity of this peak was found in the zone corresponding to the RF value of prostaglandin
E„ The remaining two-thirds had a higher R, value (see below).
Fig. 2. Silicic acid chromatography (1 g column) of splenic blood extracts. Elution at 1 ml./min ;
20 ml. fractions collected. Ordinate: biological activity assayed on the rat fundus in terms
of ng of prostaglandin Ei. Abscissa: upper line, fraction number ; lower line, % of ethyl
acetate in benzene used for elution.
These results were confirmed with a larger sample (252 ml.) of blood collected from
another dog during 60 sec of splenic nerve stimulation. In this experiment an activity
equivalent to 20 gg of prostaglandin Ei was eluted with 40% ethyl acetate in benzene.
The material from this peak was run on a preparative thin-layer plate in the AI solvent
system, the zone corresponding to the prostaglandins E was eluted and divided in three
aliquots. One was re-chromatographed in the AI system. On spraying the plate with
phosphomolybdic acid only one spot was seen corresponding to the RF value (0.54) of
the prostaglandins E. The second aliquot was chromatographed on a silica gel plate
impregnated with AgN03 in the All solvent system. On spraying with phosphomolybdic
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acid only one spot appeared, corresponding to the position of prostaglandin E, (RF 0.53).
On the marker plate prostaglandins E2 and E, had mean RF values of 0.52 and 0.74
respectively.
The third aliquot from the AI preparative plate was used for parallel biological assays
using prostaglandin E2 as the standard for comparison (Table 2). Like prostaglandin
E2 the prostaglandin extracted from splenic blood contracted the rat fundus, guinea-pig
ileum and rabbit jejunum but inhibited acetylcholine contractions of the cat trachea.
The assay results on the four tissues also agreed well quantitatively.
Table 2
PARALLEL BIOLOGICAL ASSAYS OF A FINAL EXTRACT OF SPLENIC VENOUS BLOOD
IN TERMS OF PROSTAGLANDIN E2
Occurrence of other lipids in extracts of splenic venous blood
In addition to prostaglandin E., several other biologically active lipids were found in
extracts of splenic venous blood collected during and after splenic nerve stimulation.
On thin-layer chromatography in the AI solvent system of the material in the " prosta¬
glandin E" peak from the silicic acid column (Fig. 2), four substances with an R,
value greater than the prostaglandins E were detected in addition to the prostaglandin
Eo. A mixture containing these four substances was biologically active on the rat fundus,
but they have not been studied individually.
When the material in fractions 27-33 from the silicic acid column (Fig. 2) was run on
thin-layer plates, at least two spots were present in each fraction as visualized by spraying
with phosphomolybdic acid. We have no evidence as to which of these contained the
biologically active principle.
In one experiment a small amount of prostaglandin F was also detected. The
evidence for this was based on its chromatographic behaviour on column and thin-layer
chromatography and on parallel biological assays.
Free fatty acid levels
In several experiments unesterified fatty acid levels were estimated by titrating an
aliquot of the material before partitioning between petroleum and 67% ethanol. The
residue was dissolved in ethanol and titrated with n/100 alcoholic KOH using thymol
blue as the indicator. An experiment (Fig. 3) illustrates the increase in prostaglandin E.>
and a slight decrease in free fatty acid levels in the sample collected during and after
nerve stimulation. This confirms that the nerves to adipose tissue adjacent to the spleen






























Fig. 3. Dog, 11.0 kg. A: Reduction in splenic volume in response to a train of 600 stimuli at
10/sec applied to the splenic nerve. A pooled blood sample was collected for the 7 min period
during and after the stimulus, as indicated by the event marker. B: Assay of prostaglandin E»
and free fatty acids in a control blood sample I taken 3 min before nerve stimulation and the
blood sample II.
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Identification of a prostaglandin E in extracts of dog spleen
Five dog spleens weighing a total of approximately 400 g were macerated in ethanol
and extracted by the procedure outlined in Fig. 1. On the basis of column and thin-layer
chromatography it was concluded that dog spleen contains a prostaglandin E, but there
was insufficient material for identification by chromatography in the All solvent system.
On the basis of extracting another spleen weighing 24 g the concentration seemed to be of
the order of 2 ng prostaglandin E2/g tissue.
DISCUSSION
Identification of prostaglandin Es
As discussed at length by Horton & Main (1967), the identification of prostaglandins
on the basis of chromatographic behaviour and biological activity is not conclusive but
the evidence is strongly suggestive. From the experiments described in this paper it can
be stated that the behaviour of the substance isolated from splenic venous blood collected
during and after nerve stimulation was identical to prostaglandin E, on three chromato¬
graphic systems and could not be distinguished from prostaglandin E, by quantitative
parallel biological assay on four tissues, three of which contracted and one of which
relaxed in response to prostaglandin E2. It is certain that this activity was not caused by
a prostaglandin F nor by prostaglandins Ej or E3. Nor from the data published by others
was it likely to have been prostaglandin Au B,, A2 or B. or one of their 19-hydroxy-
derivatives (Hamberg & Samuelsson, 1966).
Presence of other prostaglandin-like substances
Although the major biologically active constituent of the extracts was prostaglandin
E2, the presence of other prostaglandins cannot be excluded. There were certainly other
substances with partition and chromatographic behaviour similar to the prostaglandins,
but the nature of these is unknown except in one experiment in which a prostaglandin F
was tentatively identified. It seems likely that the stimulus which releases prostaglandin
E2 causes a simultaneous release of several prostaglandin-like substances. This fact should
be taken into account when considering the physiological implications of these
observations.
Origin of the prostaglandins
The absence of any increase in free fatty acid levels when splenic nerves were
stimulated excludes the possibility that the prostaglandins arise from adipose tissue
adjacent to the spleen. This is not to say that fatty acids other than prostaglandins are
not released from the spleen itself, but the amounts concerned are likely to be minute
compared with the large output which occurs when fat is mobilized.
The absence of prostaglandins in samples collected after administration of phenoxy-
benzamine suggests that the prostaglandins are released in response to the action of
noradrenaline at the post-synaptic site but an action of phenoxybenzamine in blocking
prostaglandin release from a pre-synaptic site, though less likely, cannot be excluded.
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Physiological significance of prostaglandin release
Prostaglandins are kidely distributed in animal tissues (Bergstrom & Samuelsson, 1965)
and are known to be released in response to a variety of stimuli. For example they are
released from the central nervous system on sensory nerve stimulation (Ramwell & Shaw,
1966), from the rat isolated diaphragm on stimulation of the phrenic nerve (Ramwell,
Shaw & Kucharski, 1965), from the adrenal glands in response to acetylcholine (Ramwell,
Shaw, Douglas & Poisner, 1965) and from adipose tissue in response to adrenergic nerve
stimulation (Shaw, 1966). The experiments in this paper provide a second instance of
prostaglandin release on stimulation of adrenergic nerves, although there is some
evidence that the release from the diaphragm is caused by stimulation of adrenergic fibres
in the phrenic nerve (Ramwell et al., 1965). Our experiments provide the first demonstra¬
tion that prostaglandins are released directly into the blood from an organ. It is
significant that the output following nerve stimulation for 1 min was greatly in excess
of the total amount of prostaglandin which could be extracted from a spleen. This
suggests a rapid synthesis and agrees with the findings on cat adrenal glands (Ramwell
et al., 1965).
In view of the known inhibitory actions of prostaglandins E on the adenyl cyclase
system which, in many instances, is thought to mediate the actions of adrenaline and
noradrenaline, the possibility of a local feedback mechanism has been envisaged by
various workers (see Bergstrom & Samuelsson, 1967). Prostaglandin Ei antagonizes
some of the vascular effects of the catecholamines (Holmes, Horton & Main, 1963), but
the results in the following paper indicate that such an antagonism does not occur in the
dog spleen (Davies & Withrington, 1968). Further information is needed about the
mechanism of prostaglandin release and about release from other organs on sympathetic
nerve stimulation, before any conclusions can be drawn as to how these findings fit into
the picture of events at adrenergic synapses.
SUMMARY
1. In five dogs prostaglandin-like activity was detected in splenic venous blood
samples collected during and after nerve stimulation.
2. Prostaglandin E, was identified in extracts of the splenic blood by its behaviour on
solvent partition, chromatography in three systems, and by its biological activity on four
isolated tissues.
3. Several other lipids which stimulate smooth muscle were also detected but these
have not been identified.
4. Prostaglandin output was blocked by the administration of phenoxybenzamine
(5 mg), whereas noradrenaline output was increased.
5. Splenic nerve stimulation did not increase free fatty acid levels in splenic venous
blood, which excludes the possibility that the prostaglandins arise from adipose tissue
adjacent to the spleen.
6. A prostaglandin E has been extracted from splenic tissue but the amounts present
were too small to permit complete identification.
This work was supported by a grant from the Medical Research Council. Prostaglandins were
kindly supplied by Dr. D. A. van Dorp.
PROSTAGLANDINS IN SPLENIC BLOOD 135
REFERENCES
Bergstrom, S. & Samuelsson, B. (1965). Prostaglandins. A. Rev. Biochem., 34, 101-108.
Bergstrom, S. & Samuelsson, B. (1967). Proc. 2nd Nobel Symposium, Stockholm, 1966.
Davies, B. N., Horton, E. W. & Withrington, P. G. (1967). The occurrence of prostaglandin E2 in
splenic venous blood of the dog following splenic nerve stimulation. J. Physiol., Lond., 188, 38-39P.
Davies, B. N. & Withrington, P. G. (1968). The effects of prostaglandins E, and E2 on the smooth
muscle of the dog] spleen and on its responses to catecholamines, angiotensin and nerve stimulation.
Br. J. Pharmac. Chemother., 32, 136-144.
Green, K. & Samuelsson, B. (1964). Thin layer chromatography of prostaglandins. J. Lipid Res., 5,
117-120.
Hamberg, M. & Samuelsson, B. (1966). Prostaglandins in human seminal plasma. J. biol. Chem., 241,
257-263.
EIolmes, S. W. & Horton, E. W. (1967). The nature and distribution of prostaglandins in the central
nervous system of the dog. /. Physiol., Lond., 191, 134-135P.
Holmes, S. W., Horton, E. W. & Main, I. H. M. (1963). The effect of prostaglandin Ei on responses of
smooth muscle to catecholamines, angiotensin and vasopressin. Br. J. Pharmac. Chemother., 21,
538-543.
Horton, E. W. & Main, I. H. M. (1967). The identification of prostaglandins in central nervous tissues
of the cat and the chicken. Br. J. Pharmac. Chemother., 30, 582-602
Ramwell, P. W. & Shaw, J. E. (1966). Spontaneous and evoked release of prostaglandins from cerebral
cortex of anaesthetized cats. Am. J. Physiol., 211, 125-133.
Ramwell, P. W., Shaw, J. E., Douglas, W. W. & Poisner, A. M. (1966). Efflux of prostaglandin from
adrenal glands stimulated with acetylcholine. Nature, Lond., 210, 273-274.
Ramwell, P. W., Shaw, J. E. & Kucharski, J. (1965). Prostaglandin: release from the rat phrenic
nerve diaphragm preparation. Science, 149, 1390-1391.
Shaw, J. E. (1966). Prostaglandin release from adipose tissue " in vitro " evoked by nerve stimulation or
catecholamines. Fedn Proc., 25, 770.
blood to give a final concentration of 1 (ig/ml. The blood was
Immediately mixed with 4 vol 96% aqueous othnnol and filtered.
The filtrate plus washings wore evaporated to dryness; the residue
was dissolved in water and assayed on the rat isolated fundus.
Ethyl acetate extraction of prostaglandin from dor's brain
Recovery experiments wore performed as follows :
Prostaglandins E^ was added to fresh dog's blood at 37" and
incubated for 5 min. The blood was diluted with an equal volume of
water and, by dropwide addition of hydrochloric acid, its p II was
adjusted to 3.0 using a pll meter. The acidified diluted blood
was then partitioned twice with an equal volume of ethyl acetate.
The ethyl acetate was evaporated to dryness and the residue
dissolved in aqueous solution for biological assay.
Incubation of prostaglandin with blood
Dog's blood and a solution of prostaglandin E^, in 0.9,o
sodium chloride solution were warmed to 37° and mixed to make
the appropriate concentration of prostaglandin in blood. The
mixtures and control samples of blood (to which saline but no
prostaglandin had been added) were incubated in a shaking water
bath for periods up to 3 hr. The samples were then extracted
with ethyl acetate as described above.
-3-
Recovery of tritium-labelled prostaglandin E ^
Il-prostaglandin E^ was added to dog's blood and extracted
with ethyl acetate as described above. Specific activity was
t
measxired using a Packard Tricarb Scintillation Counter.
•• ;..V
Electrophoresis of prostaglandin and plasma containing
prostaglandin E^
An aqueous solution of prostaglandin E- or dog*s plasma
to which prostaglandin had been added, was applied to strips
of cellulose acetate. Electrophoresis was performed in a
•Shandon paper electrophoresis apparatus using a constant current
of 0.6mA/cm. Plasma proteins were visualised by staining of the
strips with 0.2% naphthalene black 10B in icethanol/acotic acid
(9/1). Prostaglandin was detected by eluting strips of the
paper and assaying the oluatod biologically on the rat fundus
strip.
Results
Ethanol extraction of dog's blood containing prostaglandin E ^ or Eg...
Between 5 and 10!& of the added prostaglandin E^ or Eg (1 ug/ml
was recovered from the filtrate after ethanol extraction of dog's
blood. Tho control blood samples to which no prostaglandin had
been added contained no detectable biological activity when
assayed on the rat fundus.
-4-
Ethyl aetata extraction of acidified clo^-; ,s blood containing
Pi^ostayiandin
When the concentration of added prostaglandin was
0.1 - i.O ug/ral : recoveries wore 55 - 13% (10 estimations). At
concentrations of 20 and 50 ng prostaglandin E^/ml : recoveries
were more variable and sometimes as low as 25%. None of the
control blood samples (no added prostaglandin) contained any
detectable prostaglandin (<1 ng Ej/ml blood).
Recovery of trit ^uni.-lflb^lQd prp^tqglandip
When the dog*a blood containing 135 ng/ntl of tritiated
•»(
prostaglandin E^ was incubated for 5 riinutes at 37°C and then
extracted into ethyl acetate it was found that 80% of the
added radioactivity was present in the ethyl acetate fraction.
Effect of incubation of prostaglandin E^ with blood
Prostaglandin was incubated with blood at a concentration
of 1 ug/nil for periods from 5 min. to 3 hr. The amount of
prostaglandin recovered at the end of each incubation period
was within the range of that recovered by extracting the blood
immediately after adding the prostaglandin.
—5
Electrophoresis of prostaglandin and plasma to which
prostaglandin had been added
Pure prostaglandin and dog's plasma ivere subjected to
electrophoresis in parallel dn separate cellulose acetate strips.
The electrophoratically fraptionated plasma proteins were located
by staining and the strips on which prostaglandin E^ alone had been
run was divided into zones corresponding to these fractions. The
f
biological activity due to the prostaglandin oluted mainly from
the zone corresponding to the cu globulin fraction, some was
present in the a0 globulin zone. No activity could be detected
in other zones.
When dog's blood containing prostaglandin E^, 5 jfg/ml, was
incubated for 30 min. or 1 hr. at 37°C : all tho added
prostaglandin was recovered from tho and a2 globulin zones
after electrophoresis of the plasma. No biological activity was
» detected in other zones.
Discussion
There have been several reports recently of the release of
prostaglandins from tissues (1, 4, 5> 6, 7» 8). One of these
concerned the identification of prostaglandin E^ in venous blood
colls cted from the dog's spleen (1). When the prostaglandin had
been positively identified, the next step was to devise a method
for the quantitative estimation of this substance in blood. The
f
*
experiments reported here show that extraction with ethanol is not
efficient for extracting: added prostaglandins from blood, although
it lias proved an effective method with other tissues. One
explanation for those poor recoveries is that the added prostaglandin
becomes bound to a substance such as plasma protein which is
precipitated by the ethane!. The eloctrophoretic evidence indicates
that if such an association occurs, it must be with an a globulin.
The modified extraction procedure, which simply involves
omission of the initial ethanol extraction, is similar to that used
by earlier workers for the extraction of prostaglandins from seminal
plasma (9, 10). The method gives good and fairly consistent
recoveries provided that the concentrations of prostaglandin are
sufficiently high (0.1 ug/ml or more). Whether this is within the
physiological range is unknown; although in one experiment
reported previously splenic venous blood contained 200 ng Ej/ml even
when using the ethanol extraction procedure* If the 5 - 10%
recoveries with ethanol extraction also applied to those experiments,
the concentration of prostaglandin Ej in splenic venous blood may
have been as high as 1 - 2 ug/ml. It should be noted, however,
that poor recoveries of added prostaglandins are not necessarily
evidence that the naturally-occurring compounds will not be
extracted efficiently by a given procedure. The converse is, of
course, also true.
7-
A better method capable of recovering quantitatively lower
blood concentrations of prostaglandin is highly desirable. The
basis for such a method may be found in the recent report of
Ilickler who uses a methylal — ethanol mixture in the initial
extraction of plasma (11). '
■ 'i'.if
Using the method described here it has been shown that
prostaglandin is not biologically inactivated by incubation
r
with dog's blood in vitro for periods up to 3 hr. It is
concluded that the removal of prostaglandins from the
circulation is by a mechanism other than inactivation by enzymes
in blood. This finding is in agreement with that of Ferreira and
Vane using the blood-bathed superfused organ technique.
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Reduction of the pressor responses to adrenaline in the rabbit following administra¬
tion of prostaglandin Ei has been confirmed. The effect is, however, nonspecific since
noradrenaline, angiotensin and vasopressin are also antagonized. Analogous responses
were observed in blood flow experiments on the cat hind limb but not on the
rabbit isolated auricles or the rabbit isolated duodenum. Contractions of the cat
nictitating membrane produced by sympathetic preganglionic stimulation or by
adrenaline were not decreased following injection of prostaglandin Ei but the
relaxation period was shorter. Contractions of the rabbit vas deferens induced in vivo
by adrenaline were smaller after prostaglandin Ei and this effect tended to be long-
lasting.
In 1938, Euler observed that pressor responses to adrenaline in the rabbit were
reduced following an intravenous injection of prostaglandin. Steinberg, Vaughan,
Nestel & Bergstrom (1963) have recently made a similar observation using pure
prostaglandin E,. These authors have also shown that the break-down of triglyceride
in adipose tissue induced by catechol amines is antagonized. In this investigation
we have confirmed the action of prostaglandin E, on pressor responses to catechol
amines and have shown that this effect is nonspecific since responses to angiotensin
and vasopressin are also reduced.
METHODS
Blood pressure experiments. Blood pressure was recorded from a carotid artery using either
a mercury manometer or a Statham pressure transducer. Cats were anaesthetized with pento¬
barbitone sodium (40 mg/kg), rabbits and rats with urethane (1.75 g/kg) injected intra-
peritoneally. In some experiments rats were anaesthetized with ether and pithed using a strong
wire introduced through an orbit and passed down the cerebrospinal axis.
Cat hind-limb blood flow. Cats, weighing 2.5 to 4.5 kg, were anaesthetized with pento¬
barbitone sodium (40 mg/kg) injected intraperitoneally. The trachea, a carotid artery and
both external jugular veins were cannulated. Blood pressure was recorded by a mercury
manometer. Venous outflow from a hind-limb was recorded by passing blood from the
femoral vein through a Palmer drop-chamber connected to a Gaddum drop-recorder, the blood
being returned into a jugular vein. The artery supplying the gracilis muscle was cannulated
with fine polyethylene tubing connected to a three-way tap for retrograde intra-arterial
injections. Heparin (1,000 U/kg) was injected intravenously and further doses of 500 U/kg
were given every 2 hr. Contractions of the hind-limb muscles produced by stimulation of
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the sciatic nerve (3 to 4 V, 0.2 msec duration, 6 shocks/min) ensured a brisk venous outflow
throughout the experiment.
Nictitating membrane contractions. Nictitating membrane contractions were recorded iso-
metrically using a Grass force-displacement transducer (model FTO3). The ipselateral pre¬
ganglionic cervical sympathetic nerve was stimulated and intra-arterial injections were made
retrogradely through a polyethylene cannula in the ipselateral lingual artery.
Rabbit isolated auricles. The method described by Burn (1952) was used. The auricles
were suspended in a 4 ml. organ-bath containing Locke solution gassed with oxygen and their
spontaneous contractions were recorded isometrically using a Grass force-displacement trans¬
ducer (model FT03).
Rabbit isolated duodenum. A 3 to 4 cm segment of duodenum was suspended in a 4 ml.
organ-bath containing Tyrode solution at 35 to 36° C gassed with air. Longitudinal contrac¬
tions were recorded isometrically with a frontal writing lever on a smoked drum. A tension
of 1 g and a lever magnification of five-times were used. The dose cycle was 5 min with
40 sec contact.
Rabbit va.s deferens. Male rabbits, weighing 2 to 3 kg, were anaesthetized with urethane
(1.75 g/kg) injected intraperitoneally. The trachea, an external jugular vein and a carotid
artery were cannulated. The abdomen was opened and the viscera were displaced to allow
access to one vas deferens. The distal end was ligated and the proximal end was cannulated
with a polyethylene cannula introduced through a small incision and tied in position. The
cannula was filled with Tyrode solution and connected to a Statham pressure transducer.
Intraluminal pressure was then recorded from this artificial blind sac of vas deferens. The
preparation showed spontaneous activity and responded by contraction to intravenous injections
of adrenaline.
Drugs. These were (—)-adrenaline acid tartrate (B.D.H.); (—)-noradrenaline bitartrate
(Levophed, Bayer) ; valyPangiotensin II aspartyl-/3-amide (Hypertensin, Ciba) ; vasopressin
injection B.P. (Pitressin, Parke, Davis & Co.); and histamine acid phosphate (B.D.H.).
RESULTS
Blood pressure experiments. Following an intravenous injection of prostaglandin
(10 ^g/kg) into the rabbit, pressor responses to adrenaline were smaller than
before (Fig. la). Although responses to successive doses of adrenaline gradually
increased, complete recovery was long-delayed (15 to 30 min) and in some
experiments did not occur. Similar reductions in pressor responses to both
adrenaline and noradrenaline were also observed in the cat and the rat. In the
experiment illustrated in Fig. lb pressor responses to 0.2 ug noradrenaline in the
rat anaesthetized with urethane did not return to their former magnitude during
the course of the experiment after an intravenous injection of prostaglandin Ex.
This effect was not specific for catechol amines. Pressor responses both to angio¬
tensin and to vasopressin were similarly reduced following injection of prostaglandin
E,. In an experiment on a pithed rat illustrated in Fig. lc, the pressor response
to 2.5 mU of vasopressin was similarly reduced.
Blood flow experiments. Vasoconstrictor responses to intra-arterial injections
of adrenaline, noradrenaline or angiotensin into the hind limb of the cat were reduced
following an intra-arterial injection of prostaglandin Ei (Fig. 2). In one experiment
as little as 32 ng of prostaglandin E, caused detectable inhibition of the vaso¬
constriction due to 100 ng of noradrenaline and in the same animal 500 ng of
prostaglandin Ei almost completely abolished the response to 100 ng of nor-
540 S. W. HOLMES, E. W. HORTON and I. H. M. MAIN
(C) |
s V V V PGE, V V V
0.25 1.25 2.5 2.5 2 2.5 2.5 2.5




Fig. 1. Records of carotid arterial blood pressure from: (a) a rabbit (2 kg) anaesthetized with
urethane; (b) a rat (290 g) anaesthetized with urethane; and (c) a pithed rat (200 g). Drugs
were injected intravenously. Adr=adrenaline (fig); NA=noradrenaline (fig); V=vasopressin
(mU); PGE^ prostaglandin Ej (fig); S=saline (ml.). Time calibrations are 1 min. In
(c) the lower figures indicate times in minutes after administration of prostaglandin Ej at which
doses of vasopressin were given.
adrenaline. Similar results were obtained with adrenaline and angiotensin but
responses to neither drug appeared as sensitive to prostaglandin E, as that to nor¬
adrenaline. The effect of prostaglandin Ej on the vasodilatation due to isoprenaline
(100 ng) was insignificant for doses of prostaglandin up to 5 «g. Inhibition of the
response to the vasoconstrictor drugs was maximal immediately after the prosta¬
glandin had been administered, with a gradual return to normal in 5 to 15 min.
Similar effects were found when other vasodilator drugs, for example histamine
and bradykinin, were injected in place of prostaglandin E,.
Contractions of the cat nictitating membrane. The force of contraction of the
nictitating membrane in response either to sympathetic preganglionic stimulation or
to intra-arterial injection of adrenaline was not reduced after administration of
prostaglandin E, in doses up to 20 /ig/kg. However, the duration of the contraction
was markedly reduced (Fig. 3).
Responses of other smooth muscle preparations. Increased force of contraction
of the rabbit isolated auricles following administration of isoprenaline or adrenaline
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Fig. 2. Records from cats (a, 2.2 kg; b, 2.5 kg) anaesthetized with pentobarbitone sodium, 40 mg/kg
injected intraperitoneally. Upper trace, hind-limb blood flow; lower trace, carotid arterial
blood pressure. Drugs were injected retrogradely into the femoral artery from a cannula in
the artery to the gracilis muscle. Time calibrations are 1 min. All doses in Mg. NA=nor¬
adrenaline; PGE!=prostaglandin Ex; Ang=angiotensin II.
5 g
shocks
Fig. 3. Cat (2.35 kg) anaesthetized with pentobarbitone sodium, 40 mg/kg injected intraperitoneally.
Isometric contractions of a nictitating membrane in response to stimulation of the ipselateral
preganglionic cervical sympathetic nerve with 5 V shocks of 1 msec duration. Figures indicate
number of shocks. PGE,=prostaglandin Et (jig) injected retrogradely through a cannula in
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was not altered by prostaglandin Ex in concentrations up to 2.5 /ig/ml. Similarly,
relaxations of the rabbit isolated duodenum induced by adrenaline were unaltered
by prostaglandin in a dose which itself caused contraction of the muscle.
Contractions of the rabbit vas deferens induced in vivo by adrenaline were,
however, reduced following administration of prostaglandin (Fig. 4). This effect
was also observed in the rabbit vas deferens in vitro.
Adr Adr Adr PGE| Adr Adr Adr
10 20 10 20 10 10 10
Fig. 4. Rabbit (2 kg) anaesthetized with urethane injected intraperitoneally (1.75 g/kg). Records
of the intraluminal pressure of one vas deferens in vivo. Adr=adrenaline, PGE]=prostag-
landin E,, each injected intravenously. Doses are in /ig. Time calibration, 1 min.
DISCUSSION
Effect of prostaglandin El on vascular smooth muscle. The experiments described
here indicate that the antagonism of pressor responses to catechol amines reported
by Euler (1938) and Steinberg et al. (1963) is nonspecific since responses to
angiotensin and vasopressin are similarly affected. This lack of specificity has
been demonstrated both on blood pressure and on blood flow. Similar antagonism
of responses to catechol amines was observed when other depressor substances such
as bradykinin were used instead of prostaglandin Ej. Such "physiological"
antagonism might be expected to occur from algebraic summation of effects when
a pressor and depressor substance are injected either simultaneously or within a
short time of each other, but there is the alternative possibility, mentioned by
Steinberg et al. (1963), that prostaglandin Et blocks a biochemical sequence of
events initiated by vasoconstrictor substances, but has no vascular effects in the
absence of these substances. From the experiments described here we conclude
that, if the latter is the actual mechanism, the site of block must be somewhere on
the final common path for the actions of catechol amines, angiotensin and
vasopressin.
Effect of prostaglandin E1 on other smooth muscle preparations. Prostaglandin E,
also modified responses of other smooth muscle preparations. Contractions of the
rabbit vas deferens induced by adrenaline were reduced, although resting tone and
spontaneous contractions were unaffected. On the cat nictitating membrane,
prostaglandin Et did not reduce the size of contractions in response to sympathetic
nerve stimulation or to injection of adrenaline, but recovery time was shortened.
Whether these actions of prostaglandin are of any physiological significance is
unknown. It is clear that prostaglandins are of much wider distribution in the
body than was formerly suspected and we suggest that their presence in organs
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containing smooth muscle may be associated with a function as local mediators
of smooth muscle inhibition. The finding that break-down of triglyceride is also
modified (Steinberg et al., 1963) shows that the action of prostaglandins is not
restricted to smooth muscle. It is possible that prostaglandins inhibit a biochemical
pathway which is activated by different substances and which is common to several
different tissues. Consequently this inhibition may lead to entirely different effects
depending upon the tissue.
We are very grateful to Professor S. Bergstrom for a gift of pure prostaglandin Ei and to
Dr E. D. Nicolaides for a gift of synthetic bradykinin.
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Prostaglandins of the E series inhibit hormonally-induced
lipolysis and vasopressin-induced increase in water
•' /• ' ' ■ ■ ■ ■ '
permeability of the toad bladder''. Both of these hormonal actions
are known to be mediated by the formation of cyclic 3/, 5A.M.P.^'
Prostaglandins do not antagonise the actions of cyclic
• * i a
3/, 5'- A.M.P. in those systems but they may exert their
V- .• • ■■' ■ : r. , . • V V ■ ■■<'' . \ ./J;/'"*
* ,J.f v: ;■ .: ... , ; . •" ... 1 J:
effects by inhibiting the formation of this nucleotide.
Cyclic 3', 5'- A.M.P. has been shown to be a mediator in the
stimulant action of luteinizing hormone on ovarian steroidogenesis
$10 ^ ' ' 'i
in vitro ~ . This provides another system for investigating
the possible inhibitory action of prostaglandins on the formation
of cyclic 3', 5'- A.M. P.
Method
Chopped rabbit ovaries were evenly distributed among three
flasks, each containing 15ml. of Krebs Ringer solution. One
flask served as a control to verify the activity of the
-2-
gonadotrophins. The other two flasks contained human chorionic
ponadotrophin ("Pregnyl") and pregnant mare's serum ("Cestyl"),
each in a final concentration of 1 unit/ml. The prostaglandin
under investigation tvas added to one of the flasks containing
the gonadotrophins. All flasks wero then incubated in a
\
metabolic shaker at 37'C for three hours with continuous passing
with a mixture of 95^2 an<* ^
After incubation the contents of each flask were immediately
chilled and the ovarian tissue, homogenised in the incubating
medium. The homogonates wero titrated to pH 11.0 with sodium
hydroxide, and the steroids extracted by the method of Dorrington
and Kilpatrick**, followed by the two-dimensional thin-layer
12
chromatography as described by Armstrong ot al . This resulted
in the isolation of the two major steroids produced by rabbit
ovaries under those conditions, progesterone and
20a - hydraxypregn - 4 - on - 3 - one. Those steroids were
olutod with methanol (1.5ml. followed by 1.0ml.) and
absorption at 240mu measured against an eluate of a blank area
of the plate, using a double-beam recording spectrophotometer.
Results
Ovarian steroidogenesis was consistently stimulated by the
mixture of gonadotropins, as shown by the increase in steroid
-3-
1
production by ovarian tissue incubated in the presence of
gonadotrophins over that incubated in control flasks containing
Krebs solution alone.
The effects of prostaglandins E^ and E? on steroidogenesis
in the presence of ponadotrophins are shown in Table 1 and 2.
There was no evidence that either prostaglandin E^ or E2 had
an inhibitory effect on steroidogenesis. However, in five
out of six experiments prostaglandin E2 caused a substantial
increase in the production of 20a - hydroxypregn - 4 - en - 3 - one
Discussion
The results of this preliminary investigation do not support
the hypothesis that either of the two prostaglandins
investigated inhibit the formation or action of cyclic 3', 5'-
A.M.P. in the rabbit ovary. The increased production of
20a - hydroxypregn - 4 - en - 3 - one. in the presence of
prostaglandin E2 may be due to a direct action of prostaglandin E2
on steroidogenesis or may reflect a potentiation of the effect
of the gonadotrophins.
Further experiments are in progress to investigate the
6
effects of different concentrations of prostaglandins on
ovarian steroidogenesis stimulated by pure ovine luteinizing
/ *
hormone and cyclic 3 > 5 - A.M.P.
h'o are grateful to Dr. D.A. van Dorp of Unilever Research
Laboratories, Vlaardingen, The Netherlands, for the
prostaglandin E. and Dr. J,E. Pike of the Upjohn Company, Kalamazoo,
Michigan, for supplies of prostaglandin E0. The Up.john Company
if
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Effects of orally administered prostaglandin E^ on gastric
secretion and gastro-intestinal motility in man
by
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Summary
The effects of prostaglandin E^ administered orally in doses
of 10 - 40 fig/kg have been studied in three human subjects. There
was no inhibition of pentagastrin-induced gastric secretion.
Following the higher doses of prostaglandin, gastric juice
contained large amounts of bile. Prostaglandin also increased
intestinal motility resulting in loose faeces.
1.
Introduction
Prostaglandins are fatty acids which have been found in
a wide variety of tissues (Bergstrom, 1967; Pickles, 1967) >
including human gastric mucosa (Bennett, Murray & Wyllie, 1968).
One member of this group, prostaglandin E^, has recently been
shown to inhibit the secretion of gastric juice in rats (Shaw, 1968;
Shaw fy Rnmwoll, 1968) and dogs (Robert, 1968; Robert, Nezamis &
Phillips, 1967). The investigation reported here was undertaken
in an attempt to extend these observations to man.
Methods
Collection of gastric juice
Three healthy male subjects aged 30, 31 and 38 and weighing
70, 60 and 80 Kg respectively, were fasted overnight for ten hours.
A 4" plastic stomach tube was passed via the nose into the stomach
at approximately 8.30 a.m. The subject then lay horizontally on
his left side throughout the remainder of the experiment. Blood
pressure in the right brachial artery and pulse rate were recorded
at 5 to 15 minute intervals.
Fasting gastric juice (sample ) was removed as completely
as possible and further samples were withdrawn 15 and 30 minutes
later (samples Fg and F^).
Two-fifths of the total dose of prostaglandin E. (or solvent
control) diluted in 25 ml water was then drunk by the subject.
Fifteen minutes later, residual fluid in the stomach was aspirated
2.
and one-fifth of the total prostaglandin dose dissolved in 5 ml
water Mas administered through the tube. Pentagastrin 6 ug/kg
was then injected subcutaneously. The stomach was emptied as
completely as possible at 15, 30, 45, 60 and 75 minutes after tl
injection. Two further doses, each amounting to one-fifth of tl
total dose, of prostaglandin dissolved in 5 ml water were
administered via the tube after the 15 and 30 minutes samples
were withdrawn. Each dose was washed in with 5 ml water. In tl
control experiments the same procedure was followed using the
solvent control.
Prostaglandin solution and solvent control
A stock solution (1 mg/ral) of prostaglandin E^, kindly
supplied by Professor D.A. van Dorp of the Unilever Research
Laboratories, Vlaardingen, was prepared by dissolving 9.5 mg in
1 ml othanol and making up the volume to 9.5 ml with water. A
solvent control was prepared by diluting 1 ml othanol to 9.5 ml
with water.
Estimation of total acidity
The volume of each sample was measured. The total acidit;
of each was measured by titration with N/2q sodium hydroxide
solution using phenolphthalein as indicator.
3.
Experiments to check the purity, toxicity and biological activity
of the prostaglandin used
Since the prostaglandin E^ used in this investigation had beer
subjected to extensive purification procedures before despatch,
elaborate tests of identification or purity were considered
unnecessary. An aliquot of the material was chroniatographed on
a plate of silica gel in Green and Samuelsson's AI solvent system
(Green & Snmuelsson, 1964). It behaved like a single substance
with an Rf value equal to that of a sample of authentic prostaglandd
V
A second aliquot of the prostaglandin E^ was tested for
biological activity and toxic effects in mice. Intravenous
injection of 5 and 10 mg/kg to three mice produced signs (sedation,
ptosis and moist faeces) which have been described previously with
lower doses of prostaglandin E^ (Holmes & Horton, 1968). There
wore no deaths. The higher dose in mice was 250 times greater
than the largest dose (40 ug/kg) administered (orally) to man in
this investigation.
.
Using the Ghosh & Schild (Ghosh & Schild, 1958) technique,
it was confirmed that this particular batch of prostaglandin
perfused through the stomach of a rat in a concentration of 6 pg/ml
caused up to 45?o inhibition of gastric acid secretion induced by
continuous intravenous infusion of pentagastrin 9 Ug/kg/hour.
Finally, the prostaglandin E^ was given to one subject to
detect unexpected toxic effects. The subject who had fasted
overnight was given prostaglandin (10 ug/kg) as a single dose
(total 0.8 mg) dissolved in 25 ml water. The only side effect
was the passing of loose faeces 2 hours after the prostaglandin
administration. Thereafter defaecation was normal and no change
in frequency was observed. The arterial blood pressure and heart
rate were unaffected.
Effects of nentagastrin on subjects dosed with the solvent control
The gastric secretory response to pentagastrin (6 ug/kg) was
detectable after 15 minutes but had passed its maximum by 45 minutes
The response lasted 60 to 75 minutes. Pentagastrin caused flushing
of the face, an effect which began 2 minutes after the injection
and subsided compotely within 15 minutes. This effect was reported
by the subjects and was usually apparent to the observer. In one
experiment vasodilatation of the skin was widespread over the body
and an unpleasant sensation of severe heat accompanied by sweating
was experienced.
Effect of prostaglandin E^ on gastric secretion in man
In four experiments prostaglandin was given orally in
doses of 10, 20, 25 and 40 ug/kg to three subjects. In none of
these experiments was there any detectable reduction in volume or
acid content of the gastric juice secreted in response to
pentagastrin compared with the controls (Table l). There may
even have been an increase in secretion following prostaglandin
administration. The pentagastrin-induced flushing was also of
similar intensity and duration in subjects who had received
prostaglandin to that observed in the control experiments. There
was no change in pulse rate or arterial blood pressure.
Effect of prostaglandin on the presence of bile in gastric
samples
In throe subjects treated with prostaglandin E. in doses of
I
20, 25 and 40 jig/kg, there wore largo amounts of bile in the samples
particularly those collected 30 and 45 minutes after pentagastrin.
In two subjects bile was detected in the gastric juice sample
collected 15 minutes after the administration of prostaglandin,
that is before the pentagastrin had been injected. In none of the
subjects was any bile observed in the gastric juice secreted in
response to pentagastrin, when prostaglandin had not been
administered.
Effect of prostaglandin E^ on Intestinal motility
In the five experiments in which prostaglandin was
administered, the passing of loose faeces was observed between 2
and 4 hours after administration. At the 40 ug/kg level the faeces
were completely liquid, but defaecation was subsequently normal.
From 1 hour after the prostaglandin administration until defaecation
occurred, sensations of increased intestinal motility wore felt.
There were sometimes mild colicky pains. In the control experiments
the faeces were unchanged and defaecation did not occur with any
regular time relationship to the administration of the test solution
Between experiments faeces were of normal consistency in all subject
and there was no change in normal frequency of defnecation.
Prostaglandin content of the gastric juice
The prostaglandin content of fasting gastric juice
(nine experiments) and juice secreted in response to pentagastrin
(four experiments) was estimated.
In four experiments in which prostaglandin E^ was administered
to the subjects, part of the dose was removed from the stomach at
each aspiration. The total amount of prostaglandin recovered
in this way is shown in Table 1.
No prostaglandin ( 1.5 ng equivalent/ml) could be detected
except in one fasting sample when activity equivalent to a
concentration of 7 ng prostaglandin Ej/ml was found. This was not
i
7.
positively identified as a prostaglandin.
Discussion
The results of this investigation show that prostaglandin E^
administered orally in man fails to inhibit gastric secretion in
doses which have effects on gastro-intestinal motility. Shaw and
Ramwell reported inhibition of pentagastrin-induced gastric
secretion in the rat with prostaglandin perfused through the
stomach at a rate of 0.5 to 1 jig/min (Shaw, 1968; Shaw fV Ramwoll,
1968). The conditions of the two investigations were different
and a direct comparison cannot be made. In the present study
prostaglandin was present in the stomach continuously for 1 hour
15 minutes before and 45 minutes after the pentagastrin injection.
In the four experiments reported here, concentrations of
prostaglandin in the omj>ty stomach wore at least 13» 22, 24 and
50 Ug/ral at the beginning of each 15 minute period. Our results
do not exclude the possibility that human gastric secretion might
have been inhibited if a higher dose of prostaglandin had been
used.
Prostaglandin E^ is released from the rat's stomach when
gastric secretion is stimulated (Shaw, 1968; Shaw & Ramwell, 1968).
It ha3 been suggested that the action of this released prostaglandi
8.
may bo to inhibit further actions of the secretagogue by a negative
feed-back mechanism (Shaw, 1968). We have been unable to obtain
convincing evidence in man for the presence of prostaglandin in
either fasting juice or in juice secreted in response to
pentagastrin. It is possible that any biologically-active
prostaglandins released could have been destroyed by the gastric
juice. This negative finding coupled with the failure of
prostaglandin E. to inhibit secretion does not support a role
for this compound in human gastric secretion similar to that
postulated for rats. Human gastric mucosa contains prostaglandin Ej
(Bennett, Murray Wyllie, 1968). It is possible that this
compound and not prostaglandin Eg would be effective in inhibiting
gastrin secretion in man. However, both prostaglandins are equally
active in dogs (Robert, 1968; Robert, Nezamis & Phillips, 1967).
The large quantities of bile in the aspirated gastric contents
after prostaglandin must have been due to a reflux of duodenal
contents; it is possible that prostaglandin E^ relaxes the
pyloric sphincter. Some evidence in support of this comes from
the observation that both prostaglandin E^ and prostaglandin E2
relax circular muscle of the human stomach in vitro (Bennett, Murray
& Wyllie, 1968). This side effect may be considered a disadvantage
if oral prostaglandin E^ wore to be used therapeutically.
9.
The purgative action of prostaglandin in man is similar to
that observed in mice following intravenous or subcutaneous
injection (Holmes & Horton, 1968), and may be due to a direct
stimulant action on intestinal smooth muscle as observed in vitro
(Horton & Main, 1963). Although the effects of prostaglandins on
human intestinal smooth muscle have not been reported, prostaglandins
E^ and E0 do contract longitudinal muscle of the human stomach in
vitro. Recently, patients with thyroid carcinoma have been shown to
have raised prostaglandin levels in the blood; all these patients
had diarrhoea (Williams, Karim & Sandler, 1968). Our observations
provide some evidence that prostaglandins may indeed by the causal
agents. Since prostaglandins have been identified in menstrual
fluid (Eglinton, Raphael, Smith, Hall & Pickles, 1963), they may
possibly account for the increased frequency of defaecation observed
at the beginning of menstruation (McCance & Pickles, I960). They
also should be borne in mind when considering the mechanism of
diarrhoea associated with other disorders.
Numerous side effects have previously been reported in man
following administration of prostaglandin Ej, by intravenous infusion,
(Bergstrom, Duner, Euler, Pemow & Sjovall, 1959; Carlson, 1967;
Bygdomnn, Kwon & Wiqvist, 1967). Those include cardiovascular effects,
headache and a feeling of oppression in the chest. None of these
symptoms nor any obvious cardiovascular change occurred in the
10.
present Investigation. Conversely, the increase In Intestinal
motility and diarrhoea observed in our experiments have not been
reported by previous groups. This may reflect a difference in
route of administration or the dose of prostaglandin which was
considerably higher in the present study.
The facial flushing after pentagastrin injection was a
consistent finding which may correspond to the sensation of skin
heat reported by others (Logan & Connell, 1966). It is of interest
that the flushing was not potentiated after prostaglandin
administration, since prostaglandin is a potent vasodilator
and itself caused facial flushing in ten out of thirteen cases on
intravenous infusion (Bergstrom, Dun^r, Eulor, Poraow & Sjovall,
1959; Carlson, 1967; Carlson, Irion & Oro, 1968).
andonintestinalmotility
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MR. CHAIRMAN, Ladies and Gentlemen. First let methank you Mr. Chairman for your introduction and for
explaining the purpose of this Lecture. My own concept of
an Inaugural Lecture is biased by undergraduate memories of rather
grand occasions when new professors addressed impressively large
and distinguished audiences on subjects which I could rarely under¬
stand. I do remember, however, on one of those occasions
contemplating what I would choose as my subject in the unlikely
event of my ever having to give such a Lecture. The title was to be
simply "What is Truth?". That was some years ago. When faced
with the reality of having to decide upon a title for to-day's lecture, I
felt unqualified to speak for an hour on such a philosophical topic.
Nonetheless, it is a subject to which I shall refer, because the
search for truth underlies all that University life stands for,—whether
at the undergraduate or postgraduate level. I hear a good deal
about teaching and research—referred to as if there were two
separate parts of University education—one sometimes suspects that
time and facilities for research are being offered as a kind of sugar
coating around the bitter and unpalatable pill of teaching. This
is a mis-conception of true University education.
I well remember the amazement, indeed dismay, that I experi¬
enced when as a Lecturer I received a circular from Senate House
addressed to "Teachers of the University". What kind of University
is this I thought that calls its academic staff teachers? Now I have
become accustomed to the term but it still evokes a mildly unpleasant
reaction.
The essence of University education is that the student does the
work; after all he is supposed to be reading for a degree. It's not
a question of the student absorbing as much factual knowledge as his
"teachers" can cram into him. All members of a University should
be studying and in that sense all are students, whether they be under¬
graduate, postgraduate or members of staff. All should have as
their aim the discovery and further understanding of the Truth.
A comment of my former professor, Sir John Gaddum springs
to mind and I should like here to pay tribute to him, because without
his interest, encouragement and inspiration I should certainly not be
in Pharmacology. It is indeed an honour to follow in his footsteps
as Professor of Pharmacology at this school. On the occasion I
refer to, Professor Gaddum was rather annoyed because I was
quibbling about the priority of some quite trivial discovery. He
told me "It doesn't matter who makes the discovery, all we're inter¬
ested in is the truth". This statement might profitably be posted
above the door of every University laboratory, whether the lab. be
3
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designated "teaching" or "research". Both should have as their
aim the search for truth.
But to pass on from the general to the particular case of pharma¬
cology. What is the function of a pharmacologist in a University?
What kind of truth does he look for. One of his functions is to study
the mode of action of drugs. But this immediately raises the
question "What is a drug?". The most appropriate definition I
know is familiar to many of you already, and I owe it to Professor
Feldberg who has defined a drug as a substance which when injected
into an animal gives rise to a scientific paper.
There is, however, a potentially infinite number of drugs for a
pharmacologist to study and equally a potentially infinite number
of biological preparations on which to test them. It follows that
some limitation must be imposed on the field of interest of any one
pharmacologist. One way is to study only drugs which are of
potential therapeutic or clinical interest, which in many fields
implies the further limitation that the drug must be active when
taken by mouth. Unfortunately the synthetic organic chemists are
so productive that to-day's drug of choice in the clinic may be
relegated to relative obscurity in a year or two's time.
Another limitation to one's field of interest is study of drugs
which are actually derived from animal tissues. This approach has
little risk of becoming outmoded. Whatever the organic chemist
may synthesize or the clinician prescribe, we can be sure that our
bodies (unless otherwise poisoned) will continue to produce the same
drugs for the remainder of our fives. The substances will still be
of interest because they are basic to the biological mechanisms of
animal cells and tissues. Furthermore in studying such drugs of
animal origin we may not only learn about their pharmacological
mode of action but in so doing may contribute to the further under¬
standing of the functioning of cells.
It is hardly surprising that so little is really known about how
drugs act, when one realizes how little is known about cell physiology.
But the pharmacologist with a more practical or applied outlook
may object. Opium was used for centuries before anyone knew
anything about the physiological or pathological mechanisms of
pain. Local anaesthetics were discovered without any knowledge of
the mechanism of nerve conduction. The extreme view is exempli¬
fied in the statement "It doesn't matter knowing how the drug works
so much as whether it does the job without causing ill effects".
Certainly if a pharmacologist's primary objective is to discover
drugs for the treatment of disease he cannot and should not wait
until the fundamental physiological and pathological processes
involved have been elucidated. Even if we understood these pro-
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cesses in their entirety, it does not necessarily follow that we would
be able to discover a new drug to fulfill every therapeutic need,
though it should certainly be easier to understand how such a drug
acted and to predict what side effects it would be likely to have.
But even though therapeutics and applied pharmacology cannot
be held up while advances in more basic sciences are made, it would
be foolish to ignore such advances or to pretend that they are
irrelevant. If the job of the academic pharmacologist is to study
the mode of action of drugs rather than to discover new ones, he
must also be vitally interested in the wider aspects of biology and
should contribute to such knowledge himself.
The study of drugs of animal origin in some measure may help
to achieve both objectives simultaneously. It is here that pharma¬
cology and physiology overlap. It is not inappropriate, I think,
that in the department of Pharmacology in this School which also
has responsibilities for Physiology and Biochemistry (not to mention
Anatomy and even it is rumoured Zoology) should be interested in
this field which has been called Autopharmacology.
Now how does the autopharmacologist go about his work? It
is not enough simply to accumulate more and more factual data
about a drug's pharmacological actions. One of a scientist's aims
is to discern a pattern amongst a mass of data. The pattern may be
obscured either by too many results or by an insufficiency, or most
likely of all because the scientist just cannot see what is there.
The most important advances in basic medical science have
resulted when a new pattern or concept has emerged and been sup¬
ported by experimental evidence. Obvious examples are the concept
of hormones and the concept of chemical transmission at nerve
endings. Both these fields have been and are still being extended.
In recent years we have had the discovery of new hormones such as
calcitonin, erythropoietin and the hormones of hypothalamic origin.
In the field of synaptic transmission, much progress has been made
on the nature of chemical mediators in the central nervous system.
It now seems fairly conclusive that acetylcholine, noradrenaline,
dopamine and 5-hydroxytryptamine have such a role. Other drugs
like substance P, gamma-aminobutyric acid and the prostaglandins
are like actors waiting for a part to be assigned to them.
In addition to hormones which reach their target organs via
the circulation, and chemical transmitters which are released by
nerve endings in close proximity to their site of action, there is a
miscellaneous group of substances which also interest autopharma-
cologists. These may be called local hormones, or perhaps better
autacoids. The group includes histamine, a local mediator of
gastric secretion and the triple response, and bradykinin, the most
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potent vasodilator substance of mammalian origin, which probably
accounts for functional hyperaemia in salivary and other glands and
may be a mediator of the inflammatory response.
To some extent histamine and bradykinin like 5-hydroxy-
tryptamine, substance P and now the prostaglandins have been sub¬
stances in search of a function. Knowledge of their pharma¬
cological actions did not lead immediately to an assignment of a
physiological role, possible physiology was lagging behind. In the
case of acetylcholine and the catecholamines, their pharmacological
actions imitated the effects of electrical stimulation of certain nerves
thus the physiological and pharmacological approaches fused lead¬
ing to the idea of chemical transmission. Such a fusion has not
occurred so dramatically with the local hormones.
The question may legitimately be asked whether it is not better
to study a physiological mechanism, and try to identify the active
principle which may be concerned in it, rather than to study the
pharmacological actions of an active principle extracted from a
tissue and then try to find (or even invent) a function for it. I
believe that both approaches are valid. If in the course of our
research we discover in tissues a new compound which has powerful
and new pharmacological actions it would be wrong to ignore it
simply because it did not immediately fit into any obvious
physiological niche.
Some of these points may be illustrated by recent developments
in a new series of compounds of animal origin, the prostaglandins,
which are currently attracting a good deal of attention (Bergstrom
& Samuelsson, 1965; Horton, 1965; Euler, 1966). I would apolo¬
gise for talking in such detail about my own interests but for two
reasons, first a friend gave me this advice when I said that I was a
little uncertain what to talk about in this lecture, she said "talk about
what you're interested in, after all they are not coming to hear you,
just to see what you are like"; and the second reason is that if I talk
about other drugs of animal origin there are bound to be people
here who know far more about the subject. The work on prosta¬
glandins illustrates some of the fascinations but also some of the
snags of starting with a drug rather than with a mechanism.
Prostaglandin like adrenaline, the posterior lobe hormones,
substance P and many other animal drugs was discovered by a
biologist making an extract of a tissue, and testing its activity on a
biological preparation. The discoverer of prostaglandin, Professor
U. S. von Euler was searching for a substance with a particular kind
of biological activity.
Yon Euler's work throughout the 1930's established that
prostaglandin was a hydroxy acidic lipid and thus differed chemically
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from all pharmacologically-active substances then known (see
Euler, 1966 for references).
It often happens in this field of autopharmacology, that a big
surge forward in research interest occurs when the isolation and
structural elucidation of a substance is announced. This happened
for example with the adrenal corticoids, bradykinin and angiotensin.
The chemical structure of prostaglandin was reported early in the
1960's by Professor Bergstrom and his co-workers at the Karolinska
Institute. Two prostaglandins were originally described, but soon
other prostaglandins were found and at least 14 of these compounds
are known, all with pharmacological activity Figs. 1 and 2 (Berg¬
strom & Samuelsson, 1965).
When the first of these substances became available for
investigation five years ago, little was known about the biological
actions of the prostaglandins except that they acted upon various
isolated smooth muscle preparations and that they caused a fall in
arterial blood pressure when injected into an animal. One could
hardly speculate very far about a physiological role on the basis of
such limited data, especially when it is further recalled that prosta¬
glandins at that stage were not known to occur in tissues other than
the male reproductive tract.
As more information about the prostaglandins has accumulated
attempts have been made to fit them into concepts with which we
are already familiar namely, that of a hormone, of a chemical trans¬
mitter at nerve endings or of a local hormone. In describing the
experiments which follow I should like to acknowledge the great
contribution made by my co-workers, Drs. Main, Thompson and
Holmes and more recently Drs. Davies and Withrington.
First are prostaglandins hormones? That is to say are they
substances released by one group of cells transported via the circula¬
tion to act upon another group of cells? The evidence clearly
indicates that they are, at least in humans. They are secreted in
large amounts by the seminal vesicular glands of the male
(Bygdeman & Samuelsson, 1966) and absorbed from the vagina of the
female in amounts sufficient to modify the tone of reproductive smooth
muscle (Horton, Main & Thompson, 1965; Sandberg, Ingelmann-
Sundberg & Ryden, 1967); the amounts required to produce effects
on the Fallopian tubes and uterus are minute—something like
10-150 ng prostaglandin Ej/kg/min (Bygdeman, Kwon & Wiquist,
1967). The approximate dose of prostaglandin administered by the
male at the time of coitus is about 10 gg/kg. It has in fact been
demonstrated that the amounts absorbed are sufficient to affect
intraluminal pressure in the tubes (Eliasson & Posse, 1965).
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Thus prostaglandins are an unusual kind of hormone produced
by the male but acting upon the reproductive tract of the female.
There is little doubt that this mechanism does occur in humans
under physiological conditions and it is thought that it may be
concerned with transport of sperm. Certainly there is some evidence
that low prostaglandin levels may be associated with infertility
(Hawkins & Labrum, 1961).
As work on the prostaglandins continued it became evident that
they were not confined to tissues of the reproductive tract. Dr.
Ambache (Ambache, Reynolds & Whiting, 1963) had shown that
brain contains a smooth muscle stimulating hydroxy unsaturated
fatty acid, and on the assumption that this might be a prostaglandin
we began to look for central nervous actions (Horton, 1964).
Evidence that prostaglandins have actions on the central
nervous system has now accumulated from work in several labora¬
tories. Dr. Main and I made some observations on unanaesthet-
ized chicks (Horton & Main, 1965). Fig. 3 illustrates the actions of
two prostaglandins, Ex which on intravenous injection produces a
sedative-like condition and F2a which caused contraction of the
extensor muscles of the body. The first effect appeared likely from
its nature to be a central action but the second has also been shown
to be so.
In the spinal decapitated chick the extension of the limbs in
response to prostaglandin F2a can be recorded by measuring tension
in the gastrocnemius muscle. When the muscle on one side was
denervated the intravenous F2a caused contraction of only the
innervated side. Both sides responded to decamethonium after
denervation. The action of F2a is not peripheral on the muscle and
there is other evidence that F2a does not produce this effect by stimu¬
lating afferent neurones. It is concluded that F2a acts upon
neurones within the spinal cord (Horton & Main, 1967). A direct
action on neurones has in fact been demonstrated by Avanzino,
Bradley & Wolstencroft (1966) by applying prostaglandin to single
nerve cells by micro-iontophoretic techniques.
Further evidence for an action on the spinal cord has come
from experiments on reflexes. In the spinal chick F2a potentiates
the crossed extensor reflex and the effect of this single dose (2 pg)
lasted 30 minutes or more. Similar effects with E: have been
observed in the spinal cat.
These observations have been confirmed by Duda and
McPherson at the Royal National Orthopaedic Hospital. In their
experiments on cats anaesthetized with chloralose, the prosta¬
glandins were injected close arterially to the spinal cord and their
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measured. In a dose of 50 jag Fla produced a 2-3 fold potentiation
of the reflex which lasted more than 4 hours. In contrast prosta¬
glandin Ex (50 pg.) inhibited the monosynaptic reflex.
I think that the potency of the prostaglandin as centrally
acting substances should be emphasised. In spinal chicks doses for
threshold effects on spinal reflexes were of the same order as those of
strychnine. What is more, (though this may not apply to the chick)
on intravenous injection very little prostaglandin E: ever reaches the
central nervous system. In mice in which Ex certainly has central
actions, autoradiographic studies show that little or no prosta¬
glandin reaches the brain or spinal cord (Hansson & Samuelsson,
1965). It was found chiefly in the liver, the kidneys and connective
tissue.
Although prostaglandins have powerful central actions they
could not be transmitters unless they are present in the central
nervous system and unless they are synthesized there. It has in fact
been demonstrated conclusively that prostaglandins do occur
naturally in the brains of the species we have been using for the
pharmacological experiments Table 1, and they have also been iso¬
lated from dog and chicken spinal cord (Horton & Main, 1966;
Holmes & Horton, 1967).
Van Dorp (1966) has reported that the brain contains the
enzyme responsible for synthesizing prostaglandins from the
essential fatty acids as shown in Fig. 4, starting with linoleic acid, a
normal constituent of the diet. You will note that the four prosta¬
glandins which occur in dog brain have separate biosynthetic path¬
ways.
If prostaglandins are transmitters it might be expected that they
would be released in response to neuronal firing. In fact prosta¬
glandin release occurs spontaneously into the subarachnoid space
(Ramwell & Shaw, 1963; Coceani & Wolfe, 1965) and cerebral
ventricles (Feldberg & Myers, 1966) from many regions of the brain,
and an increase on nerve stimulation has been reported by Ramwell
& Shaw (1963). There is no evidence however that the prostaglandin
originates pre-synaptically rather than post-synaptically.
The usually accepted view is that a chemical transmitter must be
inactivated rapidly following its release. Enzyme systems which
metabolise prostaglandins by the pathways shown in Fig. 5 have
been described (Anggard & Samuelsson, 1965; Samuelsson, 1965)
but so far these enzymes have not been looked for in the central
nervous system. It is worth noting however that these two meta¬
bolites retain some pharmacological activity on various preparations
9
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(Anggard, 1966). Information about their central nervous actions is
not yet available but would be particularly relevant.
If prostaglandins were transmitters, their concentration would
be highest in areas rich in prostaglandinergic (or prostanergic)
neurones. It might be expected by analogy with other transmitters
that these would not be evenly distributed throughout the central
nervous system. For example noradrenaline and 5-hydroxytrypt-
amine are concentrated in the hypothalamus and dopamine in the
striatum. Recent work in the department here shows that in the dog
four different prostaglandins are distributed fairly evenly through¬
out the various regions of the central nervous system (Holmes &
Horton, 1967). We feel that this is evidence against a transmitter
role but more information is required. Subcellular fractionation
may help to solve this problem and such investigations are in
progress.
Whether or not prostaglandins are transmitters in the central
nervous system, their role in other tissues is still unexplained.
Their widespread distribution (Table 2) is parallelled by a wide
variety of pharmacological actions (Horton, 1965; Euler, 1966) and
a release from many tissues in response to stimulation of nerves or to
drugs on hormones (Table 3).
If the sympathetic nerves to adispose tissue are stimulated
prostaglandin Ex is released (Shaw, 1966), similarly if the splenic
nerves are stimulated prostaglandin E2 is released into the blood
stream (Davies, Horton & Withrington, 1967).
Now it is well established that the mediator at sympathetic
nerve endings is noradrenaline, and there is no question of prosta¬
glandins usurping that function. When injected to the arterial
supply to adipose tissue or the spleen, prostaglandins do not mimic
the effects of nerve stimulation as noradrenaline does. In fact in
adipose tissue they have the opposite action and inhibit noradrena-
line-induced lipolysis (Steinberg, Vaughan, Nestel, Strand &
Bergstrom, 1964; Bergstrom, Carlson & Oro, 1964). This then
raises the question of whether such prostaglandin release could be
functionally concerned with limiting the action of the transmitter.
This idea of prostaglandins as modulators has been put forward by
several groups of workers to explain the antagonism between prosta¬
glandins and catecholamines at various sites, and between prosta¬
glandins and vasopressin on the renal tubule (Orloff & Grantham,
1967).
Fig. 6 illustrates some of these antagonist actions of prosta¬
glandin Ex. It had been reported that Ex was a potent adrenaline
inhibitor (Steinberg, Vaughan, Nestel & Bergstrom, 1963) and our
object was to investigate whether such antagonism was specific or
10
DRUGS OF ANIMAL ORIGIN
non-specific (Holmes, Horton & Main, 1963). The figure shows
that it is a non-specific antagonism since effects of vasopressin were
antagonized. In other tissues for example the guinea-pig uterus
prostaglandins potentiate the action of vasopressin (Clegg, Hall &
Pickles, 1966) and on the rabbit tracheal muscle the inhibitory
action of adrenaline is potentiated (Clegg, 1966).
Thus there are interesting interactions between the prosta¬
glandins and other drugs of animal origin, and it is possible that this
is how prostaglandins function within the central nervous system by
modifying the action of transmitters rather than being transmitters
themselves.
It is likely that we are still far from an understanding of the mode
of action and functional significance of the prostaglandins. Certain
key pieces of information are needed and certain tools or methods
could greatly help in solving some of the outstanding problems. We
need to know for example in more detail how prostaglandins produce
their effect on neurones—what is the effect on the membrane
potential, ionic transport etc. We need to know where in cells
prostaglandins are stored and whether this is near to the site of
formation. There are many puzzling species differences in response
to prostaglandins so that it is dangerous to generalize from animal to
another. There is also the danger of talking about prostaglandin as
if it was one substance instead of a group of at least 14 not to mention
many precursors and metabolites, observations with one substance
need not to extend to another. Perhaps our greatest need of all is
for specific antagonists for the different prostaglandins and I have
little doubt that it will not be long before such compounds are
synthesized. These together with drugs which would inhibit
specifically the enzyme systems concerned in the biosynthesis,
release, uptake and metabolism of the prostaglandins would be of
enormous help as tools in the elucidation of the mode of action and
significance of these substances.
But there is more to hope for than this. Despite my apparent
devotion to truth for the sake of truth, almost, it would seem, to the
exclusion of searching for anything that might be useful, we must I
think be ever on the look out for possible clinical applications.
Experimental medicine and pathology are not far removed from
physiology and pharmacology and it may well be, for example, that
abnormalities in prostaglandin metabolism could account for certain
disease states. The possibility must always be kept in mind.
Prostaglandins may not themselves have a therapeutic application
but a search for substances which interfere with the biological
mechanisims which I have described should prove a rewarding field
for anyone interested in breaking into fresh ground from the point
11
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of view of applied pharmacology. Such research may even enable
us to understand the mode of action of some drugs already known.
That is the position with regard to my current interests in
pharmacology. I like to use drugs of animal origin (at the moment
it happens to be the prostaglandins) as tools; first for investigating
physiological or pathological mechanisms, secondly for the study
of their mode of action and last as a means of searching for new drugs
which may have pharmacological activity by acting upon some path¬
way in the physiological system being considered. Such drugs
would at the very least be of great importance as further tools for
research, but a therapeutic application is something which I would
personally also welcome. Such an application would come as an
unexpected and undeserved bonus because this at present is not the
primary aim of my research.
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THE PROSTAG LAN DIN S
Prostaglandin was the name given by von Euler (1935a)
to a smooth muscle stimulating lipid of unknown structure, which
he discovered in human seminal plasma. Substances with similar
biological activity were found in the seminal plasma of sheep
and extracts of prostate and vesicular glands (Euler, 1939).
In 1957 Bergstrom and Sjovall (see Bergstrom, 1996) reported
the isolation of two prostaglandins and later their full chemical
, t» M
structures were announced (Bergstrom, Ryhage, Samuelsson & Sjovall,
A993; see Bergstrom, 1966 for full list of references). Since
then many other naturally occurring prostaglandins have been
identified. Thus the word 'prostaglandin' is no longer used to
refer to a^ single substance, but is a generic term for a family
of closely related compounds, all derivatives of prostanoic acid
(Bergstrom & Samuelsson, 196-5) (Fig. 1).
A mixture of prostaglandins probably accounts for some or
all of the biological activity of several previously unidentified
lipids, namely darmstoff (Vogt, 1949; Vogt, Suzuki & Babilli,
1966), the menstrual stimulants (Pickles, 1957; Eglinton, Raphael,
Smith, Hall & Pickles, 1963), irin (Ambache, 1957, 1959; Ambache,
reynolds & Whiting, 1963), vesiglandin (Euler, 1935b) and medullin
(Lee, Covino, Takman & Smith, 1965).
2.
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In 1929 Burr and Burr demonstrated that certain unsaturated
long chain fatty acids, such as linoleic acid, are essential
constituents of the diet (Burr & Burr, 1929). Linoleic acid is
converted by a three-stage reaction (Fig. 1) to arachidonic acid
in animal tissues and these products of linoleic acid metabolism
can substitute for it in the diet. Until I964 there was little
indication as to the physiological role of these essential fatty
acids. Then the essential fatty acid field was linked to the
fundamental to most if not all animal cells
(Bergstrom & Samuelsson, 1965; Samuelsson, 1965a, b). Table 1
was made; there is good& but less complete evidence based upon
chromatographic behaviour and biological properties that other
%
tissues and tissue fluids contain prostaglandins. These findings
in
prostaglandin field by the important discovery that prostaglandins
are synthesized in tissues from ai^achidonic acid and its precursor
tr
di-homo-y-linolenic acid (Bergstrom, Danielsson & Samuelsson, 1964;
Dorp, Beerthuis, Nugteren & Vonkeman, 1964).
In parallel with these chemical and biochemical advances
tl
it has been shown that prostaglandins have a wide variety of
pharmacological actions and that they are released from various
*
tissues in response to nerve or chemical stimulation. It seems
fl-Uke ly that these compounds have a biochemical role which is
ifS;
Isolation and Identification of Prostaglandins in Animal Tissues
KsS
The isolation of prostaglandins from animal tissues (Table 1)
and the elucidation of their chemical structure have been reviewed f
gf
refers only to those organs where a full chemical identification
Si-
TABLE 1_
Animal tissues from which prostaglandins have
been isolated and identified chemically
. Prostaglandin

















An asterisk denotes (hat the prostaglandin has been isolated from that iissije,
Human semen also contains prostaglandins A|, Aj, It and It and the lour cot re¬
sponding lu-hydioxy-prostaglandins (sec t able .1) and pig kidney also contains A;
(l.ee (7 it/., |9o5). (Data from Beigstrdm A Samuolsson, 1965.)
TABLE 2
Conversion (per cent) of di-homo~Y-linolenic acid into
prostaglandin E^ by particulate enzyme fractions from
different organs (incubation with 25 ug. C20-3 and
150 tig. GS1I/10 mg. protein for 15 min. at 30°C.)
Sheep
t '—-i Guincapig Rat
Organ 9 9 O
Genital system 70 0-37 004 0-38
Intestines 2-8 1-9 ()■ 18 000
Lung 0 34 •006 000
Thymus 0-26 — —
Liver 003 0-23 002
Kidney 001 017 002
Heart 0-05 .— \ —!
Pancreas 00 1 —
Brain — 003
(T>at;i from van Dorp, 1966,)
3.
are described under the appropriate biological system.
The extraction of prostaglandins from tissues
Since prostaglandins are fatty acids they can be extracted
by partition between a suitable organic solvent (diethyl ether or
ethyl acetate) and water. At pH 4 or less, the prostaglandins
are almost entirely in the non-ionized form and are more soluble
in the organic phase. At pll 8 or more, they are ionized and
remain in aqueous solution. This property provides a convenient
method for separating prostaglandins as a group (together with
other organic acids) from other lipids and most other known
biologically-active substances (Samuelsson, 1964a; Horton & Main,
1967c).
By further partition between 67% aqueous ethanol and
petroleum, prostaglandins can be separated from organic acids
1
lacking hydroxyl groups for example arachidon.ic acid.
Various chromatographic procedures for separation of the
individual prostaglandins have been described. Partition
•
/ ;,.y. 1
chromatography on columns of silicic acid and reversed phase
chromatography have been used extensively. Green & Samuelsson,
(1964) have described several solvent systems for thin laver
$
chromatography, a particularly useful method in this field.
Identification of Prostaglandins
The complete structural elucidation of the different
v.5r '
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prostaglandins lias been achieved using classical and modern
analytical techniques (see Bergstrom & Samuelsson, 1965, for
references). In many instances the amounts of prostaglandin
present in a tissue extract are too small to permit such
extensive analysis. It may then be permissible to base the
identification upon chromatographic behaviour and parallel
quantitative biological assays. Such techniques are only of
use if the substance to be identified has already been isolated,
its structure is known and it is available in pure form. Even
then only negative evidence can be conclusive, a positive
identification is never certain though it may be extremely
probable depending upon the amounts and kind of evidence obtained
(see Horton b Main, 1967c, for a fuller discussion of this problem).
Estimation of Prostaglandins
The most sensitive preparations for the biological assay of
the prostaglandins E are the rat fundus, guinea-pig ileum and
guinea-pig uterus. The rat fundus, rabbit jejunum and rat uterus
are the tissues most sensitive to prostaglandins F. Other
preparations which have been used include the colon of the jird,
hamster, rat and guinea-pig, the cat trachea (which is relaxed by
prostaglandins) and human myometrium. Little information is yet
available about suitable assay preparations for the prostaglandins
A and B and their 19-hydroxy derivatives.
A chemical method has been devised for the estimation of the
5.
prostaglandins E which are first oxidized to their 15-oxo
derivative by an enzyme in swine lung and then dehydrated to
8 12
the A form with alkali. The chromophore consisting of two
oxo groups and two double bonds can be used for absorptiometric
estimation (Anggard & Samuelsson, 1966).
Gas liquid chromatography offers the most likely solution
to the problem of estimating prostaglandins and their various
metabolites. So far the prostaglandins E 1b ve been estimated as
methyl esters after dehydration to the corresponding B compound,
while prostaglandins F have been estimated as trimethylsilyl
derivatives also as methyl esters (Bygdeman, Hamberg & Samuelsson,
1966). Using flame ionization detectors the sensitivity is of
the order of 50 ng; but it is hoped, by analogy with work in the
steroid field, to increase this sensitivity many fold by preparing
halogenated derivatives and using an electron capture detector.
Concentrations of Prostaglandins in Tissues
In only a relatively few instances has the concentration of
prostaglandin in a tissue been reported. In most cases the workers
were concerned primarily in identifying the compound* Exceptions
to this are human seminal plasma (see Table 3) and ox brain where
a concentration of 300 ng. prostaglandin 6issue has been
reported (Samuelsson, 1964a).
TABLE ,1
Concentrations of prostaglandins in human seminal
fluid and their threshold concentrations for
actions on human myometrium in vitro
Threshold concentration
(gg./ml,)
Effect on . <—-—— —r —
(i.p./ntl. semen myometrium Non-prcgnaut Pregnant
Ei 25 ]
l;j 21 51*5 Inhibition 0-01-0*1 0*03-0-3
E, 5*5 J
E|<* 3*6 (_ ^ Stimulation 0*3-0*5 001-0 03
1 :•« 4*4 I
;vi about 50 Inhibition 0*3-1*0
)9hydroxy A| ]
|0 hydroxy Aj j
I1) hydroxy Ht f
I1) hydroxy It J
Hi
B,
i v ( [drout 200 Inhibition 1*0 3*019 It
(I ioru Hygdeman, Hambcrg <St Samuclsson, l%6.)
TABLE 4
Actions of prostaglandins on human Fallopian tubes in vitro








E= excitatory action; I™inhibitory action, (Sandberg, Ingelman-Sundberg &
Rydcn, 1963, 1964, 1965.)
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Metabolism of Essential Fatty Acids and Prostaglandins
The metabolic pathways from linoleic acid and linolenic
acid to the prostaglandins and their metabolites are illustrated
in Figs. 1 and 2. It should be emphasized that prostaglandins E
and F are formed by different routes and that there is no known
interconversion between a prostaglandin E and a prostaglandin F
(Samuelsson, 1967). The enzyme systems for prostaglandin
biosynthesis are widely distributed (Table 2) but are present
in largest amounts in sheep vesicular gland homogenates.
An enzyme system in guinea-pig lung homogenates metabolizes
prostaglandins E first by the reduction of the 13 double bond
followed by oxidation of the 15 hydroxyl (Fig. 1) (Anggard &
Samuelsson, 1964a; Anggard, Green & Samuelsson, 1965). Pig lung
contains an enzyme, 15-hydroxy-prostaglandin dehydrogenase, which
oxidizes the 15 hydroxyl without previous reduction of the double
bond and which is highly specific for 15-hydroxy-prostaglandins
(Anggard &1 Samuelsson, 1966). Prostaglandins F are metabolized
with the loss of a two carbon fragment (Granstrom, Inger &
Samuelsson, 1965). Data on the further steps in the metabolic
pathways are not yet available, nor has it been reported which
other tissues contain the metabolizing enzymes.
Distribution and fate of in.iected Prostaglandin E^
Autoradiographic studies of the distribution of tritium-
labelled prostaglandin after intravenous injection in mice
showed high concentrations of radioactivity in the liver, kidney,
subcutaneous connective tissue, blood and uterine muscle during
the first 30 min. after injection. After 1 hour, the highest
concentrations were in the liver, bile, intestines, kidney and
urinary bladder. Some radioactivity was detected in lung,
pancreas and salivary glands, but little or none could be seen in
the central nervous system (except the choroid plexus), adipose
tissue, endocrine glands, heart, blood vessels, organs of the male
reproductive tract or the ret.iculo-endothelial system. In the
intestine the highest concentrations were in the lumen and in
the connective tissue; there was none in the smooth muscle.
There was also a high concentration in the thoracic duct (Hansson
& Samuelsson, 1965; Samuelsson, 1966a).
On intravenous infusion of labelled E^ in rats 50^ of the
radioactivity was excreted in the urine over a period of 20 hours.
About one fifth of the dose was recovered either from the faeces
or from a cannulated bile duct. After a subcutaneous injection of
labelled E^ in female rats, the highest concentrations of radio¬
activity were found in the kidneys and liver and considerably less
in the lungs which nevertheless contained a higher concentration
than other tissues. The maximal activity in the lungs was reached
5 to 10 min. after injection somewhat earlier than the peak in
liver and kidneys. The adrenals, pituitary and heart were similar
to the lungs in this respect. As in the mouse experiments little
or no 'radioactivity could be found in brain, skeletal muscle, adipose
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tissue or thymus (Samuelsson, 1964b), There is evidence that in
the urine, liver and kidney the labelled compound is a more polar
derivative of prostaglandin E^.
Similarly in male and female sheep very high concentrations
of tritium were found in liver and kidney following injection of
labelled E^. Relatively high concentrations were also found in
the reproductive tract of both sexes, the lungs, adrenals and
pituitary (Samuelsson, 1965a).
Pharmacological actions of Prostaglandins
Reproductive Tract
In 1930 Kurzrok and Lieb reported that strips of myometrium
taken from fertile women relaxed in the presence of human semen
but that similar strips from infertile women contracted. On the
basis of these experiments they classified uteri as either
receptive (fertile) or rejective (infertile) (Kurzrok & Lieb, 193<
It now seems likely that the active principle concerned was a
mixture of prostaglandins, since 13 of these compounds have been
isolated from human seminal plasma, (Table 3), and since numerous
in vitro studies indicate that prostaglandins act upon the smooth
muscle of both human uterus and Fallopian tubes (Table 3 and 4).
The nature of the response depends upon the particular prostaglam
and to some extent upon the hormonal status of the preparation
(Bygdeman, I964).
It has been shown that prostaglandins also act upon female
reproductive smooth muscle in vivo thus accounting for the known
stimulant action of seminal plasma when introduced into the uterus
(Cockrill, Miller & Kurzrok, 1935; Karlson, 1959). In pregnant
women intravenous infusions of prostaglandin at a rate of
0.6 pg/min. or more increased the amplitude and frequency of
contractions (Bygdeman, Kwon & Wiqvist, 1967). Similarly, in
Rubintest (tubal insufflation) performed at mid-cycle, prosta¬
glandin administered intravaginally increased the resistance to
insufflation of the tubes (Eliasson b Posse, 1965). In these
experiments the prostaglandins must have been absorbed from the
vagina into the circulation; evidence that such absorption can
occur was first obtained in rabbits (Asplund, 1947; Horton, Main
& Thompson, 1965) and then in non-pregnant women using tritium-
labelled prostaglandin E^ (Sandberg, Ingelman-Sundberg & Ryden,
1967).
It now seems certain that following normal coitus prosta¬
glandins originating from seminal plasma are absorbed from the
vagina in amounts sufficient to affect smooth muscle tone in the
female reproductive tract. The physiological significance of
this hormonal mechanism is unknown though it may be concerned with
either sperm transport or retention of the ovum within the
Fallopian tube until fertilization has taken place. Certainly
there is a suggestion that in some infertile males seminal
10.
prostaglandin levels are lower than normal (Hawkins b Labrum, 1961;
Bygdeman, Hamberg b Samuelsson, 1966).
The isolation and identification of prostaglandins and
^2o, ^rom I1""1311 menstrual fluid and endometrium (Eglinton, Smith,
Raphael, Hall & Pickles, 1963) coupled with the known action of
these substances on the myometrium has raised the question of
whether they may be implicated in dysmenorrhea (Pickles, Hall,
&
Best & Smith, 1965). There is evidence that prostaglandin-like
substances are relased into the circulation during menstruation
and these may account for the associated increase in gastro¬
intestinal motility.
Prostaglandins have been identified in human amniotic fluid
(Karim, 1966) and umbilical cord vessels (Karim, 1967). A possible
mechanism for termination of pregnancy by their oxytocic actions
can be envisaged. It may also be relevant that 'prostaglandin'
constricts placental vessels (Euler, 1938).
Actions of prostaglandins on the reproductive tract smooth
muscle of other species have been reported (Tables 5 and 6). In
some cases the isolated tissue has proved useful for the biological
estimation of prostaglandins, and some preparations have been used
for the study of the mode of action of prostaglandins on smooth
muscle and their interaction with other hormones and inorganic ions
For example in addition to a direct stimulant action on the guinea-
pig isolated uterus the prostaglandins E enhance the contractions
TABLE
Actions of prostaglandin on female reproductive
tract smooth muscle of various species
III villi' III vivo
(ng./ini.) (p.g./kg.) Reference
Rot utcruH F. (10-100) Hergstrdm, liiasson,
Fuler Si Sjovall, 195'';
i I lorton & M'lii)', l'%3;
Sullivan, 1966
< iuineu-pig uterus ' (0-5-70) F(l) Rergstrtim vt«/., 195');
Sullivan, I960; Uerti
Nuim/uda, 1965
Rabbit .uterus I (•10(1) 1(2) Rergslrdm ct <il., 19.59;
I lortoil <7 ill., 1965
Rabbit cervix 1(2) I lotion <7 til., 1965
Kabbil oviduct 1(50) 1(0 03) I lorton & Main, 1963;
I lorton el til., 1965
Sheep oviduct F or I (2'5-800) E or I (0-4-2*5) Morton <7 a!., 1965
I excitatory action; 1 inhibitory action. Figures in parentheses refer to approxi¬
mate threshold'concentrations (ng./nil.) or doses (Rg./kg.)
TABLE 6
Biological activities of different prostaglandins
and analogues in stimulating rat and guinea-pig






15-oxo Ft —_ 3
15-oxo-dihydro F, — 6
nor f.| too 1
F,« too 3
F i(i 4 0-
r jot 700
Di-homo-y-linolcnic acid 6 ' -
Arachidonic acid 3
(Data front Morton Main, 1966; AnggArd, 1966; Ciekles, 1967.)
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produced by other oxytocic substances added subsequently or by
electrical stimulation (Clegg, Hall & Pickles, 1966; Sullivan,
1966), This enhancement does not occur with prostaglandinsF nor
on the rat uterus (Pickles, Hall, Clegg & Sullivan, 1966) and
the enhancement unlike the direct stimulation is unaffected by
changes in calcium and magnesium ion concentrations. It has also
been shown that unlike human myometrium the hormonal status of
the uterus of rat and guinea-pig does not affect their sensitivity
to prostaglandins (Sullivan, 1966). The oviduct of the rabbit is
inhibited by prostaglandin (Horton et al. , 1965)jfurthermore
contractions of this preparation in response to adrenaline are
inhibited. Similar inhibition of adrenaline-induced smooth
muscle contractions has been reported with rabbit vas deferens
(Holmes, Horton & Main, 1963) but contractions of guinea-pig
seminal vesicles are enhanced (Eliasson & Risley, 1966).
Cardiovascular System
The effect of prostaglandins on the cardiovascular system
varies with the particular prostaglandin and with the species
being studied. For example, prostaglandin E^ injected intravenous!
lowers the systemic arterial blood pressure in all species so far
investigated whereas prostaglandin F^^ raises the blood pressure
in the dog, rat and spinal chick (Horton & Main, 1967a; du Charme
& Weeks, 1967) but lowers it in the cat and rabbit (Anggard &
Bergstrom, 1963).
The fall in arterial blood pressure may be due partly to
vasodilatation, since prostaglandins dilate blood vessels in
•• O
skeletal muscle and skin (Anggard b Bergstrom, 1963; Horton, 1963;
Horton b Main, 1963, 1965b), and prostaglandin E. also antagonizes
the vasoconstrictor action of the catecholamines, vasopressin and
angiotensin (Holmes et al., 1963). In the blood-perfused rabbit am
cat lung preparation prostaglandin E^ has a vasodilator potency
about equal to that of adrenaline, but unlike adrenaline the
effect is neither abolished nor reversed by propanolol and is
unaffected by phentolamine (Hauge, Lunde b Waaler, 1967).
The pressor action of in the dog and the rat is thought
to be due to a venoconstrictor action, and is dependent upon an
intact sympathetic nerve supply to the veins (du Charme b Weeks,
1967). The increased venous return increases cardiac output
thus accounting for the rise in arterial blood pressure. The
mechanism of the pressor action of F2a in the spinal chick is
unknown but the response is not blocked by hexamethonium,
phenoxybenzamine or pronethalol (Horton b Main, 1967a).
Blood pressure responses to prostaglandins cannot be accounti
for satisfactorily by their actions on the heart. E^ injected
intravenously produces tachycardia in humans, dogs and cats wherea
F2a causes bradycardia in the cat but has no effect on heart rate
in the rabbit. The tachycardia in dogs is abolished by ganglionic
blockade or reserpine (Carlson, 1966). Both and increase
cardiac output in the dog but reduces cardiac output in man
it
and the rat (Bergstrom, Duner, Euler, Pernow h Sjovall, 1959;
Weeks & Wingerson, I964).
The responses of the Langendorff perfused hear t to
prostaglandins has been studied in various species. The force of
contraction and rate of the guinea-pig heart is increased by E^,
and effect which is even more striking if the calcium concentration
of the perfusing fluid is halved (Berti, Lentati &1 Usardi, 196 5;
Mantegazza, 1965). These effects are not abolished by adrenaline 3
receptor blockade. The force of contraction of the rat isolated
heart is increased by but less markedly by E^, which has a
powerful coronary vasodilator action (Vergroesen, de Boer &
Gottenbos, 1967). There is a similar increase in the force of
contraction of the perfused frog heart in response to E^, an
effect which resembles that of calcium. It is of interest that
cardiac phosphorylase in vitro is activated by E^ (Piccinini, 1965)
Prostaglandins E„, F. and A. have potent actions in reducing
« 101 I
blood pressure in renal hypertensive dogs (Muirhead, Daniels, Pike
& Hinman, 1967) and in human hypertension (Lee, Myler, Covino,
Smith & Kocot, 1967). Since prostaglandins E^ and A^ occur in the
kidney (lee et al,, 1965), the possibility of a hormonal role in
controlling blood pressure must be considered.
Adipose Tissue
Prostaglandin E^ in concentrations of 20 ng./ml or more
inhibits the release of glycerol and free fatty acids from rat
epididymal fat pads incubated in vitro, whether the release is
basal or following the addition to the medium of noradrenaline,
adrenaline, corticotrophin, glucagon or thyroid stimulating
hormone (Steinberg, Vaughan, Nestel & Bergstrom, 196,3). Similar
results have been obtained in vj tro with human subcutaneous fat
(Bergstrom & Carlson, 1965).
In anaesthetized dogs intravenous injections and infusions
of E^ in low dosage raise, but in higher doses lower, plasma free
fatty acid levels induced by the administration of adrenaline or
noradrenaline (Bergstrom, Carlson & Oro, 1965, 1966a,b; Carlson,
1966; Steinberg, Vaughan, Nestel, Strand &• Bergstrom, 1964). In
healthy male volunteers infusions increased plasma-free fatty
acids and glycerol levels (Bergstrom, Carlson, Ekelund &■ Oro,
1965a,b; Carlson, 1966), higher doses could not be tested owing
to the side-effects of infusion in man.
There is evidence that the action of E^ on lipolysis is due
to changes in cyclic AMP concentration (Butcher, Pike & Sutherland,
1967; Paoletti, Lentati, Korlkiewicz, Puglisi & Solyom, 1967;
Steinberg & Vaughan, 1967).
Since stimulation of the adrenergic nerves to adipose tissue
results in the release of prostaglandins in amounts sufficient to
inhibit the lipolytic actions of noradrenaline, the possibility
that prostaglandin acts by a local negative feed-back mechanism
15.
has been suggested (Shaw, 1966, 1967).
Nervous System
Prostaglandins have several sites of action on the central
nervous system (Tables 7 and 8). Injections of E^, and
(10 to 60 fig.) into the cerebral ventricles of unanaesthetized
cats are followed after a latent period of 20 min. or more by
signs of sedation, stupor and catatonia (Horton, 1964). The
stupor lasts for several hours and the cat shows diminished
spontaneous activity and lack of interest in its surroundings
for up to 48 hours after the injection. During the catatonic
phase which is maximal between 1 and 4 hours after the injection,
the animal can be placed in bizarre postures which are maintained
unchanged for periods up to 90 min. When the cat is placed on
its side, a forelimb can be flexed so that the paw rests behind
the neck or upper thorax - such a position may be retained for
several minutes without interference by the observer. On the
other hand, the righting reflex is always present and when the
cat is disturbed its movements are brisk showing no evidence of
ataxia. These responses to intraventricular injection of E^ have
been observed in 14 cats (6 male and 8 female). In marked
contrast, F^ produced no detectable changes in four cats following
injections into the cerebral ventricles in doses equal to or higher
than those of E^ necessary to produce catatonia in the same animals.




Central nervous actions of prostaglandins in the cat














Spinal section at C2, Intravenous
brain destroyed
Ej, Fi* 1. Potentiation of decerebrate regidity
2, Contraction of gastrocnemius muscle
Ei, E-, F2-. Excitation or inhibition of medullary reticulo¬
spinal neurones (see Table 9)
E\ 1. Contraction of gastrocnemius muscle, not
abolished by acute dorsal root section
2. Potentiation of crossed extensor reflex
3. No effect on patellar reflex
Horton, 1964
Horton & Main, 1965a
Horton & Main, 1967a
Avanzino, Bradley &
Wolstencroft, 1966









1. Abolition of tremor
2. Reduction in gastrocnemius muscle tension
No effect on tremor
No effect on tremor
Horton & Main, 1967b
Intact Intra-aortic
lontophoretic
E, Inhibition of spinal mono-synaptic reflexes
Potentiation of spinal mono-synaptic reflexes












None Intact Intravenous Et, E2, Ej Sedation. Loss of righting
reflex
F|«, I72« Contraction of extensor
muscles
None Spinal section Intravenous F-,*
at C4,
decapitated
1. Contraction of gastro¬
cnemius muscle
2. Potentiation of crossed ,
extensor reflex
E, Potentiation of crossed
extensor reflex
Chloralose intact Intravenous F2a 1. Contraction of gastro¬
cnemius muscle
2. Potentiation of crossed
extensor reflex
E, Inhibition of crossed
extensor rellcx
t Irethane Intact Intravenous |'2a 1. Contraction of gastro¬
cnemius muscle





(Data from Horton, 1964; Horton & Main, l1965a; 1966,1967a, 1967b.)
16 .
and arachidonic acid are also inactive (Horton & Main, 1965a,
1966) .
Intravenous injection of E. (20 pg./kg.) in unanaesthetized
cats produces transient sedation. A decrease in spontaneous
activity of mice lasting about 60 min. is observed following
intravenous or subcutaneous injections (Horton, 1965). In the
young chick which is believed to lack a blood-brain barrier
prostaglandins are particularly active on the central nervous
system (Table 8). E^, E£ and E^ in doses of 25 pg./kg. injected
intravenously cause sedation with cessation of spontaneous
movements, closure of the eyes, and, in higher doses, loss of
righting reflexes (Horton, 1964). In contrast, F2a produces
not sedation but extension and abduction of the legs and dorsiflexior
of the neck (Fig. 1, Horton & Main, 1965a) the effect on the
legs is abolished by cutting the sciatic nerve and as it can be
elicited in the chick after mid-cervical cord transection it
appears to be an action of F2a directly on the spinal cord (Horton
& Main, 1967a). This conclusion is supported by experiments in
decerebrate and spinal cats in which both E^ and Increase
gastrocnemius muscle tension on intravenous injection but not on
close-arterial injection to the gastrocnemius muscle. The response
in spinal cats is abolished by cutting the motor nerve supply to
the gastrocnemius muscle but not by de-afferentation (dorsal root
section). These observations are compatible with an action of
prostaglandins in facilitating the firing of a-motoneurones,
although an additional effect on Y~m°6°neurones cannot be
excluded. It is not known whether the action is a direct
facilitation of excitatory pathways or by inhibition of
inhibitory inputs like strychnine. The crossed extensor reflex
in the spinal chick and cat is potentiated by both and E^,
but no significant changes have been observed on the mono-syrfaptic
patellar reflex in the cat with E. (Horton & Main, 1967a). In
the chloralosed cat F. potentiates but E, usually inhibitsla ^ 1 17
monosynaptic spinal reflexes recorded by electro-physiological
techniques - the effects are very long lasting (Duda, Horton &
McPherson, 1968).
In the lightly chloralosed chick or pentobarbitone-anaesthe-
tised cat, tremor or shivering is commonly observed during
recovery from anaesthesia; E^ abolishes this tremor and reduces
gastrocnemius muscle tension (Fig. 5) when injected intravenously.
However, E. injected into the cerebral ventricles of the cat has
no effect on tremor whereas on direct application to the cerebral
hemispheres of the chick, E^ abolishes tremor as it does on
intravenous injection (Horton.& Main, 1967b).
Evidence that these effects are due to an action of
prostaglandins on central neurones has been obtained by micro-
ionfcophoretic application to single neurones in the central nervous
system. Medullary reticular neurones in the decerebrate cat have
been shown to respond to E^, E2 and F2a (Avanzino, Bradley & Wol-
stencroft, 1966). About 20-30% of neurones are excited with
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E^ and a smaller proportion are inhibited, the remainder showing
no response (Table 9). Tachyphylaxis was frequently observed but
it was short-lasting and there was no cross-desensitization between
the three prostaglandins. The effect appeared to be fairly
specific since linolenic and di-homo-y-l inolenic acids had a very
small effect. There was no obvious correlation between the effects
of prostaglandins and acetylcholine applied to the same neurone.
Moreover different prostaglandins never had opposite effects on
the same neurone.
Other effects of the prostaglandins may be mediated via
the central nervous system, for example eye-opening in the
anaesthetized chick with intravenous > and the depressor
component of the blood pressure response to ?2a in the anaesthetized
chicks with intact brain (abolished by spinal transection). It
has been shown that neither E, nor F, releases adrenaline from1 la
the adrenals in the cat on close-arterial injection (Horton, 1963,
unpublished), nor is the adrenaline output in response to brady-
kinin inhibited (Horton, unpublished), yet the effects of
prostaglandin E^ on blood glucose levels are dependent upon an
intact adrenal medulla in rats (Paoletti et al., 1967).
Prostaglandins are released from the adrenals in response to
acetycholine (Ramwell, Shay, Douglas & Poisner, 1965).
Contractions of the cat nictitating membrane elicited by
pre-ganglionic cervical nerve stimulation were unaffected by E^
TABLE 9
Actions of prostaglandins on spontaneously firing
brain stem neurones in the decerebrate cat
Prostaglandin
Response I'd I'd F2a
Excitatory, SO 10 40
Inhibitory 9 0 15
No effect 243 50
_ 100
Total number of
neurones tested 341 69 155
TABLE 10
Identification of prostaglandins in the central
nervous system
Species Prostaglandin Reference
On (brain) 11 Jty, Samuelsson, 1064a
<■ at tstipraeollu'ulat' hraini 1 1 i 1 lotion At Main, |967c
Chicken thiaini I'd*, 1 1 lorton •'i Main, 1907c
(spinal cord) lv„ IT
Kabbil (cerebral beniispheresl 1 31. 1 3 Ainbaelte, llrummer. Rose
Whiting, 1966
1 )og cortex OJlUt «' (S
Id. I'd








injected either intravenously or into the common carotid artery,
although relaxations of the membrane after cessation of
stimulation were more rapid in the period immediately following
E^ administration (Holmes et al., 1963). Close-arterial injection
of Ej to the superior cervical ganglion did not modify the
contractions due to pre-ganglionic stimulation or to intra-arterial
acetylcholine (Horton & Lewis, unpublished).
Prostaglandin E. in concentrations from 0.1 to 50 ug./ml
applied to exposed blister bases on the human forearm did not
give rise to any sensation of pain or itch, whereas bradykinin
(0.1 (jg./ml.) and serotonin (0.01 fig./ml.) were effective in
producing pain on these preparations (Horton, 1963). E^ (100 trg./ml
produced a barely detectable sensation of pain, but it was about
half as potent as its precursos, di-homo-y-linoleic acid, and
arachidonic acid (Horton & Main, 1966).
Prostaglandins occur naturally in the brain (Table 10), and
they occur in rather similar concentrations in different regions
(Holmes & Horton, 1967). They have been detected in ventricular
cerebrospinal fluid (Feldberg & Myers, 1966; Holmes & Horton,
I
unpublished) and in perfusates of cerebral cortex, cerebellar
cortex and spinal cord (Ramwell & Shaw, 1966; Coceani & Wolfe,
1965; Ramwell, Shaw & Jessup, 1966). The out-put may be increased
by nerve stimulation or chemicals.
Although prostaglandins have powerful central actions and
occur in the brain and are released from nervous tissue on
stimulation, it is by no means established that these substances
are or even could be transmitters. It has been shown that
stimulation of peripheral nerves may lead to prostaglandin
release from other tissues, for example from the diaphragm
(Ramwell, Shaw & Kuchariski, 1965), the spleen (Davies, Horton &
Withrington, 1967.) and adipose tissue (Shaw, 1966 ) and at these
sites the transmitter is already known. It may be that
prostaglandins are released in the central nervous system from
post-synaptic membranes in response to stimulation by the
transmitter or other substances but that they are not transmitters
themselves.
Respiratory System
The bronchoconstrictor effect of vagal stimulation or of
histamine is reduced after an intravenous injection of prostaglandin
in guinea-pigs (0.1 pg./kg) and rabbits (1.6 pg./kg). In
some preparations a decrease in bronchial resistance after
can be demonstrated without first inducing bronchoconstriction
with vagal stimulation or histamine (Main, 1964). In contrast
to these results both E^ (0.3 fig./kg) and F2a (1.5 pg./kg) in the
cat increase bronchial resistance as measured by the Konzett &
0 ft .
Rossler technique (Main, 1964; Anggard & Bergstrom, 1963).
An inhibitory action of prostaglandins on respiratory smooth
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muscle in vitro has been shown with tracheal chain preparations
from several species (Table 11) (Main, I964). On the cat tracheal
chain which is the most sensitive of these, prostaglandins E^ and
E2 are about equi-active but prostaglandins F^ and have only
0.2 and 3% respectively of the activity of the prostaglandins E
(Main, 1964; llorton & Main, 1965b).
In view of these differences in pharmacological activity it
.is of interest that the lungs of most species contain predominantly
prostaglandin F£a (Table 12). This led to the hypothesis that
prostaglandin F£a might be stored as a pharmacologically less
active precursor of prostaglandin F^ in lung (Horton & Main, 1965b)
and in other tissues (Horton, 1965). Biosynthetic studies show
however that these two prostaglandins are derived from arachidonic
acid by independent pathways and that inter-conversion between
the two seems unlikely to occur.
The role of prostaglandins in the lung if unknown. It is
of interest that lungs remove prostaglandins from the circulation
at a high rate during intravenous infusion as shown by comparing
the pharmacological effects of intravenous and intra-aortic
" ° ft
injection (Anggard & Bergstrom, 1963; Horton et al., 1965) and by
assaying the amounts of prostaglandins in blood after passage
through the pulmonary circulation (Vane, unpublished). Vane has
reported that as much as 95% of an infusion of prostaglandin E^ is
taken up by the lungs possibly by reticuloendothelial cells.
Whether the lungs are acting purely as filters to remove excessive
amounts of prostaglandins or as the target organ for these
TABLE 11
Threshold concentrations (ng./ml) of f°r inhibition
of isolated tracheal smooth muscle
Before prostaglandin administration
muscle contracted by;
Species Acetylcholine Barium chloride Inherent tone
Cat I .250 NT
Monkey 20 >2500 . NT
Rabbit 50 NT NT
Guinea pig 5 <250 ■ 5
Ferret ■ 1 5 250
Sheep 5000 . *50 >1000
Fig 250 NT > 2000
N T indicates no initial tone, even in the presence of the stimulant drug, therefore
possible inhibitory actions of T, could not be detected, (f)ata from Main, l%T)
TABLE 12








(Data from Anggiud, |9tj5; llergMrdm, Dressier,
Krahiseh, Uvhage A Njovttll, |')62; Ntinniclfison, I'Mvl,
1%.\)
TABLE 11
Threshold concentrations (ng./ml) of prostaglandins
which contract gastro-intestinal smooth muscle
Preparation F. ! T : FJ :
Rat fundus 0 1 , - 01
Rat duodenum 250 — i —
Rat jejunum 10-30 K0-300 —
Hamster colon 12 50 1 '5
Chicken rectal caectrm 7-30 10
Chicken jejunum M 300 —
Rabbit duodenum- 3-10 3-10 0-25-1
jejunum
Guinea-pig ileum 10 350 10-50
Reference
Coceani & Wolfe, 1%7
Horton, 1963
Bcrgstrom el a I., 1959
Horton & Main, 1963,
1965 b
Bergstront ft al,, 1959
Morton & Main, 196.3,
1965b; ngAgtlrd &
Bergstrom, 1963;
Bergstrom ct til,, 1959
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contractile response of the guinea-pig ileum to E^, Spike
activity in the guinea-pig taenia coli preparation is increased
by E1.
The isolated rat fundus is particularly sensitive to both
prostaglandin E^ and ' Contractions are not affected by the
presence of atropine, papaverine or serotonin-blocking drugs.
Responses are potentiated by procaine, bretylium, dichloroiso-
prenaline, ascorbic acid, doubling the calcium ion concentration
or increasing the potassium ion concentration. Responses to
prostaglandins are reduced by isoxuprine, noradrenaline, reduction
in bath temperature, reduced oxygenation, carbon monoxide, sodium
azide, cyanide ions or reduction in calcium ion concentration
(Coceani 61 Wolfe, 1966).
Threshold concentrations for prostaglandins on various gastro¬
intestinal smooth muscle preparations are summarized in Table 13.
Prostaglandins are released from intestinal smooth muscle
(Vogt & Distelkotter, 1967) and the possibility that they contri¬
bute to non-neuronal smooth muscle activity must be considered.
The suggestion that circulating prostaglandins account for
increased gastro-intestinal motility during menstruation has been
mentioned above.
Miscellaneous Actions
The presence of E^ does not appear to affect the motility
of spermatozoa (Horton, 1965), the beating of cilia (Horton, 1965)
or the growth of several pathogenic micro-organisms (Holmes, 1965).
On the toad bladder preparation, E^ inhibits the action of
vasopressin which increases permeability to water (Orloff, Handler
& Bergstrom, 1965). This action of is thought to be exerted
on adenyl cyclase (Orloff & Grantham, 1967). E^ also decreases
permeability to water in the isolated renal tubule of the rabbit
and inhibits the action of vasopressin on this tissue. E^
increases capillary permeability (Horton, 1963) possibly by
releasing histamine from mast cells, an effect which has been
demonstrated in vitro, E^ being more active in releasing histamine
and heparin from mast cells than 48/80 (Paoletti, Vincenzi &
Cabut, 1967). This may also account for the oedema observed in
rats on continuous infusion of (Du Charme & Weeks, 1967). It
is not known whether these effects of E^ on permeability are
related to the changes in skin permeability to water in essential
fatty acid-deficient rats. So far all attempts to treat essential
fatty acid deficiency in rats and mice by prostaglandins have
proved unsuccessful (Dorp, 1965; Du Charme & Weeks, 1967).
Prostaglandin E^ can substitute for calcium in blood coagu¬
lation (Ferri, Galatulas & Piccinini, 1965) and prostaglandins
also have effects on platelet aggregation (Kloeze, 1967).
Prostaglandin E^ inhibits but prostaglandin enhances aggrega¬
tion of pig and rat platelets induced by ADC in vitro, With
human platelets prostaglandin E^ inhibits aggregation (threshold
25.
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concentration 1-10 ng./ml) but E£ is Inactive.
Substances related to the Prostaglandins
Vesiglandin
Euler (1935a) found that monkey seminal vesicles contained
a lipid which lowered blood pressure but differed from 'prosta¬
glandin' in not stimulating isolated smooth muscle preparations.
In the light of recent work it seems probable that vesiglandin
is a prostaglandin A.
Darmstoff
In 1949 Vogt reported that the frog intestine releases a
lipid which stimulates intestinal smooth muscle. In order to
obtain larger quantities of this material for chemical identi¬
fication Vogt prepared acid extracts of horse intestine. He
isolated and identified acetylphosphotidic acid. However, on
returning to the frog intestine, he found that the original
darmstoff was a mixture of fatty acids, the most active of
which correspond to the more recently isolated prostaglandin E
and F.
Irin
It has long been known that antidromic stimulation of the
trigeminal nerve produces an atropine-resistant meiosis in the
rabbit. Ainbache (1957, 1959) followed up this observation and
discovered in rabbit iris tissue a lipid which differed from all
other smooth muscle stimulants then known and which he called 'irin'.
MBHliuiBnijii3»iiuaimui«BiiTOi».,ri^'^Htt!i:^.n^!aaaiTOiaimxg«a™a-4W...«-..«iiiiBBiBiiBgian«Buwwfl<i!i«w
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This substance produces miosis in the rabbit and probably accounts
for the observations seen on trigeminal nerve stimulation.
Furthermore, since irin produces vasodilatation it could be
concerned in antidromic vasodilatation observed in other regions.
O
Anggard & Samuelsson (1964b) more recently have identified
prostaglandin F„ and severai other prostaglandin-like substances
^(X
in sheep iris. It thus seems probable that irin is a mixture of
prostaglandins. Ambache and his colleagues (Ambache et al.3 1963)
had also found irin in rabbit brain, and here again the active
substances appear to be prostaglandins.
Menstrual stimulants
Human menstrual fluid was found by Pickles (1957) to contain
smooth muscle stimulating lipids which may have a hormonal function
at the time of menstruation. Pickles and co-workers (Eglinton et
al., 1963) isolated two of these lipids which they identified as
prostaglandins E2 and F2a. There are other unidentified lipids
in extracts of menstrual fluids. These remain to be identified.
Medullin
Lee and his colleagues discovered an acidic lipid in rabbit
kidneys which has a potent depressor action (Lee et al., 1965).
This differed from prostaglandins E£ and F^a which were also
present in the extract because it lacked any non-vascular smooth
muscle stimulating activity and because of different chromatographic
behaviour. It was identified as prostaglandin A^ but it is now
27.
disputed whether this substance was not formed from prostaglandin
E£ as an artefact during extraction. Nevertheless its potent
depressor action is of great interest.
Concluding Remarks
It is now established that prostaglandins are substances
which occur in most, if not all, tissues of higher animals.
Furthermore, they are released from certain tissues in response
to a variety of stimuli, for example from the brain, spinal cord,
spleen and diaphragm on stimulation of the appropriate nerve;
from adipose tissue in response to adrenaline and from the adrenals
in response to acetylcholine. Their close association with chemi¬
cal transmission suggests that they may have some modulator
function at the synapse or that in certain instances (for example
the central nervous system) they could be transmitters themselves.
Pharmacological actions do not necessarily reflect a
physiological role, and so one must be cautious in assigning any
functional significance to the many and varied pharmacological
actions of the prostaglandins. Two points should be emphasized at
this stage. Prostaglandins have extremely potent actions on systems
as different as adipose tissue, nerve cells, smooth muscle and
platelets. Secondly, prostaglandins comprise of a large groups of
substances and generalizations cannot be made about the signifi¬
cance of this group as if it were a single substance.
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The Isolation of Bradykinin: A Plasma Kinin
and E. W. Hobton. (National Institute for Me
Bradykinin belongs to a group of peptides which
stimulate smooth muscle and have vasodilator
activity, and which have been given the generic
name of plasma kinins (see Lewis, 1958). It is
formed by the action of trypsin on plasma globulins
(Andrade & Rocha e Silva, 1956; Rocha e Silva,
Beraldo & Rosenfeld, 1949).
In the present investigation ox-serum proteins
were fractionated by addition of ammonium
sulphate, the solid precipitating between 33 and
45 % of saturation being collected and salts re¬
moved by dialysis. After treatment at 37° with
O-lN-hydrochloric acid, to inactivate bradykinin -
destroying enzymes, the solution was incubated
with pure trypsin for 6 hr. The reaction was termi¬
nated by addition of boiling ethanol and the sub¬
stances soluble in 75 % ethanol were subjected to a
short counter-current distribution to remove lipoid
material and salt.
Further purification was carried out by elution
chromatography on two successive carboxymethyl-
cellulose columns in ammonium acetate buffer at
pH 6-5 and 5. The solid remaining after evapora¬
tion of the buffer contained 10-25% of pure
bradykinin.
Complete purification by paper chromatography
or paper electrophoresis was hampered by the
presence of magnesium in this peptide mixture;
/
from Ox Blood. By D. F. Elliott, G. P. Lewis
Heal Research, Mill Hill, London, N.W. 7)
same spectrographs analysis revealed the pre-
flence of approximately 1 %by weight. Itwas there¬
fore necessary to remove at least the greater part
of the magnesium by performing the second
carboxymethylcellulose-column fractionation in
presence of ethylenediaminetetra-acetic acid. These
results suggest that bradykinin has a high affinity
for magnesium ions and this may have some bearing
upon its mode of action.
The pure peptide was obtained by preparative
paper electrophoresis. On acid hydrolysis brady¬
kinin yielded serine, glycine, proline, phenylalanine
and arginine in the molar proportions 1:1:2:2:2.
The purity was confirmed by the presence of a
single A-terminal residue, that of arginine. The
biological activity of the pure polypeptide has been
found to be comparable with that of histamine
and acetylcholine.
The authors wish to express their thanks to Miss M.
Kinsella and to Messrs R. Blakemore, A. W. Hemmings and
E. Stevens for experimental assistance.
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Biological activity of pure bradykinin—a plasma kinin from
ox blood. By D. F. Elliott, E. W. Horton and G. P. Lewis.
National Institute for Medical Research, London, N.W. 7
The plasma kinin bradykinin has been isolated and was found to contain
the following amino acid residues: arginine, phenylalanine, proline, serine,
glycine, in the proportion 2:2:2:1:1 (Elliott, Lewis & Horton, 1959).
In the present investigation the biological activity of the pure poly¬
peptide has been compared with a crude preparation similar to those used
in most other investigations. The two were compared on the following
isolated smooth-muscle preparations, the guinea-pig ileum, rat uterus, rat
duodenum and rabbit duodenum. In addition, comparisons were made for
vasodilatation in the skin of cat hind limb, for depressor activity by
intravenous injection into cats and rats, and for effect on capillary
permeability by intradermal injection into the skin of guinea-pigs and
rabbits. It was found that pure bradykinin was active on all these prepara¬
tions and within the errors of biological variation the increase in activity
from the crude material was proportional in all tests.
All these activities are therefore inherent properties of the pure poly¬
peptide which is probably mainly responsible for the biological activity of
the crude mixture of polypeptides. However, the observations do not
exclude the possibility of the presence of other active peptides differing
only quantitatively from bradykinin.
The active concentrations of the pure polypeptide varied between
0-2 ng/ml. required to contract the rat uterus and 400 ng/kg to cause a
depressor response in cats. On a molar basis, bradykinin was approxi¬
mately as active as acetylcholine as a vasodilator and about 10 times more
active than histamine in increasing capillary permeability.
Bradykinin therefore ranks among the most active of biological sub¬
stances, and may be responsible for all the actions of the group of poly¬
peptides which have been classified under the name of plasma kinin.
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THE REFLEX RESPONSE TO INTRA-ARTERIAL NOCICEPTION
WITH BRADYKININ
Fed. Proc. 20, 310 (Mar 61)
Frank Guzman, C. Braun, R.K.S. Lim, E.W. Horton
and G.D. Potter. Med. Sci. Res. Lab. Miles
Laboratories, Elkhart, Indiana.
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The intra-arterial injection of agents algesic in man
(bradykinin, acetylcholine and KC1) into somatic and splanchnic
areas evokes in the chloralose cat or dog the same reflex
.
response (viz. vocalization, hyperpnea and hypertension) as
electrical stimulation of the sciatic nerve. This response is
thus identical with the pseudaffective response of Woodworth and
Sherrington, (1904) obtained by nociception in decerebrate
preparations. The reflex nature of this response is demonstrated
by the fact that unilateral dorsal root ganglioneetomy (L2 to Si)
.
prevents the response to intra-arterial injection of algesic
agents on the same side, whereas unilateral sympathectomy does
not. Although other receptors are stimulated, only the nociceptors
evoke vocalization. The vocalization response, taken as signal
of pain, can be partially or completely blocked by narcotic and non
narcotic analgesics. Nociceptors are known to be present in skin,
■
but since the algesic agents will evoke the same response after
skin removal, and after intra-arterial injection into the spleen
or intestine, they are located also below the skin. These
visceral nociceptors are peri-vascular and appear to be located
near capillaries. Bradykinin being active in 1.2 meg dose may be
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Thin layer chromatography and bio-assay of prostaglandins
By E. W. Horton and C. J. Thompson. Miles-Ames Research Labora¬
tories, Stoke Poges, Buckinghamshire
Several prostaglandins have been isolated from lung, prostate and
semen by Bergstrom and his co-workers (Bergstrom & Sjovall, 1960;
Bergstrom & Samuelsson, 1962; Bergstrom, Dressier, Ryhage, Samuelsson
& Sjovall, 1962; Bergstrom, Dressier, Krabisch, Ryhage & Sjovall, 1962).
The following simple method has been used to estimate prostaglandins
in extracts of tissues and tissue fluids, especially semen.
Samples of human semen are mixed with pH 4-0 phthalate buffer,
extracted three times with ether and the extract evaporated to dryness.
The weighed residue is dissolved in a small volume of methanol-chloro-
form (1:1) and a solution containing approximately 2 mg applied to a
20 cm plate (silica gel 250 p thick) and run in petroleum ether 40,
ether 50, acetic acid 5, methanol 5 parts. A marker plate is run simul¬
taneously with pure prostaglandin E1 (RF 0-25-0-35, which was kindly
provided by Professor Bergstrom). The spots are located under it. v. light
after spraying with fluorescein and contrasting with bromine vapour. The
spot corresponding to prostaglandin E1 is scraped off and eluted with
methanol, the solution evaporated to dryness, and the residue dissolved in
1 ml. of water.
The solution is assayed in parallel on the atropinized rabbit duodenum
and the hamster colon against prostaglandin E1.
The method is sensitive (1 pg prostaglandin Ex can be detected) and
specific. Other pharmacologically active substances are distinguished
by their different chromatographic behaviour and by the parallel assays.
Supplies of semen from fertility clinics were obtained through the kind co-operation of
Dr D. F. Hawkins of University College Hospital Medical School.
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The action of intravaginal prostaglandin Ej on the female repro¬
ductive tract
By E. W. Horton, I. H. M. Main and C. J. Thompson. Miles-Ames
Research Laboratories, Stoke Poges, Buckinghamshire
In 1947 Asplund reported that crude prostaglandin extracts injected
intravenously inhibit tubal peristalsis (Asplund, 1947). He further claimed
that the same effect could be observed following intravaginal admini¬
stration. Since high concentrations of prostaglandins are found in semen,
effects following intravaginal administration are of particular interest.
Blood pressure and intraluminal pressure of one Fallopian tube were
recorded with Statham transducers. Pure prostaglandin Ex in doses of
1 yg/kg or more injected intravenously in the urethanized rabbit reduced
tubal tone and peristalsis. This was accompanied by a fall in blood pressure.
Prostaglandin Ex is a potent vasodilator, but other vasodilators such as
acetylcholine and bradykinin produced a similar fall in blood pressure
without inhibition of the tubes.
Intravaginal administration of higher doses ofprostaglandin was followed
after a variable latent period by similar inhibition of tubal tone and peri¬
stalsis. This observation indicates that prostaglandin is absorbed from
the vaginal mucosa into the blood, thence acting upon the Fallopian tubes.
The possibility that prostaglandin might have reached the Fallopian
tube from the vagina directly via the uterine lumen is excluded since the
psil ateral horn was always ligated, and sometimes divided.
In other experiments contractions of the cervix were shown also to be
inhibited following prostaglandin Ex but no change in the tone of uterine
horn smooth muscle could be detected.
These results provide some support for the hypothesis that prosta¬
glandins may be important in promoting conception by reducing smooth
muscle tone at those points where spasm is most likely to occur, and thus
allowing easier access of the sperm to the ovum. If this proves to be a
physiological mechanism, it will be an interesting example of a hormone
produced by one individual and acting upon the tissues of another.
We are grateful to Professor S. Bergstrom for a gift of pure prostaglandin E,.
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Congenital Cloaca in a Ram
Sir, A 15-monlh-pUl crossbred sheep (Kerryhil!
ram X Border Leicester ewe) supplied for j->hy.si<r-
logical investigations was found on examination to
have only one external orifice in the perineal region.
There was no vagina, no penis and no visible urethral
orifice. When pressure was applied 10 the urinary
bladder post mortem, foul - smelling faecal-
contaminated urine escaped through the anus. The
urethral opening was located in the ventral wall of
the rectum approximately 3 cm. from the anal
sphincter. Although the urine in the bladder was
faccujent, there were no macroscopic signs of infec¬
tion of the urinary tract. Both kidneys appeared
healthy.
The sex of the animal was determined by the
presence of well-developed vasa defcrentia and by
the absence of female genital organs. The proximal
ends of the vasa opened into the upper urethra,
around which there was glandular tissue. The
position suggested this to be seminal vesicles and
prostatic tissue. Distally, the vasa could be traced
through the inguinal canals and were found to
terminate as thin bands merging superficially with
the surrounding connective tissue. Neither testes
nor epididymes were present, and there were no signs
of a scrotum. As the early history of litis annual
is unknown, llieAbscnco of testes may be.'attributable
to castration. In support of this is the finding that
llto vasa had migrated through their respective
inguinal canals. Il is unlikely that this would have
occurred if teslcs had not. at some lime, been present.
On the other hand, the position of the urethral
orifice, and the cloaca so formed, must represent a
congenital, not an acquired, abnormality. This
primitive arrangement resembles that found in lower
vertebrates. Amongst mammals, only the rnono-
trcmes have a true cloaca, into which the urethra
opens both directly and via the penis which itself
forms part of the ventral wall of the cloaca (Parkcs,
1056). The congenital abnormality described here
could be regarded as a partial reversion to the
monotreme type of anatomy,
.Ittntuirv 14///, 1964. Yours faithfully,
12. W. MORTON.
1. H. M. MAIN.
Miles-Antes Research Laboratories, Stoke Pogcs,
Buckinghamshire.
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CENTRAL NERVOUS ACTIONS AND OCCURRENCE OF THE
PROSTAGLANDINS
E.W. HORTON and I.H.M. MAIN
Department of Physiology, The Medical College of St. Bartholomew's Hospital,
Charterhouse Square, London, E.C.I., England
In unanaesthetized cats prostaglandins Ei, E2 and E3 (10 to 60p.g) injected into the
cerebral ventricles produce stupor and catatonia but these effects are not observed
following intravenous injection nor do they occur on injection of prostaglandin F2a
(15 to 100 p.g) into the cerebral ventricles. On intravenous injection in young chicks
prostaglandin Ei, E2 and E3 (10 to 200 p.g/kg) produce sedation with loss of the
righting reflex in higher doses whereas Fi« and F2a (25-450 p.g/kg) produce extension
of the neck and legs without any signs of sedation (Horton, 1964; Horton & Main,
1965a; 1966a). Catatonia, stupor and sedation are difficult to quantitate whereas the
extension of the legs observed after F2a could be measured in the anaesthetized chick.
In chicks lightly anaesthetized with chloralose or urethane an intravenous injection
of F2a (2 [Ag/kg) was followed by an increase in tension of the gastrocnemius muscle,
thus confirming that the extension of the legs seen in the unanaesthetized chick was
due to contraction of the extensor muscles. The effect could not be obtained in deeply
anaesthetized chicks, suggesting that it was central. Similar responses were obtained
with F2^c in the decapitated chick spinalized in the midcervical region, indicating
that the brain was not necessary for the mediation of this effect. The response was
abolished by acute denervation of the gastrocnemius muscle showing that F21 does
not produce its effect by an action on the neuromuscular junction or the skeletal
muscle.
Similar effects were observed with both F2a (5-30 p.g/kg) and Ei (5-50 p.g/kg) in
the decerebrate and spinal cat. Again, the contraction of gastrocnemius muscle was
abolished by cutting the sciatic nerve but not by de-afferentation. Furthermore
contraction of the gastrocnemius muscle did not occur when Ei (50 p.g) was injected
close-arterially to the muscle either in the innervated, acutely denervated or chroni¬
cally denervated preparation. It is concluded from these results that F2a in the chick
and Ei and F2« in the cat produce contraction of the gastrocnemius by an action on
the spinal cord possibly by facilitation of the a-motoneurones.
Potentiation of the crossed extensor reflex in the spinal chick and cat was observed
following the injection of F2<* or Ei. The effect was prolonged and was observed with
smaller doses than those necessary to produce contraction of the gastrocnemius
muscle. The monosynaptic patellar reflex in the cat was not usually potentiated by Ei.
In addition to these effects on the spinal cord, it is evident that prostaglandins
also have actions on higher centres. For example, in the lightly anaesthetized chick
2
(urethane) or cat (pentobarbitone, with intact brain) Ei (3 pg/kg) injected intrave¬
nously reduced gastrocnemius muscle tension and abolished tremor or shivering which
is commonly observed during recovery from these anaesthetics. This is in marked
contrast to the increase in gastrocnemius tension described above and observed in
the spinal and decerebrate cat. Some evidence that this effect is mediated via higher
centres was obtained by direct application of Ei to the cerebral hemispheres of the
chick; tremor was abolished and gastrocnemius muscle tension reduced. On the
other hand, tremor in the pentobarbitone-anaesthetized cat could be abolished only
by intravenous injection of Ei, not by injection into the cerebral ventricles (30 fig).
In the spinal chick F2<x (2 fig/kg) had a pressor effect, but in other preparations
it had depressor effect. Prostaglandin Ei was depressor in all preparations studied.
The pressor effect of F2a in spinal chicks is not abolished by hexamethonium or
phenoxybenzamine, and therefore does not seem to be mediated via sympathetic
nervous pathways.
We conclude that there is good evidence that F2a and Ei act on the spinal cord
(Horton & Main, 1965b) and that Ei acts on higher centres in the brain. Micro-
iontophoretic application of Ei and F2a to single cells has confirmed that these
substances do have actions on central neurones in the cat (Avanzino, Bradley &
Wolstencroft, 1966).
While these observations were being made, Samuelsson (1964) announced the
isolation of prostaglandin F2a from ox brain. We have used his separative procedures
to isolate the prostaglandins in cat brain, chicken brain and chicken spinal cord.
On silicic acid chromatography peaks of biologically-active material corresponding
to prostaglandins E and F were found. By a combination of thin layer chromatography
on two systems and parallel biological activity, we have shown that F2a is present in
cat fore-brain (supracollicular) and that both E2 and F2a are present in chicken brain
and spinal cord (Horton & Main, 1966b).
Ramwell & Shaw (1963) have shown that prostaglandins can be identified
in the superfusates of cat cerebral cortex and frog spinal cord. This evidence
together with the identification of prostaglandins in the central nervous system and
their potent central nervous actions raises the question of their physiological signif¬
icance. The possibility that these substances are central transmitters cannot yet be
excluded. However, their widespread occurrence and variety of pharmacological
actions is suggestive of a modulator role possibly affecting a biochemical pathway
which is common to several different tissues.
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The identification of prostaglandins in central nervous tissues of
the cat and the fowl
By E. W. Horton and I. H. M. Main. The Department of Physiology,
Medical College of St Bartholomew's Hospital, Charterhouse Square, London,
E.C. 1
Brain extracts contain several biologically active lipids, one of which
has been isolated (from bovine brain) and identified as prostaglandin
P2a (Samuelsson, 1964).
We now report the identification of prostaglandins in extracts of
central nervous tissues from the cat and the fowl, the species in which
prostaglandins have been observed to have pharmacological actions on the
brain and spinal cord (Horton, 1964; Horton & Main, 1965a, b; Avanzino,
Bradley & Wolstencroft, 1966).
Cerebral tissue removed at inter-collicular decerebration under ether
was used as the source of cat brain. Whole brains and spinal cords from
adult fowls were dissected out after exsanguination. The tissues were
homogenized and extracted by Samuelsson's (1964) procedure which
briefly consists of ethanolic extraction, solvent partition and silicic acid
column chromatography. When the cat brain extracts were chromato-
graphed on silicic acid, a small peak corresponding to prostaglandin E
and a large peak corresponding to prostaglandin F were obtained.
The fractions from the F peak were pooled and chromatographed on
thin layer plates of silica gel G in Green & Samuelsson's (1964) AI solvent
system which separates prostaglandin E's from prostaglandin F's. All
the biological activity was recovered from the zone corresponding to
prostaglandin F. The material was then chromatographed on thin layer
plates of silica gel containing 4 % silver nitrate using the A II solvent
system of Green & Samuelsson, which separates prostaglandins according
to their degree of unsaturation. All the active material was eluted from
the zone corresponding to prostaglandin F2a. In all experiments a marker
plate was run simultaneously and the rabbit isolated jejunum was used for
the biological assays.
On the basis of parallel assays on six smooth muscle preparations, of
the silicic acid chromatography, and of the thin layer chromatography in
the AI system, it is concluded that the substance isolated from cat brain
is a prostaglandin F; it could not be a prostaglandin E.
There is no reliable way of distinguishing between different prostaglan¬
din F's by parallel biological assay (Horton & Main, 1965c). Thus the
identification of the prostaglandin F from cat brain as F2a is based on its
[p.T o.
chromatographic behaviour in the All system, which certainly excluded
the possibility that it was either prostaglandin Fla or F3(Z. Like F2a,
it potentiated the crossed extensor reflex and had a pressor effect on
intravenous injection in the spinal chick.
The presence of a PGE peak on silicic acid chromatography was sug¬
gestive that cat brain also contains a prostaglandin E, but there was
insufficient material for conclusive identification to be made.
Using similar techniques we have identified prostaglandin E2 and pros¬
taglandin F2ct in both the brain and the spinal cord of the fowl.
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The nature and distribution of prostaglandins in the central
nervous system of the dog
By S. W. Holmes and E. W. Horton. The Department of Pharmacology,
School of Pharmacy, Brunswick Square, London, W.C. 1
Eighteen dogs were anaesthetized with pentobarbitone sodium and
exsanguinated. The required areas of the central nervous system (no more
than four from any one animal) were dissected out, weighed and macerated
in ice-cold ethanol. The time from death until the samples were placed in
ethanol varied from 2 to 10 min. The extraction procedure, previously
described by Horton & Main (1966), separated the polar acidic lipids
including the prostaglandins.
Substances which behaved chromatographically (column and thin layer)
and biologically (rat fundus and rabbit jejunum) like prostaglandins
E1; E2, Fla and E2a were isolated from whole brain and also from each
region of the central nervous system examined. There were no large
differences in prostaglandin concentration between regions (Table 1).
With the exception of the prostaglandin E content of the medulla and
white matter, variations could more probably be attributed to variations
between individual dogs than between areas.
Table 1. Distribution of prostaglandins in the central nervous system of the dog. Total
prostaglandins E expressed in terms of E, and total prostaglandins F in terms of Fla. All
values are uncorrected for recovery and are expressed in terms of ng/g tissue. The number
































This widespread central nervous distribution is compatible with the
reports that prostaglandin-like substances are released from many regions
of the brain (anterior and inferior horns of the lateral ventricles, the third
ventricle and the subarachnoid space over the cerebellar and somato¬
sensory cortex) and from the perfused spinal cord (Coceani & Wolfe, 1965;




On the basis of the occurrence, release and pharmacological actions of
prostaglandins a role as transmitter at central nervous synapses might
be postulated. The presence of four different prostaglandins, each known
to have its own independent biosynthetic and metabolic pathway, would
necessitate the postulation of four such transmitters. The even distri¬
bution of these four substances throughout the brain is however suggestive
of some other function.
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The occurrence of prostaglandin E2 in splenic venous blood of the
dog following splenic nerve stimulation
By B. N. Davies, E. W. Horton and P. G. Withrington. Department of
Physiology, St Bartholomew's Hospital Medical College, London, E.C. 1
Prostaglandins are widely distributed in animal tissues (Bergstrom &
Samuelsson, 1965) and have numerous pharmacological actions (Horton,
1965). Shaw (1966) showed that prostaglandins are released from the rat
epididymal fat pad in vitro, in response to sympathetic nerve stimulation.
Whether prostaglandins are released from other organs with an adrenergic
innervation is unknown.
To examine this possibility, experiments have been made on the isolated
dog spleen, perfused with blood from the femoral artery of a donor dog.
The splenic venous blood was returned to the femoral vein of the donor
except during the collection of a sample, when it was diverted out of a side
arm. During the collection of a sample, blood from a reservoir was pumped
into the donor. Electrodes were placed on the splenic nerves and the spleen
was bathed in liquid paraffin at 37° C.
Splenic venous blood collected during and after electrical stimulation
(600 impulses at 10/sec) of the splenic nerves, contained prostaglandin E2
in concentrations up to 200 ng/ml., whereas blood collected in the absence
of stimulation contained no detectable prostaglandin (< 1 ng/ml.).
The evidence that the substance in splenic venous blood was prosta¬
glandin E2 is as follows. It was soluble in 96% aqueous ethanol, and it
behaved like a polar acidic lipid on solvent partition. On silicic acid column
chromatography it had an elution time corresponding to a prostaglandin
E. On thin layer chromatography in Green & Samuelsson's (1964) A I
solvent system, it had an RF of 0-54 compared with prostaglandin E,
(= E2) 0-54, and Floc 0-37, and in their All solvent system it had an RF
of 0-53 compared with E2 0-52 and E, 0-74. The substance isolated by this
extraction procedure was assayed against prostaglandin E2 on the rat
fundus, guinea-pig ileum and rabbit jejunum. The results were in close
agreement (0-6, 0-6 and 0-7 jug E2 respectively).
Other acidic lipids which contract the rat fundus were also present in
blood following nerve stimulation. These lipids have not been identified,
except in one experiment in which some prostaglandin F was detected.
Phenoxybenzamine given by close arterial injection in a dose (5 mg)
sufficient to block the response of the spleen to nerve stimulation, abolished
the output of prostaglandin.
The prostaglandin could originate from either the sympathetic nerves
[P.T.O.
themselves, or from the smooth muscle of the spleen as a result of its
response to stimulation. It is unlikely that it originated from adipose
tissue adjacent to the spleen because nerve stimulation did not increase the
output of free fatty acids.
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Problems in the Identification of Submicro-
gram Amounts of Prostaglandins
By E. W. Hobton. (Department of Pharmacology,
The. School of Pharmacy, University of London)
The word ' prostaglandin' is a generic term for a
family of closely-related compounds, all derivatives
of prostanoic acid (Bergstrfim and Samuelsson,
1907). Some twenty of these fatty acids have been
isolated from animal tissues or tissue fluids and
their full chemical structure has been elucidated.
Most of these compounds are known to be directly or
indirectly biosynthesized from the straight chain
unsaturated fatty acids, dihomo-y-linolenio and
araehidonie acid.
Prostaglandins are not only widely distributed in
animal tissues but are released from certain organs
into the surrounding medium or blood either
spontaneously, on nerve stimulation or in response
to drugs. In such experiments the amount of
prostaglandins released, for example from the
brain, may be less than 0-1 pg./hr. (prostaglandin
Ei equivalent), Such minute amounts can, at
present, be detected only by bioassay techniques.
The question is raised as to how much evidence
is needed to justify the claim to have identified a
particular prostaglandin? Ideally a complete
chemical analysis with structural elucidation should
be performed. Even with the most favourable
conditions it is unlikely that such information could
be obtained from mass Hpeefrometrie analysis using
a single sample containing less than I fig. of isolated
compound.
The problem is, therefore, to identify prosta¬
glandins in a sample containing amounts (1 fig. or
less) insufficient for mass spectrometrio or other
chemical analysis. This can only bo attempted if
samples of pure prostaglandins of known structure
are available for comparison. Isolation of the
prostaglandin or prostaglandins can be achieved by
solvent partition and a combination of column and
thin-layer chromatographic procedures. Location
of the prostaglandin in particular fractions or zoiich
is dependent upon biological assay. Chromato¬
graphic evidence alone does not provide positive
evidence of identification although it may bo
possible to conclude that an unknown substance is
not a particular prostaglandin on tile grounds of a
difference in chromatographic behaviour. Further
evidence of identification may be obtained from
quantitative parallel biological assays on several
tissues. By using suitable; combinations of tissues
it is easy to distinguish a prostaglandin E from a
prostaglandin E, but difficult to distinguish say
prostaglandin E| from prostaglandin Eh which are
very similar in their biological activities. It may
thus be possible to conclude with confidence that,
an isolated substance is not, say, prostaglandin
because of its different chromatographic behaviour
and/or lack of agreement betweon the parallel
assays. (In the other hand, agreement between the
behaviour of the isolated substance and a particular
prostaglandin in all these respects does not provide
conclusive evidence. It is permissible to conclude,
under these circumstances, that the chromato¬
graphic and biological properties of the unknown
are compatible with its identification as a certain
prostaglandin. The more parallel assays between
which agreement is obtained, the greater is the
probability that a correct identification has been
made.
Bergstrom, S. & Samuelsson, B. (1997). Prostaglandins.
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